Abstract
Differential and even opposing functions of two major antioxidant transcription factors Nrf1 and Nrf2 (encoded by Nfe2l1 and Nfe2l2, respectively) are determined by distinctions in their tempospatial positioning, topological repartitioning, proteolytic processing, and biochemical modification, as well as in their shared evolutionary origin. As a matter of fact, the allelopathic potentials of Nrf1 and Nrf2 (both resembling two entangled ‘Yin-Yang’ quanta that comply with a dialectic law of the unity of opposites) are fulfilled to coordinately control redox physiological homeostasis so as to be maintained within the presetting thresholds. By putative exponential curves of redox stress and intrinsic anti-redox capability, there is inferable to exist a set point at approaching zero with the ‘Golden Mean’ for the healthy survival (i.e., dubbed the ‘zero theory’). A bulk of the hitherto accumulating evidence demonstrates that the set point of redox homeostasis is dictated selectively by multi-hierarchical threshold settings, in which the living fossil-like Nrf1 acts as a robust indispensable determinon, whereas Nrf2 serves as a versatile chameleon-like master regulon, in governing the redox homeodynamic ranges. This is attributable to the facts that Nrf2 has exerted certain ‘double-edged sword’ effects on life process, whereas Nrf1 executes its essential physiobiological functions, along with unique pathophysiological phenotypes, by integrating its ‘three-in-one’ roles elicited as a specific triplet of direct sensor, transducer and effector within multi-hierarchical stress responsive signaling to redox metabolism and target gene reprogramming. Here, we also critically reviewed redox regulation of physio-pathological functions from the eco-evo-devo perspectives, through those coding rules (redox code, stress-coping code, and topogenetic code). The evolving concepts on stress and redox stress were also further revisited by scientific principles of physics and chemistry. Besides, several novel concepts such as oncoprotists, Reverse Central Dogma, and Grand Redox-Unifying Theory’ (GRUT) of life, together with diffusive reactive species (DRS)-based murburn concept integrating all stochastic electron-, proton- and/or moiety-transfer reactive and interactive processes (e.g., PCHEMS), are introduced in this interdisciplinary and synthetic review.
Keywords: Nrf1, Nrf2, homeostasis, determinon, regulon, topogenetics, redox stress, eco-evo-devo, redox code, stress-coping code, oncoprotist, ‘zero theory’, Reverse Central Dogma, Grand Redox-Unifying Theory (GRUT), and murburn concept
Abbreviations
ARE - antioxidant response element
BAT - brown adipose tissue
Cat - catalase
CHR - cell homeostatic response
CNC-bZIP - cap 'n' Collar and basic region leucine zipper
CSR - cellular stress response
DEG - differentially expressed gene
DRS - diffusive reactive species
ECM - extracellular matrix
EMT - epithelial mesenchymal transition
EpRE - electrophile response element
ER - endoplasmic reticulum
ERAD - ER-associated protein degradation
ESC - embryonic stem cell
Frx - ferredoxin
GAS - general-adaptation syndrome
GH - growth hormone
GOE - great oxidation event
GRUT - Grand Redox-Unifying Theory
Grx - glutaredoxin
HDL - high-density lipoprotein
HGT - horizontal gene transfer
IRC - intrinsic reactive compounds
KO - knockout
LUCA - last universal common ancestor
LXR - liver X receptor
MI - myocardial infarction
NASH - non-alcoholic steatohepatitis
NESR - neuroendocrine stress response
NOE - Neoproterozoic oxygenation event
NST - N-glycosylated transactivation
NTD - N-terminal domain
OHR - organismal homeostatic response
OSR - organismal stress response
Prx - peroredoxin
RNS - reactive nitrogen species
ROS - reactive oxygen species
RSS - reactive sulfur species
RXR - retinoid X receptor
SOD - superoxide dismutase
TAD - transactivation domain
TM - transmembrane
Trx - thioredoxin
TU - tunicamycin
UBL - ubiquitin-like domain
UPR - unfolded protein response
UPS - ubiquitin-proteasome system
USP - ubiquitin-specific proteases
VLDL - very low-density lipoprotein
WAT - white adipose tissue.
INTRODUCTION
By searching the PubMed-cited literature on the reductive and oxidative (redox called collectively, but dictated by gain or loss of electrons and/or hydrogens, respectively) and anti-redox (antioxidant and anti-reduction), it is absolutely amazing to find that an overwhelmingly large number of publications by such relevant conceptual terms had been collected within at least 2,177,092 entries of this library (at https://pubmed.ncbi.nlm.nih.gov), until the 18th of Dec, 2023, heretofore. As shown in Figure 1, this is placed in an exponentially expanding field, with greatly broad implications in physiology, pathophysiology, biomedical and life sciences, except for early crawling over a century after the first experimental report in 1807 by Dispan 1 on the gaseous oxide of azote and the second one in 1811 by Wollaston on cystic oxide, a new species of urinary calculus 2. Nonetheless, a great majority of redox studies have been focused disproportionately (95%) on those oxidative and antioxidant topics, whereas the other studies on reductive and anti-reduction topics were done only by a ratio of lesser than 0.5 % (Figure 1, top box). The distinction demonstrates that (anti)-reductive researches had been roughly neglected or ignored for a rather long term. Rather recently, the crucial importance of (anti-)reductive studies appears to be gradually recognized in this redox research field 3,4,5,6,7,8, but still needs to be further imposed.
Figure 1 . FIGURE 1: An exponentially increasing tendency of publications in the redox-relevant fields.
The concept of oxidative stress was firstly proposed by Paniker et al. in 1970 9 and later formulated by Helmut Sies in 1985, and further redefined by Dean P. Jones in 2006 10,11,12. Albeit such a continuously-heating topic on redox stress (including reductive stress 13) and redox defense response seem to have thoroughly penetrated into the cell stress zeitgeist, it is remaining open to arouse great concerns from workers in distinct fields and also is one of the most persistently-existing intractable problems to be addressed for health and disease 14, particularly in a vast variety of changing environmental conditions. Among its merits elicited by evoking biological stress responses, a steady-state redox balance is constantly maintained within a homeodynamic threshold range by cell respiration, aerobic metabolism and redox switches governing redox stress defense responses 10,11. In the meantime, the pitfalls of oxidative stress could also lead to another indiscriminate use of this term as a global concept, but without a clear relation to ‘real redox chemistry’ per se, in each of particular cases. For the underlying molecular details, the major roles for antioxidant and anti-reductive defense systems are fulfilled predominantly by those redox-controlling biomolecules, such as key proteins, enzymes, transcription factors and co-factors, which are involved in cellular redox biochemical and metabolic processes, as well as by the adaptive reprogramming of their relevant gene expression profiles in the normal physiological and even pathophysiological responses to redox stress during distinct eco-evo-devo stages of life histories.
In this synthetic review, we firstly introduce the past and present of redox-based systems in the ‘redox central theory’ (that are distinctive from, but correlative to, the generally nonspecific ‘stress-coping system’), along with their pivotal roles being exerted during the course of life’s origin and ensuing evolution. Secondly, we have critically reviewed redox regulation of physio-pathological functions from the eco-evo-devo perspectives, through distinct mechanisms and obligate coding rules (e.g. redox code, stress-coping code, and topogenetic code, all selected by nature). Thirdly, the evolving concepts of stress and redox stress were further revisited by scientific principles of physics and chemistry, together with redox stress and anti-redox response being quantitatively stratified with the ‘zero theory’, in addition to two novel concepts of ‘oncoprotists’ and ‘reverse central dogma’ being proposed by a means of the interdisciplinary synthesis. Fourthly, we listed a host of convincing evidence, revealing that the antioxidant Nrf1 (nuclear factor, erythroid 2-related factor 1, encoded by Nfe2l1) is a living fossil’s transcription factor, that is rather closer than Nrf2, to their commonly-shared ancient orthologues arising from the eco-evo-devo process of life histories. Of sharp not, Nrf1 also exhibits its unique pathophysiological phenotypes, all of which are distinctive or absent from Nrf2 (nuclear factor, erythroid 2-related factor 2, encoded by Nfe2l2). This is attributable to the unique topogenetic folding of Nrf1 and dynamic topovectorial repositioning of this CNC-bZIP factor across endoplasmic reticulum (ER) membranes to dislocate the nucleus before transcriptional regulation of cognate target genes. Lastly, we have also critically reviewed the uniquely differentiated yet integrated roles of both Nrf1 and Nrf2 in governing cellular redox, energy, and metabolism homeostasis and organ integrity during distinct life processes, in which activation of Nrf1 is evoked by distinct regulatory mechanisms. Overall, the allelopathic potentials of Nrf1 and Nrf2 (both dubbed as two entangled ‘Yin-Yang’ quanta abiding by a dialectic law of the unity of opposites) are fulfilled to coordinately control redox physiological homeostasis within certain homeodynamic threshold ranges, which are being perpetually maintained for the normal healthy survival.
THE FAR PAST AND PRESENT OF REDOX-BASED SYSTEMS
‘Central redox theory’ refined by the nature
From the origin of life and its ensuing evolution to the modern present of the 21st century, all cellular life forms have greatly experienced a vast variety of challenges within diversely changing environments, a major one of which is spawned predominantly by cellular stress, particularly redox stress, threating normal homeostasis of a life system 15,16,17. It is since life fundamentally depends on the free energy (ΔG) provided by electrochemical disequilibrium between reduced (electron-donating) and oxidized (electron-accepting) environmental substrates 18 11 and also has a crucial ability to further convert such a redox environmental disequilibria into its intracellular disequilibria, as defined by Schrödinger 20. The redox (i.e., electron exchanging) reactions had, de facto, existed early in both the chemical and metabolic worlds during the origin of life and have been always persisted in all life processes throughout the entire evolutionary course until now 6,21,22. Of note, those reductive stressors are much likely to provide a primordial force, insomuch as to meet essential bioenergetics needs for the origin of life and its long-term evolution 18,23, and has been embodied and embedded in the present-day’s life processes 15,24. This is remaining to be accompanied by an ancient anti-reduction strategy for fitness to prevent excessive reduction of intrinsic compounds by undergoing reduction themselves or by removing of ambient dihydrogen (H2, which enables reduction of sulfate to H2S, along with certain organic materials being oxidized) 8. However, much less attentions have been paid on such anti-reductive responses to reductive stress, relative to their counterparts in an overwhelming majority of studies for the prevailing antioxidant responses to oxidative stress.
A bulk of accumulating evidence has demonstrated that, the hitherto known free radicals and reactive species of sulfur (RSS), nitrogen (RNS), oxygen (ROS), carbonyl (RCS) and halogen (RHS), along with transition metals (e.g., Fe, Cu, Mn, Zn, Ni, Co, Mg) and minerals (e.g., Se, As), all of which can be collectively construed as ‘Redox X species’, serve as constantly electron- and/or proton-exchanging key players in distinct series of multi-hierarchical redox reactions, relevant interactions and/or relationships with biomolecules 25,26,27,28. In such process, a considerably large portion of those active reactants and redox products per se have the Janus face with being reduced and also oxidized as ‘redoxidants’ (for example, as shown in Figure 2A). It is of crucial importance to notice that redox balance between redox stress and anti-redox response is maintained for health life process in a certain robust homeostatic state, as summarized in the ‘redox code’ with a particular conceptual proclivity for ROS-based oxidative stress and antioxidant protection 29,30,31,32. The inaccurate scenario of ‘central redox theory’ biased for the oxidative stress defense system 11,33,34 should have been established on the foundation of the so-called ‘ox-tox’ hypothesis 35,36, as a commonly accepted antioxidant mechanism to detoxify the bourgeoning production of O2 and ROS. This is exemplified by the statement in believing to be "…richly elaborated in the oxygen-dependent life where activation/deactivation cycles involving O2 and H2O2 contribute to spatiotemporal organization for differentiation, development, and adaptation to the environment" and where "disruption of the organizational structure during oxidative stress represents a fundamental mechanism in system failure and disease" 29.
Figure 2. FIGURE 2: Major redox reactive species and their physiological significances in the eco-evo-devo process of life.
(A) H2S and relevant reactive sulfur species (RSS), along with reactive nitrogen species (RNS), part of which are from the NO respiratory chain by a series of reductases to produce energy under anaerobic conditions 23. (B) The upper panel shows that H2S is involved in anoxygenic photosynthesis to yield energy and building blocks, and also in its successive oxidative reactions to yield RSS together with S2 and Sn (polysulfides) 37. The lower panel shows that O2 arises from the oxygenic photosynthesis, and is involved in the aerobic respiratory chain to yield biological energy and building blocks, aside from it being reduced to reactive oxygen species (ROS). In addition, portion of evolutionally conserved oxidoreductases were also indicated. In RSnR’, R and R’ represent CysSH, GSH, 3mpSH (3-mercaptoSH) and/or protein-SH. All other abbreviations were defined in the text and relevant references cited. (C) The physiological roles of major reactive species in co-evolution of life with its surrounding environments on the earth. Those reactive species arise from the ecological environmental evolution of early earth (left panel), to provide energy for redox-based systems and serve as driving forces to promote the origin of life and its evolution (right panel). (D) Multi-dimensional orthogonality of redox regulation by integrated ‘tensor’ networks of multi-hierarchical signaling with distinct omics systems across strata, levels and scales of biological self-organization. The complexity of life’s body plan (Y axle) dictated by its functional information is incrementing with the evolution timing of life (X axle), which complies with a law of Darwinian evolution dynamics 38. Note: a part of this panel was adapted from 39.
The evolving redox-based systems
As a matter of fact, the cellular life began in an anoxic ferrous ocean approximately 3.8 billion years ago (Ga) and then experienced its nearly seven-eighths of evolution course under almost no or less (< 0.1% PAL) oxygenized environments 16 17 40. As such being the case, the appearance of those so-called ‘classic antioxidant’ enzymes, which include catalase (Cat), superoxide dismutases (SODs), glutaredoxin (Grx), thioredoxin (Trx), peroredoxin (Prx), sulfiredoxin (Srx), and other oxidoreductases, seems to be rather coincidently and closely aligned with the origin of anoxygenic photosysthesis (i.e., H2S with CO2 is reduced to yield methane and oxidized polysulfides) over a billion years prior to the great oxidation event (GOE, arising from the incrementing oxygenic photosysthesis (i.e., H2O with CO2 is oxidized to yield O2 and methane) 21,37,41,42,43,44. Such O2/ROS-detoxified defense systems 43 45 46, together with the early respiratory nitric oxide (NO) reductases (NORs, structurally related to the present-day respiratory O2 reductases (alias cytochrome/quinol oxidases or Complex IV) 23 44, were further corroborated to be existing in the ‘obligate O2/ROS-tolerant anaerobes’ created at the early stages of the evolution of life, and even emerged in the primordial populations of protocells known jointly as the last universal common ancestor (LUCA) of all life forms on the Earth. Importantly, several lines of experimental evidence have validated that such ‘classic antioxidant’ enzymes (e.g., Cat, SOD, Trx, Grx, Prx) are essentially involved in the redox metabolism of H2S and polysulfides (H2Sn, n=2-8), which are collectively referred to as RSS, viewed as a physiological relevant O2-sensing mechanism 37 47 48 49. Altogether, it is inferable that these ‘antioxidant detoxification’ systems should be lent and also evolutionarily extended from copying with the prior sulfur-based redox reactions in anti-redox signaling response to RSS, possibly via RNS, towards dealing with the nowadays prevailing oxygen-based redox reactions in relevant cytoprotective response to ROS (Figure 2B). This notion was also proposed by 39 49 50, albeit it remains really hard to distinguish disparate causal efficacy of RSS from ROS in relevant redox stress responses by means of the hitherto established methodologies 51, whereby RSS was, rather, measured more sensitively than ROS per se 37,49,52,53.
Clearly, it was conjectured from the mounting evidence that the onset of life was driven by redox disequilibria resulting from the evolution of nascent terrestrial niches, followed by co-evolution with its surviving environments during a long-term highly reducing (H2S/RSS) to another gradually oxygenated (O2/ROS) status 22,37,54,55,56. Such biological evolution of life takes place abiding by (pre)Darwinian law 38,57 of the nature selection for its novelty to ensure that its functional information will increase within the possibility space of configurations, which are also preferentially selected based on its functions and enable all of those growing functions to be efficiently performed, during the redox-driving process (Figure 2C). Hence, the origin of life and its ensuing evolution appears to be ‘open-ended’, forging its adaptations to the changing environmental challenges and constructing its expectable functional configuration spaces, all of which are selected in a stochastic manner 38 58. Collectively, the redox-driving force (provided by redox recycling reactions and interactions) should play a central role for the evolving life system to be selectively self-organized, self-replicated and self-maintained. In the redox central theory, redox code remains as a quintessence of the conserved functional traits achieved from adaptive co-evolution of life with its environments. Yet, such ‘redox code’ should also be refined by encompassing the H2S/RSS-based redox and anti-redox principles, because this ever-existing H2S/RSS-based system exerts certain pivotal and indispensable effects to be stored for ‘redox memory’ and then reused for ‘redox recycling’, which are substantially disparate from those ‘one-off’ effects of the O2/ROS-based redox system 37,47,53. More importantly, a considerable key portion of the O2/ROS-based redox and anti-redox effects within the ‘originally defined redox code’ 29 are de facto transferred to the H2S/RSS-based redox system and hence indirectly executed by this reactive thiol-switching system 26,37,50,59.
REDOX REGULATION OF PHYSIO-PATHOLOGICAL FUNCTIONS IN THE NATURE ECO-EVO-DEVO PROCESS
As an evolving self-organizing system, life is simply dichotomously defined to comprise two parts (selected for adaptation and variation) as a whole, by a Darwinian evolutionary law 38, along with another law of incrementing functional information, albeit as its complexity is gradually increased 58. The major stably-selected portion of life should be made of those predominantly statically-persistent systems with a stronger robustness. By stark contrast, the remaining variated part of life should be principally composed of those dynamically-persistent systems with a versatile plasticity to explore its novelty. The variating novelty is determined by newly generated organic codes, an arbitrary set of those principally-coding rules from a geological point of view that amounts to a sudden event 60,61,62, which could be yet predicted by its experience-building memory (storage of functional information acquired by sensing and measuring) and/or by a memory-independent fashion 58. Thereby, it is plausible that those stable configurations of life and its selected physiological functions should be maintained and perpetuated by its robust homeostatic mechanisms, and further remodeled by two distinct and even opposing mechanisms, homeorhestasis and allostasis, respectively 63.
Redox regulation by distinct mechanisms
In this regulatory process, redox and anti-redox systems certainly play vital determinant roles in orchestrating the configurations of life during its morphogenesis and regulating the architecture of its physiological functions at normal morphostasis 50,64,65,66,67. This is due to the fact that redox and anti-redox systems have inherently evolved to establish a set of lingua franca for life 39, unifying the entire eco-evo-devo (i.e., ecological, evolutionary, and developmental biological) process 30,68,69,70. Besides ‘redox code’, there are also existing those innately codifying biology mechanisms, which are executed directly by the redox electrochemical reactions and the relevant specific biochemical modifications. As aforementioned, most of these (but not all) enable to be stored for ‘redox memory’ within the redox-derived lingua franca dictionary and, if being later required for biological needs, reused for ‘redox recycling’ to directionally switch redox regulation of physiological and pathophysiological functions. These redox-reactive species and redox-bearing carriers also enable to be transported throughout intracellular and extracellular (interstitial) fluids, insomuch as to allow for efficient redox signaling communications between different subcellular organelles, distinct cell lineages, and diverse tissues and organs 26,37,47,71.
Such redox communications are yet remaining to be, to certain extents, confined by those inherent ‘kinetic’ barriers that frustrate their immediate diffusion and free dissipation so as to reach a somehow (electrochemical) equilibrium, leading to disparate redox-compartmentalized distributions throughout intracellular and extracellular contexts 72,73. Consequently, discrete ‘redox potential gradients’ with a selective modularity are established in diverse topovectorial processes and ‘phase spaces’ that are redoxokinetically compartmentalized so to give rise to distinct redox potential energy capacitors (Figure 2D), as evinced by distinct status of ‘redox phenotypes’ 74. Such ‘redox gradients’ have been shown to act as an internal impetus to the embryogenesis and ensuing physiological development, and healthy growth during life process 30. But, conversely, ‘aberrant redox gradients’ were also implicated in the ageing and pathogenesis of relevant diseases 31,50,72.
In addition to redox reactions and interactions with all other regulatory elements (e.g., organic codes, topogons, minimotifs) and signaling molecules in redox interactome and systems biology, the redox electrochemical reactive systems also enable to arouse certain extents of their intrinsic quantum biological effects on the relevant physio-pathological regulation by virtue of their unique quantum mechanics’ mechanisms 75,76. Thus, it is inferable that such redox-reactive quanta (along with putative quantum effects exerted possibly via a system of ‘meridians’ recognized for the long history of traditional Chinese medicine 77) could play an essential role in critically unifying all systems networks to regulate diverse physiological and pathophysiological functions across all distinct strata of life from molecular and subcellular levels to the whole body.
‘Redox code’ acquired and refined from the eco-evo-devo process
The self-organizing life appears to be also conjectured as a self-manufacturing artifact by self-copying and self-codifying according to those pre-existing templates and/or coding rules, all of which are selected by (pre)Darwinian evolutionary law, during its nature eco-evo-devo process 38,62,78. All distinct types of constituents of life (e.g., components, adaptors, topogons, minimotifs, templates, and codes) are stereochemically patterned and further self-assembled in certain topovectorial phase spaces to yield diverse topoforms (each with specific physiological functions and unique behaviors) of molecular machines, subcellular apparatus, body-planned cells, tissues, organs or organismic individuals (Figure 2D). All of these have well fulfilled according to their cognately-coding rules in a combination with their topological orders, biochemical relationships and ontological status 61,79,80. In reality, most components and adaptors of the living systems should be plastically changed in the long run of the eco-evo-devo processes, but only a few of them (also including codes, templates, minimotifs, topogons) must be absolutely conversed to gain the robustness of living systems. Of note, the arbitrary coding rules are also highly conserved, because they serve as a universally governing mechanism that nature has constantly employed in the course of life’s origin and ensuring evolution. From the eco-evo-devo scenario, it is inferable that the ‘redox-based coding rules’ should predate the establishment of the commonly accepted genetic code and other organic codes, because ‘redox code’ (defined by Jones & Sies 29) has originally taken an early leading place, particularly in transforming the inanimate to animate worlds 37,81,82. This notion is based on the finding that far ancient genetic templates are likely executed by the living fossil-like ‘basic-region zipper minimotifs’, albeit with a low infidelity 83,84,85, which are later evolutionarily replaced by the polynucleotide templates (i.e., RNAs or DNAs).
According to the general ‘code theory’ modelled by Barbieri 62,78, redox code is referred to as a set of the consensus rules for codifying all redox-based spatiotemporal systems and their interactions with other biological systems in the body-planning networks of life, and tightly governing its intrinsic anti-redox responsive mechanisms to cell stress. Such ‘refined redox code’, like those organic codes 62, is also reckoned to have gone through five possible phases from its origin to being completely established. In the beginning of redox code, its 1st version had emerged possibly as a means of performing a series of particular redox-relevant functions by diverse redox reactive cascades with organic macromolecules, but with certain extents of necessary ambiguity to enable a closer linkage of the inanimate to animate worlds during the origin of life. Such ambiguity was, in the 2nd phase of redox code, steadily reduced by gradually-improved compartmentalization of redox-based systems to yield distinct gradients and stereotyped capacitors with different redox potential energy, enabling life to effectively distinguish its internal milieu of life’s body from the surrounding environments, but enable certain interchanges between the internal and external environments across its membrane-based platform system. In the 3rd phase, the redox code was optimized by selecting its specificity to monitor those particular physiological functions by gradient redox potential energies within distinct redox compartments, and across those redox-configured microdomains, e.g., by NAD(P)H/NAD(P)+-driven redox metabolisms, and O2/H2O2-, NO/RNS- or H2S/RSS-leading redox signaling networks, altogether with relevant (bio)chemical modifications. In the 4th phase of redox code, its major transition is much likely yielded by redox switching of putative physio-pathological functional activation or inactivation of some molecular machines and subcellular apparatuses primarily by thiol-active and/or -reactive redox (re)cycling networks, especially upon the cellular redox sensing to signaling responses with interactomes. The stress-leading damage repair and disposal mechanisms are also likely embedded in this major transformation phase, which is manifested by certain changed configurations. In the last 5th phase, the conservation of redox code is de facto embodied by either programming or reprogramming of redox signaling to cellular redox metabolism and relevant gene expression profiling critically for its genetic, and epigenetic (and topogenetic) responses to diverse redox stress. The inheritable conservativity of redox code may be enforced by intra- or inter-generationally incorporating selenocysteine (Sec), persulfidated cysteine (CysSnH, n >= 2) and other redox-active not-yet-identified amino acids (e.g., HO-Pro) into redox proteomes during alternative translation of potential redox-responsive gene transcripts 71,86. Of note, those known basic-region (zipper) superfamily of transcription factors, HIF1α, Nrf2 (encoded by Nfe2l2) and Nrf1 (encoded by Nfe2l1, Figure 3A), together with NF-κB and FOXO, are identified to act as the conserved players in the redox programming or reprogramming responses 64,65,87,88, and further govern the proteostasis of the redox proteome during coping with stress 89.
Figure 3. FIGURE 3: Distinct roles of Nrf1 and Nrf2 in redox homeostatic equilibrium.
(A) Maintenance of redox homeostasis by balancing between oxidants (and/or anti-reductants) and antioxidants (also with reducing bistability) within certainly presetting homeodynamic threshold ranges in the eco-evo-devo process. In each side, there is also existing a redox ‘Yin-Yang’ equilibrium that abides by a dialectic law of the unity of opposites. Of note, distinct roles of Nrf1 (as a robust determinon) and Nrf2 (as a master regulon), which are dubbed as two entangled ‘Yin-Yang’ quanta, are integrated for their coordinate control of redox homeostasis. CHR and CSR represent cell homeostatic and stress responses, respectively. (B) Deficiency of Nrf1 leads to severe imbalanced redox stress arising from augmented ROS production, but this phenotype cannot be rescued by the hyperactive Nrf2, albeit it was accumulated in Nrf1((( cells (as graphically adapted from 115).
Redox kinetic barriers dictated by membrane topogenesis (via ‘topogenetic code’)
Differential positioning of redox gradient distributions in distinct topovectorial phase spaces and subsequent repartitioning of redox-based systems across diverse topovectorial spaces are all dictated predominantly by redox-compartmentalized membranes serving as certain ‘kinetic’ barriers (including redoxsome). More importantly, such membranes have fulfilled an irreplaceable pivotal role in transmitting architectural orders during self-organization of cellular life 90,91,92. This is just because cell membranes possess an indispensable topological property to be never constructed de novo, enabling them to be always growing from its pre-existing membranes and passing down from one generation to the next in an uninterrupted chain of descent 93 94. Since this remarkable innate property of cell membranes has been defined as a chromosome-like ‘membrane heredity’ 61 93, it is inferable to be determined by its ever-existing, but not-yet-identified, ‘topogenetic code’ for manufacturing distinct types of membrane topogenesis and further orchestrating most of the self-assembling topobiological structures of cellular life in real tempospatial phases on diverse membrane-based platforms, to perform accurate physiological functions in orderly organization. Such place (i.e., position in space)-dependent morphogenesis endowed with unique physiological functions during the eco-evo-devo process is dictated by membrane-associated topology and topobiology 92 95 96.
Initially, topobiology was only referred to as the place-dependent interactions of differential cell adhesion to extracellular matrix (ECM) via membrane-based platforms to drive morphogenesis in the developing embryo, and the origin of living systems 96,97,98. This paradigm was later revised to include force-dependent molecular switches, cell and tissue tension and reciprocal interactions with the microenvironments through conversed decision-making modules (switch, connector, capacitor, transistor and topogon) to specify the morphogenesis of multiscale forms with a unique functionality 95. The morphostasis is maintained by spatial segregation and organization of those anchored proteins and secreted factors through emergent properties of tissues, including tension fields and energy optimization. The concept of topobiology, as an important key decision-making mechanism accounting for the eco-evo-devo process has been further refined by applying its original mathematic and physic laws of topology into life science and medicine, aiming to unlock real Gordian knots (e.g., of redox electrochemical and quantum systems) in biology 99,100,101,102. Collectively, such inheritable membranes cannot only determine the compartmentalization of redox microdomains and its kinetic systems, and also dictate the orderly morphogenesis of self-organizing life and its morphostasis (of a given topoform with specified physiological function).
On the evolving membrane-based platforms, the redox-reactive system of H2S/RSS together with iron sulfide (FeS) plays a vital role in the morphogenesis and morphostasis of early life 37 103. This is supported by molecular evolution of ancient ferredoxin (Frx), which consists of only 23-aa with four Cys residues enabling a [4Fe-4S] cluster to be anchored on a positively charged mineral surface and thus mediating the electron transfer in the primordial membrane system prior to the origin of species diverged from the LUCA 104. Subsequent evolutionary respiratory NO to O2 reductases, possibly with Frx, contribute to energy metabolism by distinct species’ membrane systems 23,105, but also to the yield of H2O2/ROS, NO/RNS and H2S/RSS in the electron transferring processes 47,65. The membrane-tethered NAD(P)H oxidases (NOX, also called NAD(P)H-dependent reductases) cannot only reduce O2 to yield most of ROS (i.e., O2- and H2O2) and remove O2 to water (H2O) 106. Furthermore, O2/Fe2+-dependent prolyl hydroxylases (PHDs, as transmembrane enzymes governing the HIF1 turnover, but conversely induced by HIF1 107 108 109 110), together with Cu2+-dependent lysyl oxidases (LOXs), of collagens (secreted from the ER to the ECM) dictate the rigid formation of its stereotyped ‘tensor networks’ by multiple-crosslinking with cell adhesive molecules, transmembrane-tethering proteins (e.g., integrins and fibronectins), and consecutively associating with membrane-enclosed cytoskeleton and karyoskeleton, together with all the subcellular organelles being connected with one another through their membrane extensions (e.g., stromules, peroxules, and matrixules). Collectively, these membrane-based topobiology (possibly via ‘topogenetic code’ rules for body plan) cannot only enhance the compartmentalization of redox microdomains and its kinetic systems in all distinct intracellular and extracellular matrix contexts, but further determine distinct topoforms of cell lineages (by their interaction forces), tissues, organs and even individual beings in distinct positioning sizes of topovectorial phase spaces.
Coordinated control of redox responsive mechanisms by Nrf1 and Nrf2
Overall, such diverse topogenetic phenotypes are also modulated by distinct redox status, as dubbed ‘redox phenotypes’, which is being maintained at certain physiological homeostasis during normal conditions. Once such homeostasis (along with morphostasis) is markedly disrupted by excessive redox stimulation for a long term, this results in relevant pathophysiological deterioration and pathogenic phenotypes of many chronic diseases including cancer, diabetes, atherosclerosis, and neurodegenerative diseases 111 112. Hence, in order to combat excessive redox stimulation, all cellular life forms have been evolutionarily armed with a series of innate powerful anti-redox defense systems. Amongst them is a set of such essential anti-redox, detoxification and cytoprotective mechanisms governed by the cap 'n' Collar and basic region leucine zipper (CNC-bZIP) family of transcription factors 87,113,114. Of striking note, Nrf1 and Nrf2 are two principal CNC-bZIP factors in vertebrates, to finely tune transcriptional expression of cognate genes by binding the consensus antioxidant or electrophile response elements (AREs/EpREs) in their promotor regions. In fact, we unraveled that the allelopathic potentials of Nrf1 and Nrf2 (both resembling two entangled ‘Yin-Yang’ quanta that comply with a dialectic law of the unity of opposites, as illustrated in Figure 3A) are exerted so to coordinately govern a certain redox physiological homeostasis to be maintained within the presetting threshold ranges 115.
To date, a large number of studies on Nrf2 have revealed that it functions as a master regulator of antioxidant response and relevant redox signaling 116. However, such versatile Nrf2 acts de facto as a promiscuous, but not essential, player for optimally ARE-binding to most of its target genes 117. This supports a concluding notion that Nrf2 is dispensable for normal growth and development 118, with not any obvious pathological phenotypes being manifested in its global knockout mice. As a matter of fact, Nrf1, rather than Nrf2, is a living fossil with its ancestral properties, because it shares an evolutionary conservativity with SKN-1, Cnc and Nach factors 114. Like its ancient homologues 119 120, Nrf1 is topologically integrated within the ER, then repartitioned and dislocated across ER membranes to enter extra-ER subcellular compartments, in which it is processed to yield a mature N-terminally-truncated factor, similar to Nrf2, before transactivating its cognate target genes 121,122,123. Collectively, such a highly-conserved, indispensable role is fulfilled by Nrf1 (with a unique topobiological feature), but not by Nrf2, for maintaining the steady-state threshold of normal redox homeostasis. This is much likely to further dictate the morphostasis of distinct topogenetic phenotypes with healthy physiological functions, because the loss of its function results in severe endogenous oxidative stress, as accompanied by disruption of cellular lipid, glucose and protein homeostasis and organ integrity, leading to cancer development and malignance, even though Nrf2 is aberrantly accumulated in such Nrf1α-deficient cells (Figure 3B) 115.
SCIENTIFIC CONCEPTUAL EVOLUTION OF REDOX STRESS FROM PHYSICS AND CHEMISTRY TO BIOMEDICINE
To gain a better understanding of physio-pathological effects of redox stress (also including the secondary redox stress trigged by many other types of stress) on biological systems and their correspondingly coping strategies, it is rather imperative to properly define the ‘stress’ and the resulting ‘strain’ that triggers all relevant compensatory, adaptive, maladaptive and neutral responses in target cells, tissues, organs and organisms (Figure 4A), all of which are placed at stressful bottlenecks of the nature evolutionary selection pressures 124. This is because distinct stress-induced changes and its target coping responses give rise to certain heritable phenotypes for fitness, and also leads to some phenotypic variations at the population levels 88,125, which is conductive to adapt for host survival and maintain its homeostasis under stress arising from the changing eco-evo-devo processes.
Figure 4. FIGURE 4: Axiomatic representation of redox stress and defense response systems in cellular life.
(A) Axiomatic representation of cellular adaptive response to stress induced by distinct stimuli. The stress and its resulting strain are viewed in physics as two coherent parameters of force acting on targets, whereas its counteracting force arises from adaptive responses to strain by cell homeostatic and stress responses (i.e., CHR and CSR). Taken together, different outcomes are output as an integrated adaptive or maladaptive status with distinct physio-pathological phenotypes. (B) Schematic diagram of redox stress and its coping responses by distinct mechanisms and obligate coding rules (i.e., stress code and stress-coping code). The detailed explanations are provided in the text. OHR and OSR represent the organismal homeostatic and stress responses, similar to CHR and CSR at cellular levels, respectively. (C-F) Schematic rationales for redox balanced or imbalanced statuses, along with the concise explanations as indicated. (G) A graphic abstract of distinct extents of redox stress, including oxidative stress and reductive stress. Distress (also called hyperstress) can lead to severe overstress damage, whilst sustress (also called hypostress) could give rise to inadequate subthreshold stimulative effects, in addition to eustress enabling adaptive hormestic effects for the healthy survival.
Axiomatic concepts of stress and relevant parameters revisited by principles of physics
Physics-based concepts of stress and parameters in biology
Although the contemporary concepts regarding ‘stress’ employed conventionally in a wide variety of scientific disciplines have evolved over the past 2½ millennia 126 127, it remains to be a hot subject of distinct scientific debates. In fact, the word ‘stress’ originates etymologically from the common proto-Indo-European root ‘str’, which has been historically associated with exertion of pressure 126. Until 1660, ‘stress’ was introduced in mechanical physics and accurately formulated by Hooke’s law of elasticity (F=ΔL×k); the relationship of ‘stress’ (σ=F/A=ΔL×k/A, a ratio of the internal force brought into play when a substance is distorted to the area over the force acts, whereas the external force producing the distortion was defined as ‘load’ 128) over the resulting ‘strain’ (ε=ΔL/L0, a ratio of such distorted change in size or shape to their original ones) was further scientifically defined by Thomas Young’s elastic modulus (Em= σ/ε = L0×k/A) in 1807 129. Such original meaning of stress per se was also used to denote the internal force generated within a living body by any force which leads to strain (or distortion) of the body 128. The Hooke’s law was recently extended by Dietmar Kültz for its application in biological systems, aiming to properly and unambiguously refine the concept of stress by its original physic principles, which was hence restated as F=ΔHc×k 124. Here, k is a constant that describes the phenotype of a biology system at the time of exposure to the force F arising from stress, while ΔHc represents the extent of dysregulation of this system differing from its set-point of the homeostatic norm (H) of the most critical and limiting physiological variables c.
As F= ∫f(ΔHc)×k was refined here, this is because a maximally informative yet minimally complex set of variables ΔHc may be modeled by a certain function (f) of their core endogenous network 130,131 and further integrated (∫) in ontogenetics and phylogenetics 132, the topology of which would accurately reflect the amount of strain (deformed) on this system during stress. Since ‘stress σ’ and ‘strain ε’ were restated as σ= F/R =∫f(ΔHc)× k/R and ε = ΔHc/Hc, respectively 124, this system’s elasticity (or plasticity) may be formulated as P=[∫f(ΔHc)]/ΔHc× Hc× k/R, and further simplified as P ≈ Hc× k/R, only if f(ΔHc) = ΔHc, in which R represents the robustness of a living system (i.e., cell or organism) and acts as an inherent property of this evolving, complex dynamic system. Moreover, if the stress potential energy stated Es = ½ k× (ΔHc)2, it may be rewritten as Es= ½ k× (ΔG+ΔS×T)2, because free energy (ΔG) is formulated by ΔG= ΔHc-ΔS×T. Herein, the stress-reactive entropy is represented by ΔS, it is due to the nature of stress on the atomic level in dense polymer systems (of cell or organism) was classically viewed as being molecular, based on the ‘entropic spring’ concept 133, stating the intrinsic monomer stress by contribution of the individual monomer to the macroscopic stress referred to a local moving coordinate system in which its backbone bonds attached to the monomer are fixed. ΔG is equal to do the responsive work, i.e., W= ∑ (WCSR+WCHR+WOHR), arousing a counteracting impetus of the host against stress by distinct coping mechanisms 88 125 126. Collectively, stress, strain, plasticity and robustness, along with other relevant parameters, can all be subjected to precision evaluation and axiomatic demarcation by princples of physics.
Non-physics-based concepts of stress response evolving in biomedicine
However, it should also be noted that all those other evolving definitions of stress, as known so far, seem to be largely irrelevant to the original meaning of its physics 128 134 135 136 137 138. As such being the case, multi-faceted stress and relevant responses remain to be partially delineated by their evolving concepts nearly for a century after being introduced into biology, revealing the reaction and interaction of diverse changing environmental (including social and psychosomatic) stimuli with all life systems from distinct aspects of bioscience and medicine (Figure 4A and B). From a fluid matrix of life’s body demarcated as ‘millieu interieur’ by Claude Bernard 139 124 to its steady state named as ‘homeostasis’ by Walter Cannon 141 142, the stress and strain of homeostasis were first described in a biological system, ‘in terms of a homeostatic index (H0/Hc), which states the measured ability to react, without disturbance of the fluid matrix, to a group of standard stresses that may readily distturb it’ or cause ‘an excessive strain upon the protective agencies’ 142. Later, the stress may be defined by Hans Selye as a ‘nonspecific deviation from the normal resting state; it is caused by function or damage’, but also ‘stimulates repair’ 143. This is just due to ‘the facts that stress is not necessarily the result of damage but can be caused by physiological function, and that it is not merely the result of a nonspecific action but also comprises the defense against it’. Thereby, the remaining portion, after subtraction of all the specific changes caused by distinct stimuli and their reacting targets, is considered as ‘the general-adaptation syndrome (GAS) produced by diverse nocuous agents’ 144. The GAS was determined by such nonspecific commonly-shared responses to all types of stresses, with all the relevant activities (e.g., to affect behavior, temperament, physiological homeostasis and anatomic morphostasis) being harmoniously integrated by the hormonal and nervous system of organisms. The autonomic neuroendocrine responsive systems (e.g., HPA and SAM predominantly) and extended immune systems to any stress were all collectively referred to as ‘stress response system’ 126 127 143. By contrast with physiological protective responses for the purpose of a fit healthy resilience, prolonged or exaggerated stress is rather accompanied with a continuum of inappropriate adaptive to maladaptive responses, ultimately leading to development of a series of pathological phenotypes and even chronic diseases (i.e., ‘stress-led syndromes’, including psychosomatic disorders) 126,143,145,146.
Ontological concepts of redox stress revisited by principles of chemistry
Scientific basis for redox stress in chemistry
Redox stress is integrated in term of a Janus-faced parameter of redox electrochemical potential disequilibrium arising from ‘biologically inappropriate’ reactive imbalances amongst all oxidative, antioxidant, reductive and anti-reductant agents involved during interaction of adequate stimulus with the host and ensuing transformation to its adaptive responses. This collective definition of whether is prone to favor oxidative or reductive stress depends on the principle of which stress changes the nature of redox potential energy. This may be accurately determined by the Nernst-Peters derived equation Eh = E0 + 0.03× log10 [oxidant/reductant] 147. Hence, ΔEh = Eh -E0 was calculated by a logarithmic ratio of [oxidant] to [reductant] (ΔEh = 0.03× log10 [oxidant/reductant]; their relationship was also shown in a sigmoid buffering curve 147. The term ‘near equilibrium’ is defined to describe the reactions in which there is essentially zero free energy (ΔG = 0) available from putative electrons (and/or hydrogens) being transferred or exchanged because this reaction is maintained so very close to an equilibrium of redox distribution between reactants and products 32. That is, ΔG = ΔEh = 0, such that [oxidant] is equally balanced to [reductant]. Therefore, it is inferable that such a redox equilibrium of biology systems in cells or organisms should be preserved only by tightly governing a ratio of ∑[oxidants] to ∑[reductants] balanced to near zero extents (as theoretically shown in Figure 4C).
Such being the case of an imbalanced redox status, whether or not an onset of the oxidative or reductive stress remains depends on the antioxidant or anti-reductant capacity of life, respectively, together with its detoxifying cytoprotective capability in its emergency response system. This poses a challenging question of how the cells and organism deal with a mounting pool of redox equivalents to properly balance the generation of ‘reactive X species (including ROS, RNS and RSS) and their elimination, and optimize all those redox buffer couples (e.g., NADH/NAD+, NADPH/NADP+, GSH/GSSG, CysS/CysSX, O2/H2O2, and H2S/RSSn), particularly during cellular stress. To address this question, it is required to clearly figure out the scientific distinctions amongst oxidative (oxidant) stress, reductive (reductant) stress and redox stress, just because of their previously confounded terms of which had been employed disparately by biologists, but distinguishably from chemists 148.
Debating concepts of oxidative stress in biology
The term ‘oxidative stress’ was initially used in 1970 by Paniker et al. for a study of the erythrocytic glutathione metabolism affected by glutathione reductase (GSR) deficiency, which was determined by measuring a ratio of GSH to GSSG in the cell response to exogenous H2O2 (viewed as a stimulus of oxidative stress imposed on the cell) 9. At the end of 1970, the intracellular H2O2 changes were first discovered in eukaryotes by Helmut Sies and Britton Chance through a pioneering collaboration by spectrophotometry of isolated hemoglobin-free perfused rat livers 149. Later, such a phenomenon of ‘oxidative stress’ was originally formulated by Sies H. in 1985 as ‘a disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage to intact cells and organs’ 150 151. Since that time to date, oxidative stress has been inspiring too many investigations of all relevant fields as a mechanism for inducing a unique set of adaptive homeostatic responses in cells and organisms (i.e., CHR or OHR, in Figure 4B). This notion has also evolved in biomedical research as an experimental method for exploring adaptive redox responses and as a putative determinant of ageing and other pathological processes 148. In this process, ‘oxidative stress’ was also further refined by Jones D.P. in terms of ‘an imbalance between oxidants and antioxidants in favor of the former oxidants, leading to a disruption of redox signaling and control and/or molecular damage’ 10,12.
Quite recently, the concept of oxidative stress was updated by Lushchak VI and Storey KB, who revisited it in terms of ‘a transient or long-term increase of steady-state ROS levels, disturbing cellular metabolic and signaling pathways, particularly ROS-based ones, and leading to oxidative modifications of an organism’s macromolecules that, if not counterbalanced, may culminate in cell death via necrosis or apoptosis’ 152. Overall, as to biologists, oxidative stress implies that a cell or organism produces or is exposed to an excess of the highly reactive molecules (i.e., RXS), predominantly oxygen- and/or nitrogen-centered ROS/RNS, which exceeds its endogenous antioxidant capacity (to be endowed on the organism with a host of all those oxidoreductases, reductases, and small-molecule antioxidants, as illustrated in Figure 4D).
Major challenges for precision definition of oxidative or reductive stress by chemistry
Herein, it should be noted that a critical pitfall of oxidative stress may lead to indiscriminate use of this term as a global concept with certain ambiguity and circularity, but without a clear relation to redox chemistry, in each of particular cases 10. Accordingly, by reevaluating those previously-debating concepts of oxidative stress from the chemical perspective, it was found that most of those definitions by biologists appear ‘too vague and imprecise to recognize explicitly what the oxidants are set in a given set of intracellular and extracellular circumstances and how their reactivity is countered, controlled or quenched, and most importantly, what the reductants are really to which the oxidants must be coupled for the redox reactions to proceed’ 148. Rather, to achieve a precision definition of oxidative stress by redox chemical ontology in complex biological systems, there are existing certain unavoidable challenges for the following reasons. i) It is very hard to identify or quantify each specific species of ROS/RNS (not as a global index 153), in a hitherto uncompleted picture of all their sources, sinks and fluxes 148. ii) Their chemical reactions, particularly with the very short-lived free radicals involved in a wide range of redox potential propagating to terminating reaction cascades, are often too rapid to be accurately determined within their availably measured time scales of the presently established techniques 51. iii) The redox compartmental heterogeneity of ROS/RNS in their gradient distributions varies with changing status of the intracellular and extracellular contexts, so that they are difficult to trace in the real-time topovectorial space by relevant reporters, an ideal molecule that can react sufficiently and rapidly with each interest species of ROS/RNS with exquisite specificity, at its low enough concentrations so as not to affect the steady-state level of the indicated species 148. iv) Many of the currently ROS/RNS-estimated methods may also have actually and more sensitively detected RSS, such that they are rarely distinguished from each other 37 49 52. In fact, the ratio of ROS to RSS in cells was examined to be considerably less than three (ROS/RSS < 3), because H2S/RSS can be co-produced with H2O2/ROS (e.g., by SOD, Cat, respiratory chain), so that its production may well exceed the yield of ROS on most occasions 3 47. As such being the case, the term ‘oxidation’ exemplified this ingrained bias as there is no equivalent term ‘reduction’. But, as a biological consequence of oxidative stress, it is cognized only in light of the reductants that have been oxidized in this process and the effects of those coupled redox reactions on the biological functional pathways in which the redox-active molecules are involved. Collectively, it is inferable that this complicated redox biochemical process cannot be well generalized by an overly simplistic biological principle and nor determined by another chemical precision algorithm applied for a statistically complex ensemble of such redox reactions.
Intriguingly, the most of important biological oxidants (connoting oxidative stress) are derivatives from O2 (with a proclivity for electrons), but they exist in partially reduced forms, including superoxide anion (O2·-) and H2O2, from a simple chemical perspective. Coincidently, these ‘Janus-faced redoxidants’ can oxidize some molecules of the appropriately matched negative redox potential (ΔEh < 0), as accompanied by reducing other molecules of more positive redox potential (ΔEh > 0) 148. For instance, O2·- can reduce disulfides (to yield reduced thiol forms) and simultaneously oxidize α-tocopherol, leading per se to its oxidation to O2 and its reduction to H2O2, respectively. Similarly, H2O2 can reduce ferrylhemoglobin (to yield O2-carrying Fe2+Hb) and oxidize methionine or the thiol-active proteins, leading per se to its oxidation to O2·- and its reduction to H2O, respectively. As a consequence, certain disulfide linkages are constructed by oxidation of thiol-active proteins to facilitate their proper folding to gain a functional configuration or crosslinking with other proteins in the more oxidizing ER and extracellular environments. From these points, a certain excess of O2·- and H2O2 is not necessary for leading to a simply ‘oxidative stress’. Conversely, this should be just as well viewed as imposing a ‘reductive stress’ potential on biological systems from a chemical perspective, since as partially reduced forms of ROS involving redox reactions in which they reduce those molecules of more positive redox potential (ΔEh > 0). Therefore, ‘misleading definitions’ of oxidative stress by biologists appear to be only focused on the oxygen-centered nature of ROS without regard to the precision chemistry of redox-coupled reactions in which they can be involved and/or to the precious changes in redox compartments where they are generated or controlled 148. That is, on the contrary, a properly scientific definition of ‘oxidative or reductive’ stress by a chemical principle should be dictated by the flow of those electrons (or hydride anions) exchanged in the redox-coupled reactions in which all the reactive species have been implicated.
Proper definition of redox stress as ‘a generic term’ by biological chemistry
Reductive stress was originally observed in hypoxia hepatocytes by Gores et al. 13; this phenomenon caused by respiratory inhibition favors the formation of toxic oxygen species (i.e., hydroperoxide), as was accelerated during aerobic but not anaerobic chemical hypoxia. This stress was further found to contribute to lethal cell injury, which was greater during aerobic, as compared with anaerobic, chemical hypoxia, but delayed by desferrioxamine or cyanidanol, rather than by SOD ± Cat, during intermittent or incomplete oxygen deprivation 13. In this setting, reductive stress is only recognized, from a biological perspective, ‘as a complement of oxidative stress in virtue of providing an excess of reducing equivalents’ that cannot be adequately quenched by endogenous oxidoreductases and accommodated by the existing oxygen counterparts in the local environments (due to oxygen being a terminal electron acceptor in the respiratory chain electron transport and redox reactions in living systems) 148. However, such a definition of ‘reductive stress’, if interrogated from a chemical perspective, can also pose the same misleading and confusing readers in this process as the aforementioned ‘oxidative stress’. For an instance of even the absence of re-oxygenation by reperfusion, sustained hypoxia leads to an increase in ROS, albeit as oxidative stress from the biological angle, whilst these species are de facto partially-reduced forms of O2 that can evolve in this setting to hierarchically increase reducing equivalents, with their consequences depending on the redox-coupled reactions in which they are involved. Taken together, given the ‘oxidative and reductive’ complexity as yet oversimplified previously with chemical imprecision, ‘redox stress’ should be commonly accepted as ‘a generic term’, to describe the ‘disturbances in the oxidation-reduction reactions arising from an excess of oxidants or reductants, with their functional consequences in a biological system’ 148. Also, it is critically important for ‘a need to be as explicit as possible about the particular molecular species (most of which are Janus-faced and varied within distinct ambient contexts) involved in the redox reactions that modify biological phenotypes’.
Stress-coping code acquired by evolving cellular life responses
Generally, a physiological or pathophysiological functional consequence of redox stress depends on the extent and duration of whether or not there is a mismatch between the excess of oxidants or reductants in the redox biological systems of organisms and its intrinsic anti-redox capacity to counteract or mitigate their potential damaging effects in the (mal)adaptive responses to those reactive species during the life process (Figure 4B-F). Thereby, such redox stress has been recognized, by the eco-evo-devo perspective, as a powerful mechanistic mediator of the life history trade-offs between its traits (arise and reflect constraints imposed by the environment and physicochemical laws during the evolutionary process) 154 155 156 157 158. If an organism can appropriately recognize and respond to the changing environmental stress challenges, with minimal costs, it is an important physiological attribute, with a great adaptive value (Figure 4C vs E). On the other way round, if this organism is unable appropriately to do so, with greater costs, it fits into a pathophysiological or (pre)pathological attribute, with another great maladaptive value (Figure 4D and F). Such striking distinctions in those costs and benefits arising from diverse mechanisms that selectively enable for the organisms to cope with the changing stresses experienced from the predictable and controllable to unpredictable and uncontrollable status are manifested to distinctive extents at different life stages, and hence can serve as a strong selective pressure to drive the evolution of life histories 159.
In the life process, a ‘stress-coping code’ is acquired by nature selection for a set of arbitrary rules accounting for discrete organisms to cope with distinct types of stresses (including primary and secondary redox stress, and even psychogenic stress) instigated by all challenges from internal and external environments. Such a proper code for life to cope with stress by ‘the nonspecific response of its body to any demand’, as early conjectured by Hans Selye 160, should be constructed ‘primarily based on the laws of nature, all of which must be accepted’ within the ready-made machine. That is based on how the body works (and/or how it should work) within a stress-coping code founded on nature laws (which was figured out as a basic necessity of living systems, especially work whose fruits can be accumulated), as with the ‘genetic code’ containing the receipt of all those traits inherited in chemical language 160. However, such putative stress-coping code does not yet appear to be unveiled heretofore, albeit animal adaptive stress responses fall into two coding styles (i.e., proactive hawk and reactive/passive dove) of their behavior, physiological health and relevant pathological diseases 158 161 162 163.
Following nature principles applied to code biology 61 62 79, ‘stress-coping code’ could be defined as a series of set rules that can enable distinct cellular life forms to cope with all various stresses caused by changing internal and external environments. Such ‘stress-coping codes’ have experienced five phases, as well done by other organic codes 62. In the beginning phase, the first version of the coding rules appears in a living system as means of performing a particular function to cope with stress by governing all relevant adaptors and components, which were orchestrated into an ensemble of both ‘stress-sensing’ (e.g., physiochemical, electrochemical, or quantum chemical) reactive cascades and its ‘strain-leading’ biochemical metabolisms with its responsive signaling pathways. The certain ambiguity of this code in its second phase is evolutionarily reduced insomuch as to steadily improve its particular functional specificity to cope with stress, as a result, giving rise to distinct subsets of multi-hierarchical stress-coping physiochemical reaction cascades in their real spatiotemporal orders coupled with multi-dimensional signaling responsive transduction pathways, comprising a complex gradient-ordered ‘tensor’ network. Such code in its third phase is further optimized by distinct mechanisms (such as hormesis, homeorhesis, homeostasis, alloststasis and morphostasis, as in Figures 4B and G). The consequence enables a living life to establish two major classes of ‘stress-coping responses’, i.e., cellular homeostatic response (CHR) and cellular stress response (CSR), both of which are also extended to organismal homeostatic response (OHR) and organismal stress response (OSR), as described by Dietmar Kültz 124 125. In the fourth phase, this optimized code is further subjected to a major transition (by an integral functional and structural means of distinct strata of molecular, subcellular, cellular, tissue to organismal and even population levels), so far as to construct a perfect responsible set of ‘stress-coping systems’ coordinately regulated by distinct mechanism (as proposed by two groups of Kültz D. 88 124 164 and Chrousos G.P. 126 127 165). In the last fifth phase, such stress-coping code continues to evolve by selective programming and further reprogramming with its requisite specificity. So ultimately, it becomes an intact set of highly conversed inheritable rules, that can tightly monitor all the relevant responsive behavior, physiological and pathophysiological adaption or even maladaption to various stresses (e.g., two distinct coping styles), aside from that can be virtually transmitted by genetics, epigenetics and topogentics to the descendants. For example, the CSR is one of the most highly evolutionary conserved responses inherent in all cells, which represents a prerequisite for evolution of the neuroendocrine stress response (NESR). This NESR cannot only integrate the response to stress in metazoans, but also, in turn, is another prerequisite for the evolution of psychological and/or emotional stress response (PESR) in the vertebrates to its preeminence in humans 88,124. Overall, stress is not something to be avoided, no matter what happens; there thus arises a demand for stress-coping code to provide the necessary principles for the tempospatial order to perform the tasks required to maintain the homeostasis of cellular life, and also resist and adapt to the changing influences from its internal and external environments (including redox stress).
QUANTITATIVE STRATIFICATION OF REDOX STRESS AND ANTI-REDOX RESPONSES
In 1977, the stress of life was simply qualified by Hans Selye 160, to be good eustress or bad distress, and also quantified as hyperstress (overstress) or hypostress (sustress); all four basic variations are deciphered in Figure 4G. Three decades later, Nel A. et al. presented a hierarchical redox stress model, in which Tiers 1 to 3 were first defined by distinct extents of oxidative stress with the inverse ratios of GSH/GSSG 166, but Tier 0 at the normal physiological conditions was left in a blank space. This blank space was filled by our work focused on Nrf1 167. Moreover, oxidative (and reductive) stress was classified by relevant dose-effect curves on the basis of its intensity and its time course 152,168. Oxidative eustress and distress were quantitatively distinguished by Helmut Sies and colleagues, based on extracellular and intracellular H2O2 concentrations (i.e., [H2O2]ex and H2O2]in) 64 169 (as shown in Figure 5A).
Figure 5. FIGURE 5: Quantitative stratification of redox stress and anti-redox responses into distinct output statuses.
(A) The exponential curve was drawn from the data published by Sies and colleagues 64,169. The Y axle shows a positive correlation of exponential changes in [H2O2]ex to the life-threatening intensity, while the X axle shows distinct oxidative statuses defined by [H2O2]ex, as indicated at Tier 0 to Tier 3, from predictability and controllability to unpredictability and uncontrollability. (B) The quadripartite curves are composed of oxidative stress and antioxidant capability, together with reductive stress and anti-reductive capability. In the Golden Center of normal physiological redox homeostasis 170, there exists a theoretical ‘zero’ setpoint (P0) within the homeodynamic threshold range. The eustasis for fitness principally takes place between Tier 1 and Tier 2, whereas cacostasis from maladaption to exhaustion occurs at Tire 3. (C) Simplification of the above-curved parameters by a base-10 logarithm. The Golden mean of normal redox homeostasis is demarcated for the healthy physiology with the ‘zero’ theory (at P0). Oxidative stress arises primarily from an excess of those oxidizing equivalents and electrophiles, whilst reductive stress results from excess of those reducing equivalents and nucleophiles. Yet, such redox stress and relevant defense responses occur, all of which also rely on the overall antioxidant and/or anti-reductive capability of intrinsic reactive compounds.
Updated hierarchical modelling of redox stress and anti-redox capability
As illustrated in Figure 5A, a natural exponential curve was drawn from the data of [H2O2]ex reported by Sies, H. et al. 64 169. The X-axle represents changes from predictability and controllability of eustress to unpredictability and uncontrollability of distress challenged at distinct oxidative status (Tiers 0 to 3), while the Y-axle shows the life threatening intensity of [H2O2]ex (µM). On this base, according to the natural law of symmetry (as a fundamentally driving force), we thus conjecture that a robust steady-state redox system should be, at least in theory, demarcated by four dynamic curves, which represent oxidative stress, reductive stress, antioxidant capability and anti-reductive capability (of intrinsic reactive components), respectively (Figure 5B). In such parameter spaces, it is inferable there exists a highly conversed ‘habitable Goldilocks Zone’, in which all those essential redox and anti-redox biochemical elements should be tightly governed within certain homeodynamic threshold settings for its normal physiological hemostasis. The redox homeostasis could also be represented by a ‘Golden Center’ of healthy living systems, just as proposed by Ursini F. et al. 170. Equally importantly, a set point at approaching zero (P0) co-exists within this ‘Golden Mean’ for healthy living beings. This may be dubbed the ‘zero theory’, similar to that of a mathematic function, f(x) (± CR, a robust constant). Taken altogether, this conserved symmetry of redox stress and anti-redox responsive system closely adheres to Noether’s theorem (which states that the symmetry of their action corresponds to a conservation law, also with a conserved quantity).
The point of limit (PL ) is represented to allow for the resilience of this system to its normal archetype by proper responses to eustress, albeit this can lead to a novel eustasis for fitness 165. Conversely, further deterioration of redox distress could result in a server malfunction status of this response system (called cacostasis), with its maladaption or even exhaustion (Figure 5B). These can be reflected by more explicit Figure 5C, which was obtained from simple generalization by a base-10 logarithm of the above-curved parameters (e.g., log10[H2O2]ex), which is fully in accord with the Weber-Fechner law (S = k logc X). Moreover, it should be noted that those aberrant redox set-points (Pox or Pre) may emerge during the malignant transition to cacostasis, and are monitored possibly by allostatic mechanisms 158 171.
Differential involvement of Nrf1 and Nrf2 in redox stress responses stratified by physio-pathology
As shown in Figure 6A, we further refined distinct tiers of redox stress responses by being optimally stratified from their molecular, subcellular to cellular levels, which are established on the base of previous multi-hierarchical models 166 167. Of note, Tier 0 is defined under the normal physiological (healthy) status, which is predominantly dictated by Nrf1 (and its long isoform TCF11), together with its unique subset of target genes responsible for anti-redox, detoxifying and cytoprotective roles in maintaining cell homeostasis and organ integrity. This is just due to ever-accumulating facts that the loss of Nrf1/TCF11’s function results in severe endogenous oxidative stress 115,172,173; this is also accompanied by significant spontaneous pathological phenotypes as reviewed in detail 87 174. By contrast, loss of Nrf2 enables the resulting deficient cells and/or animals to become more susceptible and vulnerable to redox stressors or carcinogens, but not accompanied by any obvious spontaneous phenotypes 175. These demonstrate that Nrf1 is essential for CHR, whereas Nrf2 is not required for CHR, but still for CSR as defined by Kültz 124. At Tier 1, which is generally accepted as a redox eustress status with hormesis 166 167 176 177, the anti-redox, detoxifying and cytoprotective defense system is aroused by predominantly Keap1-sensing redox signaling to Nrf2-mediated target genes (driven by those cis-regulatory consensus antioxidant and/or electrophile response elements, called AREs/EpREs, within their promoter regions) in cellular responses to redox stress, particularly acute stress (Figure 6A). At Tier 2, is viewed as a major pathophysiological transition switching from a subhealthy status into the onset of certain pathology if redox stress has deteriorated, its responses become hence complicated. In addition to overstimulation of those (nonspecific) stress signaling networks responsible for activation of pathophysiological switching, the inflammatory responsive pathway mediated by NF-κB is critically activated and even hyper-activated, leading to the onset of certain pathologies and some pathogenesis of chronic diseases. When redox stress is further deteriorated from Tier 2 to Tier 3 (as a distressed status), severe cytotoxicity along with accumulating damage signaling to cell process, including mitochondrial dysfunction, leads to metabolic, epigenetic and genetic reprogramming, topogenetic remodeling and even cell and/or organ reshaping, with aberrant immunopathology. As consequence, this results in cell apoptosis and ageing-related chronic diseases, or otherwise aberrant proliferative carcinogenesis overstimulated by this distress. Collectively, the underlying molecular and cellular details in the response to distinct tiers of redox stress (Figure 6B) are required to be further elucidated. However, the major role of antioxidant and anti-reductive defense system (aiming to prevent, intercept, repair and eliminate) is fulfilled predominantly by redox-controlling enzymes, key transcription factors (e.g., Nrf1 and Nrf2) and co-factors involved in cellular redox biochemical and relevant metabolic processes, as well for a long-term adaption principally by reprogramming of their regulatory gene expression profiles in the physiological and pathophysiological responses to distinct severity of redox distress.
Figure 6. FIGURE 6: Definition of distinct hierarchical physio-pathological responses to distinct extents of redox stress.
(A) Stratification of the physio-pathological defense responses to distinct extents of redox stress, with distinct progressive outputs established on the basis of previous multi-hierarchical models 166,167. Of note, distinct major roles of Nrf1 and Nrf2 are predominantly exerted to determine distinct statues defined at Tier 0 and Tier 1, respectively. (B) A three-dimensional graphic abstract of multi-hierarchical physio-pathological adaptive responsive curves (at Y axle) to distinct extents of cytotoxicity (at Z axle) arising from redox stress exposed for distinct lengths of time (at X axle). Overall, distinct physio-pathological statues are determined by these different X, Y and Z parameters. (C) Distinct time courses of stably expressing Nrf1α, TCF11, TCF11ΔN and Nrf2 induced by a tetracycline-inducible HEK293 cell system (for detailed descriptions, please see the text and two cited references 123,178).
As shown in Figure 6C, stably expressed Nrf2 is rapidly induced within 2 h and then fast reaches to its maximal peak at 6 h of induction by a tetracycline-inducible HEK293 cell system (as described by 123 178), but thereafter gradually diminished and even extinguished. By sharp contrast, Nrf1α and its long isoform TCF11, along with its N-terminally-truncated isoform TCF11ΔN, are gradually induced by this tetracycline-inducible system to reach their maximal activation from 8 h to 12 h of induction and then maintained at so higher levels until experiments stopped. Additional two shorter Nrf1β and Nrf1γ (as a dominant negative form) are stably induced by tetracycline (Figure S1). Of note, both Nrf1α and TCF11 are required for N-linked glycosylation and then deglycosylation before being selectively processed to remove its N-terminal portion and thus give rise to a mature active CNC-bZIP factor, such as TCF11ΔN (Figure S2A and C). All these distinct isoforms of Nrf1/TCF11, with differential half-lives of their protein stability (Figure S2), enable them to exert distinct or even opposing roles in the transcriptional regulation of their target genes 123 178. As such being the case, Nrf1/TCF11 is innately endowed to fulfill a unique indispensable function, that is distinctive from that exerted by Nrf2, in response to distinct tiers of redox stress. Hence, it is inferable that Nrf1α/TCF11 exerts an irreplaceable and pivotal role in governing CHR, whilst Nrf2’s role in handling such a rapid emergency response (CSR) has provided a way of ‘buying time’ for the transition to the lagging CHR mediated by Nrf1α/TCF11, insomuch as to coordinately cope with redox stress threatening cell homeostasis and organ integrity of living systems.
Adaptive landscapes accounting for distinct responsive phenotypes to redox stress
Based on the mathematic models of Darwinian evolutionary laws and systems biology developed by Ao’s group 38 179 180 181, it is inferable that discrepant responsive physio-pathological phenotypes (and genotypes) to distinct tiers of redox stress should be determined predominantly by coordinated control of Nrf1/TCF11 and Nrf2, along with their differential but yet integral transcriptional regulation of cognate target genes responsible for anti-redox, detoxifying and cytoprotective defenses, as deciphered by distinct adaptive landscapes (Figure 7A-D). This is because distinct phenotypic (and/or genotypic) steady-states are dictated by different profiling of those key differential expression genes at the distinct status of each multi-hierarchical robust endogenous molecular-cellular network. Therein, differential expression of such a minimum set of key genes at distinct strata is de facto exhibited at their abundances, activities and topoforms at different topovectorial phase transitions, along with their intricate interactions between those core modular molecules in different subcellular, intracellular, and extracellular contexts.
Figure 7. FIGURE 7: Adaptive landscapes account for distinct responsive phenotypes to redox stress.
(A) The adaptive landscape at healthy redox state (dictated by Nrf1/TCF11), which is maintained within a homeodynamic threshold range (around the presenting P0), but can also be transformed into another robust state through saddle point. (B) The subthealthy adaptive landscape triggered by aberrantly augmented Nrf2 to yield a novel rise of setpoint at Pox. Its acute state is likely transited into another chronic state, while the intrinsic reactive compounds (IRC) were, at least in part, consumed along with Nrf1/TCF11 being declined by redox stress. (C) The pathogenically switching landscape was determined by redox stress-consumed IRC and decreased Nrf1/TCF11, leading to the onset of certain pathological phenotypes and even chronic pathogenesis. Of note, this cannot only be rescued, but conversely, further deteriorated by hyperactive Nrf2 under some conditions. (D) The pathological adaptive landscape is also likely transformed into chronic curable or even incurable disease states, at which the IRC was largely exhausted by severe redox stress, with the progressive loss of Nrf1’s function. (E) Geometric landscape of redox potential energy, with a strong correlation of redox adaptive responses to distinct redox stress statues (adapted from the model proposed by Lekaa Hussain 184).
A healthy redox homeostasis is maintained within a certain homeodynamic threshold range around P0 preset by Nrf1/TCF11-leading CHR to normal redox physiological fluctuations, in a robust basic redox metabolic network with cell respiration and aerobic energy metabolism (Figure 7A). According to the homeodynamic model (Figure S3) based on the theory for self-organization of dynamic systems by Lloyd D. et al. 182, homeostasis is only viewed as an exclusive mode of operation to emphasize the stability of the internal milieu toward perturbation, which is tightly governed by a series of feedback mechanisms controlling the normal physiological steady-state. That is to say, it is a relatively balanced (i.e., redox and anti-redox) stage of dynamics with monotonic states (fixed points). Since biological systems are indeed endowed with the dynamic capability to be self-referenced, self-organized and self-maintained in the eco-evo-devo process, they are placed as a steady state with high activity, particularly at certain phase transitions (of saddle points as a bistable redox switch at the excitable bifurcation, or contingently as a spontaneous oscillator with chaotic potentials so to lose their stability, but rapidly retake their resilience) 182 (Figures 7A and S3). Such processes could proceed on different spatiotemporal scales from those very rapid reactive processes between redox and anti-redox molecules within the membrane-compartmented spaces to other very slow evolutionary changes of, e.g., ‘redox-coded homeostasis’, in life histories 177 183.
When the redox homeostasis is threatened by stress, the response of life experiences at least three phases: i) alarm reaction, ii) adaption with resistance, and iii) exhaustion leading to ‘general adaption syndrome’ 144. The time course of such redox adaptation was also classified into instant (emergency) response, short-term (metabolic) and long-term (transcriptional) adaptations 111 185. In addition to homeostatic feedback regulations, it is also required for multi-hierarchical homeorhetic regulations from molecular, and cellular to organismal strata (Figure 6B). Once a homeostatic loss of stability at the redox excitable bifurcation to a certain extent, the heterostasis and even allostasis mechanisms are switched to reset a new point of Pox or Pre 186 187. The robustness of the homeostatic regulation is based on high-gain integral feedback mechanisms, while heterostasis could be associated with low-gain integral feedback processes, when organisms are submitted to the unitary-step disturbances or changes of the set-point (Pox/Pre) for the novel feedback loop at the entrance of subhealthy eustasis or pathological cacostasis, which depend on whether such new Pox/Pre are prescribed within an acceptable or even unacceptable ranges 188 (as shown in Figure 7B-D). Of note, the regulatory mechanisms for redox responsive adaptations are dependent on crucial roles of those key intrinsic reactive compounds (IRC), including important functional signaling molecules, metabolic enzymes, and transcription factors (e.g., Nrf1, Nrf2, HIF1, HSF and NF-κB) in reprogramming their critical signaling cascades, metabolism networks and target gene expression profiles insomuch as to dictate distinct redox physio-pathological phenotypes 64 65 87 88. If too much loss of homeostatic stability enables it to be gradually exhausted, so that its adaptive resilience is not fully recovered, or otherwise allostasis is overloaded, even to reach cacostasis, certain pathophysiological maladaptive responses are triggered, consequently leading to the putative pathogenic switches to chronic diseases, particularly when IRC is almost largely consumed or even exhausted, of which Nrf1 is diminished or abolished (as deciphered by adaptive landscapes in Figure 7C-D). Moreover, another explicit interpretation by a geometric landscape of redox potential energy coordinated with the redox responses to distinct redox states of different physio-pathological phenotypes is presented (in Figure 7E), as consistent with that model proposed by Lekaa Hussain 184.
NRF1 IS A LIVING FOSSIL’S TRANSCRIPTION FACTOR, THAT IS CLOSER THAN NRF2 TO THE ANCIENT ORTHOLOGUES ARISING FROM THE ECO-EVO-DEVO PROCESS OF LIFE HISTORIES
Just for certain limitations existing in the past three decades, the origin of CNC-bZIP proteins seems to be only traced back to vertebrates, although their highly conserved CNC domain was first identified in the Cnc gene from Drosophila melanogaster 189 and thereafter unraveled in the Skn-1 from Caenorhabditis elegans 190. Another noteworthy topic of such CNC-bZIP study is disproportionately focused on Nrf2 (also called NFE2L2), a stress-emergency responsive gene enabling to be rapidly examined by available experimental tools along with a necessary and powerful preference of its non-lethal knockout animals 87. The consequence was positively misleading to the putative state that the priority of Nrf2, together with its negative regulator Keap1 (Kelch-like ECH-associated protein 1), was evolutionally selected 191, so as to enable it to serve as a predominant and essential determinant responsible for antioxidant, detoxification and cytoprection against a variety of cellular stress 11 64 65 170 177 192 193 194. Nonetheless, such is not an accurately true case as a matter of objective facts that should be clarified hereby.
Nrf1 is much closer than Nrf2 to the ancient orthologues emerged during evolution of life
A neighbor-joining phylogenetic tree (Figure 8A) seems to be fan-shaped with three distinct clades and a bundle, to clarify the phylogenetic relationship of all selected CNC-bZIP family members by analyzing the evolutionary conservation of their amino acid sequences. Amongst them, a major clade is comprised of Nrf1 (also called NFE2L1, along with a long isoform TCF11 and another short form LCR-F1 or Nrf1β and), Nrf3 (also called NFE2L3) and Nach (i.e., Nrf and CNC homology) proteins from distinct metazoan species, which are much closer to their founding members Cnc and Skn-1 (Figure 8A, right panel). By contrast, Nrf2 and NFE2 p45 are closely clustered in the second clade, whilst the third clade is made up of the transcription repressors Bach1 and Bach2 (Figure 8A, left panel). These CNC-bZIP family members are also further gathered closer to both the sMaf/Maf and Jun subfamilies, within a relatively larger phylogenetic tree, that was constructed by distinct families of 495 bZIP proteins (Figure S4), as described previously in detail 114. This early-originated basic-region superfamily of transcription factors also includes those containing the basic helix-loop-helix zipper (bHLH-ZIP, e.g., SREBP1/2) or the bHLH-PAS domain (e.g., HIF1α). Such basic-region minimotifs, which were conjectured as a primordial peptide-replicated template 83, albeit with a rather lower fidelity, have been retaining divergently in most viral, bacterial and archaeal reigns, and all eukaryotic kingdoms of cellular life since the origin of their last common ancestor (LUCA, Figures S4 and S5).
Figure 8. FIGURE 8: The living fossil-like Nrf1 is much closer than Nrf2 to their commonly shared ancient orthologues.
(A) Two distinct models of the neighbor-joining phylogenetic tree of the CNC-bZIP family transcription factors, including Nach1 to Nach8, CncC, Skn-1, p45Nfe2, Nrf1, Nrf2 and Nrf3 from distinct species, as described elsewhere 200. (B) Schematic representation of distinct structural and functional domains of CNC-bZIP family members, along with some motifs indicated. For the detailed descriptions, please see the relevant text and another cited reference 87. (C) An alignment of multiple amino acid sequences within the DNA-binding CNC (conserved with the EHR)-adjoining basic regions from Nach1 to Nach8, CNC, Skn-1, Nrf1, MafG, and other putative homologous factors.
These CNC proteins except Skn-1 can heterodimerize with their partners sMaf 195 or other bZIP proteins (e.g., Jun, c-Fos, Fra1, ATF2, ATF4) 196 by physical interaction of their bZIP domains, before binding cognate target genes involved in antioxidant, detoxification and cytoprotection against oxidative and other stresses 197. Besides the bZIP region, the unique DNA-binding CNC domain is highly conserved in all the family members, including the D. melanogaster Cnc 198, C. elegans Skn-1 199 and other metazoan proteins Nach1 to Nach8 114, which emerged at the early evolutional stage of life histories (Figure 8B), but none of their orthologues are identified in plants and fungi. Of note, such a novel subgroup of Nach1-8 with high homology with all the vertebrate CNC-bZIP proteins (e.g., NFE2p45. Nrf1, Nrf2 and Nrf3) are identified to be predominantly present in the Echinodermata, Mollusca, Actiniaria, Placozoa, Porifera and bacteria, respectively (Figure 8A and B). Collectively, these findings demonstrate that the CNC-bZIP proteins are originated from the marine bacteria to the multicellular organism.
However, a perplexing gap appears to exist between the marine bacteria to the multicellular metazoa (e.g. Amphimedon queenslandica), because none of their orthologues have been identified in the unicellular protozoans. Further alignment of multiple amino acid sequences (Figure 8C) revealed that there still exists a conserved basic-adjoining region homologous with the CNC domain and another extended homology region (HER, within the Maf/sMaf family 201) in the filasterean bZIP protein (XP_004343898.1) from Capsaspora owczarzaki and also in the choanoflagellate bZIP protein (XP_001744453.1) from Monosiga brevicollis. Moreover, this is likely represented by a CNC-like Smc domain in the cyanobacteria bZIP protein (PHJ76996) from Nostoc linckia z2 (Figure 8C, bottom line). Together with the marine bacterial Nach 1/2, these suggest that they were endowed with such an ancestral conservativity from the bacteria to the protozoa, to be commonly shared by all four families of CNC, Maf/sMaf, ATF2 and XBP1, albeit with certain variations. In addition, a bZIP protein (KRG21159.1) is yielded by Candidatus Berkiella aquae, a g-proteobacterium that exists as the obligate intranuclear endosymbiont of freshwater amoebae 202 [202]. This suggests a putative horizontal gene transfer (HGT) may occur during the protozoan evolution.
Of note, only one or two Nach proteins are found in each species such as ascidian, sea urchin, octopus, fly and hydra, with no exception of CNC/EHR-like bZIP proteins in the aforementioned protozoan organisms. This indicates that the expansion and diversification of the CNC-bZIP family seem to take place only in the vertebrate, leading to the yield of four to ten homologues encoded by distinct genes 114. Further comparison of structural domains in these CNC-bZIP proteins (as deciphered in Figure 8B) revealed that functional distinctions between Nrf1 and Nrf2 are dictated predominantly by an extra membrane-binding NTD (N-terminal domain, which contain an ER-targeting NHB1 signal peptide and another protease-processing NHB2 motif) and another N-glycosylated transactivation (NST) domain in Nrf1, but not in Nrf2 203. Such ER-associated NTDs are also present in Nach3, Nach5, Nach6, Nach7, CncC, Skn-1A and Nrf3, implying they should be endowed with similar topobiological features to those conferred upon Nrf1 87 119 120. By contrast, the stability of Nrf2 and its transcriptional activity are principally negatively regulated by Keap1, a redox-sensing adaptor targeting the former CNC-bZIP protein to the ubiquitin-mediated proteasomal degradation system 204. The negative regulation of Nrf2 by Keap1 is dictated primarily by physical interaction of the DGR domain of Keap1 with the N-terminal Neh2 domain of Nrf2 205 206. Similar Keap1-binding Neh2L domains are represented in Nach3, Nach4, Nach6, Nach7 and Nach8, as well in CncC and Nrf1, but not Skn-1 (Figure 8B). Yet, Keap1 is also absent in the sponges, placozoans, sea anemones or nematodes, although putative Keap1-like orthologues were found in some invertebrates, such as ascidian, sea urchin, octopus and fruit fly 207.
Taken altogether, these demonstrate that Nrf1 rather than Nrf2 is much closer to its ancient orthologues (e.g., Nach, Skn-1 and Cnc) of this CNC-bZIP family emerged during the early evolution of life. This notion is also supported by the facts that distinct length isoforms of CNC or SKN-1, like Nrf1 are yielded from alternative splicing of various transcripts of their single genes, and ensuring alternative translation and post-translational processing of these proteins, an N-terminally-truncated isoform (as similar to Nrf1ΔN or TCF11ΔN) of which functions as done by Nrf2 (Figure 7B and C), whilst their full-length isoforms (CncC and Skn-1A) evinced similar to the intact Nrf1α/TCF11 (Figure 8B). Therefore, it is inferable that the vertebrate Nrf2 is evolutionally selected by genetic duplication of a putative Nrf1-like gene that has been trimmed off the negative regulatory NTD, which enables it to rapidly mediate an efficient emergence response to stress and thus acquire a ‘buying time’ for the robust homeostatic response mediated by Nrf1/TCF11.
Nrf1 is a living fossil of the CNC-bZIP transcription factors emerged in the redox eco-evo-devo process
From the origin of life and its co-evolution with the surrounding atmosphere (consisting of N2, O2, CO2, CH4) and ocean (SO4-2, P and Fe+2-containing) redox environments of life histories to give rise to diversity of the modern biomes on Earth was deciphered schematically in Figure 9. At least nine of the major historical events of life had occurred (as indicated on the top) throughout the entire eco-evo-devo process, nearly seven-eighths of which were dominantly placed on the sulfur-based reductive environments, whereas only the recent one-eighth of life histories was principally based on the oxygen-centered oxidative environments 37 48. In such distinct challenging conditions, the intracellular redox homeostasis of almost all life forms has steadily been maintained within a homeodynamic threshold range by evolving their intrinsic anti-redox responsive mechanisms (CHR, CSR, OHR and OSR), which are differentially monitored by the CNC-bZIP family transcription factors, as described above (in Figures 3, 4B and 6A).
Figure 9. FIGURE 9: Co-evolution of life with redox atmosphere and oceans throughout the post-Archean (about 4.0 Ga to present).
(A) Evolution of major constituents of the Earth’s atmosphere 208. Dinitrogen (N2, carmine line) may have tracked to the O2-levels due to an oxidative weathering and denitrification source of N2, but the changes in the partial pressure of nitrogen (pN2) are debated 209,210, as shown by a schematic of the speculative pN2 range in different time intervals consistent with very sparse proxy data (carmine shading). The O2 curve (blue line) shows a ‘classical, two-step’ view of atmospheric evolution 17,211: the first proposed O2 level of < 0.1% PAL between 1.8 and 0.8 Ga 40,212 and the second proposed O2-level of 10-40% PAL around 0.54 Ga 213. The median hydrogen carbon (CO2) with a 95% confidence interval (green lines) is from a carbonate-silicate climate model 214; this curve merges with a fit to CO2 proxy estimates from 0.42 Ga ago to present 215, also with various Precambrian pCO2 proxy estimates 216,217,218,219,220. A schematic history of methane (CH4) constraints (orange lines) is from a biogeochemical box model coupled to photochemistry 81, as consistent with possible biological CH4 fluxes into atmospheres of rising O2-levels at the GOE (Great Oxidation Event) and in the Neoproterozoic. The notion that such moderately high levels of methane may have contributed to greenhouse warming in the Proterozoic 221,222,223 has been disputed 224,225, which may depend on the fluxes from sources on land 226. The curve from ~0.4 Ga ago to the present is adapted from 227. (B-D) Evolution of marine sulfate concentrations [SO42-] (B) estimated by data sources 228,229,230,231. Similar variations in the ocean phosphorus concentrations [P] (C) 232,233,234,235. Evolution of the deep-water iron concentrations [Fe2+] (D, below storm wave base) 236, with the lower limit of iron concentrations for Banded Iron Formation (BIF) and Marine Red Beds (MRB) being 50 μM and 4 nM, respectively. (E) Ocean redox conditions have evolved through time 237,238. The evolution of oxygenic photosynthesis permitted episodic accumulation of O2 (i.e., ‘oxygen oases’) along the late Archean ocean margins. Widespread surface ocean oxygenation accompanied the GOE. Elevated rates of microbial sulfide production at sites of a high organic carbon export enabled the development of euxinic conditions at mid-depths (and in restricted basins). The deep oceans remained predominantly ferruginous 239. The expansion of ferruginous deep oceans is thought to have occurred during a major crustal growth event at 1.88 Ga and during the severe Neoproterozoic glaciations. Widespread ocean oxygenation commenced by the Ediacaran Period 82,240,241. Yet, significant oscillations in ocean redox conditions may have occurred until a Devonian oxygenation event (DOE) led to permanent ventilation of the oceans (except for sporadic and transient oceanic anoxic events). (F) The evolutionary history of life on the Earth. The earliest records of life (in oldest stromatolites) are as old as ~3.7 to 4.1 Ga 242,243. Oxygenic photosynthesis must be present before the GOE, either directly before the GOE 244 or as early as 3.0 Ga 40,55. The earliest convincing evidence for eukaryotic life is present at ~1.7 to 1.6 Ga 245, albeit the origin of eukaryotes could have been much earlier 246. Records of the multicellular eukaryotes appear as early as ~1.2 to 1.6 Ga 247,248. The first appearance of animals, as indicated by the biomarker evidence for early sponges, occurs during the Cyrogenian ‘Snowball Earth’ episode 249. The Neoproterozoic Oxygenation Event (NOE) possibly unleashed major biological innovations, including the appearance of new biological and ecological strategies: the first metazoans 249,250, the appearance of the first large and architecturally complex organisms during the Ediacaran 251, the Cambrian Explosion with subsequent rapid increases in diversity of species (yellow-to-red shaded area) 252,253, the emergence of mobility and predation 254,255. The upper logarithmic curve shows the increase of the maximum size of organisms throughout the Earth’s history, such as prokaryotes (orange dots), protists (dark green diamonds), vendobiont (probable multicellular eukaryotes, e.g. Dickinsonia, carmine square), animals (blue squares), vascular plants (green line), which was modified after Payne et al., 2009 256. Of note, all annotations on the bottom were based on Supplemental Figure S6, and interpreted in the text.
Co-evolutionary histories of life with its ambient redox environments
Redox evolution of the Earth’s atmosphere environments 208 was dependent on changes in the major constituents of small molecular gases, such as H2/H2S, NO/N2, O2/H2O2, and CO2/CH4. Of note, only one-eighth of life histories nearly to the present had relied on the oxygen-based redox ambient atmosphere, as shown by the O2 curve (Figure 9A). A ‘classical, two-step’ view of atmospheric evolution 17 211 revealed the first proposed O2 level of < 0.1% PAL between 1.8 and 0.8 Ga 40 212 and the second proposed O2 level of 10-40% PAL around 0.54 Ga 213. Another curve merges with a fit to CO2 proxy estimates from 0.42 Ga ago to the present 215, also with various Precambrian pCO2 proxy estimates 216 217 218 219 220. A schematic history of methane (CH4) is from a biogeochemical box model coupled to photochemistry 81, as consistent with possible biological CH4 fluxes into atmospheres of rising O2 levels at the GOE and in the Neoproterozoic oxygenation event (NOE). By contrast, the prior seven-eighths of life histories relied on sulfur-based redox environment, with early energy metabolism from the H2S/FeS and respiratory NO pathways 23 37 105. The NO is produced primarily by successively cascaded reduction by the NO3- → NO2-→ NO pathway, which is reduced to yield N2O, the latter continuously reduced to generate N2 (as shown in Figure 2).
The origin of life and its ensuing evolution was de facto dictated by evolving the ocean redox environments on the Earth 237 238. The beginning of life was recorded in the oldest stromatolites (Figure 9F) from ~3.7 to 4.1 Ga ago 242 243. That is, the origin of life was placed in an anoxic (no O2) and reducing (H2/H2S) environments, and also dominated by ferrous iron (Fe+2/FeS) in the ferruginous oceans, demonstrating that the first organisms (i.e., LUCA) were likely sulfur-metabolizing. About 200 million years later, anoxygenic photosynthesis appeared allowing organisms to escape from a chemotrophic existence by using H2S to reduce CO2 to yield organic carbon (e.g., CH4) while oxidizing sulfur to polysulfide (Sn) (Figure 9, on the top). In this anoxygenic process CO2 may be partially reduced to HCO3- along with H2O being oxidized to yield minor H2O2. Around 3.0 Ga when the efficiency of light-gathering antennae increased, H2O is sufficiently used as the reductant to generate O2 in oxygenic photosynthesis (appeared firstly in cyanobacteria). The evolution of oxygenic photosynthesis permitted an episodic accumulation of O2 (i.e., ‘oxygen oases’) along the late Archean ocean margins. Widespread surface ocean oxygenation accompanied the GOE in a slight increase of atmospheric O2 levels. Such slightly increased O2 in the atmospheric conditions enabled sulfur to be oxidized to sulfate (SO4-2) that was then washed to sea, in which this sulfur was also reduced insomuch as to form massive euxinic oceanic areas that were anoxic and sulfidic (H2S/RS) (Figure 9E). The elevated rates of microbial sulfide production at sites of a high organic carbon export enabled further development of euxinic conditions at mid-depths (and in the restricted basins), but the deep oceans remained predominantly ferruginous 239. Expansion of the ferruginous deep oceans is thought to have occurred during a major crustal growth event at 1.88 Ga and during the severe Neoproterozoic glaciations. Then widespread ocean oxygenation commenced by the Ediacaran Period 82 240 241. Yet, significant oscillations in the oceanic redox- stratified conditions may have occurred until a Devonian oxygenation event (DOE) led to permanent ventilation of the oceans, except for sporadic and transient oceanic anoxic events 82.
From the evolutionary history of life (Figure 9F), oxygenic photosynthesis must be present directly the GOE 244 or as early as 3.0 Ga 40 55. The earliest convincing evidence for eukaryotic life appeared in the euxinic environments at ~1.6 to 1.7 Ga 245 and shortly thereafter plants also emerged, albeit the origin of eukaryotes could have been much earlier 246. The records of multicellular eukaryotes appear as early as ~1.2 to 1.6 Ga 247 248. The first appearance of animals, as indicated by the biomarker evidence for early sponges, occurs during the Cyrogenian ‘Snowball Earth’ episode 249. The NOE occurred when a considerable amount of O2 was produced predominantly by plants, besides cyanobacteria, gradually rising to present-day levels, allowing the ocean to be sufficiently oxidized, such that the sulfide disappeared, before major biological innovations were unleashed. Those include the appearance of new biological and ecological strategies: the first metazoans 249 250, the first large and architecturally complex organisms during the Ediacaran 251, the Cambrian Explosion with subsequent rapid increases in diversity of species 252,253, along with the emergence of mobility and predation 254 255.
Nrf1 is a living fossil of the CNC-bZIP factors arising from distinct evolutionary stages of life
All those CNC-bZIP and CNC-like transcription factors existing in distinct species, so far as we have known, were marked according to the evolutionary tree of life (Figure S6, adapted from https://evogeneao.s3.amazonaws.com/images/tree_of_life/tree-of-life_2000.png ). The possible emergence of distinct evolutionary stages of life histories was markedly associated with the ecological co-evolution of their relevant ambient environments (Figure 9, on the bottom). Since the oldest stromatolites are an intriguing fissile of the prokaryotic life being first emerged from ~3.7 to 4.1 Ga ago 242 243, the facts that both Nach1 and Nach2, along with ancient CEBP were found in the marine g-proteobacteria 114, and their CNC-bZIP domains are highly conserved closer to those early originated animal Nach4, Nach5 (both in sponges), Nach6 (in anemones) and Nach3 (in placozoans) (Figure 8C) demonstrates that the CNC-bZIP family of transcription factors is at least early originated from the marine bacteria (Figure 9, on the bottom). Further, the vertebrate Nrf1 rather than Nrf2 or other homologues is evolutionarily conserved closer to the metazoan CNC-bZIP factors, such as Skn-1 (with no Keap1 in nematodes), CNC (in fruit flies), Nach7 (in octopus) and Nach8 (in sea urchin) (Figures 8 and 9). In addition, it is important to note that two bacterial transmembrane CNC-like transcription activators CadC and ToxR 257 258 were found in Escherichia coli and Vibrio cholerae, respectively (Figures 8C and 10). Taken together, these demonstrate that the transmembrane-associated Nrf1 is a living fossil-like CNC-bZIP factor, that is much closer to the above-mentioned ancient orthologues arising from distinct stages of life evolutionary histories, when compared with the water-soluble Nrf2 factor.
From the evo-evo-devo perspective, the euxinic oceanic reductive environments (H2S/RSS without O2) leads to the appearance of the first eukaryotes, i.e., unicellular protozoans, albeit after the GOE aroused from oxygenic photosynthesis in cyanobacteria (with CNC-like Smc domain-containing bZIP protein, PHJ76996). Coincidentally, two protozoan CNC/HER-like bZIP proteins (i.e., XP_004343898.1 and XP_001744453.1) were found to exist in the filasterean Capsaspora owczarzaki and the choanoflagellate Monosiga brevicollis, respectively, and also highly conserved with the CNC, Maf/sMaf, ATF2 and XBP1 families (Figure 8C). According to the endosymbiotic theories for eukaryote origin 259 260, the naissance of the chimeric eukaryote was accompanied by origin of the nucleus from the karyomastigont in amitochondriate protists. This notion is further supported by an obligate intranuclear endosymbiont of a g-proteobacterium in the freshwater amoebae Candidatus Berkiella aquae (encoding a bZIP protein, KRG21159.1) 202. Thereby, it is postulated that bacterial CNC/bZIP-encoding genes were allowed for the putative HGT to be retained in the earliest eukaryotes (i.e., the unicellular protists) and further differentiated to yield different ancient progenitors sharing with distinct families of versatile bZIP transcription factors emerged in the subsequently evolving protozoans, and even in the multicellular metazoans.
It is of equal importance to notice that the transmembrane CNC-bZIP transcription factors (Nach5) emerged as accompanied by the first appearance of animals, as indicated by the biomarker evidence for the early sponges 249. Similar ancient transmembrane-bound orthologues Nach3, Nach6 and Nach7 are present in placozoans, anemones and octopus, respectively, alongside CncC and Skn-1 (Figure 8). Besides, two additional bacterial transmembrane CNC-like transcription activators CadC and ToxR 257 258 were also found in E. coli and V. cholerae, respectively. Hence, it is inferable that a putative fusion gene encoding a transmembrane-associated polypeptide fused with another portion of CNC-bZIP protein is much likely generated by homologous recombination of an endosymbiont transmembrane CNC-like gene with another host CNC-bZIP gene and efficiently expressed during the origin of multicellular metazoans. The appearance of such a membrane-tethered CNC-bZIP factor enables the ancient animals to require adaptation to the H2S/RSS-based euxinic oceanic environments. Thereafter, the expansion and diversification of this CNC-bZIP family took place only in the vertebrate, leading to a yield of 6 to 10 homologues (e.g., Nrf1, Nrf2, Nrf3, p45NFE2, Bach1 and Bach2) encoded by distinct genes that had been duplicated and also differentiated during evolution 114. This is contributable to an efficient response to the NOE caused primarily by plant photosynthesis, which leads to the gradual appearance of the first large and architecturally complex organisms (e.g., vertebrates) and subsequent rapid increases in the diversity of life species 251 252 253.
Overall, the transmembrane-bound Nrf1, rather than water-soluble Nrf2, is a living fossil-like CNC-bZIP factor that is highly conserved with the aforementioned ancient orthologous members emerging at distinct stages of life evolutionary histories. Such objective facts demonstrate that Nrf1 is innately endowed to fulfill a subset of certain unique, intrinsic and indispensable biophysiological functions, which are distinctive from those done by Nrf2, at maintaining cell homeostasis and organ integrity 87. Conversely, loss of Nrf1’s function is inevitable to resulting in severe redox stress and pathological phenotypes 87 174. For example, the conditional knockout of Nrf1 in mouse livers leads to spontaneous non-alcoholic steatohepatitis (NASH) and subsequent malignant transformation into hepatoma 261 262. The full-length Nrf1α-specific knockout by two distinct gene-editing techniques in human HepaG2 cells leads to several redox stress and lipid deposition, along with metaflammation 263 264 and cancer malignance 265 266. Collectively, these indicate that Nrf1, particularly Nrf1α/TCF11, is intrinsically conferred to act as a potent cancer-repressor 123 167.
Cancer is likely defined as ‘oncoprotists’ by the eco-evo-devo ontology of its origin
From an integrated eco-evo-devo perspective 267 268 269, cancer could be defined by the ‘nature scientific essence of cancer’ to selectively survive as an atavistically specialized unicellular life form (like protists) originated from the host tissues comprising collective multicellular sets in a harmonious cooperation with distinct types of cell lineages. Generally, cancer is early originated from an oncogenically-specialized cell, that was derailed from the integrated multicellular collective controlling system setting for the host tissue homeostasis and had also undergone adaptive selection pressure by laws of Darwinian evolutionary dynamics under ecological conditions of redox stress damage and/or long-term inflammatory infection within the host tissues, particularly upon the loss of Nrf1. Ultimately, it turned out that such a specialized oncogenic cell-proliferating population has undergone an exclusive continuum of the retrogressive and degenerative process by reprogramming of cell metabolisms, genetics, epigenetics and topogenetics during intragenerational proliferation insomuch as to return the original status of its unicellular life. This is, in ontological essence, viewed as a single-cellular protozoan, hence designated as ‘oncoprotists’, some with primitive characteristics of polyploid giant cancer cells (PGCC) 270. This notion has been already evidenced by experimentally establishing almost all cancer unicellular lines and all relevant tumor-transplanted xenograft models. From this view, it is inferable that the most critical core of scientific questions in the current cancer research is how to decode the origin and evolution of oncoprotists (i.e., cancer life); that is, nothing in this core makes sense except in the light of cancer biology. Thereby, there is deduced to exist a vital key for cancer prevention strategy from dedifferentiation of host cells (N →1) to generate an ‘offbeat’ oncogenic organism (i.e., oncoprotist) and in the meantime, how to induce the oncoprotists to be redifferentiated further to switch onto the right normal physiological paths (1→ N).
UNIQUE TOPOGENETICS OF NRF1 AND ITS DYNAMIC DISLOCATION ACROSS MEMBRANES TO THE NUCLEUS BEFORE REGULATING TARGET GENES
The basic concepts of topogenetics about membrane heredity, membrane system platform and relevant coding rules in topobiology have been introduced above (in Section "Redox kinetic barriers dictated by membrane topogenesis (via 'topogenetic code')"). Briefly, the early origin of almost all cellular life forms was dictated predominantly by the topogenesis of the most primordial membrane platforms and subsequent evolving membrane systems with inheritance. These cellular membrane-based frameworks are multi-hierarchically cross-linked with intracellular and extracellular matrix-scaffolding networks to selectively self-assembly an adaptive ‘toposkeleton’ preset for the body plan to self-organize a topoform-specific life. Thereby, the membrane system platform is essentially constructed for laying a solid foundation of the origin of life and ensuing evolution. Such membrane-relevant topogenetics should be tightly governed by key transmembrane-molecular machinery, of which critically membrane-bound transcription factors are encompassed in order, to serve especially as essential controls of the topogenetic transformation, e.g., between the epithelial and mesenchymal status of cellular life.
The peptide minimotifs evolving from primitive templates to specific DNA-binding transcription factors
According to the Central Dogma (i.e., DANN→ RNA→ Protein), the diversity of almost all cellular life’s identifications and behaviors, with a vast variety of topoforms and relevant physio-pathological status should be predominantly determined by this dogma-governed gene expression profiling. Such gene-centered determinism dominating life sciences for over 70 years seems to be almost not questioned. Although the genetic codes for Central Dogma were selected by Nature during a long-term eco-evo-devo process, it is impossible that the first formation of such DNA encoding genes was de facto made in the primordial worlds (e.g., ‘chemical world, metabolic world, lipid world, peptide world, and RNA world’), all of which were likely to be included within the membrane-based vesicles at the early beginning of cellular life. Hence, it was conjectured that the primeval replicating templates in the reproducing pre-cells or proto-cells are likely executed by those living fossil-like minimotifs (e.g., ‘basic-region zipper’) 83 84 85, albeit with low infidelity (to yield multiple paraorthologous polypeptides by direct self-replication). Besides, the natural selection from such genetic minimotifs of peptides can also enable the ‘reverse translation’ to give rise to the first single-stranded nucleotides (RNAs and/or DNAs) of life’s origin 271. Such a reversed flow of the genetic information from the peptide minimotifs as templates to yield the primitive RNA/DNA (i.e., peptide → RNA/DNA), alongside another flow of known genetic information from RNA to DNA or topological folding chromatin 272, should thus collectively be referred to as the ‘Reverse Central Dogma’, an obligate rule that is de facto followed in the course of prion propagation 273, although not central to biology. Moreover, the route of information transfer from protein to the genome might not be completely blocked; that is, so formally, the strict validity of the Central Dogma could be questioned 272, possibly by the convergence of foundational discoveries from synthetic biology (e.g., of centriole).
Conversely, in the ensuing molecular evolutionary process, a house of such fissile-like minimotifs-containing polypeptides (e.g., the ‘basic-region zipper’ superfamily) were ultimately selected as distinct sets of specific DNA binding transcription factors, which are innately endowed to fulfill essential functions in controlling their cognate genes. Of note, a portion of such trans-acting transcription factors was further subjected to distinct topogentic folding to be integrated and positioned within and around the membrane-based platforms (Figure 10).
Figure 10. FIGURE 10: Unique topogenetic folding of Nrf1 and its dynamic dislocating across the ER membranes to the nucleus.
(A) A set of transmembrane transcription factors selected from all distinct kingdoms of life on the earth. These life species include prokaryotes (bacteria), and unicellular and multicellular eukaryotes (yeasts, algae, plants and complicated animals). Most of their functional domains of Nrf1, Nrf1D and others have been identified (in the relevant references) except the viral Gag. (B) Several highly conserved structures of the DNA-binding domains (e.g., CNC-bZIP, bHLH-ZIP) from those indicated key transcription factors, which were adapted from αFoldDB (https://www.uniprot.org/). (C) By membrane-topogenetic folding of the heretofore identified transmembrane transcription factors, they are divided into five distinct classes. Of note, Nrf1 is distinctive from other factors, because it is endowed with unique membrane-topogenetic folding and dynamic repositioning across membranes, before selective proteolytic processing of this CNC-bZIP factor and then dislocating from the ER to the nucleus, before regulating cognate genes.
Distinct topological folding of transmembrane transcription factors existing in all kingdoms of life
Such membrane-spanning transcription factors were predicted computationally to exist in all kingdoms of life, and even in viruses 274. Amongst them, transmembrane-associated CNC-ZIP transcription factors (Nrf1, Nrf1D, Nrf3, Skn-1A, CncC, Nach3, Nach5, Nach6, and Nach7 in Figure 7B) were identified by their conserved NHB1 signal sequences targeting the ER and anchoring the ER membranes 114 203 275. In bacteria, a group of membrane-spanning transcription factors (e.g., CadC, ToxR, ompR) with distinct sensors for pH, toxin, osmotic changes across the membranes (Figure 10A) were identified to regulate target genes by directly DNA-binding wHTH (winged helix-turn-helix) domains 257 258, which seems to be topologically folded as similar to that of the CNC-like domain (Figure 10B). One of the extensively studied pH-responsive systems is CadC, which is a genetic transmembrane one-component sensor for dynamic regulation of D-xylonic acid accumulation 276. The monotonic membrane-spanning ToxR regulon is also linked to the lipid-remodeling gene expression profile in V. cholerae 277; its life cycle is controlled by regulated proteolysis of ToxR allowing rapid adaptation to stress 278. NanH was identified to act as a bitonic membrane-spanning HTH transcription regulator that binds the promoters of genes involved in sialic acid metabolism of the anaerobic pathogen Clostridium perfringens 279 280, in which the sialidase mediates the early-life colonization by a pioneering gut commensal 281. This is just attributable to the fact that NanH facilitates commensal resilience and recovery after antibiotic treatment in a defined microbial community, revealing a co-evolutionary mechanism with microbiota by the host-derived glycans to promote stable colonization. Furthermore, by genetically dissecting the functions of regulatory proteins and enzymes responsible for catechol metabolism in the human gut bacterium Eggerthella lenta, another widespread family of the polytonic membrane-spanning LuxR-type transcriptional regulators was also revealed to be topologically folded, as similar to DadR, HcdR and CadR 282.
In yeasts, two homologous transmembrane NF-κB-related transcription factors Spt23 and Mga2 are processed selectively in proximity to the ER by an internal proteasomal cleavage within the ANK repeat domains (retaining a voltage-dependent potassium channel) to be released as mature trans-activators 283 (Figure 10B and C2). Both factors play distinctive roles in the activation of the Δ9 fatty acid desaturase gene OLE1 (crucial for de novo biosynthesis of unsaturated fatty acids as lipid building blocks) in Saccharomyces cerevisiae 284, but the fatty acid-mediated regulation of the Mga2 activity is independent of its proteolytic processing to yield a soluble transcription activator. Of note, Mga2p was originally identified as the first eukaryotic sensor for low temperature and oxygen to induce the OLE1 expression 285 through the low oxygen response elements (LOREs) in their promoter regions, but this gene is repressed by unsaturated fatty acids 286. The OLE pathway is generally accepted as the best-characterized, eukaryotic sense-and-control system to regulate the membrane lipid saturation by Spt23 and Mga2 287, two key factors to determine the maintenance of a fluid lipid bilayer as membrane integrity and even cell viability. This is just based on the fact that such membrane fluidity and phase behavior are dictated by a proper proportion of both saturated and unsaturated acyl chains in the composition of membrane lipids.
In almost all eukaryotes from yeast to humans, another link exists between the ER membrane lipid sensing by a juxta-membrane amphipathic helix within the transmembrane domain of inositol requiring enzyme 1 (IRE1, acting as both kinase and endoribonuclease) and the resultant IRE1 signaling activation by detecting lipid bilayer stress to trigger the unfolded protein response (UPR) mediated by XBP1 (along with its homologous HAC1 in yeasts and bZIP60 in plants) 288. This fissile-like IRE1-XBP1-UPR axis 289 is induced by lipid disequilibrium to counteract membrane stress-induced cell death by reprogramming protein homeostasis and maintaining membrane functions without affecting its composition 290. For this, the expression of different responsive genes to lipid bilayer stress and/or unfolded protein stress is regulated by spliced XBP1/HAC1/bZIP60 through the IRE1 sensor 291. However, the unspliced XBP1u mRNA and its protein are targeted to the ER membrane 292 293 294. Under normal conditions, the prototypic XBP1u protein is anchored within membranes through its C-terminal transmembrane (TMc) region (Figure 10C2), in a topological fashion similar to the C-terminal Nrf1D, before eliciting its unique function as a transcriptional repressor against its spliced effects 114. Upon exposure to ER stress, the splicing of XBP1u mRNA transcripts by IRE1 to remove 26 nucleotides gives rise to an open reading frame-shifting variant XBP1s (Figure 10B), which lacks an available TM-targeting peptide to directly translocate the nucleus and regulate target genes involved in the UPR 289. Similarly, the TMc peptide of prototypic DMRT2u (of 226 aa) enables it to anchor within membranes (Figure 10C2), but alternative splicing of its transcripts in the stop codon-containing exon 4 gives rise to a fusion protein (DMRT2s) with an additional 328-aa polypeptide sharing 58% identity with Terra critical for somitogenesis and sex determination 295.
Another classic ER stress signaling axis to UPR is monitored by the TM sensor ATF6, which is folded to adapt its initial membrane-topology within and around the ER (Figure 10C3). If stimulated by ER stress, it is transported to the Golgi apparatus, in which this bZIP protein is allowed for the progressive two-step process by Site-1 and Site-2 proteases (i.e., S1P and S2P) to yield a cleaved ATF6n factor 296 297. Then, ATF6n is released to enter the nucleus and activate target genes driven by either UPR elements or ESRE (ER stress response element) within their promoter regions. Similar topological folding and processing also take place in the case of OASIS (Figure 10C3). By contrast, although sterol regulatory element binding protein 1 (SREBP1) contains two TM domains with distinct local topologies integrated within and around the ER, only its TM1 is folded in a similar orientation to that of ATF6. When its target genes are required for cholesterol and other lipid synthesis, SREBP1 is allowed for a similar transfer to ATF6 and then dislocated from the ER through the Golgi to the nucleus (Figure 10C3). This processing is attributed to intramembrane proteolysis by S1P and S2P, successively, in the Golgi apparatus so to generate a cleaved activator SREBP1n 297 298. Additional evolutionarily conserved TM-bound transcription factor MYRF (myelin regulatory factor) was identified in invertebrates to vertebrates, which is subject to proteolytic self-processing into an active factor required for myelin development and relevant diseases 299 300 301 302. Overall, the intracellular redox, protein and lipid homeostasis all are robustly maintained and thereby tightly governed by all aforementioned transmembrane proteins together with other canonical sensors and transducers increasing during evolution from yeasts to vertebrates in the response to distinct types of stresses.
Unique topological processing of Nrf1 to yield an active CNC-bZIP factor along with short isoforms
The unique membrane-topogenetic folding of Nrf1, its post-synthetic modifying and proteolytic processing in close proximity to the ER were comprehensively reviewed in detail 87 167. Briefly, the NHB1 signal peptide of Nrf1 enables its TM1 to be integrally anchored within the ER membranes in a co-translocational way 203 303, and also determines its topological folding of adjacent domains (and amphipathic helix-adjoining domains) to be selectively partitioned into either the luminal side (e.g., its transactivation domains) or the cytoplasmic side (e.g., its DNA-binding CNC-bZIP domains) of membranes 275 304 (Figure 10C5). In the ER lumen, Nrf1 is allowed for N-linked glycosylation in its NST domain by oligosaccharyl transferase to yield an inactive glycoprotein 203 305 306. When required for biological cues, dynamic repositioning of the luminal-resident transactivation domain (TAD) of this intact CNC-bZIP factor is driven by p97-fueled retrotranslocation machinery through the Hrd1-leading retrotranslocon across membranes to enter the cytoplasmic side 275. Once its NST domain of Nrf1 is dislocated out of the ER, this protein is allowed for deglycosylation by N-glycanase 1 (NGLY1), so that its amino acid sequence is re-edited from those glycosylated asparagines to deglycosylated aspartates, thus potentiating its transactivation activity 275 307; (similar work was later confirmed on Skn-1 308). In the cytoplasmic subcellular compartments, Nrf1 is also likely modified by O-GlcNAcylation in its Neh2L region of TADs 309 and its Neh6L adjacent to CNC-bZIP domain, respectively 310 311. Such similar but differential modifications can bi-directionally (i.e., negatively and positively) monitor the protein stability of Nrf1 and its transactivation activity. In the extra-ER subcellular compartments, this CNC-bZIP protein is further subjected to selective proteolytic processing by cytosolic proteases DDI1/2 or proteasomes to yield an active N-terminally-truncated CNC-bZIP factor (e.g., Nrf1/TCF11ΔN), together with distinct lengths of other short isoforms (e.g., Nrf1β and Nrf1γ) 122 312 313 314. Such distinctive functional isoforms are released from membranes and translocated into the nucleus, in which each isoform of Nrf1 is only enabled to form a functional heterodimer with its partner sMaf or other bZIP proteins, before ensuring them to exert different transcriptional regulation of target genes 87.
Collectively different tempo-spatial modifications and selective proteolytic processing of Nrf1 are dominantly dictated by the dynamic topovectorial folding and trafficking of this CNC-bZIP protein within and around the ER to dislocate the nucleus, which determines its protein stability and transcription activity to regulate cognate genes 87 315. This notion is further supported by experimental evidence provided by Martinon’s group 316. They also found that both Rad23A and Rad23B are required for proteolytic processing of Nrf1 by DDI2, which was promoted by HRD1-mediated ubiquitination of this CNC-bZIP protein 316. However, our experimental evidence revealed that the ubiquitination of Nrf1 is not a prerequisite for its proteolytic processing, but it is further activated by de-ubiquitination by USP19, enabling Nrf1 to rescue from the ER-associated protein degradation (ERAD) by proteasomes 317. Like Rad23 and Dsk2, DDI2 can also serve as a shuttling factor, but it contains a retroviral protease domain that influences the binding of ubiquitylated proteins (e.g., Nrf1) through its N-terminal ubiquitin-like domain (UBL) and ensuing proteasomal degradation 318. Altogether, these indicate that DDI2 determines the selective proteolytic processing of Nrf1 to either yield a mature active factor (by this protease) or to be targeted for proteasomal degradation (via this shuttling factor). However, Nrf1 is, indeed, also likely processed by other DDI1/2-independent proteolytic pathways 319. More importantly, rapid recovery of proteasome activity from sub-lethal proteasome inhibitors is DDI2-independent, which occurs before transcription of proteasomal genes is upregulated by Nrf1 but requires protein translation 320. The N-terminal domain of Nrf1 (containing NHB1 and NHB2) was further predicated to fold as an atypical UBL 122, similar to the equivalents of DDI1, DDI2, Rad23 and Dsk2 (Figure S7). Overall, the selective proteolytic processing of Nrf1 by DDI1/2 and/or proteasomes depends on the dynamic tempo-spatial (re)positioning of NHB2 adjoining with its putative UBL domain in different topovectorially-localized subcellular compartments 122 312 321, even though the unique topogenetic folding of Nrf1 is dictated by its NHB1-adjioning TM1 orientation within and around the ER.
It should be important to note that in unstressed conditions, only a fraction of Nrf1 is allowed for proteolytic degradation mediated by ubiquitin proteasome system, because most of this CNC-bZIP protein is in situ protected by ER membranes and then ferried through such ER-associated endomembrane network to reach the inner nuclear membrane (INM) 305, whilst its functional domains are repositioned in the nucleoplasmic compartments, so that it can be enabled to exert its unique physio-biological functions. In such topogenetic dislocation of Nrf1 from the ER to the nucleus, it is likely allowed for its topovectorial processing by another DDI1/2-independent pathway to yield a mature CNC-bZIP factor, which activates its cognate genes responsible for maintaining normal physiological homeostasis and organ integrity.
In addition, a specific variant Nrf1D arises from alternative splicing of mRNA transcripts to give rise to a reading frameshift mutation, leading to a constitutive substitution of the intact Nrf1’s C-terminal 72-aa residues (covering the second half of its zipper motif to the C-terminal Neh3L domain) by another extended 80-aa stretch, which was folded into a redox-sensitive transmembrane domain (TMc, Figure 10A), enabling it to be tightly integrated within the ER membranes, beyond its NHB1-adjoining TM1 region 322. Furthermore, Nrf1D was hitherto identified to act as the first candidate secretory transcription factor, albeit its precursor was predicated to fold as an integral transmembrane-bound CNC-bZIP protein that entails dynamic topologies within and across ER membranes 322. However, it is unknown about how to be proteolytically processed by a not-yet-identified protease within the TMc-adjoining domain, before being unleashed from the ER and then secreted to enter the blood.
UNIQUE PATHOPHYSIOLOGICAL PHENOTYPES OF NRF1 THAT ARE DISTINCTIVE FROM NRF2
From the molecular phylogenetic evolution of the CNC-bZIP family as described above (Figure 8), its members are diverged up on vertebrates 114. Of note, Nrf1 and Nrf2 are two major principal CNC-bZIP members in mammalians, of which Nrf1 appears to act de facto as an orthologue possibly by gene vertical transfer from its ancestors, whilst Nrf2, together with other homologues, should be viewed as a redundant paralogue (i.e., para-orthologues). Such ratiocination is convincingly evidenced by supportive gene-targeting experiments, revealing an objective fact that global Nrf2-/- knockout (KO) mice are viable and fertile, with neither any obvious defects nor typical pathological phenotypes (e.g., spontaneous cancer) occurring during embryonic development and postnatal growth 118 323. This demonstrates that Nrf2 is not necessary for normal development and healthy growth 324, even though Nrf2-/- mice were observed to be more susceptible than wild-type mice to chemical carcinogens 325. By contrast, Nrf1 is indispensable for determining cell homeostasis and organ integrity, because it is innately endowed with unique remarkable features that are distinctive from Nrf2 87 167 (Figure 11A and B). This is just based on those facts that were discovered by gene-targeting strategies for KO of Nrf1 that are employed to create distinct animal models with significant pathological phenotypes (Figure 11C) 261 262 326 327 328 329.
Figure 11. FIGURE 11: Unique and significant pathophysiological functions of Nrf1 that are distinguishable from Nrf2.
(A) Schematic diagram of inter-regulation between Nrf1 and Nrf2, to exert uniquely differentiated yet integrated roles in governing intrinsic anti-redox compounds involved within multi-hierarchical signaling networks so as to mediate adaptive cytoprotective responses against a variety of cellular stress. (B) Functional distinctions between Nrf1 and Nrf2 evinced in at least 15 different aspects. Nrf1 is manifested as its unique physio-pathological functions that are distinctive or event absent from Nrf2. By sharp contrast, Nrf2 acts as a versatile chameleon-like master regulon and thus often plays certain ‘double-edged sword’ effects on some aspects. (C) Schematic representation of different tissue-specific loss of Nrf1’s function in animal models, which are all significantly manifested with distinct pathophysiological phenotypes. Rather, constitutive activation of Nrf1 (to gain its function in Nrf1-Tg:MGRD mice) can also give rise to observing phonotypes, which were induced by a high-fat diet.
Global KO of Nrf1 results in embryonic lethality
Apart from elevated expression in the heart, midbrain and head mesenchyme between embryonic day (E) 8 and 9, the single Nrf1/Nfe2l1 gene is ubiquitously expressed with a constant level of its mRNA transcripts detected in all other tissues from E7.5 to E17.5 330. Conversely, global KO of Nrf1-/- in mice leads to embryonic lethality at E6.5 to E14.5, resulting from severe oxidative stress damages 326 327 328. This presages that the loss of Nrf1 cannot be compensated by Nrf2, even though both factors can elicit similar overlapping functions in regulating ARE-driven gene expression 331 as confirmed by their double KO (Nrf1-/-:Nrf2-/-) mouse model 332. This fact demonstrates that Nrf1, rather than Nrf2, fulfills its unique and indispensable functions for embryonic development.
Genetic deletion of Nrf1’s aa 172-741 causes embryonic lethality by blocking mesoderm formation
The first global KO mutant of Nrf1 (i.e., Lcrf1tm1uab, directly deleting 3.5-kb of its gene sequence with a loss of its aa 172-741) resulted in the embryonic lethality in early gastrulation on Black Swiss outbred backgrounds 327. The Nrf1-/- embryos developed to the late egg cylinder stage indistinguishable from wild-type counterparts, but thereafter arrested at E6.5 and most died before E7.5. This is attributable to the failure to form the primitive streak mesoderm with no Brachyury (T) gene expression, even though ectoderm and visceral endoderm layers appeared normal. However, the homozygous Nrf1-/- defect was rescued after injection into wild-type blastocysts, and such mutant embryonic stem cells (ESCs) remained to contribute to all cell lineages in examined chimeras 327. Overall, this Nrf1-/- defect, despite being not cell-autonomous, demonstrates that the unique function of Nrf1 is essentially exerted for the transcriptional expression of a subset of critical genes that are constitutively involved in controlling the mesoderm formation (principally by epithelial mesenchymal transition (EMT) 333 334 335).
Targeted disruption of Nrf1’s bZIP domain causes embryonic death of anemia
The second global knock-in mutant of Nrf1 (i.e., Nrf1rPGK-neo, by reversely inserting phosphoglycerate kinase-neomycin cassette was into 5‘-end of Nrf1’s bZIP-coding region for targeted disruption of Nrf1) resulted in embryonic lethality at mid-late gestation from E13.5 to E18.5 on C57BL/6J blastocyst background 328. The Nrf1-/- embryos died in utero of decreased definitive enucleated red cells and the ensuing anemia, which results from impaired maturation of erythroid progenitors in the microenvironments of the foetal liver, but without increased apoptosis of the haematopoietic cells 328. Despite such a lack of cell autonomy, Nrf1 retains to serve as an essential gene for red cell maturation because none of the compensatory functions were efficiently executed by haematopoiesis-specific NF-E2 p45, Nrf2 and/or other CNC-bZIP factors that are expressed at high levels 336 337 338. Furtherly, the hepatocyte-specific function of Nrf1 in foetal and adult livers is not rescued by the putative compensative function of Nrf2 172. This suggests that there may exist certain overlapping functions of two CNC/bZIP factors and their potential redundancy in early embryogenesis and development. This is supportively evidenced by double KO of Nrf1-/-:Nrf2-/- leading to a relatively earlier embryonic death at E10.5, which was attributable to extensively increased apoptosis and severe oxidative stress-induced growth retardation 332.
Then, mechanistic studies revealed that the p53-Noxa-mediated apoptosis was markedly induced by elevated ROS (by measuring hydrogen peroxide and singlet oxygen), which results from severely impaired expression of antioxidant defense genes (e.g. Mt-1, Gclm, Gclc, Ferritin H, Ho-1, Nqo1, but not Sod1/2), when compared to the individual Nrf1-/- or Nrf2-/- 332. This implies that there exists at least a part of the overlapping functions of Nrf1 and Nrf2 in regulating those genes essential for the intracellular redox homeostasis during early embryogenesis, which is determined possibly by both their co-expression patterns 337 338 339 and their amino acid sequence similarity beyond the CNC/bZIP domains 87. In addition, MG132-induced transcriptional expression of the proteasome (PSM) genes was also abrogated in the mouse embryonic fibroblasts (MEFs) of Nrf1-/- , but not of Nrf2-/- 340. Lastly, a disparity in such obvious pathophysiological phenotypes between Nrf1rPGK-neo 328 and Lcrf1tm1uab 327 is much likely to be attributable to different strategic gene manipulations, because the former Nrf1rPGK-neo mice also remained to be allowed for varying expression of certain Nrf1 isoforms (e.g., a C-terminally-truncated negative mutant) 326 328 340 341 342.
Genetic ablation of Nrf1’s bZIP domain leads to the hepatocyte apoptosis in the late gestation
Additionally, a lethal phenotype of the homozygous Nrf1-/- embryos was obtained by deleting its 2.2-kb genomic fragment encoding the bZIP domain to yield the Nrf1lacZ mice 172), which was similar to that of Nrf1rPGK-neo; their livers were smaller, lighter and hypoplastic, prominently by E13.5-E14.5 328. However, such developmental arrest cannot be interpreted by the impaired erythropoiesis in the foetal liver, because these erythropoietic cells still grew normally in vitro and the Nrf1-/- ESCs were also efficiently contributed to erythroid cells of chimeric mice generated with the wild-type blastocysts 328. Several chimeric embryos were also observed with anemia, which occurred before the detection of cell death in the liver parenchyma 172. From this, it is inferable that the anemia is secondary to the failure to sustain haematopoiesis in the impaired liver microenvironment.
To circumvent the embryonic lethality, alternative chimeric mice were generated by injecting positive Nrf1-/- ESC clones with 129/Sv background into the C57BL/6J mouse blastocysts where Nrf1 is normally expressed 172. By characterizing these chimeric mice at 8 to 16 weeks of age, it was found that loss of Nrf1 resulted in an impaired contribution of such Nrf1-/- mutant ESCs to the adult, rather than foetal, hepatocytes, even though they were still contributable to other tissues (e.g., lung, kidney, muscle and heart) in the adult animals, wherein Nrf1 was highly expressed, if under normal genetic conditions 172. Significantly, although the Nrf1-/- ESCs were contributable to the foetal liver development at E14.5, the hepatocytes in the chimeric embryos underwent widespread apoptosis in late gestation 172. Further examinations uncovered that the hepatocyte apoptosis resulted from increased oxidative stress and decreased expression of antioxidant genes (e.g., Gclc, Gclm, Gpx1, Ho-1, and Mt-1/2). Therefore, these demonstrate a cell-autonomous role for Nrf1 in protecting the hepatocytes from apoptosis and also enabling their healthy survival during late foetal development, primarily by maintaining normal redox homeostasis.
Liver-specific KO of Nrf1 causes spontaneous development of NASH and hepatoma
Since there existed massive cell death and degeneration in the livers of chimeric embryos derived from the Nrf1-/- ESCs 172, such chimeric animal models cannot be employed to determine the critical role of Nrf1 in the maturation of hepatocytes. To bypass this obstacle, conditional KO models of Nrf1 in the mouse livers were created by using a specific Cre-loxP transgenic system, aiming to determine the unique essential function of Nrf1 in adult hepatocytes beyond embryonic development 261 262.
Adult hepatocytes-specific deletion of Nrf1’s aa 296-741 results in NASH and hepatoma
Liver-specific KO of Nrf1 (to delete the fourth exon encoding aa 296-741, i.e., LCR-F1/Nrf1β) in the adult mouse resulted in a typically pathologic phenotype that resembles NASH and hepatic neoplasia, including hepatocellular adenomas and carcinomas, which spontaneously developed as early as four months after birth 261. Before cancer development, the Nrf1-/- livers also exhibited interrelated steatosis, apoptosis, necrosis, inflammation and fibrosis. In addition to such precancerous lesions, loss of Nrf1-/- per se may also be directly contributable to tumourigenesis by promoting chromosome mis-segregation 343. The tamoxifen-inducible KO of Nrf1-/- (from Nrf1flox/flox:Cre-ERT2) increased the numbers of abnormal nuclei and micronuclei by 3-fold higher than controls. Such Nrf1-/--led genetic instability appears to be closely associated with decreased expression of the kinetochore genes Ndc80, Nuf2, and Spc25, as bad as the spindle assembly checkpoint gene Sgol1 343. Together, these suggest a possibility that Nrf1 could function as a tumor repressor in the hepatocytes.
To gain an insight into the molecular pathological basis for NASH caused by Nrf1-/- in livers, further experiments revealed that the Nrf1-deficient hepatocytes acquired for increased susceptibility to oxidative stress and relevant damages, along with down-regulation of some ARE-battery genes (e.g. Gstm3, Gstm6 and Gstp2) but up-regulation of Cyp4A genes 261. The loss of Nrf1’s function resulted in a significant increase in the intracellular ROS levels, which were at least in part generated by β-oxidation of fatty acid using proliferated microsomal CYP4A (i.e., in the ER). The increased ROS levels are also associated with elevated lipid and other pathogenesis leading to NASH. Similar pathological damages were also observed in the mouse liver of another hepatocyte-specific Nrf1-/- model 262. Such pathophysiological phenotypes demonstrate that Nrf1 acts as a unique vital player in mediating the expression of critical genes for maintaining intracellular redox and lipid homeostasis in livers. Further experimental evidence revealed that lipid accumulation in Nrf1-/- livers at five weeks resulted from the up-regulation of 1,500 genes and down-regulation of 1,700 genes 344. Such genes involved in lipid metabolism (e.g., Lipin1, PGC-1β, PPARα), amino acid (e.g., methionine) metabolism, the TCA cycle and mitochondrial respiration, as well as 26S proteasomes, were decreased, whereas other genes responsible for the cell cycle and DNA replication were increased, but these Nrf1-target genes are unaffected by loss of Nrf2 or Keap1.
A bulk of ubiquitinated and/or oxidative damaged proteins, besides lipids, was also accumulated in the Nrf1-/- hepatocytes, leading to the ER stress-associated steatosis 345. This is just attributed to impaired transcription of the PSM genes and increased expression of ER stress response genes (e.g., Atf4, Atf6, Bip, Chop, Gadd45β, Herp); this was accompanied by phosphorylation of the PERK-eIF2α signaling 345. Further microarray analysis revealed down-regulation of 52 Nrf1-dependent genes (i.e. Mt1/2, Clrf, Gcn20, Gadd45γ, Mfsd3, Pdk4 and Spp3) by >= 3-fold. Intriguingly, the adaptive activation of 20 Nrf2-target genes by the single KO of Nrf1-/- was abolished by another double KO of Nrf1:Nrf2 262. This demonstrates that Nrf1 exerts an essential physiological function required for the basal constitutive expression of a subset of cytoprotective responsive genes against endogenous (redox, proteotoxic and lipotoxic) stresses (that trigger the activation of Nrf2). Rather, no significant changes in those prototypic Nrf2-target genes (e.g., Gclc, Gclm, Gss, Nqo1) were observed upon acute hepatic loss of Nrf1 in the 3-methylcholanthrene- inducible KO mice (Nrf1flox/flox:Cyp1A1-Cre), which also led to profound NASH, but without obvious oxidative stress 346. Collectively, these demonstrate that Nrf1 enables to regulate a separate battery of genes, that are distinctive from those regulated by Nrf2.
Cholesterol-led NASH is deteriorated by the hepatocytes-specific loss of Nrf1’s bZIP domain
The hepatocyte-specific KO of Nrf1 (to delete a fragment spanning exons 4 and 5 of this gene encoding its DNA-binding domain in the homozygous mice obtained by crossbreeding C57BL/6N-A/a chimeric males with C57BL/6J females) led to the substantial aggravation of cholesterol-led pathological phenotype in the liver that resembles human hepatosteatosis and NASH 347. Such cholesterol-fed Nrf1-/- mice developed dramatically weighted fatty livers, showing massive lipid accumulation and indications of hepatocyte ballooning and damage, although no increases in their body weights, as compared to wild-type control mice 347. The cholesterol-exposed Nrf1-/- mice exhibited a substantial rise in the cholesterol esters accounting for more than 50% of total lipid in the livers. Such an elevated presence of cholesterol, cholesterol ester, and cardiolipin, whilst all other classes were unchanged, coincided with a greater ratio of cholesterol to phospholipid in livers. These indicated a critical physiological role of Nrf1 for the hepatocytes in protecting the livers from excessive cholesterol. This notion is further evidenced by subsequent experiments, revealing that Nrf1 controls a transcriptional program for hepatocyte adaptation to cholesterol as a means of averting stress and limiting cholesterol accumulation, although repression of such Nrf1 activity is indeed evoked by cholesterol 347. This repression of Nrf1 by cholesterol is further aggravated by directly sequestrating this CNC-bZIP factor within ER membranes through its cholesterol recognition amino acid consensus (CRAC) motifs 122 275 304 347, such that their connecting (PEST-)degrons can be buried in the lumen and hence escape from its proteolytic processing, to form a negative regulatory feedback circuit on the Nrf1-target genes.
Conversely, Nrf1-deficient livers develop severe pathological problems, because they were relatively refractory to the transcriptional changes induced by a cholesterol challenge, i.e., only within 93 differentially expressed genes (DEGs, 0.91%) out of 10,174 detectable genes, whereas 826 DEGs (8.12%) were measured in cholesterol-fed Nrf1 wild-type mice 347. Further, 790 DEGs identified in the wild-type cases were absent from Nrf1-/- livers, which were defined as Nrf1-dependent genes regulated by cholesterol, and enriched by gene ontology clustering to the acute inflammatory response, lipid transport and sterol metabolic process 347. Further experimental analysis of Nrf1-/- livers with cholesterol-led increased levels of H2O2 and phosphorylated JNKs, revealed that Nrf1 suppresses cholesterol accumulation and stress-triggering inflammation (NASH) by down-regulated CD36 (and AbcA1, AbcG1, Gltp, ApoC2, F4/80, C1Q8, Orm2, Saa2), but also promotes cholesterol excretion by up-regulated Cyp7a1, Cyp7b1 and Cyp8b1 (besides Ces1f and Insig1), when compared to wild-type controls. Notably, induction of Srebp1c, AbcA1 and AbcG1 by cholesterol or the liver X receptor (LXR) agonist GW3965 in Nrf1-/- primary hepatocytes was blunted by ΔNT-Nrf1, which acts as a constitutively active but cholesterol insensitive isoform of Nrf1, but could not rescue Nrf1-deficient livers. This implies that this much likely relates to an interference of the nuclearly-located Nrf1 factor on LXR (and/or SREBP1), which is consistent with the role of LXR as a multifaceted countermeasure against excess cholesterol. Besides, two ER membrane-spanning transcription factors Nrf1 and SREBP2 (Figure 10) are also likely co-evolved as a ‘Yin-Yang’ counterbalance whereby SREBP2 promotes cholesterol production, while Nrf1 promotes cholesterol removal (Figure 12), to achieve cholesterol homeostasis and stabilize relevant metabolic activity.
Figure 12. FIGURE 12: Comparison of liver-specific Nrf1-/- phenotypes with those of the constitutive active Nrf1-Tg:MGRD mice.
(A) Schematic representation of the collective pathophysiological phenotypes of liver-specific Nrf1-/- mice, which are manifested with spontaneous development of progressive fatty liver diseases, such as hepatosteatosis, nonalcoholic steatohepatitis (NASH) or metabolism-associated steatohepatitis (MASH) and even hepatoma, as also accompanied by reduced glycemia (hypoglycemia) in some cases. Of note, a major pathogenic mechanism accounting for these phenotypes results from disrupting the ‘Yin-Yang’ counterbalance between Nrf1 and SREBP2/LXR 347. (B) The constitutive activation of Nrf1-Tg:MGRD mice to gain its function also results in a lean phenotype with insulin resistance and even development of diabetes mellitus, which are more obviously induced by high-fat diet 329, but ameliorated by heterozygous Nrf1-/- mice.
The pathogenesis of NASH is accelerated by combined deficiency of Nrf1 and Nrf2 in hepatocytes
The reduced growth of Nrf1, but not Nrf2-deficient mice (with 80% knocked out by floxed Nrf1/Nrf2-encoding alleles at 14 days after infecting a liver-targeting adeno-associated virus expressing Cre recombinase via thyroxine binding globulin promoter) was observed, albeit both groups exhibited normal appearance and behavior 348. By contrast, substantial weight loss and morbidity (e.g., poor grooming and slow movement) were caused by both deficiencies of Nrf1:Nrf2; such effects were so severe that 46% (5/11) of males and 27% (3/11) of females did not survive for 28 days 348. This is attributable to increased lipids (i.e., triglyceride and cholesterol) deposited in the livers of combined Nrf1:Nrf2 deficient mice, along with sex-dependent increases in the plasma cholesterol, low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) cholesterols in the males but not females, apart from reduced secretion of liver VLDL in Nrf1- or Nrf1:Nrf2-deficient mice.
The histopathological phenotype of modestly increased steatosis and inflammation (i.e., steatohepatitis) was manifested in the Nrf1, but not Nrf2-deficient livers, and their combined deficiency caused a significant phenotype of steatohepatitis, resulting in the hepatocyte ballooning 348. This was accompanied by increased mRNA levels of chemokine ligand 2 (ccl2), TNFα, TGFβ, and collagens (col1a1, col1a2, col3a1), and also increased plasma alanine transaminase (ALT) in Nrf1:Nrf2, or Nrf1, but not Nrf2 deficient livers. The steatohepatitis caused by Nrf1-deficiency was also featured by p62-enriched Mallory-Denk bodies, intracellular hyaline inclusion bodies or aggresomes, aside from lipid droplets. Cholesterol crystals, as a hallmark of steatohepatitis and hepatic cholesterol overload 349 350, were determined in Nrf1 but not Nrf2-deficient livers, and significantly increased by combined deficiency of both factors in both males and females 348. Collectively, these demonstrate certain complementary roles of Nrf1 and Nrf2 in guarding against hepatic cholesterol overload, increased triglyceride storage, cholesterol crystallization, and diet-induced steatohepatitis, and the roles are also vital for whole-body viability. Conversely, the combined deficiency of hepatocyte Nrf1:Nrf2 accelerated the pathogenesis of steatohepatitis, as accompanied by increased cholesterol accumulation and crystallization, altered bile acid metabolism, and decreased biliary cholesterol.
Such severe steatohepatitis in nutrient-overloaded livers was much more likely ameliorated by combined induction of Nrf1 and Nrf2, as therapeutic co-targets for effectively treating the metabolic associated steatohepatitis (MASH). This notion is further supported by the experimental evidence revealing that the therapeutic effects of the Nrf2-activating drug bardoxolone methyl require Nrf1, as a key contributor, due to their co-regulation of immunometabolic stress defense genes that eliminate cholesterol overload and mitigate oxidative stress damage and inflammation 348. The complementary gene programming of Nrf1 and Nrf2 can thus counteract a pathological progressive continuum of cholesterol-associated fatty liver diseases (including NASH). As such, the modest pathological phenotype caused by deficiency of Nrf1, rather than Nrf2, cannot be rescued by the latter compensatory increased expression of Nrf2 by ~40% of its mRNA levels in the Nrf1-deficient livers 348. This strongly demonstrates that Nrf1 should have to exert an essential role, that is irreplaceable by Nrf2, in the hepatic pathophysiological process (Figure 12).
Further RNA-sequencing analysis revealed that those functions related to the synthesis, transport and metabolism of cholesterol and bile acids were inhibited by altered retinoid X receptor (RXR)-dependent pathway activity 348. The RXR-linked control of immunometabolism was disrupted by hepatocytic deficiency of Nrf1 and Nrf2. Their co-target gene-binding activity was also confirmed by ChIP to txn1 (thioredoxin 1, for redox stress defense), lonp2 (lon peptidase 2, for peroxisomal proteostasis defense), and abcg8 (ATP binding cassette subfamily G member 8, for cholesterol excretion); all three were reduced by combined Nrf1:Nrf2 deficiency to a greater degree than that by single deficiency of Nrf1 or Nrf2. By sharp contrast, Nrf1-specific targets Psma1 and Psmc2 were, to similar extents, reduced by deficiency of Nrf1 or Nrf1:Nrf2, whilst Nrf2-target Ces1g (carboxylesterase 1G) and Gstm1 (glutathione S transferase mu 1) in biotransformation and phase 2 detoxification were, to similar extents, reduced by deficiency of Nrf2 or Nrf1:Nrf2. Together, these overlapping and exclusive genome sites enable to which Nrf1 and Nrf2 interact responsible for cognate target gene regulation in the liver.
Combined Nrf1:Nrf2 deficiency also resulted in greater reduction of PPARα (peroxisome proliferator activator receptor α) and CAR (constitutive androstane receptor), two known transcription factors that regulate lipid, bile acid and peroxisome metabolism, as well as liver detoxification and ROS defense, along with reduced BAAT (bile acid-coenzyme-A amino acid N-acyltransferase), AbcG5, PRDX1 (peroxiredoxin 1) and Cat (catalase), as compared to single deficient cases 348. Conversely, greater increases in the two known NASH-drivers IHH(Indian hedgehog) and tnfrsf12a (TNF receptor superfamily member 12A) were caused by combined Nrf1:Nrf2 deficiency, and also accompanied by increased expression of 4-hydroxynonenal (4HNE)-conjugated proteins, as well as of TAZ (taffazin) and YAP1 (yes-associated protein 1), which drive IHH expression and steatohepatitis 351 352. Collectively, these demonstrate a co-regulatory role for Nrf1 and Nrf2 in hepatobiliary detoxification of cholesterol and bile acids.
Recently, it was further found that significantly reduced levels of HDL (high-density lipoproteins) cholesterol and apolipoprotein A1 (ApoA1) were caused by combined deletion of Nrf1:Nrf2, but not by their single deletions 353. This was also accompanied by a decreased capacity of HDL to accept cholesterol undergoing efflux from macrophages and to counteract the TNFα-induced inflammatory effect on endothelial cells. This coincided with substantial alterations in the HDL-resident proteome, which fully correlated with liver gene expression profiles of corresponding proteins (e.g., ApoA1, ApoA2, ApoA4, ApoE, C3. C9, ApoJ, Cpn2, Gpld1, Itih2, and Itih4); they are responsible for mediating reverse cholesterol transport, reducing inflammation, and abrogating oxidative damage. Their modest changes were also observed from the deficiency of Nrf1 but not of Nrf2 353. Thereby, these revealed a coordinating control of HDL functioning by Nrf1 and Nrf2 to improve hepatoprotective and even atheroprotective actions, in which Nrf1 likely exerts a vital role.
Hepatocyte-specific deficiency of Nrf1 results in reduced glycemia (hypoglycemia)
Albeit as stress-defense transcription factors, both Nrf1 and Nrf2 can also exert their complementary but exclusive regulatory roles in programming genes responsible for hepatocytic glucose metabolism and even systemic glucose homeostasis 354 355 356. Conversely, reduced glycemia (hypoglycemia) was caused by hepatocyte-specific loss of Nrf1 or Nrf1:Nrf2, but not Nrf2, in mice (fed with a mild stressful fat-fructose-cholesterol diet for one to three weeks), but this phenotype did not occur in the leptin-deficient mouse model with obesity and diabetes (leptinob/ob:Nrf1flox/flox) 356. This indicates there exists an Nrf1-supporting defense for hepatocytes to counteract hypoglycemia but not promote hyperglycemia or diabetes. As consistent fully with this, Nrf1 deficiency resulted in reduced levels of hepatic glycogen and glycogen synthase (e.g., GYS2) expression, as also accompanied by decreased insulin and insulin-like growth factor-1 (IGF1), and increased growth hormone (GH), with no marked alterations in all other examined glycemia-influencing hormone (e.g., glucagon, ghrelin, cortisol, triiodothyronine, thyroxine, and gastric inhibitory polypeptide) 356. Although the capacity of Nrf1-deficient livers to produce glucose via gluconeogenesis appeared to be unaffected 356, glucose starvation-induced rapid death of human Nrf1α, but not Nrf2-deficient hepatoma cells results from its fatal defects in the redox metabolism reprogramming 354. Altogether, these reveal an essential role of Nrf1 in modulating glucose homeostasis setting for the steady-state euglycemia through the GH-IGF1 signaling axis to the liver glycogen storage (Figure 12). In turn, reduced expression of GH receptor (by sensing GH to stimulate liver IGF1 secretion) was contributable to reduced glycemia caused by deficiency of Nrf1 or Nrf1:Nrf2, but not Nrf2 356.
Gain-function of Nrf1 loses body weights but gains the risk of diabetes with insulin resistance
The physio-pathological function of Nrf1 seems somewhat uninterpretable by the evidence obtained from the above-mentioned loss-of-function mutants of Nrf1 in mice, because they manifested with severe liver dysfunction and metabolism disorders. To bypass this, the gain-of-functional transgenic mice (i.e., Nrf1-Tg:MGRD) were thereby created by engineering over-expression of the Nrf13xFlag, which is driven by the MafG-regulated promoter domain 329. Consequently, increased expression of Nrf1 leads to a loss of body weight in Nrf1-Tg:MGRD mice fed with normal and even high-fat diets. Thereafter, the high-fat diet-induced obesity model mice further developed a pathology resembling human diabetes mellitus, also with markedly higher levels of blood glucose after insulin injection 329. Therein, the pancreatic islets of Nrf1-Tg:MGRD mice were much larger than those of wild-type mice, as the insulin-positive areas were increased, implying constitutive activation of insulin secretion in Nrf1-Tg:MGRD mice leading to systemic insulin resistance. Similar insulin resistance also occurred in the normal-fed Nrf1-Tg:MGRD mice, with a positive correlation of increased Nrf1 expression.
The induction of insulin resistance appears to be interpreted by disruption of cell signaling to metabolic perturbation by forced Nrf1 expression; this was evidenced by the supportive findings 329 that: i) insulin-induced phosphorylation of Akt-Ser473 was obviously prevented in the liver and skeletal muscle, but not in white adipose tissues, of Nrf1-Tg:MGRD mice, implying that Nrf1 suppresses insulin signaling to Akt phosphorylation; ii) Nrf1-Tg:MGRD mice showed increased weights of livers, but not skeletal muscle or white adipose tissues; such increased weights of livers were further augmented by the high-fat diet, with altered hepatic metabolism; iii) both glucose utilization and production in livers were impaired by Nrf1-Tg:MGRD’s repressing those insulin-regulated glycolysis-related genes (e.g., GCK, AldoB, PGK1 and PK), gluconeogenesis-related genes (e.g., Fbp1 and Pck1) and glucose transporter 2 (Glut2), particularly in the high-fat diet conditions; iv) the entry of glucose into the glycolytic pathway was suppressed by Nrf1-Tg:MGRD, leading to marked decreases in the levels of glucose-6-phosphate (G6P) and fructose-6-phosphate (F6P), as accompanied by increased pyruvate, along with reduced lactate, such that the entry of the TCA cycle was increased, with elevated levels of acetyl coenzyme A (CoA), citrate and ATP in the liver of Nrf1-Tg:MGRD mice fed by high-fat diets; v) the utilization of hepatic CoA to generate β-hydroxybutyrate was increased from other fuels (i.e., fatty acids) beyond glucose and amino acid catabolism. Lastly, such impaired glucose metabolism was also obviously ameliorated by decreased expression of Nrf1 in heterozygous Nrf1+/- mice, when compared with wild-type mice, even though both were fed high-fat diets. Collectively, impaired insulin signaling and dysregulated glucose metabolism by constitutive induction of Nrf1-Tg:MGRD results in the development of diabetes mellitus triggered by the high fat diet (Figure 12). However, except that insulin-induced Akt phosphorylation was repressed by forced expression of Nrf1, no obvious changes in the expression levels of major components of the insulin signaling pathway were determined by microarray analysis of the liver and skeletal muscle of Nrf1-Tg:MGRD mice 329. This indicates that insulin resistance is triggered by Nrf1 through a distinct pathway from transcriptional repression of the insulin signaling components.
In addition, a single nucleotide polymorphism (SNP) rs3764400 located in the 5‘-flanking region of the human Nrf1 gene represents a risk factor for obesity with body mass index (BMI, with a P value of 5 x 10-6) 357. The reporter gene activity showed that rs3764400, as a regulatory SNP of Nrf1 expression with a ~2.2-fold higher level, was driven by the risk C allele, when compared to that mediated by its control T allele, within the 2.1-kb promoter region upstream from the first transcription start site 329. The major T allele of rs3764400 (5‘-CAGT/CT-3‘ 357) composes a consensus c-Myb-binding sequence 5‘-CAGTT-3‘ (reversed by 5‘-AACNG-3‘) 358, whilst the minor C allele (enabling for induction of Nrf1 329) cannot allow c-Myb related factors to bind the altered motif. Thus, it is inferable that c-Myb is much likely to act as an upstream regulator of Nrf1 for transcriptionally controlling glucose metabolism, but its dysfunction leads to increased expression of Nrf1 contributable to the pathophysiology of obesity and relevant glucose metabolic dysregulation. Moreover, differential regulation of glucose metabolism by Nrf1 and Nrf2 is supported by further experimental evidence revealing that blood glucose levels were increased by gain-of-function of Nrf1 329, but decreased by loss-of-function of Nrf1 but not of Nrf2 356, as bad as decreased by gain-of-function of Nrf2 359 360.
Pancreatic loss of Nrf1 causes impaired insulin secretion and glucose metabolism leading to diabetes
The failure of pancreatic β-cells to secrete insulin sufficiently to meet the increasing demand of glucose metabolism is defined as a major contributor to type-2 diabetes with the secondary loss of β-cells. The impaired β-cell function to reduce glucose-stimulated insulin secretion (GSIS) is a critical pathophysiological event of diabetes. Coincidently, β-cell-specific Nrf1-KO mice exhibit severe fasting hyperinsulinemia, as accompanied by reduced GSIS and glucose intolerance 361. The pathophysiological phenotype results from deficiency of almost all Nrf1 isoforms in mouse islets and MIN6 β-cells, leading to a marked increase in basal insulin release with reduced GSIS; this was viewed as a β-cell phenotype reminiscent of the early stage of type-2 diabetes. To our knowledge, hyperinsulinemia has been accepted as a compensatory response to insulin resistance and its prolonged status can also deteriorate induction of insulin resistance and even obesity 362 363. Thereby, the pathological phenotype of pancreatic Nrf1-KO mice is likely to account for ensuing glucose intolerance.
Further biochemical examinations of Nrf1-deficient islets and β-cells revealed substantially increased ratios of both NADPH/NADP and ATP/ADP, which is attributable to enhanced glycolysis and mitochondrial metabolism (e.g., β-oxidation) rather than oxidative phosphorylation 361. The silencing of Nrf1 up-regulated expression of glucose transporter 2 (Glut2) and glycolytic proteins, such as lactate dehydrogenase 1 (Ldh1), glyceraldehydes 3-phophate dehydrogenase (Gapdh), hexokinase 1 (HK1), but with down-regulation of glucokinase (Gck). Interestingly, such impaired glycolysis and GSIS resulting from the loss of Nrf1’s function can also be rescued by the knockdown of HK1. However, no changes in the expression profiling of mitochondrial protein complexes I, II, cytochrome c and ATP synthase F1, as well as mitochondrial biogenesis-related PGC-1α, PGC-1β and nuclear respiratory factor 1 (called aPalNRF1 364) were determined in Nrf1-deficient cells, when compared with wild-type controls 361. Collectively, β-cell-specific depletion of Nrf1 leads to a shift from the oxidative phosphorylation to aerobic glycolysis for energy, a consequence similar to the Warburg effect in cancer cells 365 366. Furthermore, altered expression levels of p53, phosphorylated AKT and AMPKα were observed in Nrf1-deficient cells 265 355 or in the constitutive active mice of Nrf1-Tg:MGRD 329. These imply these signaling molecules are involved in altered glucose metabolism. Altogether with the evidence provided by 367, it is inferable there may exist a couple of metabolic reprogramming switches with signaling responses to endogenous redox stress status in Nrf1-defienct cells.
Adipose-specific loss of Nrf1 disrupts its plasticity, adaptive thermogenesis and metabolic homeostasis
Adipocytes possess remarkable adaptive capacity to respond to nutrient excess, fasting or cold exposure, with distinct types of adipocytes for the maintenance of proper metabolic health. Brown adipose tissue (BAT) is a crucial metabolic organ in facultative thermogenesis (acute response), also with great plasticity to respond to long-term cold adaptive thermogenesis. The thermogenic capacity of BAT is dependent on the neurohumoral response to sympathetic stress stimulation 368. Such BAT is distinguishable from white adipose tissue (WAT), just because it is richly innervated by the sympathetic nervous system (SNS, in which norepinephrine is released at the nerve endings activating adrenergic receptors on brown adipocytes) and highly vascularized in brown adipocytes, with several small lipid vacuoles and many large mitochondria 369. In addition to such critical roles in maintaining thermal homeostasis and even energy homeostasis, BAT is involved in plasma triglyceride clearance and glucose homeostasis 370 371. This fact demonstrates an essential functionality of BAT to combat obesity and metabolic diseases (e.g., diabetes and cardiovascular disease). By contrast, WAT is composed of a population of specialized white adipocytes for energy storage (in the form of triacylglycerols) and its mobilization (as fatty acids), and hence, long considered as an inactive tissue that primarily served as a thermal insulation purpose. Lipid and glucose metabolism in white adipocytes also confers a pivotal role to WAT in whole-body homeostasis, particularly energy homeostasis 372. Conversely, dysfunction in white adipocyte metabolism is also viewed as a cardinal event in the development of insulin resistance and associated disorders (e.g., type 2 diabetes mellitus). In such distinct adipose tissues, the specific knockout of Nrf1, as a key thermogenic factor in mice, resulted in different pathophysiological phenotypes 374 375.
BAT-specific KO of Nrf1 in mice that cannot adapt to rising thermogenic activity
Conditional deletion of Nrf1 expression was created by using homozygous floxed Nfe2l1 alleles (coding its DNA-binding domain) mice under the control of the Ucp1 promoter-driven Cre (to yield Nfe2l1ΔBAT mice) or Ind.Nfe2l1-/- mice raised by tamoxifen-inducible Cre under another control of the chicken β-actin promoter-enhancer coupled with the cytomegalovirus immediate-early enhancer (CAGGCre-ERTM) 373 and then subjected to investigating a linkage of cold adaptive response to its target proteasome in BAT. This is due to ERAD to remove those unfolded, damaged or dispensable proteins by the ubiquitin-proteasome system (UPS) in this UPRER, and it was also found, from adipocyte-specific deficiency of IRE1α (encoded by Ern1) or XBP1 in mice, that this conserved canonical branch of the UPRER is dispensable for the BAT-mediated homeostasis 373.
As compared to that at 30°C, cold adaptation caused markedly increased expression of Nrf1 in wild-type BAT, (aside from the minor expression in inguinal WAT). The induction of Nrf1 by exposure to cold in brown adipocytes yielded higher levels of the ER-localized form of Nrf1 protein, as well as its cleaved, transcriptionally active form in BAT. By contrast to wild-type controls, markedly lower expression of Nrf1 at mRNA and protein levels was observed in cold-adapted Nfe2l1ΔBAT mice, implying thermoneutrality is a state of natural Nrf1 deficiency 373. Thermogenesis requires cold-inducible proteasomal functionality driven transcriptionally by Nrf1, just because cold adaptation of BAT induces Nrf1 to increase proteasomal activity crucially for maintaining ER homeostasis and cellular integrity, particularly while the cells were placed in a state of high thermogenic activity. Under such thermogenic conditions, BAT-specific deletion of Nrf1 enabled Nfe2l1ΔBAT mice in a hyper-ubiquitinated state and hence resulted in ER stress, metainflammation, markedly diminished mitochondrial function and whitening of the BAT. This suggests that Nrf1 is required for the BAT activity to maintain metabolic adaptation, besides ER homeostasis, which was supported by Nfe2l1ΔBAT-leading hyper-ubiquitinated 228 proteins that were most notably enriched with mitochondria and organelle homeostasis, particularly related to ER proteins and energy metabolism. Thus, Nrf1 in thermogenic fat cells acts as a metabolic guardian, preventing tissue stress and inflammation, independently of BAT differentiation, mass or expandability.
Mice lacking Nrf1 in brown adipocytes are born normal, but alterations in the BAT of Nfe2l1ΔBAT develop as a function of cold and age. At thermoneutrality, where BAT activity is minimal, Nrf1 was lowered in BAT, but in this environment neither proteasome inhibition nor genetic deficiency of Nrf1 is more deleterious for the tissue. This indicates that Nrf1-mediated transcriptional programming is required for adaptation to rising thermogenic activity. This is also corroborated by the phenotype of tamoxifen-induced deletion of Nrf1 expression in adult Ind.Nfe2l1-/- mice 373. The BAT thermogenic activation following cold adaptation or treatment with CL316243, an adipocyte-specific β3-adrenergic agonist 376 at thermoneutrality de facto requires an Nrf1-mediated increased activity of proteasomes to fulfill its metabolic potential, but such proteasomal activity is impaired in obesity. In mouse models of both genetic and dietary obesity, stimulation of proteasomal activity by adenovirus-mediated expression of Nrf1 or the proteasome activator PA28a to enhance proteostasis in BAT resulted in obviously improved insulin sensitivity. Altogether, Nrf1 emerges as a novel guardian of brown adipocyte function, providing enhanced proteometabolic quality control for thermogenic adaptation to cold or to obesity.
Another recent study revealed that adipocyte-specific Nrf1-KO [Nfe2l1(f)-KO] mice develop an age-dependent whitening and shrinking of BAT, with signatures of the down-regulated proteasome, impaired mitochondrial function, reduced thermogenesis, pro-inflammation and elevated regulatory cell death 377. This is attributable to the fact that deficiency of Nrf1 in brown adipocytes predominantly caused down-regulated expression of lipolytic genes (PNPLA2, ATGL, HSL, MGL, PLIN1), decelerating lipolysis so that BAT cannot fuel thermogenesis and thus leading to hypertrophy of brown adipocytes (enriched with larger lipid droplets and swollen mitochondria), inflammation related to regulatory cell death, and consequently cold intolerance. Further single-nucleus RNA-sequencing of BAT unraveled that deficiency of Nrf1 caused significant transcriptomic reprogramming, and led to aberrant expression of a variety of genes involved in thermogenesis (Ucp1), lipid metabolism (e.g., Prdm16, Elovl3, Cpt1b, Pparα), mitochondrial (respiratory) stress (Cox8b, Cox7a1, PGC1α COXIV, NDUFS4, FIS1,OPA1), inflammatory response (Adgre1, Ifng, IL1b, Cd68, F4/80), and regulatory cell death (Casp1, Nlrp3, Pycard), besides proteasome, in distinct subpopulations of brown adipocytes 377. Overall, these demonstrate that Nrf1 functions as a key transcription factor determining the thermogenesis, subsequently cell fate and heterogeneity of BAT in mice by controlling their lipidometabolic and proteometabolic homeostasis.
Adipocyte-specific KO of Nrf1 disrupts WAT plasticity and metabolic homeostasis
Nfe2l1(f)-KO mice were generated by crossing mice bearing a floxed Nfe2l1 allele 262 with mice expressing another adipocyte-specific Cre recombinase under the control of adiponectin gene promoter (Adipoq-Cre) 374. Then, it was found that the Nfe2l1(f)-KO mice exhibited abnormal fat distribution, with dramatically reduced mass of subcutaneous adipose tissues, but slightly increased mass of gonadal WAT. Importantly, Nrf1-deficient mice also displayed glucose intolerance, insulin resistance, adipocyte hypertrophy, and severe adipose inflammation 374. Furtherly, mechanistic studies revealed that deficiency of Nrf1 caused significantly diminished expression levels of a set of genes involved in adipogenesis, lipogenesis, lipolysis and general adipocyte function in inguinal WAT, but was accompanied by dramatically increased expression of macrophage markers and inflammatory response genes, such as Adgre1 (adhesion G protein-coupled receptor E1), Cd68, Ifng (interferon γ), IL1b (interleukin 1β), as well as pyroptosis-related genes, e.g., Casp1 (caspase1), Nlrp3 (NLR family pyrin domain containing 3), and Pycard (apoptosis-associated speck-like protein containing a CARD 374. Notably, the expression of adipogenic genes (Pparg2 and Cebpb) was significantly increased in the gonadal WAT of Nfe2l1(f)-KO mice, but no marked changes in the mitochondrion-related Ppargc1a and Cox8b were observed when compared to controls. Collectively, these demonstrate that the deficiency of Nrf1 results in aberrant expression of genes related to lipolysis in WAT, leading to adipocyte hypertrophy followed by inflammation, pyroptosis, and even insulin resistance. Therefore, this finding revealed a vital role for Nrf1 in regulating adipose tissue plasticity and energy homeostasis.
An in-depth examination of the stromal vascular fraction isolated from the WAT of Nfe2l1(f)-KO mice revealed augmented adipogenesis, along with elevated expression of adipogenic markers and lipid accumulation 378. The enhanced and accelerated adipogenic differentiation was further corroborated by stable knockdown of Nrf1 in 3T3-L1 pre-adipocytes. Conversely, such adipogenesis induced by dexamethasone-methylisobutylxanthine-insulin (DMI) was substantially attenuated by forced overexpression of Nrf1α, but not any of its shorter isoforms, in 3T3-L1 cells 378. Mechanistic investigation revealed that Nrf1α negatively regulates the transcription of peroxisome proliferator-activated receptor γ (PPARγ), particularly PPARγ2 (as a master regulator of adipogenesis), as well as Cebpα, Cebpδ, aP2, CD36 and Glut4. Altogether, these indicate that Nrf1α is much likely to act as a critical negative regulator of adipogenesis by suppressing PPARγ, whilst Nrf1β may play a contrary role in basal expression of PPARγ.
The crucial roles of Nrf1 constitutively in adipocytes were further evaluated by treatment of juvenile Nfe2l1(f)-KO mice with CL316243, a β3 adrenergic agonist to promote the effect of lipolysis on adipose inflammation 379. The 4-week-old juvenile adipocyte-specific Nrf1-KO mice displayed a normal fat distribution, but exhibited reduced fasting plasma glycerol levels and elevated adipocyte hypertrophy and macrophage infiltration in inguinal and gonadal WAT, when compared to adult mice. This is likely to result from decreased expression of multiple lipolytic genes and reduced lipolytic activity in WAT of Nfe2l1(f)-KO mice 379. Their altered expression of inflammation- and pyroptosis-related genes, as well as macrophage infiltration in the WAT, was dramatically alleviated following CL316243 treatment for seven days. However, the phenotype of Nfe2l1(f)-KO mice was aggravated after treatment for three weeks with rosiglitazone (a thiazolidinedione agonist of PPARγ, applied for the treatment of type 2 diabetes mellitus by stimulating genes in favor of storage of triglycerides), as accompanied by increased expression of those genes related to inflammation and pyroptosis in their shrunk WAT 380. Collectively, these highlight a notion that, since Nrf1 plays a fundamental regulator of the lipolytic gene expression and defends relevant metainflammation, it may be, thereby, considered as a potential therapeutic target to improve adipose plasticity and lipid homeostasis, as well as whole-body energy homeostasis.
Skeletal myocyte-specific KO of Nrf1 results in an oxidative lean phenotype with muscle remodeling
Skeletal myocyte-specific Nrf1-mKO mice were generated by crossing the floxed-Nfe2l1 mice 373 with mice expressing Acta1-Cre (skeletal muscle-specific Cre recombinase under the control of the actin-α1 promoter) 381. The mKO mice displayed lowered body weights, which were predominantly caused by slightly lower lean mass, but not fat mass. A prominent reduction of the gastrocnemius muscle in size and weight was also associated with lower grip strength in Nrf1-mKO mice compared to wild-type controls 381. A major phenotypic change in the gastrocnemius muscle of Nrf1-mKO mice unraveled a shift towards a more oxidative profile. Such phenotypic switch towards more oxidative fibers was also supported by analyzing myosin heavy chain gene expression, as indicated by higher levels of slow-twitch Myh7 and lower levels of fast-twitch Myh2. Of note, the perinatal myosin heavy chains Mhy3 and Mhy8 were markedly higher in Nrf1-mKO mice, implying the presence of regenerative muscle fibers. An insight into the muscle ultrastructure by transmission electron microscopy revealed that the loss of Nrf1 leads to the aberrant myofibrillar organization in muscle tissues of Nrf1-mKO mice, where its mitochondria seemed bulged and disrupted, with less coenzyme Q:cytochrome c reductase, a component of the oxidative phosphorylation Complex-III 381. Less respiration after addition of the ADP and succinate, as bad as reduced maximal respiration capacity, was detected in isolated muscle fibers of Nrf1-mKO mice, when compared to wild-type controls. Collectively, these demonstrate a fiber-type switch from fast to slow-twitch fibers, with aberrant mitochondrial bioenergetics in the gastrocnemius muscle of Nrf1-mKO mice.
Knockdown of Nrf1 by silencing siRNA led to lower levels of proteasomal activity and subunit gene expression (Psma1, Psmb1) in differentiated C2C12 cells, but with higher levels of ubiquitylated proteins after proteasome inhibition by bortezomib 381. Similarly, genetic deletion of myocytic Nrf1 resulted in markedly lower proteasome subunit gene expression in Nrf1-mKO muscle tissues, so that the ex vivo proteasomal activity was blunted, leading to markedly higher levels of ubiquitylation 381. Rather, trypsin-like activity remained higher in tissue from Nrf1-mKO mice, possibly indicating a dynamic remodeling of proteasomal activity independently of Nrf1. Overall, these demonstrate the importance of myocyte Nrf1 for proteasomal function and UPS in skeletal muscles. This is further evidenced by proteomic hyperubiquitylation (of 2832 differentially expressed) in Nrf1-mKO muscles, which highlighted energy metabolism and filament organization as major pathways 381. RNA-seq analysis of soleus and gastrocnemius muscles from matched Nrf1-mKO mice uncovered the imperative role of Nrf1 in energy metabolism and the UPS, and also pointed towards its impact on respiration, ATP metabolic process, and muscle cell differentiation 381. Metabolomics of the gastrocnemius muscle revealed a strong difference in metabolites related to glucose metabolism, the Warburg effect and anti-oxidative characteristics. Therefore, the critical role of Nrf1 for UPS and proteostasis in skeletal muscle dictates muscle function and energy metabolism, but the loss of Nrf1 causes a profound phenotypic change in the gastrocnemius muscle, whilst the impact on soleus was rather mild.
By a linear regression modeling of the relationship between energy expenditure and body weight, it was found that energy expenditure was higher in the Nrf1-mKO mice, which displayed more food intake to fuel their elevated energy expenditure, but no evident differences in physical activity, as compared to wild-type controls 381. This indicates that systemic energy metabolism for animal whole body is regulated by myocyte Nrf1 in vivo. Conversely, loss of myocytic Nrf1’s function protects the mice from body-weight gain and metabolic imbalance caused by high-fat diets, because mice lacking Nrf1 displayed hormetic energy metabolism and resistance to high fat diet-induced obesity, and were associated with a lean phenotype and muscle fiber type switching 381. Distinct metabolic conditions of obesity were analyzed by a multi-omics approach to be associated with recalibration of the UPS in muscle. Overall, these define an adaptive role for the fine-tuning proteasome towards UPS governed by Nrf1 in the remolding of muscle proteome and its biological function.
Cardiomyocyte-specific KO of Nrf1 prevents neonatal heart regeneration and repair
The cardiomyocyte-specific Nrf1-cKO mice (generated by crossbreeding Nrf1fl/fl mice with αMHC-Cre transgenic mice) exhibited no aberrations in cardiac morphology or function at 2-month age 382. But, following myocardial infarction (MI), Nrf1-cKO hearts showed decreased cardiac function (measured as fractional shortening, ejection fraction, and myocardial wall motion), but with increased fibrotic scarring. This is due to a greater myocardial loss at 1-day post MI, and markedly decreased proliferation of cardiomyocytes at 3-day post MI in the Nrf1-cKO hearts underlying the impaired heart regeneration, as accompanied by notably reduced proteasomal activity 382, albeit with an enhanced inducible subpopulation of cardiomyocytes that respond to injury by apoptosis and hypertrophy. During heart regeneration, the oxidative phosphorylation (OXPHOS) pathway was downregulated in wild-type cells, but upregulated (to inhibit cardiomyocyte proliferation) in Nrf1-cKO hearts, leading to a significant increase of ROS, along with upregulated expression of two cardiac stress markers Nppa and Nppb in the Nrf1-cKO MI hearts 382. By contrast, downregulated genes in Nrf1-cKO hearts were enriched with actin filament-based processes, the PI3K-AKT and Wnt signaling pathways, aside from the known Nrf1-target genes (Hmox1 and Psmd1). Such a loss of Nrf1 prevented neonatal cardiomyocytes from initiating the transcriptional response required for heart regeneration.
After ischemia/reperfusion injury, the mice pre-injected with the Nrf1-expressing adeno-associated viral vector (AAV9-Nrf1) showed significantly reduced infarct area (from 52% to 40%) and also improved their cardiac function. Additional increases in diastolic and systolic volumes of the left ventricle were observed in control MI hearts, but profoundly attenuated in AAV9-Nrf1 treated mice, which show reduced cardiac dilation and remodeling, as well as reduced fibrotic scarring 382. These indicate that overexpression of Nrf1 in vivo confers a cardoprotective effect in adult hearts following ischemic injury. This is also supported by further experimental evidence obtained from the neonatal rat ventricular myocytes (NRVMs) overexpressing Nrf1, revealing a consistent protective effect of this factor against all examined cardiotoxins (e.g., H2O2, peroxynitrite, doxorubicin, elastin). Notably, such protective effect of Nrf1 was much greater than that of Nrf2 in response to all these cardiotoxin treatments 382, though the latter Nrf2 was also viewed as a master regulator to confer cardioprotection 383. This fact highlights an important role of Nrf1 as a key regulator of cellular stress in the heart. Fully consistent with this, significantly increased proteasome-mediated proteolyses, such as proteasome protein catabolism and ERAD pathways, but specifically down-regulated ECM organization, were determined in NRVMs overexpressing Nrf1, but not Nrf2, but both shared with antioxidant and anti-inflammatory responses. To clarify potential redundant functions between Nrf1 and Nrf2, cardiomyocyte-specific Nrf2-cKO or Nrf1:Nrf2-dKO mice were generated 382. Consequently, the expression levels of proteasome (Psma1, Psmd1, and Psmb3) and antioxidant target genes (Hmox1, Sod1, and Cat) were reduced to greater degrees in Nrf1-cKO, when compared to Nrf2-cKO hearts, but importantly not further reduced in the Nrf1:Nrf2-dKO hearts, implying that Nrf1 plays a predominant role in regulating the expression of these genes in the heart.
By analysis of human heart ventricles from 431 donors (age 20–79) in the Genotype Tissue Expression (GTEx) database, varying expression levels (differing by over 70-fold) of Nrf1 were revealed among individuals, with a significant decline in the elderly demographic (age 60–79) 382. In these samples, 1167 genes were identified by co-expression analysis as being highly correlated with Nrf1 (Spearman correlation coefficient > 0.8, adjusted p-val < 0.00001). Apart from known Nrf1-targets PSMC1, PSMD7, SOD1 and CAT, Nrf1 co-expressed genes are clustered with key metabolic and energy production processes in the hearts (e.g., fatty acid degradation, electron transport chain, mitochondrial organization, and muscle contraction) and known Nrf1 downstream pathways (ubiquitination, proteasome degradation, and autophagy). From these, it is inferable that the degree of Nrf1 expression correlates with the metabolic and contractile properties of the heart and, hence likely affects cardiac function. Conversely, a significant reduction of Nrf1 transcript levels in heart ventricles from three independent patient cohorts with heart failure (n = 28) was revealed by further analysis of published datasets 382. Doxorubicin-induced cardiomyopathy in cancer patients carries a poor prognosis and also is frequently fatal. However, overexpressing Nrf1 enables human induced pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) to be sufficiently protected from doxorubicin-induced cardiotoxicity (and other cardiotoxins). Altogether, these unravel that the adaptive responsive mechanism mediated by Nrf1’s enabling proteasome activation and redox homeostatic balance is required for neonatal heart regeneration and also confers cardioprotection in the adult heart. Therefore, it is plausible that re-activating this mechanism in the adult heart could represent a potential therapeutic approach for cardiac repair.
Bone-specific deficiency of Nrf1 impairs osteoclast differentiation and bone formation
A mechanistic insight into osteoblast differentiation induced by the redox inducer vitamin C (i.e., ascorbic acid) 384 385 revealed a significant inducible increase in the expression of osterix (Osx), as a key osteoblast-specific transcription factor that was principally regulated by Nrf1-binding to its ARE sequence, in impaired bone marrow stromal cells 386. The mutant cells were originally derived from the spontaneous fracture mice caused by lacking the gulonolactone oxidase gene and hence leading to a deficiency of vitamin C 387. Albeit all three Nrf members have a potential to bind the ARE sequence in the Osx promoter, its expression induced by Nrf1 was 50- and 500-folds higher than those done by Nrf2 and Nrf3, respectively; the latter two CNC-bZIP factors were also unaffected in vitamin C-treated bone marrow stromal cells 386. From these, it is thereby inferable that Nrf1 is essential for transcriptional regulation of the Osx-mediated gene expression profiling, which is further supported by knockdown of Nrf1, showing decreased Osx expression, impaired osteoblast differentiation and mineralized nodules formation from bone marrow stromal cells 386. By sharp contrast, Nrf2 was considered to negatively regulate the differentiation of osteoblasts and chondrocytes 388 389.
The in vivo physiological function of Nrf1 in regulating bone formation was further determined by using osteoblast-specific KO mice generated by crossbreeding Nrf1flox/flox mice 390 with transgenic mice bearing Col1α2-iCre (in which Cre recombinase is under the control of the regulatory sequence of collagen-1α2 (Col1α2)) 391. The osteoblast-specific Nrf1-KO mice showed obvious reductions in bone size, peak bone mass, trabecular number and mechanical strength, also as accompanied by decreased expression of Osx, reduced cell differentiation, and impaired bone formation. Intriguingly, deficiency of Nrf1 enabled Nrf2 to be up-regulated by 40% but also allowed Nrf3 and MafF to be down-regulated by 60% and 50%, respectively 391, implying there exists a coordinated control mechanism amongst them. However, it should be noticed that a possible complementary pathway may be controlled by Nrf1 and Nrf3, because their transcript levels were obviously decreased upon exposure of both wild-type and Nrf3-/- mice to butylated hydroxytoluene 392, and their glycoproteins were co-localized and integrated within and around the ER in a similar membrane-topological folding fashion 275 305 393 394.
KO of all isoforms of Nrf1’s transcripts specifically in themyeloid lineage in Nfe2l1(M)-KO mice (yielded by crossing mice bearing the floxed Nfe2l1 allele with mice expressing LysM-Cre) caused the increased activity of osteoclasts, decreased bone mass and worsening of osteoporosis induced by ovariectomy and aging 395. However, no significant effects of Nrf1’s loss on the osteoblast and osteocytes were observed in Nfe2l1(M)-KO mice. Further investigations of the bone marrow cells and RAW 264.7 macrophages revealed that deficiency of Nrf1 leads to accelerated and elevated osteoclast differentiation, which is attributable to enhanced accumulation of ROS in the early stage of osteoclast differentiation and expression of Nfatc1α (encoding nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1α) 395. Such Nrf1-regulated osteoclast differentiation and the transcription expression of multiple antioxidant genes, as well as Nfatc1α were isoform-specific. The full-length Nrf1α likely functions as accelerators of osteoclast differentiation with induction of Nfatc1α and antioxidant genes, whilst Nrf1β serves as a brake controlling the accelerator effect of Nrf1α in check. This indicates differential and even opposing roles of multiple distinct Nrf1 isoforms in the osteoclast genesis and differentiation, bone remodeling and metabolism homeostasis, to provide an understanding of the pathogenesis of various bone disorders including osteoporosis and arthritis.
It was, in undifferentiated odontoblasts, found that the physical interaction of Nrf1 with C/EBPβ through their bZIP domains, concerning the binding efficiency depending on its phosphorylation by PKA at Ser569 (i.e. Ser599 situated on the boundary between the Neh6L and CNC domains in human TCF11) directs the specificity of the CNC-bZIP function to repress the basal constitutive expression of the DSPP (dentin sialophosphoprotein) gene encoding two specific markers DPP (dentin phosphophoryn) and DSP (dentin sialoprotein) 396. Conversely, the loss of such interaction between Nrf1 and C/EBPβ, in fully differentiated odontoblasts, caused an increase in the transcriptional expression of DSPP to yield DPP and DSP. These demonstrate a coordinated control of odontoblast differentiation by both bZIP factors to switch DSPP on or off.
Brain-specific KO of Nrf1 leads to the pathogenesis of neurodegenerative diseases
Nrf1 expression is also found in neuronal systems, and its evident function in central nervous system has been proven in a few studies 390 397 398. Only two groups have been working on the neuronal tissue-specific KO of Nrf1 in vivo. A neuronal-specific Nrf1 KO was achieved using Nestin as a marker for neural stem cells in the Cre-lox system 397 398. The resulting Nrf1-deficient mice displayed a notable phenotype, showing growth retardation starting at seven days postnatal and mortality by three weeks. Behavioral abnormalities, such as motor ataxia and feeding difficulties, were evident, along with hindlimb clasping reflex, indicative of neurodegenerative conditions. Interestingly, other similar phenotypes are also observed in small Maf-deficient mice (i.e., MafG-/-:MafK-/-) 399 400, suggesting the importance of cooperation between Nrf1 and small Maf proteins in the neuronal functions. Histological analysis highlighted neuronal degeneration in the hippocampus CA3 region and spinal cord. Notably, Nrf1-deficient neurons exhibited severe oxidative stress in the spinal cord, with ubiquitinated protein accumulation in the cortex's pyramidal neurons, other brain regions, and the spinal cord. Nestin expression is seen in beyond neural stem cells 401. Therefore, more specific drivers of Cre are requested to ensure the role of Nrf1 in the neuronal system. Nevertheless, Nrf1 KO by using the CaMK2cre system has demonstrated that loss of Nrf1 in the brain resulted in an accumulation of ubiquitinated proteins and reduced expression of proteasomal subunits, including PsmB6 390. Atrophy in the forebrain and decreased cortex and hippocampus thickness were observed, with significant neuronal loss and bind-limb clasping reflexes at three to four months, suggesting an essential involvement of Nrf1 deficiency in neurodegenerative pathogenesis, highlighting its causal role in neurodegeneration.
The loss of Nrf1 in the brain, as demonstrated by the CaMK2Cre-mediated deletion, has unveiled significant implications: neurodegeneration and impaired proteasome function due to the down-regulation of various proteasomal genes, whereas the NestinCre-mediated Nrf1 deletion exhibits similar phenotypes without reduced expression of proteasome genes. Although the NestinCre-mediated Nrf1 deletion exhibits ubiquitinated protein accumulation, only Nrf1’s loss via CaMK2Cre-mediated gene deletion showed reduced proteasome gene expression, possibly due to differences in the mouse models. The NestinCre model entails the global neuronal Nrf1 knockout, whereas CaMK2Cre specifically targets the cortex and hippocampus. Additionally, while CaMK2Cre demonstrates neural damage via apoptosis without oxidative stress, no evidence of neural cell apoptosis was also observed in the NestinCre model. More importantly, the NestinCre-mediated knockout of Nrf1 unveiled a loss of ubiquitin-specific proteases (USPs), with USP9x identified as one of the Nrf1 target genes 398. Because USPs play crucial roles in regulating neural activities, for instance, the presence of a mutation in USP14 in an ataxia mouse model leads to severe tremors and premature death 402. Additionally, the reduction of Usp9x promotes the degradation of Survival Motor Neuron protein, thereby inducing improvement in Spinal Muscular Atrophy 403. USP9x expression is notably high in specific brain regions, including layer V of the neocortex, certain hippocampal subfields, and Purkinje cells in the cerebellum of adult mice 404. Higher expression is found in the CA3 region than the CA1 region in hippocampal pyramidal cells, suggesting co-localization with Nrf1. Notably, the knockdown of USP9x induces the formation of toxic α-synuclein inclusions USP9X in SH-SY5Y cells upon proteolytic inhibition 405, indicating its role for neuroprotection, but its dysfunction may trigger Parkinson’s disease. Therefore, the reduction in USP9x expression resulting from Nrf1 loss may lead to the accumulation of polyubiquitinated proteins, with implications for neurodegenerative pathogenesis processes. Yet, further in-depth molecular assessments are warranted to identify the specific proteins accumulating in a ubiquitinated state upon the loss of Nrf1’s function in the neuronal system.
In addition, it should be also noted that no single KO of all other CNC-bZIP factors (i.e., Nfe2p45, Nrf2, Nrf3, Bach1 and Bach2) rather than Nrf1 gave rise to any apparent neuronal phenotypes 323 406 407 408 409. From this, it is inferable that Nrf1 is just the only candidate within the CNC-bZIP family responsible for neuronal homeostasis 398. Nrf1 does contribute to the development of the central nervous system after birth, because this was evidenced by conditional KO of Nrf1 in brains 390 397, although global KO of the gene did not cause any apparent neuronal deficits in mouse embryonic stages before death 172 326.
UNIQUELY DIFFERENTIATED YET INTEGRATED ROLES OF NRF1 AND NRF2 IN GOVERNING CELL HOMEOSTASIS DURING DISTINCT LIFE PROCESSES
From the eco-evo-devo view, Nrf1 is a highly conserved fossil-like indispensable CNC-bZIP transcription factor with ancient properties, whilst the relative younger Nrf2 is inferable to arise from the ancient gene differentiation and hence emerges in the later evolved vertebrates. As two major principal CNC-bZIP factors in mammalians, Nrf1 and Nrf2 often seem to resemble two entangled ‘Yin-Yang’ quanta, which comply with a dialectic law of the unity of opposites in biosciences (Figures 3 and 11A). Such allelopathic potentials of Nrf1 and Nrf2 are sufficiently evoked for their coordinated control of adaptive responsive protective mechanisms to maintain cell homeostasis and organ integrity within certain presetting physiological thresholds. This notion is evidenced by those supportive experiments by comparison of the combined Nrf1:Nrf2-deficient versus their respective single deficient mice 332 348. Therefore, it is of crucial importance to gain insights into the uniquely differentiated, yet integrated, roles of Nrf1 and Nrf2 in governing robust physiological homeostasis and healthy survival during distinct life processes.
Distinct regulation of Nrf1 and Nrf2 in redox responsive signaling against cancer development
The above-described distinct tissue-specific Nrf1-/- mice are manifested with certain typical pathologies, each of which resembles human non-alcoholic steatohepatitis and hepatoma 261,262, type-2 diabetes mellitus 361 and neurodegenerative diseases 390 397. These facts demonstrate that mouse Nrf1 (and/or its derived isoforms) fulfills an indispensable function in regulating critical target genes responsible for maintaining robust physiological development and growth under normal homeostatic conditions. By contrast, Nrf2-/- mice all are viable and fertile, without typical pathological phenotypes 118 323, implying it is not essentially required for normal development and growth. As such, Nrf2 has still been generally accepted as a master regulator of ARE-battery gene expression 116 410. This is based on the observation that Nrf2-/- mice were more susceptible than wild-type mice to chemical carcinogens 325, and also induction of Nrf2 (to activate ARE-driven genes) has been recognized as a potential chemopreventive and therapeutic target against carcinogenesis and its malignant progression 116 175 411. However, the hyperactive Nrf2 activity is also contrarily reconsidered as a potent oncogenic driver with those relevant hallmarks of cancer, because of its tumor-promoting effects exerted bona fide on carcinogenesis, cancer progression, metastasis, and even drug resistance to therapy 265 412. Such ‘double-edged sword’ effects of Nrf2 on cancer prevention and progression have led us to take into account seriously how the opposing activity of this factor should be tightly confined by Nrf1 (as deciphered in Figure 13).
Figure 13. FIGURE 13: Inter-regulation of between Nrf1 and Nrf2 in the opposing control of cancer progression.
(A) Different phenotypes of xenograft tumor-bearing model mice, which were inoculated with each of those indicated mutant or restored cell lines, as compared with their progenitor wild-type (WT, Nrf1/2+/+) human hepatoma HepG2 cells. These tumors were obtained from those relevant references 123,265,413,414. Of sharp note, Nrf1 acts as a potent tumor-repressor, whereas Nrf2 serves rather as a potential tumor-promotor, although both CNC-bZIP factors are inter-regulated with each other. (B) The tumor-promoting effect of Nrf2 is tightly confined by the robust expression of Nrf1 through its negative regulator Keap1 and Nrf1-target proteasome-mediated degradation pathway, albeit Nrf1 is transcriptionally controlled by Nrf2. Such inter-regulatory roles between Nrf1 and Nrf2 in oppositely and also coordinately governing multiple signaling networks accounting for the strict control of cancer development and progression, in addition to mediating antioxidant, detoxification and cytoprection against oxidative stress and concomitant damages.
Distinct regulation of Nrf1 and Nrf2 with Keap1-proteasomal and p62-autophagic disposing systems
A major role of Nrf2, as a master redox regulon of an antioxidant transcription factor that is activated in adaptive hormesis response to oxidative stress, facilitates the maintenance of cellular redox homeostasis, particularly upon being threatened by the oxygenated environments 4 64 111 176 415 416. In the absence of redox stress, the transcriptional activity of Nrf2 is rigorously confined by its negative regulator Keap1, as a redox sensing adaptor, that sequesters this CNC-bZIP factor in the cytoplasm (by binding its Neh2 domain) and enables its ubiquitination by the Cul3-Rbx1 E3 cullin-RING ligase (CRL3) complex, before being degraded by the proteasome-mediated protein disposal system. However, no similar negative effects of Keap1 appeared to be exerted on Nrf1, even though the putative Keap1-binding Neh2L domain is also represented in Nrf1 303. This is attributable to the fact that this Neh2L domain is translocationally buried in the lumen of ER, such that Nrf1 is hard to gain access to the extra-ER subcellular Keap1 275 304. Once the Neh2L domain of Nrf1 is retrotranslocated across ER membranes to enter the cytoplasmic compartments, it is allowed for binding Keap1 and stabilized by this redox-sensing adaptor, which regulates Nrf1 distinctively from Nrf2 417, but such stabilization of Nrf1 by Keap1 is hardly validated in our experimental settings 418 419. In turn, it was, to our surprise, found that specific KO of human Nrf1α (i.e., Nrf1α-/- with its long isoform TCF11) led to the substantial diminishment of Keap1 in HepG2 cells, while human Nrf2-/- (with a genomic deletion of its transactivation domains) caused an obvious increase in basal Keap1 expression, when compared with wild-type controls 265 419. This finding demonstrates a bidirectional positive and negative regulatory profile of Keap1 by Nrf1α and Nrf2, respectively. Such positive and negative regulation of Keap1 by Nrf1α and Nrf2 is likely related to its binding partner p62-driven autophagy and its subsequent lysosomal degradation of this relatively long-lived Keap1 420 421 422 423. The p62 (also called sequestosome 1, SQSTM1) is transcriptionally induced upon oxidative stress by Nrf2 by direct binding to the ARE sequence in the p62 promoter 424. Once p62 is accumulated, which also occurrs when autophagy is impaired, the increased p62 enables direct binding to Keap1 and also targets it to the autophagy-mediated lysosomal degradation, resulting in a reduced proteasomal turnover of Nrf2 via such a feed forward loop within chronic redox stress signaling. By contrast, this autophagy adaptor p62 expression was basally enhanced in Nrf1α-/- cells, implying that it is negatively regulated by Nrf1α 420, but the detailed mechanisms remain to be elucidated.
The autophagy and ubiquitin-proteasome systems are two primary cellular pathways of misfolded or damaged protein degradation to maintain intracellular protein homeostasis (proteostasis). When the proteasome is dysfunctional, cells compensate for so impaired protein clearance by activating selective autophagy to eliminate ubiquitinated or damaged protein aggregates. In studying both cross-talking mechanisms, it was found that a rapid, dramatic and selective induction of GABARAPL1 (but not other autophagy genes) and p62 (bridging ubiquitinated proteins with GABARAPL1 on autophagosomes) was caused by proteasome inhibitor treatment for 4 h, to promote cell survival before autophagy activation 425. Conversely, knockdown of p62 or GABARAPL1 reduced cell survival upon proteasome inhibition. Such transcriptional induction of p62 by Nrf1 enables enhanced survival primarily by sequestering ubiquitinated proteins in nuclear inclusions and perinuclear aggresomes 425, albeit simultaneously accompanied by induced transcriptional expression of proteasome genes (i.e., proteasome bounce-back response 340 426). The transcriptional activation of aggrephagy by Nrf1 in the response to proteasomal dysfunction is further corroborated by autophagy-related p62/SQSTM1 and GABARAPL1 (an ATG8 family gene) directly targeted by this CNC-bZIP factor 427. Interestingly, Nrf1 was also identified to be indispensable for the formation of p62-positive puncta and their co-localization with ULK1 and TBK1; both kinases may activate p62 via phosphorylation, because knockdown of Nrf1 caused substantially reduced phosphorylation of p62 at Ser403 427. Such selective upregulation of GABARAPL1 by Nrf1 also facilitates induced clearance of ubiquitinated proteins, particularly whilst proteasome is impaired 427. Rather, a prolonged treatment of proteasome inhibitor for 20 h, these cells activated autophagy and expression of most autophagy genes possibly by an Nrf1-independent mechanism 425, although this CNC-bZIP factor is recently further confirmed to regulate similar proteotoxic stress-induced autophagy 428.
The conserved proteasome bounce-back response was originally observed in S. cerevisiae 429 430 431, where chemical or genetic inhibition of proteasome activity induces new proteasome synthesis promoted by the stress-regulated transcription factor RPN4 (with its DNA-binding C2H2 zinc-finger zipper domain 461RHQNTIHAKRKIVFRCSECIKILGSEGYQKTFSRLDALTRHISKHEDLSLEQRQEVTK520), so to ensure that the proteasome capability is matched to changing proteolytic requirements. Another similar transcriptional feedback loop was also found to exist between the proteasome and SKN-1 in C. elegans 432, revealing activation of SKN-1 by proteasomal dysfunction is tied to the protein-degradation machinery of the cells and also produces a selective oxidative (proteotoxic) stress response. The increased expression of 20S proteasomes was further validated to be de facto mediated by SKN-1 and CncC in both worms and flies, respectively 433. Such compensatory recovery of proteasome activity induced by limited proteasomal inhibition was also observed in mammals 434 and identified to be predominantly activated by Nrf1 (and its long isoform TCF11, but not Nrf2) via an ERAD-dependent feedback loop 340 426. Under non-inducing conditions, Nrf1/TCF11 within and around ER membranes is targeted to the ERAD requiring E3 ubiquitin ligase Hrd1 and the AAA ATPase p97. Upon exposure to a lower dose of proteasome inhibitors, this causes an accumulation of oxidant-damaged proteins and then promotes the nuclear translocation of Nrf1/TCF11 from the ER, before permitting activation of proteasome gene expression by binding to AREs in their promoter regions. The Nrf1-driven transcriptional feedback loop regulating all those proteasomal subunits and their co-factors, as well as p97, was further confirmed in other groups 435,436. Overall, Nrf1/TCF11, rather than Nrf2, serves as a key essential regulator for activation of the highly conserved proteasome bounce-back response for 26S proteasome formation to compensate for its reduced proteolytic activity, and mediate its innate cytoprotective response to counteract proteotoxic stress caused by proteasome inhibition.
The autophagy-lysosome pathway activity is enhanced by graded proteasome dysfunction caused by a mutant of RPN10 in C. elegans 437, in which enhanced resistance to aggregation prone proteins depends on autophagy genes atg-13, atg-16.2, lgg-1, bec-1 and prmt-1, though the animals are particularly sensitive to the inhibition of lysosome activity via either RNAi or chemical means. Such moderate proteasome dysfunction can be leveraged to improve proteostasis capacity, and organismal healthy survival and longevity through the activation of compensatory mechanisms regulated by SKN-1A/Nrf1 (and ELT-2/GATA), that mediates increased expression of the genes encoding proteasome subunits (as a conserved bounce-back response), as well as those mediating anti-oxidative and heat-stress adaptive responses 437 438. The proteasome regulation by SKN-1A/Nrf1 also enables innate immune responses to be kept in check in a tissue-specific way against natural pathogens of the C. elegans. Conversely, constitutive expression of immune response programs against pathogens was triggered by the loss-of-function mutants of SKN-1A and its activating enzymes DDI1 and PNG1, leading to proteasome inhibition 438.
In addition, the ER-anchored ubiquitin-specific protease USP19 acts as a novel mechanistic modulator of Nrf1, but not Nrf2, which directly interacts with Nrf1 near the ER and also topologically functions as a deubiquitinating enzyme to remove ubiquitin moieties from this protein, thereby enabling Nrf1 to be rescued from the putative ubiquitin-directed ERAD pathway 317. In turn, the transcriptional expression of endogenous USP19 and its promoter-driven reporter genes is differentially regulated by Nrf2, as well as by Nrf1, at distinct layers within a complex hierarchical regulatory network. Recently, it was discovered that Keap1 is a crucial multifunctional player in governing and/or maintaining robust proteostasis, because it cannot only contribute to the ubiquitin-mediated proteasomal degradation system by interacting with so many ubiquitination enzymes (including Cul 1 to 5) along with 26S proteasomal core and regulatory subunits, but also conversely enables for a novel contribution to relevant protein stability (e.g., Smad2/3) by an additional deubiquitination system 419.
Inter-regulation of Nrf1 and Nrf2 with differential redox signaling to cancer metabolism
The aberrant accumulation of hyperactive Nrf2 was found to result from specific KO of human Nrf1α-/- HepG2 cells 265, which is attributable to substantially diminished expression of its negative regulator Keap1 and Nrf1-target proteasome dysfunction. Although Nrf2 is hyperactive, the malignance of Nrf1α-/--leading xenograft tumor and metastasis were enhanced 265 266. Similarly, marked results were also obtained from the knockdown of all Nrf1 isoforms (Nrf1-KD) 413. Conversely, knockdown of Nrf2 caused Nrf1α-/--derived tumor to be suppressed to a similar extent to wild-type controls (Figure 13A). By sharp contrast, the inactive Nrf2 enabled Nrf2-/--leading tumor to be dramatically repressed and almost completely abolished in the model xenograft animals 265, but the constitutive active Nrf2 (caNrf2) expression did not result in a significant change in caNrf2-derived tumor, when compared to wild-type controls (Figure 13A). These observations demonstrate that Nrf2 is much more likely to act as a tumor promoter, whilst Nrf1 serves as a tumor repressor. This was evidenced by further experiments revealing that the remarkably tumor-repressing effects on hepatocellular carcinoma were convincingly corroborated by restored expression of ectopic Nrf1 or TCF11 factors 123. Therefore, it is inferable that the tumor-promoting effect of Nrf2 is stringently confined by Nrf1 as an indispensably braking control of Keap1 and proteasome functioning in distinct adaptive responses. Besides, the transcription expression of Nrf2 was also shown to be inhibited by Nrf1, because its basal and inducible mRNA expression levels were up-regulated to varying extents in the tissue-specific Nrf1-/- mice 348 391, as well as in human Nrf1α-/- hepatoma cells 89 439 440 441. In turn, substantially reduced transcription of Nrf1 was caused by Nrf2-/- deficiency, implying that Nrf1 is positively regulated by Nrf2, and also by itself as revealed by its promotor-driven reporter assays 265. Overall, such inter-regulation between Nrf1 and Nrf2 occurs at distinct levels from their gene regulatory transcription to post-synthetic protein disposal. This is also further corroborated by the in vivo mouse model expressing the Nrf1-MafG heterodimer, revealing that Nrf1 has the potential to activate canonical Nrf2 target cytoprotective genes when strongly induced 442.
Of crucial importance is severe endogenous oxidative stress caused by loss of Nrf1’s function, which cannot be compensated by hyperactive Nrf2 accumulated in the deteriorated Nrf1α-/- hepatoma cells 89 115 263 354 439 440. Similarly, oxidative stress was also observed in Nrf1-/- mouse model systems 172 261 326 397, and further aggravated by a combined deficiency of Nrf1 and Nrf2, leading to fatal defects with typical pathologies 332 348. These demonstrate that Nrf1 acts as an indispensable determinon for robust redox homeostasis, albeit Nrf2 is accepted as a master regulon of antioxidant, detoxification and cytoprotective genes in this process 111 116. As such, the silencing of Nrf2 can rescue glucose deprivation-induced rapid death of Nrf1α-/- cells, because severe endogenous oxidative stress arising by its aberrant redox metabolism was ameliorated by knockdown of Nrf2, as a similar rescue was obtained from catalase 354. This fact indicates that the existing endogenous oxidative stress in Nrf1α-/- hapatoma cells is further augmented by hyperactive Nrf2, particularly upon glucose starvation, implying a possibly Nrf2-dependent (e.g., KLF9) pathway to stimulate increased production of ROS, as described by Zucker, et al. 443. Such switching of redox signaling by key modular molecules (e.g., GPX, PRDX) dictates cell fate decision by Nrf2-mediated dual opposing responses for adaptation or maladaptation, specifically when Nrf1 is lost.
To defend against a vast variety of challenges from changing environments, an evolutionally selected set of antioxidants, detoxification and cytoprotective systems are predominantly regulated by Nrf1 and Nrf2 for their coordinated redox control to maintain cell homeostasis and organ integrity during healthy survival. Upon loss of full-length Nrf1α causes a dramatic increase in intracellular ROS level and oxidative damage in the resulting Nrf1α-/- cells, and this increase was not eliminated by drastically elevated Nrf2, although the antioxidant systems were also substantially enhanced by hyperactive Nrf2 115. Further experiments revealed that the increased ROS production by Nrf1α-/- resulted from a remarked impairment in the mitochondrial oxidative respiratory chain and its gene expression profiling regulated by two nuclear respiratory factors (called αPalNRF1 and GABPNRF2, which are non-homologous nuclearly-controlled transcription factors (Supplemental Figures S8 and 9) 115 364 418. In addition to the intrinsic antioxidant capacity of cells, aerburg effect) by aberrantly-elevated Nrf2, so as to partially relieve the energy demands of Nrf1α-/- cells, but heavily aggravate its mitochondrial stress (to yield an evident UPRmito, which is similar to, but different from, UPRER 89 115). Besides, the generation of ROS was also differentially regulated by Nrf1 and Nrf2 via the miR-195 and/or mIR-497-mediated UCP2 pathways 115. Upon glucose starvation of Nrf1α-/- cells, the altered gluconeogenesis pathway was greatly aggravated, also as accompanied by a weakened pentose phosphate pathway, as bad as dysfunction of serine-to-glutathione synthesis, leading to accumulation of ROS and severe oxidative damages, such that the intracellular reduced equivalents (i.e., GSH, NADPH, TRX) were exhausted 354. Thereby, it is inferable that glucose starvation leads to acute death of Nrf1α-/- , rather than Nrf2-/-, hepatoma cells resulting from its fatal defects in the redox metabolism reprogramming. This is also likely attributed to distinct requirements of Nrf1 and Nrf2 for regulating the constructive and inducible expression of those key genes involved in redox metabolic reprogramming in cancer development and malignance (Figure 14) 115 264.
Figure 14. FIGURE 14: Differential but integral roles of Nrf1 and Nrf2 in regulating responsive genes.
(A) A transcriptomic analysis of Nrf1α-/- and Nrf2-/- cell lines by comparison to wild-type (WT) cells. These differential expression genes (DEGs) were subjected to clustering their functional annotations into distinct signaling pathways, principally responsible for governing cancer development and progression. (B) The inter-regulatory roles of both Nrf1 and Nrf2 in uniquely yet coordinately controlling of redox signaling, energy metabolism and other target gene networks as indicated herein. These graphs with the relevant big data analyses were adapted from 115,123.
Distinct regulation of Nrf1 and Nrf2 in cancer metabolism reprogramming
Of striking note, Nrf1 can serve as a dual sensor and regulator of glucose homeostasis, because glycosylation of Nrf1α enables it to sense the energy state 335. Dysfunction of this energy sensor leads to glucose metabolism reprogramming, so to markedly aggravating the Warburg effect in Nrf1-silenced hepatoma cells, as accompanied by the resulting mitochondrial damages. Such glucose reprogrammed effects are driven primarily by uncontrollable signaling mediated by AMP-activated protein kinase (AMPK) in Nrf1-deficient cells, because this CNC-bZIP factor negatively regulates this nutrient-sensing master kinase by direct physical interacting ‘placeholder’ 355. Of crucial importance, recent studies further revealed that the loss of Nrf1’ function also leads to lipid metabolism disorders, along with severe accumulation of ROS and lipids as deposited in lipid droplets of Nrf1α-/- cells 263 264. This is attributable to that the cellular lipid synthesis pathway was up-regulated by the JNK-Nrf2-AP1 signaling, whilst its lipid decomposition pathway was down-regulated by the nuclear receptor PPAR-PGC1 signaling. By sharp contrast, knockout of Nrf2-/- decreased lipid synthesis and uptake capacity. This indicates that Nrf1 and Nrf2 contribute to significant differences in the cellular lipid metabolism profiles and relevant pathological responses. Further studies uncovered that lipid uptake and ensuing deposition in Nrf1α-/- cells resulted from CD36 up-regulation by activating the PI3K-AKT-mTOR signaling pathway, consequently leading to an aberrantly activated inflammatory response 263 264. More interestingly, the yield of lipid droplets in Nrf1α-/- cells was strikingly alleviated by 2-bromopalmitate 263. This effect was also accompanied by substantially abolished expression of the endogenous CD36 and critical inflammatory cytokines. This finding provides a potential strategy for cancer prevention and treatment by precision targeting of Nrf1, Nrf2 or both.
Metabolic reprogramming is accepted as a central hallmark of cancer and plays a pivotal role in malignant tumor occurrence, metastasis and even drug resistance 444 445. Thereby, it is inferable from the aforementioned findings that Nrf1 and Nrf2 are differentially and integrally required for the multifaceted crosstalk between redox responsive signaling and metabolic pathways to coordinately control a vast variety of the relevant signaling molecules and metabolic enzymes involved in cancer metabolism, aiming to sustaining robust redox homeostasis and metabolism homeostasis (metabostasis, including glucose, lipid, cholesterol and protein homeostasis. The in-depth insights unraveled that genetic deletion of Nrf1 and Nrf2 resulted in distinct metabolism reprogramming in human hepatoma cells 264. That is, the loss of Nrf1α de facto led to enhanced glycolysis, reduced mitochondrial oxygen consumption, enhanced gluconeogenesis and activated pentose phosphate pathway in the hepatocellular carcinoma cells. By contrast, the loss of Nrf2 attenuated the glycolysis and gluconeogenesis pathways, but without any significant effects on the pentose phosphatepathway. Such KO of Nrf1α-/- de facto caused fat deposition and increased amino acid synthesis and transport, especially serine synthesis 264, whereas Nrf2-/- deficiency did not cause fat deposition, but attenuated amino acid synthesis and transport. Such distinct metabolic programming between Nrf1α-/- and Nrf2-/- was further revealed to result from substantial activation of the PI3K-AKT-mTOR signaling pathway triggered by loss of Nrf1, leading to increased expression of those critical genes for the glucose uptake, glycolysis, the pentose phosphate pathway, and the de novo lipid synthesis, whereas deficiency of Nrf2 resulted in the opposite phenomenon by blocking this PI3K-AKT-mTOR pathway 264. This signaling downstream transcription factors HIF1 and SREBP1/2 were further corroborated as two key players in such distinct metabolism reprogramming of between Nrf1α-/- and Nrf2-/- cells, just as described previously by 446 447. Of note, Nrf1α-/--enhanced activation of the HIF1 signaling led to increased expression of the glycolysis rate-limiting hexokinases HK1/2 and glucose transporters (e.g., SLC2A1, also called Glut1) 264 354 355.
In addition to the significantly increased uptake of lipids by CD36 263 347, the loss of Nrf1-/- resulted in enhanced de novo lipid synthesis by activated SREBP1/2 through the PI3K-AKT-mTOR pathway 264. Of crucial importance, Nrf1 acts as a direct ER membrane sensor critical for cholesterol and lipid homeostasis through SREBP1/2 and LXR 347. Such cholesterol-dependent homeostasis can also further finely tune the regulation of very long chain sphingolipid synthesis to maintain plasma membrane lipid homeostasis and cell integrity 448. Together, these indicate the Yin-Yang relationship between Nrf1 and SREBP1/2 for sustaining cholesterol and lipid homeostasis. Another recent report by Xu’s group showed activity of SREBPs is inhibited by promoting degradation of SREBP-cleavage activating protein (SCAP, a canonic cholesterol sensor) through the ubiquitin E3 ligase RNF5-dependent proteasomal pathway, the ligase is recruited to a direct target of Nrf1, i.e., the ER-resident transmembrane TMEM33 449. The TMEM33 serves as a downstream effector of pyruvate kinase isoform 2 (PKM2), which coordinates together with p97/VCP to tightly control the selective processing of Nrf1 and SREBPs, and their bidirectional regulatory capability to dictate lipid metabolism and homeostasis 449. Because Nrf1 and SREBP1 manifest distinct topogenetic behaviors around membranes 114 [114], both should be endowed with their disparate topovectorial spatiotemporal partitioning to exert their respective unique biological functionality, which occurs only after being dislocated from the ER and Golgi into the nucleus to gain access to cognate target genes (Figure 10). These demonstrate that Nrf1 is indeed contributable to the negative regulation of lipid metabolism and homeostasis through the PKM2/p97-Nrf1-TMEM33-RNF5-SCAP-SREBPs axis. Collectively, these together with an additional experimental report 319 have convincingly confirmed that Nrf1 is not a direct target of SREBP1, albeit both are involved in the rapamycin-responsive signaling networks, and this resulting point cannot thereby support the relevant view of Manning’s work 450.
Unique and overlapping roles of Nrf1 and Nrf2 in integrating multi-hierarchical signaling networks to genetic adaptive reprogramming
The considerable lines of the hitherto accumulating experimental evidence (including those described above) have unveiled the unique and overlapping roles of Nrf1 and Nrf2, as well as their differentially positive and negative regulatory effects, all of which are integrated in elaborately governing cellular homeostasis and organ integrity and tightly persevering their robust status within certainly presetting physio-pathological threshold ranges. Such robust intrinsic status should be determined by unifying all relevant endogenous molecular-cellular-organismal networks, but also shaped by switching their physio-pathological functionality 179 451. Therein, Nrf1 plays a predominant, indispensable role, albeit Nrf2 also acts as a master regulator, in determining such robust physio-pathological states. This notion is solidly based on the gene-targeting experimental evidence revealing those unique pathophysiological phenotypes of Nrf1 but not Nrf2, as evinced in those distinct tissue-specific knockout mice (see section "Unique pathophysiological phenotypes of Nrf1 that are distinctive from Nrf2"), as well by their specific knockout cell lines from the human hepatoma (Figure 13A). As such, double KO of both Nrf1 and Nrf2 in mice also results in worsened pathological phenotypes, as compared to those of the single Nrf1 KO mice 332 348. From these, it is inferable that such unique and overlapping biological roles of Nrf1 and Nrf2 are fulfilled by integrating all multi-hierarchical signaling networks into genetic adaptive reprogramming.
By analysis of the chromatin immunoprecipitation (ChIP)-sequencing combined with RNA-sequencing data, 31 differential expression genes (DEGs) were identified as co-targets of Nrf1, Nrf2 and Nrf3 (i.e., doxycycline-inducible FLAG-tagged Nrf1ΔN1-121, Nrf2 and Nrf3ΔN1-173 in the human osteosarcoma U2OS cell lines) 117. Among them, 18 genes were upregulated, plus nine genes down-regulated, by all three factors, apart from only four genes differentially regulated by at least one of their three. Additionally, 84, 84, and 22 genes were defined to be specifically up- or down-regulated by Nrf1, Nrf2, and Nrf3, respectively 117. By scrutinizing those ARE-containing ChIP peaks, it was unraveled that Nrf1 prefers its strictly binding to AREs flanked by AT-rich regions (e.g. to drive metabolism genes), but in contrast, Nrf2 prefers more loosely binding to canonical AREs adjoined by GC-rich regions 117. Furthermore, another overexpressing system of FLAG-tagged Nrf1ΔN1-84, Nrf2 and Nrf3ΔN1-112 in HEK293T cells were subjected to RNA-sequencing-based transcriptomics combined with quantitative proteomics to delineate their overlapping and differential genetic programs mediated by these three factors 452. Nrf1-specific targets were identified to include several chaperones (e.g., HSPA4, HSPA8, HSPA9, DNAJC1, DNAJA2), the chaperonin TCP complex (e.g., CCT2, CCT5, CCT8), and a set of genes for the heat shock response besides the proteasomal bounce-back response 452. This implies a crucial role of Nrf1 in cellular protein quality control by enhanced protein folding and increased proteasomal degradation to augment the proteostasis-based repair. However, it should be noted that these N-terminally truncated Nrf1 and Nrf3 were likely dubbed as two Cinderella artifacts of this CNC-bZIP family 453. Of importance, by evaluating the molecular function of the tethered Nrf1-MafG heterodimer by the mouse models, it was further unraveled that this heterodimer can in vivo activate the transcriptional expression of proteasome subunits and the proteostatic stress response genes (involved in ERAD, chaperone and ubiquitin-mediated degradation pathways) by specifically binding to ARE-related sequences in the proximity of these genes 442.
It is noteworthy that the unique transmembrane-topogenetic behavior of Nrf1 makes its functions more complicated than Nrf2, such that alternative splicing of its transcript and the selective processing of its protein are enabled to yield distinct lengths of isoforms (e.g., TCF11, Nrf1α, Nrf1β, Nrf1γ) 123 178. The tetracycline-inducible stable expression of these isoforms, together with TCF11ΔN2-156 and Nrf2, were allowed on the base of the Flp-In T-Rex HEK293T system. The transcriptomic analysis revealed that, albeit Nrf1α and TCF11 have similar yet different regulatory profiles, both contribute basically to the positive regulation of their co-targets, which are disparate from those regulated by Nrf2 (Figures 15C and S10), whereas the mutant TCF11ΔN2-156 appears to resemble Nrf2 with the largely consistent structure and function 123 (Figures 6C and S10C). The disparity in such genes regulated by Nrf1 and Nrf2, along with those of TCF11, Nrf1α, Nrf1β and Nrf1γ, was validated by scrutinizing comprehensive functional annotation of their specific and/or common target genes (Supplemental Figure S10), as well as by the combined RNA-sequencing analysis of Nrf1α-/- and Nrf2-/- cell lines versus wild-type controls 123. Notably, Nrf1α/TCF11-specific genes are focused on nutrient uptake, cellular metabolism, protein folding, sorting and degradation, along with DNA replication and repair, whilst Nrf2-specific genes were heavily weighted in the developmental process 123 [123]. However, the opposing regulatory genes of 108 by Nrf1 and Nrf2 were clustered into pathways in cancer, including the PI3K-AKT, p53, VEGF and JAK-STAT signaling, and ECM-receptor interacting EMT process, aside from antioxidant and inflammatory responses (Figure 14A). From them, 52 genes were further selected by combined transcriptomic and proteomic analysis of Nrf1/2-indicated stably expressing and deficient cell lines (Figure 15A), to build a gene regulatory network (Figure 15B). A part of such distinct genes, by mapping with metabolome analysis (Supplemental Figure S11), were denoted on the cellular sphingolipid, inositol phosphate, glutathione and purine metabolisms, as well on the phosphatidylinositol (e.g., PI3K-AKT) signaling system.
Figure 15. FIGURE 15: Distinctive or even opposing regulation of target genes by Nrf1/TCF11 and Nrf2.
(A) Combined analysis of transcriptome and proteome by sequencing of two distinct cell model systems as indicated. Firstly, transcriptomic sequencing of Nrf1α-/- and Nrf2-/- cell lines, as well as the tetracycline-inducible HEK293 cell system stably expressing Nrf1, TCF11 or Nrf2, when compared to their corresponding controls. Secondly, proteome analysis of Nrf1α-/- and Nrf2-/- cell lines vs their control cells. The results revealed that differential or even opposing expression genes were regulated specifically by either Nrf1/TCF11 or Nrf2. (B) Such a specific gene regulatory network was bi-directionally governed by Nrf1/TCF11 and Nrf2. (C) Schematic representation of Nrf1/TCF11- or Nrf2-specific gene networks, along with their shared co-target genes, which were further selected as described previously 123.
The above-described finding is consistent with our previously reported results, revealing the opposing effects of Nrf1 and Nrf2 on PTEN (phosphatase and tensin homologue) 265, which negatively regulate the intracellular levels of phosphatidylinositol-3,4,5-trisphosphate (PI3) and functions as an upstream tumor suppressor by negatively regulating PI3K-AKT-mTOR signaling (Figure 13B). Such negative and positive regulation of PTEN by Nrf1 and Nrf2, respectively, on the PI3K-AKT-mTOR signaling towards HIF1, AMPK and SREBP, led to an adaptive reprogramming of glucose and lipid metabolisms, along with certain amino acid metabolism reprogramming 263 264 354 355. In addition to PTEN, similarly opposing regulatory effects of Nrf1 and Nrf2 were executed on the p53 signaling 265 414, the WNT-β-catenin signaling pathway and the EMT process 266 413. Furthermore, Nrf1 and Nrf2 also contribute bi-directionally to the coordinated control of arachidonic acid metabolism enzymes COX1, COX2 and ALOX5 to confine the inflammatory stimulation (Figure 13B) 265. Once loss of Nrf1α-/-, uncontrollable inflammatory response was spontaneously aroused, leading to NF-κB signaling activation and increased expression of inflammatory cytokines, and accompanied by Nrf2-leading JNK-JUN (AP-1)-mediated stress response, along with aberrant accumulation of ROS and lipids 115 263 265. The EMT process of Nrf1α-/- cells was further activated by those putative ROS-stimulated signaling pathways via MAPK, HIF1α, NF-κB, PI3K, and AKT, all players involved in cancer development and progression. As a collective consequence, the inflammatory malignant transformation into carcinogenesis and cancer progression should take place in the Nrf1-deficient cases, in which hyperactive Nrf2 acts as a potent tumor promotor, because malgrowth of the Nrf1α-/- -driven tumor in xenograft model mice was significantly suppressed by silencing of Nrf2 265.
To gain insights into the mechanisms underlying such distinct pathologic phenotypes of between Nrf1α-/- and Nrf2-/-, the transcriptome data from liver cancer in the TCGA database were also mined to establish a prognostic model and calculate predicted risk scores for each cell line. The results revealed that KO of Nrf1α markedly increased the risk score in liver cancer, while the risk score was reduced by knockout of Nrf2 414. In the prognostic model, stanniocalcin 2 (STC2), as a potential biomarker expressed highly in hepatocellular carcinoma tissues with a reduction in the overall survival ratio of those patients, was significantly upregulated in Nrf1α-deficient cells, but strikingly downregulated in Nrf2-deficient cells 414. The negative regulation of STC2 by Nrf1α is dependent on Nrf2 and HIF1α (as a direct upstream regulator of the STC2 transcription 454 455). Rather, the positive regulation of STC2 by Nrf2 may also be direct, independent of HIF1α (Figure 16). In turn, STC2 may regulate Nrf2 via a putative calcium-triggering Keap1-antagonized signaling pathway so to form a positive feedback regulatory circuit. Further studies unraveled that STC2, like Nrf2, functions as a dominant tumor-promoter, because STC2-leading increases in clonogenicity of hepatoma cells and malgrowth of relevant xenograft tumors were almost completely abolished in STC2-/- cells 414. This indicates that STC2 is also likely paved as a potential therapeutic target for liver cancer, albeit as a diagnostic marker.
Figure 16. FIGURE 16: A model proposed for a better understanding of these key transcription factor inter-regulatory networks.
Differential but integral regulation of Nrf1, Nrf2 and its target HIF1 signaling controls the biomarker STC2’s role in mediating distinctive phenotypes between Nrf1α-/- and Nrf2-/-. The distinction in their pathophysiological phenotype status is determined by such a robust endogenous molecular-cellular network. Conversely, STC2 can also serve as a potent feedback regulator of Nrf2 through Keap1 and/or p62. These critical protein expression levels are also tightly monitored by Nrf1-target proteasome and/or autophagy-lysosomal disposing systems, in addition to its transcriptional responsive reprogramming. For detailed explanations, see the relevant text and the cited reference 414.
Differential yet integral roles of Nrf1 and Nrf2 in cellular homeostatic and adaptive responses
Upon exposure of cellular life to its homeostasis-threatening stress, particularly redox stress, a series of intrinsic anti-redox cytoprotective mechanisms (that have been established and developing in its eco-evo-devo possess of life histories) will be roused and activated to defend against such challenging stress in order to give rise to adaptive and homeostatic responses, to promote cellular resilience and maintain its physiological homeostasis. In such responses (i.e., CHR and CSR, as defined by Kültz 124), Nrf1 plays essential, predominant, and indispensable roles for CHR, whilst Nrf2 is involved in, but not essential for, the CHR, even although it is required for the cellular stress-adaptive response (CSR). This notion is concluded based on their distinct time-dependent responses driven by inducibly expressing Nrf1 and Nrf2 with disparate half-lives (Figures 6 and S2) and a house of the hitherto accumulated experimental evidence (as described above in the relevant sections). As such, although Nrf1/TCF11 exerts an irreplaceable and pivotal role in governing the CHR, Nrf2 in handling such a rapid emergency response and CSR also provides an invaluable way of ‘buying time’ for the transition to the lagging CHR mediated by Nrf1/TCF11 insomuch as to coordinately cope with redox stress threatening cell homeostasis and organ integrity of life systems (Figure 17).
Figure 17. FIGURE 17: A proposed model for a better understanding of the major mechanism by which Nrf1 controls cell homeostasis.
The membrane-tethered Nrf1 factor is selectively processed and hence activated to determine the cellular redox and energy metabolism homeostasis, as well as mitochondrial biogenesis, respiratory chain and its homeostatic integrity. Of importance, Nrf1 cannot only govern two key nuclear respiratory factors (αPalNRF1 and GABPNRF2) essentially required for mitochondrial function and homeostasis (see Supplemental Figures S8, S9 and S12), but also finely monitor the mitochondrial stress response by its protein quality control (i.e., UPRmito). Such unique biological functions of Nrf1 are distinguishable from those exerted by Nrf2, because the protein stability of Nrf2 and its activity are tightly confined by Nrf1. However, once the unique functions of Nrf1 are lost in its deficient cells or organs, the resulting dyshomeostasis of redox, glycose, lipid and protein metabolism, as bad as mitochondrial dysfunction with severe endogenous oxidative stress, could ultimately lead to unresolvable inflammation and malignant transformation into cancer, even rapid aging (e.g., non-infectious inflammatory ageing) and age-related neurodegenerative diseases. This graph was partially adapted from [REF]. In addition, it should be noticed that two non-homologous nuclear respiratory factors (also abbreviated often as NRF1/2) were confused with another symbols Nrf1/2 abbreviated from the nuclear factor, erythroid 2-related factor 1/2, and thus designated αPalNRF1 and GABPNRF2 (see Supplemental Figure S8, as discussed in references 364,418).
Once stimulated by stress, besides direct reactions, an acute emergence response is rapidly roused by sensing such stress signal transduction to redistribution of oxygen, nutrients and energy, followed by short-term responsive metabolism reprogramming and ensuing long-term adaptive genetic reprogramming to restore its original normal homeostasis or gain an adaptive or even maladaptive tolerance. This depends on the severity of such cellular stress and overall capacity of its intrinsic cytoprotective responses (Figures 5 and 6). In these cellular homeostatic and adaptive responses, both Nrf1 and Nrf2 fulfill their differential, yet integral, physiobiological roles by governing all relevant multi-hierarchical cellular-molecular signaling networks, in distinct topovectorial and right tempospatial ways, to shape adaptive metabolic and genetic reprogramming (Figures 14B, 17 and S12).
The cellular redox homeostasis is determined by balancing between production of all redox equivalents (Rop) and their elimination (Roe) by relevant anti-redox defense system, as formulated by ΔH = HS - H0 = ∫[Rop - Roe]×k, (in which H0 and HS represent basal redox homeostatic and stress-stimulated redox robust states, respectively). A considerable number of substantial researches, as aforementioned, have revealed that differential yet integral roles of both Nrf1 and Nrf2, in governing production of all redox equivalents and their elimination, are exerted just as two entangled ‘Yin-Yang’ defensors to coordinately regulate the anti-redox and cytoprotective transcriptional responses insomuch as to maintain and perpetuate robust redox homeostasis within a certain presetting threshold range (Figures 3 and 11A). Therein, Nrf1 has been identified to act as a robust indispensable determinon for cellular redox homeostasis (and mitochondrial homeostasis) in particular normal physiological conditions, whereas Nrf2, as a master regulon, plays a versatile role in this process, specifically mediating adaptive hormestic effects induced by stress. Of note, the loss of Nrf1’s function leads to severe oxidative stress with obvious pathological phenotypes, but also was not compensated by hyperactive Nrf2 in Nrf1-deficient mice and cell lines 115 265 332 348. Such being the case, the permanently hyperactive Nrf2 is much more likely to give rise to another reductive stress 416 440. Altogether, these may enable an additional novelty maladaptive redox homeostatic status to be ultimately created, as a collective consequence, leading to the pathogenesis of cancer and other degenerative diseases.
By brown adipocyte-specific Nrf1 KO mice that cannot acquire cold adaptation by rising thermogenic activity, Nrf1 was identified as a master regulator of thermogenesis by regulating the transcriptional expression of UCP1 373. Another uncoupling protein UCP2 was differentially regulated by Nrf1 and Nrf2 via miR-195/497 115. This implies that Nrf1 and Nrf2 have differential and even opposing or combinational roles in governing cellular energy metabolism homeostasis (i.e., Intake - Expenditure = Storage), as evidenced experimentally by gene-manipulated model mice and cell lines 263 264 344 347 348 354. For instance, the energy uptake was controlled by Nrf1-driven transcriptional expression of glucose transporters (e.g., Glut1/2) 264 354 and lipid transporter (CD36) 263 347. The energy storage utilizing fat mass and glycogen was also affected by the presence or absence of Nrf1. The reduced glycemia in hepatocyte-specific Nrf1-/- mice resulted from reduced levels of the hepatic glycogen and its glycogen synthase GYS2, together with decreased insulin and IGF1 356. Intriguingly, two similar yet different lean phenotypes with lowered body weights but not fat mass were manifested in skeletal myocyte-specific Nrf1-/- mice 381 and also in its constitutive active Nrf1-Tg:MGRD mice 329. However, a large amount of fat mass is markedly stored in those liver-specific Nrf1-/- mice 261 347 348 and cell lines 263 264. The energy expenditure was also altered by adaptive reprogramming of cellular glucose and lipid metabolisms, controlled oppositely by Nrf1 and Nrf2, through the PTEN-controlled PI3K-AKT-mTOR signaling cascades toward HIF1/AMPK and SREBP1/2-mediated transcription responses, respectively 264. Besides, Nrf1 displays as a direct energy sensor to negatively regulate AMPK, a master kinase regulator of glucose metabolism reprogramming 355. Overall, these demonstrate that Nrf1 can also function as a robust determining factor for energy metabolism homeostasis (including glucose, lipid, and nutrient homeostasis), in addition to the aforementioned redox homeostasis and proteostasis.
In mediating adaptive transcriptional responses, Nrf1 and Nrf2 are indeed differentially and integrally activated upon stimulation by distinct types of cell stress, e.g., tert-butylhydroquinone (tBHQ, a pro-oxidative stressor) 439, dithiothreitol (DTT, a reductive stressor) 440, two classic ER stressors tunicamycin (TU) 89 and thapsigargin (TG) 265 414, as well as cisplatin (a platinum-based alkylating agent type of the DNA-damaging anticancer drug) 441, besides limited proteasomal inhibitors and other agents as reviewed previously 87 167 173 174 315. In addition to antioxidant, detoxifying and cytoprotective responses, Nrf1 was also identified as a vital and irreplaceable player in mediating mitochondrial stress response (i.e., UPRmito) by the ATF4/5-CHOP signaling 115, as well in governing this organelle biogenesis and its homeostasis by two nuclear respiratory factors (αPalNrf1 and GABPNrf2) and another two mitochondrial transcription factors (TFAM and TFBM) (Figures 17, S8, S9 and S12). Importantly, it was discovered that Nrf1, rather than Nrf2, is essentially required for DNA damage repair response through the H2AX-XPC pathway 441, but hyperactive Nrf2 in the Nrf1α-/- cells manifests a strong correlation with its chemoresistance to cisplatin, albeit their mechanistic details remain elusive.
ACTIVATION OF NRF1 IS EVOKED BY DISTINCT TOPOVECTORIAL REGULATORY MECHANISMS
Activation of Nrf1 is dictated by its topogenetic folding and retro-translocation across membranes
As illustrated in Figure 18, the membrane-bound Nrf1 transcription factor is integrally anchored within and around the ER and hence conditionally sequestered by the membranes, because its TADs (including AD1, NST and AD2) are co-translationally positioned in the ER luminal side, whereas its DNA-binding CNC-bZIP domains are resided on the cytoplasmic side 112 203 275 304 305. Subsequently, the retro-translocational repositioning and selective proteolytic processing of the full-length Nrf1α (including its transcripts, as described in section "Unique topogenetics of Nrf1 and its dynamic dislocation across membranes to the nucleus before regulating target genes") can enable it to give rise to various lengths of its polypeptide isoforms with differential or even opposing functions, e.g., a mature N-terminally-truncated Nrf1ΔN (and TCF11ΔN), relatively lowered active Nrf1β, along with a negative dominant Nrf1γ (Figures 6C and S1A) 123 178 307 312. Such unique topovectoral regulation of Nrf1 can also dictate specific post-synthetic modifications of this CNC-bZIP factor and its transcriptional activity to fulfill its unique physiobiological functions (as aforementioned in sections "Unique pathophysiological phenotypes of Nrf1 that are distinctive from Nrf2" and "Uniquely differentiated yet integrated roles of Nrf1 and Nrf2 in governing cell homeostasis during distinct life processes") 122 275 304 307 312.
Figure 18. FIGURE 18: Nrf1 acts as a robust determinon for cell homeostasis by integrating its ‘three-in-one’ roles in topobiology.
The upper panel shows that Nrf1 serves, by integrating its ‘three-in-one’ role, as a specific triplet of the direct sensor (for redox, energy, cholesterol and proteotoxic changes), signaling transductor and effector in the stress defense response to being challenged from changing environments. The lower left panel shows that the unique topogenetic folding of Nrf1 and its dynamic retrotranslocation repositioning across ER membranes dictate its topovectorial regulation by specific modification and selective processing to a mature active CNC-bZIP factor and other shorter isoforms, before regulating a particular subset of target genes, portion of which, as enlisted in the lower right panel (down-regulated genes in green, up-regulated genes in black), are responsible for fulfilling their unique biophysiological functions as deciphered herein.
Such being the case, the membrane-topological regulation of Nrf1 by Hrd1/p97-driven retro-translocation of its glycosylated NST-adjoining TADs from the ER luminal to cytoplasmic sides of membranes 122 313 435 is finely tuned by the membrane lipid patterning, particularly within the ordered microdomains (composed primarily of cholesterol and sphingomyelin including ceramide). This is attributable to the presence of at least five cholesterol recognition amino acid consensus (CRAC) motifs within Nrf1, enabling this CNC-bZIP protein to sense changes in membrane constitutive cholesterol density and be also tightly anchored in those cholesterol/ceramide-enriched microdomains 122 347. Thus, it is inferable that dynamic topogenetic folding and subsequent retro-translocation of Nrf1 along with those functional domains being repartitioned, followed by its selective proteolytic processing to yield distinct isoforms, could all be confined by overloading cholesterol and/or ceramide in distinct topovectorial processes. However, the detailed mechanisms by which cholesterol and/or ceramide monitor such topobiological regulation of Nrf1 by the luminal-to-cytosolic retro-translocation of its glycosylated NST-adjoining regions (to become a real functional transactivation domain) remain to be elucidated, albeit the sphingomyelin metabolism is significantly affected by the loss of Nrf1’s function (Supplemental Figure S11).
Activation of Nrf1 depends on its specific modification and selective processing
Firstly, activation of Nrf1 is induced by TU 89 456, which is generally accepted as a classic ER stressor, because it acts as a specific inhibitor of oligosaccharyl transferases (OSTs) catalyzing N-linked glycosylation of ER-resident proteins and thus results in unfolded or misfolded proteotoxic stress. Such induction of Nrf1 by TU is corroborated to yield enhanced expression of its non-glycosylated protein and facilitate its proteolytic processing and its ensuing dislocation from the ER to enter the nucleus before regulating the target gene. Increased transcriptional expression of Nrf1 at its mRNA levels is much likely activated by TU-stimulated PERK-Nrf2 and IRE1-XBP1 signaling pathways, as well as by Nrf1 per se 89 265 457 458. However, it should be noted that such TU-stimulated effects on Nrf1 were misinterpreted by a misleading pathway 341 (with a suspected attention paid by PUBPEER, Supplemental Figure S13), and also further misled by another short commentary on Nrf1 unleashed from the ER 459, based on the wrongly designed Nrf1’s topogenetic experiments 435 [435].
Secondly, activation of Nrf1 arises by its deglycosylation catalyzed by peptide: N-glycosidase (PNG-1, encoded by NGLY1), which occurs only after its ER luminal-resident N-glycosylated NST-adjoining TADs are dynamically retro-translocated across membranes to enter the cytoplasmic side 122 203 275 304 307 313. In addition to the removal of N-linked glycan from Nrf1, the deglycosylation of this factor by NGLY1 leads to the amino acid sequence reediting of its glycosylated asparagines to deglycosylated aspartates to potentiate its acidic transactivation capacity 275. This was convincingly corroborated by additional two laboratories working on Nrf1/Nfe2l1 and Skn-1 306 308. Conversely, N-glycosylation of Nrf1 and its transactivation activity are significantly suppressed by NGLY1-specific inhibitors 307 460 or its genetic loss of such function 461 462 463 464. Upon blockage of Nrf1’s deglycosylation, its glycosylated proteins are thus accumulated and abnormally ubiquitinated by the sugar-recognizing ubiquitin ligase SCFFBS2 in NGLY1-deficient cells, resulting in the retention of aberrantly modified Nrf1 in the cytoplasmic subcellular compartments before being subjected to its proteolytic degradation 465, this is accompanied by proteasome dysfunction and proteotoxic stress. Of importance, the NGLY1 mutant patients are manifested with a congenital disorder of deglycosylation 464 466, leading to a congenital autosomal recessive disorder 467 and even death of adrenal insufficiency 462. Like brain-specific Nrf1-/- pathological phenotypes, Ngly1-/- animals develop neurodegenerative phenotypes and pathological abnormalities in the peripheral and central nervous systems 468. Similar to hepatocyte-specific Nrf1-/- cases, liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism, particularly under food stress 463. Collectively, these pathological phenotypes of Ngly1-deficient patients and animal models all result predominantly from the defective function of Nrf1, with a consequence of impaired proteostasis, accompanying proteotoxic stress-induced cell death, and down-regulated genes (e.g., GCLC and GCLM) responsible for glutathione synthesis, specifically in lymphoblastoid cells 469.
Thirdly, activation of Nrf1 is conferred by selective proteolytic processing of this CNC-bZIP factor by cytosolic proteases DDI1/2 or even activity-limited proteasome to yield a mature N-terminally-truncated active form Nrf1ΔN (and TCF11ΔN) (Figures 6C, 17 and 18) 122 314 321 470. Of note, mammalian DDI2 is conserved with, but distinct from its yeast orthologous DDI1 in its structure and Function 471, which originally acts as a shuttling factor for proteasomes 318. For instance, DDI1/2 is indeed required for the removal of replication termination factor 2 (RTF2) from stalled forks by the proteasomal degradation pathway to maintain genome integrity 472. However, DDI1/2 contains a highly conserved retroviral protease domain that influences the directly binding of ubiquitinated proteins by its ubiquitin-like domain and proteasomal degradation 318. Thereby, selective proteolytic activation of Nrf1 by DDI1/2 or its turnover by proteasomes is dictated by its ER-trafficking configurations in distinct topovectorial phases 316. Such protease activity of DDI2 is required for controlling embryonic development and inflammation by Nrf1/TCF11 473, because of DDI2-/- mouse embryonic lethality at E12.5 with severe developmental failure, which resulted from insufficient proteasome expression with proteotoxic stress, and imbalance between innate immune and autoinflammatory responses. Furtherly, the activation of Nrf1 signaling towards the ubiquitin proteasome system by DDI2, together with its anti-redox response, also protects cells from ferroptosis 474 475. In the ‘bounce-back’ response of Nrf1 to sublethal proteasomal inhibitors, it is subjected to the selective proteolytic processing by DDI1/2 to yield an active CNC-bZIP factor, with its reduced protein degradation by activity-limited proteasomes 122 313 426. This is accompanied by enhanced protein expression of Nrf2 in such conditions, which enables the transcriptional expression of Nrf1 and Nrf1-target proteasomes to be augmented, albeit it is not a direct upstream regulator of the transcriptional expression of proteasomes.
Fourthly, Nrf1 is stabilized, to facilitate its transactivation activity to promote proteasome gene expression, by deubiquitination of Nrf1 by USP19 317, USP7 476 and/or UPS15 477 (which can also negatively regulate Nrf2 by deubiquitination of Keap1 478). Such deubiquitination of Nrf1 does not only rescue it from being targeted for the ERAD pathway, but also favors its subsequent selective proteolytic processing to yield an active CNC-bZIP factor that transactivates its cognate genes (e.g., proteasome and chaperones). Of note, it should also be noted that Hrd1 cannot only serve as a critical E3 ubiquitin ligase for ubiquitination of Nrf1/TCF11 313 426 479, but also functions as an essential retrotranslocon for this CNC-bZIP factor 480 481 482. Rather, whether or how the retro-translocation of Nrf1 in its ER-trafficking is affected by its deubiquitinating enzymes remains to be further elucidated.
The transcriptional activation of Nrf1 in the defense response to distinct types of stress
In addition to directly sensing cholesterol, energy and proteotoxic stress (as described above), the membrane-tethered Nrf1 can also directly sense redox changes in between the most oxidizing ER lumen and relatively reducing extra-ER subcellular cytoplasmic and nuclear compartments by itself thiol-active groups, particularly at Cys341 and Cys360 residues (situated in its glycosylated NST domain and its DNA-binding basic region, respectively) 440. Such distinct types of stress are directly sensed and then transformed to various sorts of cellular signals, and also directly transduced to this effector of Nrf1 (albeit with an aide of Nrf2) in mediating the transcriptional response to regulate cognate target genes. That is, such integrated ‘three-in-one’ roles of Nrf1 are manifested as a highly-efficient triplet of specific sensor, transducer and/or effector in diverse stress defense responses (as illustrated in Figure 18, upper panel). This is dictated predominantly by the unique topogenetic folding of Nrf1 and its topovectorial regulation by dynamically retro-translocated repositioning of this CNC-bZIP factor from the ER lumen across membranes to enter the extra-ER compartments, before dislocating the nucleus, whereupon it regulates the transcriptional expression of a unique subset of antioxidant, detoxification and cytoprotective genes (Figure 18, lower right panel).
In turn, the transcriptional activation of Nrf1 to enhance its mRNA expression levels is indeed triggered in such redox stress conditions, which is also regulated by Pitx2/3 and αPalNRF1 418 483, Nrf2 and itself 265, as well as by other transcription factors rather than SREBP1/2 89 319. In addition, the transcriptional activation of Nrf1 is monitored by its heterodimerizing partners (e.g., sMafs, ATF4, Jun), as reviewed previously 87, and also by several transcriptional co-factors, e.g., CtBP2 (C-terminal binding protein 2) 484 and HCF-1 (host cell factor 1) 310 311.
CONCLUDING REMARKS AND FUTURE WORK
From the holistic eco-evo-devo perspective, we have listed a house of evidence revealing that Nrf1 is a living fossil’s transmembrane transcription factor, that is closer than the water-soluble Nrf2, to their commonly-shared ancient orthologues (e.g., Nach, Cnc, Skn-1) emerged from distinct evolutionary stages of life histories. Such highly-conserved Nrf1 acts as a robust indispensable determinon, whilst Nrf2 serves as a versatile chameleon-like master regulon, in maintaining the cellular redox, energy and metabolism homeostasis and organ integrity within certainly presetting homeodynamic ranges. Conversely, the loss of such unique functions of Nrf1 in distinct tissues leads to obvious pathophysiological phenotypes, which are distinctive or even absent from the loss of Nrf2. Such distinctions between Nrf1 and Nrf2 are attributable to the unique topogenetic folding of Nrf1 and dynamic topovectorial repositioning of this CNC-bZIP protein by Hrd1/p97-driven retrotranslocation across ER membranes to dislocate the nucleus before transcriptional regulation of cognate target genes (Figures 10 and 18). In distinct topovectorial processes, Nrf1 is further endowed with specific reversible modifications (e.g., N-linked or O-linked glycosylation and deglycosylation, ubiuqintination and deubiuqintination) and selective proteolytic processing by cytosolic proteases DDI1/2 and/or limited proteasomes to yield an active N-terminally-truncated CNC-bZIP factor, with several shorter isoforms with distinctive or even opposing functions. Collectively, such uniquely differentiated yet integrated roles of both Nrf1 and Nrf2 are fulfilled in coordinately governing cell homeostasis and organ integrity during distinct life processes, in which both are manifested with their allelopathic potentials to virtually resemble two entangled ‘Yin-Yang’ quanta abiding by a dialectic law of the unity of opposites (Figures 3, 11 and 17).
Of crucial importance, the full-length Nrf1α is endowed to execute its essential physiobiological functions by integrating its ‘three-in-one’ roles, evinced as a specific triplet of the direct sensor (for redox, energy, cholesterol, and proteotoxic changes), signaling transducer and also effector in the stress defense response to being challenged from changing oxygenated environments (Figure 18). Such highly-efficient activation of Nrf1α is evoked by distinct topovectorial regulatory and processing mechanisms to mediate transcription responses by a subset of antioxidant, detoxification and cytoprotective genes against those inflammatory and degenerative diseases (e.g., cancer, ageing and aging-related neurodegenerative diseases). Therefore, this provides a potential strategy for chemoprevention and treatment of cancer and other degenerative diseases to be paved by precision targeting of Nrf1 alone or in combination with Nrf2 167 174. However, in this area there remains to address the following open questions: i) how the full-length mRNA transcript of Nrf1 from its single gene is selectively processed to generate distinct lengths of isoforms; ii) whether the yield of distinct lengths of Nrf1’s transcripts is monitored by alternative 5‘- and/or 3‘ non-coding regions within its gene locus; iii) what mechanisms account for alternative translation of Nrf1 to enable for a selective yield of distinct length of polypeptide forms, and iv) what about distinct Nrf1 isoform-specific physio-pathological functions exerted in vivo?
In addition, it should also be noticed that it was not identified which isoforms of Nrf1/Nfe2l1 exactly elicited another unexpected tumor-promoting role in very few of recently-reported, but not-yet-confirmed, cases 483,484,485. The putative promotion of triple-negative breast cancer was viewed to arise by Nrf1-mediating proteasomal cytoprotective response to resist against the proteasomal inhibitor treatments 485 and/or Nrf1-driving enhanced expression of programmed death ligand 1 (PD-L1) for its immune evasion 486. Ferroptosis of oral squamous cell carcinoma was also restrained by Nrf1-target holiday junction recognition protein (HJURP), leading to the cancer progression 487. As such being the cases, these tentative and preliminary investigations also need to be further substantiated by elaborate mechanistic studies. Nrf1 is also essentially required for antitumor immune response to block immune evasion by mediating the transcriptional expression of TNFSF9/41BBL (i.e., a tumor necrosis factor superfamily transmembrane cytokine that functions as a bidirectional signal transducer and another ligand for the costimulatory receptor 41BB in T lymphocytes 488). Conversely, the dysfunction of Nrf1 in either NGLY1- or DDI2-deficient cells and animals leads to activation of those immune-related genes by both cGAS-STING and MDA5-MAVS pathways, resulting in immune dyshomeostasis accompanied by inflammatory response 473 489. Similarly imbalanced immune activation and inflammation were unveiled in experimental autoimmune encephalomyelitis, which may be caused by a combination of proteasomal subunit displacement and reduced Nrf1 expression 490. More interestingly, the transcriptional expression of immunoproteasome (i-20S) and its activators PA28αβ (which function predominantly in the antigen presentation and regulation by γ-interferon, rather than in protein degradation) was substantially suppressed in the proteasomal inhibitor-stimulated ‘bound-back’ response mediated by Nrf1 436, even though not a canonical ARE sequence exists in these gene promoters. Altogether, such debating results presage a good start for this topic to explore the potential roles for Nrf1/Nfe2l1 in the immune homeostasis along with anti-tumor immune and anti-inflammatory responses.
Moreover, differential yet integral roles of Nrf1 and Nrf2 in redox regulation of physio-pathological functions determine distinct robust steady-states (i.e., health, subhealth, pathogenesis, and disease), that may quantitatively be stratified by extents of redox stress and anti-redox defense responses relying on the base of the ‘zero theory’ (at P0). Such distinct robust states are likely demarcated through different mechanisms accounting for homeostasis, morphostasis, homeorhesis, eustasis, allostasis and cacostasis (ΔH = HS - H0), along with relevant coding rules (e.g., redox code, stress-coping code, and topogenetic code), all selected by the nature eco-evo-devo process. Since the stress and redox stress should be parsed in terms of real scientific principles of physics and chemistry, oxidative or reductive stress with anti-redox responses can be determined by redox biochemical ontology in the development of cancer as a unicellular ‘oncoprotists’-like life form, but not as a simple disease only. This definition is just based on the law of Darwinian evolutionary dynamics of life from the holistic eco-evo-devo perspective 38. The robust state is further dictated by multi-hierarchical molecular-cellular-organismal signaling cascades towards metabolic networks, key gene regulatory profiling and their reprogramming 179. All these combine so to comprise a large complex endogenous ‘tensor’ network, which can be mathematically modeled with stochastic effects 491 492 and further precisely quantified by a set of equations for network dynamics, with nonequilibrium potential function approaches 493 494. For example, as two key transcription factors in governing cellular energy metabolic processes and homeostasis, Nrf1 and Nrf2 consist of a minimum regulatory network (Figure 13B). Hence, from a quantitative and dynamical perspective, a mathematical modeling can be set up. Of note, this minimum network is de facto embedded in a large complex network which can be viewed from two sides. It is a part of the large regulatory and signal transduction network, such as those extensively studied as endogenous networks 179 180, because in this review we have discussed this aspect reasonably well. Another one is its control of metabolic networks. One of us had discoursed in 2005 on its dynamics with various approaches 491, where a set of considerations were discussed. Then, we discussed how to handle realistic experiments view examples such as in the more controlled systems 495. After a series of efforts, the quantitative modeling was summarized 493. The dynamics of the corresponding endogenous network and metabolic network should be studied together, because biologically we know they influence each other, as explored in a combined study from the modeling side 496.
ADDITION OF THE ESSENTIAL NOTIONS ON ‘GRAND REDOX-UNIFYING THEORY OF LIFE’ WITH MURBUM CONCEPT
The ‘murburn concept’, introduced by Indian biochemist Manoj, K.M. 497 498 499, represents a novel paradigm shift in understanding redox-integrated bio-physico-chemical sciences and its uniquely leading physiological roles ubiquitously implicated in all cellular life processes, including its origin, evolution and healthy sustenance with robust homeostatic physiology, as well as in even disease pathology leading to determination of life. As rooted in the interplay of diffusive reactive species (DRS, along with other mur-components), stochastic molecular reactions and interactions, and multi-parametric redox buffering (and relevant responses to redox stress), this framework challenges the traditional enzyme-centric models. Of note, those four key terms, i.e., murburn, murzyme, murzone, and murredox are integrated into electron-, proton- or moiety-transferred, redox-unified bio-physico-chemical mechanisms during life process. Here, we further review how this murburn concept bridges gaps from those existing theories (e.g., Cell Theory, Central Dogma and extended Cellular Dogma) to culminating in such a ‘Grand Redox-Unifying Theory’ (GRUT, based on physics’ unified field theory 500 501) accounting for all life kingdoms 502 503 (as deciphered in Figure 19).
Figure 19. FIGURE 19: The Grand Redox-unifying Theory (GRUT) of life integrated with murburn concept and other coding rules.
Similarly in physics, the GRUT of life kingdoms is established on the base of murburn concept. The ‘mur’ was, at five distinct layers, represented by: i) ‘mured burning; ii) mild unrestricted burning; iii) mur-components (including reactive molecules, unbound-ions and radicals) and/or radiations (transiently and/or incidentally generated) that comprise the redox system; iv) Stochastic molecule-unbound ion-radical interactions (i.e., mur-interactions) and v) multi-parametric redox buffering reactions, relevant mur-modifications and defensing responses to murredox stress. Herein, diffusive reactive species (DRS, including all reactive molecules, ions and radicals) are not commonly accepted as a series of deleterious villains, albeit they were early stigmatically perceived as chaotic damaging agents (and/or byproducts), in normal physiological and aberrant pathological states. Conversely, DRS serve de facto to function as versatile elixirs of life in all organisms that network almost all various bio-physicochemical, metabolic and physiological routines, particularly because they are obligate to be required for aerobic respiration and photosynthesis, xenobiotic metabolism and drug detoxification, and immune defensing system. In murburn processes, murzymes govern the generation of DRS and its functioning, modulation and even elimination within dynamic ecological microenvironments (i.e., murzones) of life’s origin and evolution. Such murburn-based GRUT is universal and fundamental accounting for all life forms. They, together with deterministic central dogma, extended cellular dogma, cell theory, and ‘reverse central dogma’, all are delved to gain a better understanding of life’s origin and evolution and its healthy sustenance with normal steady-state physiology and disease development. These are accompanied by a vast variety of coordinated/unified cellular physio-pathological functioning of life, in distinct vertices of bioenergetics (cellular powering and thermogenesis), coherence, homeostasis, electro-mechanics mobility, and sensing for signaling responses (PCHEMS) by electrophysiology (EM), redox biochemistry and quantum biology. Part of this figure adapted from 498,499,504.
Overall, the murburn-based GRUT redefines the emergence and evolution of all life forms by self-organized stochastic selection and variation of Nature from the primordial inanimate chemical worlds towards the animate metabolic world (of pre/pro-cells or LUCA) until the present-day ecological environments. This is also accompanied by autonomous sustenance of life in all organisms by self-regulated homeostasis and plasticity. Thereby, the intact topoform of life is maintained (and perpetuated) at a robust homeostasis status of normal physiological functioning determined by those coding principles. The long-term deterministic steady-state process is also accompanied by a series of dynamic nonlinear equilibria of all transient stochastic reactive and/or interactive bio-physico-chemical (murburn) processes, with varying extents of certain non-equilibrium fluctuations e.g., of between the integrity of life process by its topogenetically-ordered patterning activity and even its chaotic collapsibility.
A paradigm shift by murburn concept bridging physics, chemistry, biology and even societal systems
The ultimate quest of life sciences is to unify the principles governing almost all those phenomena from quantum fluctuations to ecosystems, and from the origin of life to disease evolution, and even senescent death. In traditional molecular biology, the ‘Central Dogma’ of (DANN→ RNA→ protein) devised by Francis Crick 505 and the ‘structure determines function’ paradigm have long dominated life sciences for nearly a century. However, critical limitations of these frameworks have been gradually unveiled by the hitherto accumulating evidence from the origins-of-life chemistry, redox biology, and systems theory, and remain unresolved by the Cellular Dogma proposed by Quake 506. This is just owing to their failure to explain the structure-function decoupling with phenotype plasticity, the nonlinear inheritance of epigenetic memory (i.e., epigenetic dominance), membrane-mediated topogenetics with reverse self-regulation (e.g., by mur-modifications), DRS redox-driven (prebiotic paradox) origin and evolution of life, and/or societal system incompatibility.
As deciphered in Figure 19, the GRUT of life as another revolutionary cross-scale framework is proposed on the base of murburn concept functioning as a stochastic fundamental principle, by integrating DRS-mediated nonlinear redox dynamics, topogenetics with incrementing information theory, and the ‘Reverse Central Dogma’ (as partially described in the aforementioned sections). Under this GRUT perspective, it is important to note that DRS-mediated murredox reactions (and modifications) particularly during the redox-driven life-historical processes, governed by putative ‘Reverse Central Dogma (information → function → structure, as coincided with the law of incrementing functional information 58 and also formalized by the Darwin-Ao equation with the evolutionary law of natural selection 38, represent the universal driver of life’s emergence, evolution, and even societal analogies.
By integrating experimental data from prebiotic chemistry, ensuing topological genetics and epigenetics, along with cross-disciplinary systems analysis, it is inferable that the 3.8-billion-year trajectory of life is fundamentally a redox-programmed information topology. In such long life histories, DRS-leading networks encode spatiotemporal orders and coherent patterns through redox potentials (and/or redox signaling), guide molecular self-organization altogether, and extend their cognate inherent biologics to socioeconomic dynamics. Thereby, the murburn-based GRUT does not only redefine its essence of life, as ‘a self-sustaining redox-leading information continuum’, but also establish a unified principal framework bridging physics, chemistry, biology, bioeconomics and even social sciences. This arises just from DRS-redox drives of life’s origin to topogenetic information-function-structure evolution.
Redox (and murredox) dynamics as life’s primordial engine to topogenetic building
In simulated alkaline hydrothermal vents (H₂/CO₂/Fe³⁺), DRS (i.e., H2S and HS• radicals) catalyzes acetyl-CoA formation via reductive carbonylation at 108 M⁻¹s⁻¹ 507 and primitive amino acid synthesis 508. Such mon-enzymatic proto-metabolism appears to surpass enzymatic rates constrained by diffusion limits. The prebiotic Lipid-peptide vesicles self-assemble under redox-led Eh gradients, achieving proton motive force (Δp = -120 mV) and ATP synthesis (3×105 molecules/vesicle/hr) prior to genetic systems 509 510 511. In DRS-coherent networking, redox bistability was manifested by the fundamental Fe²⁺/Fe³⁺ redox cycles with a periodicity driving pH and Eh oscillations in prebiotic micro-compartments, enabling synchronization of proto-metabolic pathways 512 513. The CoQH• semiquinone radicals in mitochondrial Complex III oscillate at 10 Hz, matching ATP synthase rotation to optimize energy coupling 514 515. These processes are all explicable by DRS-based murburn concept 498 499 516 517 518.
By molecular self-assembly rules, lipid vesicle morphology to be spherical or tubular is dictated by Fe²⁺/Fe³⁺-modulated interfacial tension (γ = γ₀ + αΔEh, α = 0.3 mN/m·mV⁻¹) 519 520 521. Microtubule curvature (κ) responds to cysteine redox state: κ = κ₀ + β([GSH]/[GSSG]), β = 0.02 nm⁻¹ per log unit 510 522 523 524. Similarly, zebrafish embryogenesis establishes ROS gradients (H₂O₂: 50 nM anterior ↔ 200 nM posterior), oxidizing VegT mRNA-binding proteins to pattern body axes 525 526 527. Plant root stem cell niches are demarcated by peroxisomal O₂·⁻ gradients, overriding classical morphogen diffusion models 528 529. Overall, self-organized morphogenesis arising from primitive lipid-peptide vesicles to diverse morphological topoforms of life is selected and evolved by redox dynamics to specify their presetting topogenetics spatial codes.
The ‘Reverse Central Dogma’ validated empirically from the redox proto-membranes to genes
In addition to the definition of ‘Reverse Central Dogma’ (ancestral peptide minimotif → nucleotide template i.e., early RNA/DANN→ DNA, as described in the section "The peptide minimotifs evolving from primitive templates to specific DNA-binding transcription factors"), a bulk of empirical evidence has revealed coevolution of those primordial peptides and proto-membrane lipids during life’s origin to give rise to the LUCA. For instance, the H⁺-conductive vesicles (serving as a proto-membrane redox channel) were constructed by coevolution of C10 fatty acid-glycine lipopeptides under Eh = -200 mV, with the proton flux (JH⁺) obeying JH⁺ = Jmax (1-e-ΔEh/V0), V0 = 50 mV) 93 510 530 531 532. Mn³⁺-catalyzed peptide templating achieves 85% fidelity via redox-stabilized β-sheet interfaces following F = 1 – e-k[Mn⁴⁺]t, k = 0.03 μM⁻¹s⁻¹ 83 271 533 534 535 536. Such limited fidelity of peptide minimotifs has led plausibly to a vast variety of biological diversity in the Earth's biosphere.
The first nucleic acid strand could emerge via redox-dependent optimization 271 536 537 538. In this process, the RNA-peptide synergy was revealed by the experiment showing that archaeal RNase P activity requires redox cycling of Cys residues in RPP21 peptide; Cys→ Ser mutation reduces tRNA processing efficiency by 90% 539 540 541 542. The Fe-S clusters in DNA methyltransferases (DNMT3A) modulate methylation kinetics: kmeth = k0[Fe₃S₄]⁺/(1 + [O₂]/Kd), Kd = 2 µM 543 544. Such redox epigenetic inheritance was also supported by reducing DNMT3A’s Fe-S cluster upon Hypoxia (pO₂ < 5 mmHg), hence lowering methylation rates by 40% and inducing heritable metabolic adaptations.
The ‘Reverse Central Dogma’ is supportively corroborated by the Darwin-Ao equation unifying DRS-leading redox information evolutionary dynamics [dI/dt = ηΔGστ ln (1 + ρDRS/ρ0)], as formalized on the base of evolutionary law of natural selection 38. The ‘I’ letter represents system information (bits); η, redox-to-information efficiency (0.15–0.35 empirically); ΔG, free energy gradient (kJ/mol); στ, topological selection pressure (function of spatial code complexity); ρDRS/ρ0, concentrations of DRS normalized to its baseline levels. This was, in microbial evolution, validated by experimentally showing that reducing ΔG (of glucose oxidation) from -2870 to -1500 kJ/mol decreases SNP accumulation of E. coli by 60%, confirming I ∝ ΔG 545 546 547. Conversely, SOD overexpression (to reduce O₂·⁻ by 90%) lowers antibiotic resistance mutations by 75%, validating I ∝ ln(ρDRS) 545 547 548 549. As for carcinogenic heterogeneity (Hcr), it is found that tumor edge ([O₂·⁻] = 120 nM) exhibits 3× higher genomic diversity (Hcr = 0.35) than its core region ([O₂·⁻] = 45 nM, H = 0.12), aligning with ρDRS dependence 550 551 552 553.
DRS-leading thermodynamics and information are integrated to enable free energy principle and Shannon entropy to be revisited. This is owing to traditional sequence entropy ignoring redox-driven epigenetic dynamics. Mathematical modeling shows DNA methylation entropy (ΔSm) correlates with DRS flux, as ΔSm = kB ln(1 + ρDRS/ρ0) 554 555 556. While Friston’s model describes homeostasis via free energy minimization, it neglects how DRS converts ΔG into heritable information. For instance, E. coli enables to use cytochrome c-generated O₂·⁻ to oxidize OmpR, activating porin genes under starvation, as a direct redox-to-genetic signal 557 558 559.
The redox-informational analogues existing in societal systems
The economic metabolism is driven by its monetary electron transport chain (mETC). This is exemplified by growth of gross domestic products (GDP, as an analogous to ATP synthesis rate) 560 561, which correlates with currency velocity (≈7.2/yr), possibly mirroring the mitochondrial CoQH• oscillation. Thereby, it is inferable that the 2008-year financial crisis could also be alluded as a ‘metabolic collapse’, in which its M1 multiplier drop (1.7→ 0.8) appears to parallel mitochondrial depolarization (Δψ: -150 → -30 mV), demonstrating a highly conserved energy-information coupling 562 563. The cultural epigenetics can be manifested by social media memory. For instance, viral tweets require >10⁴ retweets (as a DRS-similar threshold) to trigger H3K4me3-like algorithmic prioritization, decaying with t₁/₂ = 3–5 days 564 565 566 567. Similarly, if the ‘Like’ function is alluded as a DNMT3A analogue, removing ‘Facebook likes’ reduces meme persistence by 75%, mimicking DNMT3A inhibition 568 569.
The DRS-leading redox-mediated edge-of-chaos homeostasis selected from life’s origin
The murburn-based GRUT posits that life's homeostasis resides at the homeodynamic ‘edge of chaos’, balancing stochasticity and determinism (as deciphered in Figure 19). This is owing to: i) instantaneous stochastic adaptation to generation of DRS (e.g., O₂·⁻, ·OH) by quantum tunnelling (probability 10⁻⁶/e-transfer) that induces picosecond-scale conformational flickering in biomolecules, validated by single-molecule FRET (smFRET) 570 571 572 573; ii) long-term deterministic encoding for DRS to covalently modify targets (e.g., by cysteine thiol oxidation) so as to activate MAPK/NF-κB pathways with signal intensities to match redox potentials (E°'), ensuring thermodynamic precision 574 575 576; iii) membrane-constrained dissipative structures, in which plasma membranes restrict diffusion of DRS (e.g., half-life of O₂·⁻ < 1 ms), maintaining certain redox gradients and localising stochastic perturbations to prevent systemic collapse 577 578 579 580. Collectively, the steady-state homeostasis is deemed as a redox-governing continuum.
From the murburn-based GRUT perspective, abiogenesis of life originates from UV-driven DRS generation in hydrothermal vents that might have also allowed amino acid peptides and ribonucleotides to be synthesized via formamide radical reactions 271 507 508. In proto-cells, DRS was concentrated and thus compartmentalized in the lipid murzones, fostering polymerization and replication 103 498 579. A dynamic murredox equilibrium to maintain certain redox potential (Eh) was finely tuned via a series of anti-redox feedback mechanisms between production of DRS (by murzymes, e.g., NADPH oxidase) and its scavenging (e.g., by SOD). Thus, relevant disease paradigms are inferably exemplified by neurodegeneration and aging, that correlate with murredox dysregulation, implicating mitochondrial DRS disequilibrium. Overall, such redox-unifying principle holds across distinctive scales from cellular to ecosystem levels (in which coral-algal symbiosis relies on murredox signaling via ROS exchanges 581 582), and can be even applied for astrobiological implications (extraterrestrial life detection could prioritize environments conducive to murburn chemistry (similar to that in the Enceladus’ subsurface ocean 583 584).
Five dimensional codes of DRS-redox dynamics that comprise core mechanisms of GRUT
The murburn-based GRUT of life is inferable to mandate at least five distinct dimensional codes of DRS-redox dynamics. Firstly, ‘quantum code’ could be established and evolved by its tunnelling effects and chaotic dynamics, leading to nonlinear spatiotemporal distributions of DRS. In mitochondrial electron leakage, quantum tunnelling at Complex I's Q-site causes electron escape (probability of 10⁻³/ETC), amplified by cytochrome c oxidase allostery to generate respiratory oscillations 585 586 587,588. During superoxide burst phase transitions, neutrophil NOX2 activity triggers a positive feedback (at [H₂O₂] > 5 μM), with critical thresholds obeying the Ising model phase transitions (critical exponent β ≈ 0.325), revealing quantum on/off switching in immunity 589 590 591 592.
Secondly, ‘topological space code’ could be established originally from the membrane fractal architecture to signal-focusing membrane fractals (D≈2.32) to optimize DRS-redox signaling efficiency, driving self-organization and self-regulation. This is exemplified by lipid raft-mediated signal focusing on sphingomyelin microdomains (d ≈20 nm), in which NOX4 is enriched, tripling O₂·⁻ production and correlating with cancer stem cell drug resistance (r=0.78) 593 594 595. Interestingly, membrane curvature-modulated redox waves existing in mitochondrial cristae (r≈ 30 nm) enable to enhance CoQ10 diffusion, boosting DRS generation by 50% and driving ATP synthesis (with a hill coefficient n=2.1) 596 597 598 599 600.
Thirdly, ‘metabolic code’ may also be established and improved through compartmentalized redox potentials and chaos. This is manifested by dynamically (re)partitioning and/or (re)positioning of reductive equivalents (e.g., NADPH, GSH) across subcellular compartments (i.e., murzone). Such compartmentalized redox gradients of cytosol (E°'≈ -320 mV) and mitochondrial matrix (E°'≈-360 mV) are maintained via malate-aspartate shuttles, but upon its collapse (lipid peroxides > 50 μM), ferroptosis is triggered 601 602. Chaotic metabolic oscillations are embodied by glycolytic flux-ROS interactions exhibiting Lorenz attractor dynamics (Lyapunov exponent λ≈0.9), with cancer Warburg effects representing chaos-driven steady-state shifts 603 604 605 606.
Fourthly, ‘time code’ serves as a coding rule mandated by evolutionary timing with multi-scale rhythms. Here, it is crucial important to note that DRS redox dynamics can encode discrepant temporal programmes across scales. i) Ultrafast (ns-ms): mitochondrial O₂·⁻ bursts (≈10⁶/s) synchronize with electron quantum tunnelling events (with a phase error <1%) 517 607 608. Ii) Physiological scale (s-hr): NAD⁺/NADH oscillations couple with H₂O₂ peaks (at Zeitgeber time 12) to entrain circadian clocks by Sirt1-BMAL1/CLOCK pathways 609 610 611 612. Iii) Evolutionary scale (days-eons): The catalase gene duplications mirror the Earth's oxygenation history (R²=0.93), demonstrating redox adaptation over geological time 613 614 615 616.
Fifthly, ‘murzyme code’ is deciphered at five distinct layers (in the legend of Figure 19), predominantly serving DRS-driven catalytic reactors and energy transduction. Hemeproteins, flavoproteins and other murnburn-relevant factors were defined as ‘murzymes’ 516 579, forming DRS-driven ‘nuclear reactor’-like systems. Just by the electron transfer, cytochrome c oxidase achieves >90% energy efficiency via the ‘Fe-S’-cluster quantum tunnelling, surpassing classical enzyme limits (≈40%) 580. In the mitochondrial O₂·⁻ burst-moded intermediate generation, flavoproteins (e.g., NADPH oxidase) produce O₂·⁻ possibly at 10⁶/s rates, akin to ‘nuclear fission chain’ reactions, enabling rapid stress response 592 617. The Fe-S clusters at hydrothermal vents catalyze CO₂ to yield acetate, with lipid vesicles forming proton gradients 37 271 507 618. This validates ‘metabolism-first’ that reverses the Central Dogma models in DRS-driven origin of life.
Redox reshaping of Cell Theory occurs by DRS-driven evolution via membrane topogenetics. This is supported by the fact that archaeal membrane adaptation is acquired by the sulfur ester bonds in thermophilic archaea that reduce GSH consumption by 60%, enabling survival in extreme environments 619 620 621. Mitochondrial ancestors released O₂·⁻, leading to 3-fold activation of the eukaryotic host NF-κB pathways, so to drive endosymbiosis 622 623. Importantly, redox programming of cognitive function also couples with DRS dynamics. Synaptic quantum coherence is networked by O₂·⁻ bursts (≈40 Hz) from hippocampal CA1 neurons, so to enhancing NMDA receptor opening (by 70%) and long-term potentiation (LTP) 624 625. Consciousness at the edge of chaos is obtained by prefrontal H₂O₂ fluctuations (15%) to maintain cortical criticality (critical exponent β≈0.5) via GABAergic regulation, underpinning creative thoughts 626 627 628. Thereby, DRS-driven programming systems to bioenergetic powering (thermogenesis), coherence, homeostasis, electro-mechanic mobility, and sensing to signaling responses (PCHEMS) are precision-selected by accurately integrating redox biochemistry, electrophysiology and quantum biology from life’s origin (by biological intelligence) to cognitive emergence and evolution.
Several key terminologies about murburn concept
The murburn (from mur + burn) concept posits that DRS including all transient reactive molecules, unbound ions and radicals with proton quanta and/or radiations, generated via mild, unrestricted redox ‘burning’ reactions, drive these processes through stochastic, even membrane-independent, interactions and modifications. This paradigm shift necessitates a critical re-interpretation of redox biology’s foundational principles 497, because anomalies such as DRS effects, nonlinear thermodynamics and kinetics, and system-wide redox buffering remain inadequately explained, before erstwhile redox reactions (particularly central to energy transduction and homeostasis) had long been interpreted by classic enzyme-substrate specificity and compartmentalized electron transport chains.
As redox mediators beyond canonical enzymology, murzymes are referred to as biomolecules (proteins, lipids, or nucleic acids) and other factors involved in the murburn reactions and interactions that facilitate DRS generation, modulation, utilization or termination, along with no formation of stable substrate complexes 517 579 580. Its three key features include, i) DRS catalysis: hemoproteins like hemoglobin act as murzymes by releasing Fe²⁺/Fe³⁺ ions to catalyze Fenton reactions 571 629; ii) Redox buffering: thioredoxin systems regulate •NO levels via thiol-disulfide exchanges, independent of its active-site binding 42 630 631; iii) Evolutionary implications: primordial murzymes could have preceded those highly specialized enzymes, functioning as versatile redox "hubs" in prebiotic environments 499 504 631.
The spatial dynamics of redox activity driven by DRS is manifested by murzones, as specified microdomains in which DRS transiently reach to the peak of its concentration gradients, enabling redox (burning) reactions in spite of the bulk-phase instability. This is exemplified by, i) Membrane interfaces: the lipid bilayers’ hydrophobic regions stabilize radicals (e.g., lipid peroxidation chains) 570 579 632; ii) Cellular and macromolecular crowding in the cytosol to enhance radical recombination rates 633 634 635; iii) Photochemical activation: chloroplast thylakoids utilize light to generate O₂·⁻ in the murzones, driving photosynthetic electron transport 579 600 636 637.
The systems-wide homeostasis is finely tuned by murredox, denoting the integration of all murburn processes into global redox buffering and signaling responsive networks. It is inferable to explain those phenomena, such as: i) Stress resilience: glutathione’s role in scavenging DRS is amplified by murzonal •H₂O₂ diffusion 498; ii) Metabolic flexibility: cancer cellular Warburg effect may stem from murredox adaptations to hypoxic environments 606 638; iii) Cross-kingdom’s conservation: similar redox programming patterns in all existing extremophiles and eukaryotes demonstrate universal murredox principles 499 504.
Challenges and future directions in the murburn-based GRUT
A great challenge of technological frontiers is to develop real-time single-DRS imaging. Recently, plasmonic SERS (surface-enhanced Raman scattering) nanoprobes achieve a high sensitivity ( of ~10⁻¹⁸ M) for real-time O₂·⁻ tracking in the mitochondrial cristae 639 640. The decryption of topological code is also another huge challenge. Graph neural networks (GNNs) are subjected to mapping of all those protein-folding trajectories to redox potential landscapes with self-organized building blocks, predicting topovectorial spatial coding rules.
For philosophical implications, this murburn-based GRUT has transcended the Cartesian dualism, proposing ‘I oxidize, therefore I am’—as a monist view where all intelligence, consciousness, society, and life itself (as shown in Figure 19) are manifestations of self-referential redox-information flows in real essences. Thereby, it is inferable that each of life forms appears to be just a masterpiece of natural selection, as perfectly written by ‘DRS-lettered Redox settings’ as a universal lingua franca accounting for all live beings. In such redox-driven life’ language system, DRS are the most active, powerful, primitive, fundamental, and radical 'elementary letters and/or core keywords', involved ubiquitously in a vast variety of stochastic (short-term) and/or deterministic (long-term) programming by multidimensional spatiotemporal operations to exert their leading physiological functions of life (e.g., PCHEMS).
In summary on the GRUT, each life is selectively established and grown as a continuum of redox-programmed information topologies, governed by universal principles from the prebiotic chemistry to socioeconomic dynamics. By replacing the Central Dogma’s linear hierarchy with such a redox-informational framework, the murburn-based GRUT provides a predictive power across scales—from nature-designing synthetic cells to present-day modeling economic resilience. As we enter the era of redox omics and topological bioengineering, this paradigm promises to unify discrete fractured (e.g., evolutional biological) landscapes of life sciences (to all relevance’s), much as the standard model unified fundamental physics. Altogether, GRUT enables to exist as a natural evolutionary selective, fundamental, constitutional principle accounting for all cellular life forms.
AUTHOR CONTRIBUTION
Y.Z. designed this work within several novel conceptualized terms, analyzed all relevant data, prepared all figures with cartoons, and wrote and revised the paper. M.W. collected and analyzed the data measured by transcriptome, proteome, and metabolome, and prepared the relevant figures with networks, whereas Y(-ping) Z. had done bioinformatics analysis and made the phylogenetic tree with structural cartoons. C.L. and W.S. wrote the section about co-evolutionary histories of life with its ambient redox environments and made related figures. P.A. has provided an invaluable discussion about theoretical physics with its Darwinian evolution law and network dynamics. H.T. wrote and revised the section about neuroscience. X.C. and Z.Z collected relevant bioinformatics data, edited this paper, and polished the English language. Lastly, all these co-authors have read and agreed to the published version of the manuscript.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
SUPPLEMENTAL MATERIAL
All supplemental data for this article are available online at https://www.cell-stress.com/researcharticles/2025a-zhang-cell-stress/
Funding Statement
We thank the many researchers who have contributed to the understanding of Nrf1 and other members in this CNC-bZIP family, as well as all the relevance to (redox) stress, but also apologize to those whose work in these fields we were unable to cite owing to space restrictions and unintentional ignorance. This work was supported by the National Natural Science Foundation of China (NSFC, with a grant numbers 82073079 and 82473147) awarded to Prof. Yiguo Zhang (Chongqing University), but the funding source had no direct involvement in the research work.
REFERENCES
- 1.Dispan MP. Experiments on the Gaseous Oxide of Azote, by a Society of Amateurs, at Toulouse. Med Phys J . 1807;17(95):51–55. doi: 10.1080/14786440608563368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wollaston WH. On Cystic Oxide, a New Species of Urinary Calculus. Med Phys J . 1811;25(145):254–259. doi: 10.1080/14786441108563237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Handy DE, Loscalzo J. Responses to reductive stress in the cardiovascular system. Free Radic Biol Med. 2017;109:114–124. doi: 10.1016/j.freeradbiomed.2016.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Perez-Torres I, Soto ME, Castrejon-Tellez V, Rubio-Ruiz ME, Manzano Pech L, Guarner-Lans V. Oxidative, Reductive, and Nitrosative Stress Effects on Epigenetics and on Posttranslational Modification of Enzymes in Cardiometabolic Diseases. Oxid Med Cell Longev. 2020;2020:8819719. doi: 10.1155/2020/8819719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Quiles JL, Sanchez-Gonzalez C, Vera-Ramirez L, Giampieri F, Navarro-Hortal MD, Xiao J, Llopis J, Battino M, Varela-Lopez A. Reductive Stress, Bioactive Compounds, Redox-Active Metals, and Dormant Tumor Cell Biology to Develop Redox-Based Tools for the Treatment of Cancer. Antioxid Redox Signal. 2020;33(12):860–881. doi: 10.1089/ars.2020.8051. [DOI] [PubMed] [Google Scholar]
- 6.Xiao W, Loscalzo J. Metabolic Responses to Reductive Stress. Antioxid Redox Signal. 2020;32(18):1330–1347. doi: 10.1089/ars.2019.7803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chatgilialoglu C, Ferreri C. Reductive Stress of Sulfur-Containing Amino Acids within Proteins and Implication of Tandem Protein-Lipid Damage. Int J Mol Sci. 2021;22(23):12863. doi: 10.3390/ijms222312863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Becker PM. Antireduction: an ancient strategy fit for future. Biosci Rep. 2016;36(4):e00367. doi: 10.1042/BSR20160085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Paniker NV, Srivastava SK, Beutler E. Glutathione metabolism of the red cells. Effect of glutathione reductase deficiency on the stimulation of hexose monophosphate shunt under oxidative stress. Biochim Biophys Acta. 1970;215(3):456–460. doi: 10.1016/0304-4165(70)90096-6. [DOI] [PubMed] [Google Scholar]
- 10.Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180–183. doi: 10.1016/j.redox.2015.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sies H, Berndt C, Jones DP. Oxidative Stress. Annu Rev Biochem. 2017;86:715–748. doi: 10.1146/annurev-biochem-061516-045037. [DOI] [PubMed] [Google Scholar]
- 12.Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8(9-10):1865–1879. doi: 10.1089/ars.2006.8.1865. [DOI] [PubMed] [Google Scholar]
- 13.Gores GJ, Flarsheim CE, Dawson TL, Nieminen AL, Herman B, Lemasters JJ. Swelling, reductive stress, and cell death during chemical hypoxia in hepatocytes. Am J Physiol . 1989;257(2 Pt 1):C347–354. doi: 10.1152/ajpcell.1989.257.2.C347. [DOI] [PubMed] [Google Scholar]
- 14.Sies H, Mailloux RJ, Jakob U. Fundamentals of redox regulation in biology. Nat Rev Mol Cell Biol. 2024;25(9):701–719. doi: 10.1038/s41580-024-00730-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lyons TW, Reinhard CT, Scott C. Redox redux. Geobiology. 2009;7(5):489–494. doi: 10.1111/j.1472-4669.2009.00222.x. [DOI] [PubMed] [Google Scholar]
- 16.Lyons TW, Droser ML, Lau KV, Porter SM. Early Earth and the rise of complex life. Emerg Top Life Sci. 2018;2(2):121–124. doi: 10.1042/ETLS20180093. [DOI] [PubMed] [Google Scholar]
- 17.Lyons TW, Reinhard CT, Planavsky NJ. The rise of oxygen in Earth's early ocean and atmosphere. Nature. 2014;506(7488):307–315. doi: 10.1038/nature13068. [DOI] [PubMed] [Google Scholar]
- 18.Schoepp-Cothenet B, van Lis R, Atteia A, Baymann F, Capowiez L, Ducluzeau AL, Duval S, ten Brink F, Russell MJ, Nitschke W. On the universal core of bioenergetics. Biochim Biophys Acta. 2013;1827(2):79–93. doi: 10.1016/j.bbabio.2012.09.005. [DOI] [PubMed] [Google Scholar]
- 19.Baymann F, Schoepp-Cothenet B, Duval S, Guiral M, Brugna M, Baffert C, Russell MJ, Nitschke W. On the Natural History of Flavin-Based Electron Bifur-cation. Front Microbiol. 2018;9:1357. doi: 10.3389/fmicb.2018.01357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Schrodinger E. What Is Life? The Physical Aspect of the Living Cell and Mind. Cambriage University. 1944;Press. [Google Scholar]
- 21.Inupakutika MA, Sengupta S, Devireddy AR, Azad RK, Mittler R. The evolution of reactive oxygen species metabolism. J Exp Bot. 2016;67(21):5933–5943. doi: 10.1093/jxb/erw382. [DOI] [PubMed] [Google Scholar]
- 22.Hammarlund EU, Flashman E, Mohlin S, Licausi F. Oxygen-sensing mechanisms across eukaryotic kingdoms and their roles in complex multicellularity. Science. 2020;370(6515):eaba3512. doi: 10.1126/science.aba3512. [DOI] [PubMed] [Google Scholar]
- 23.Ducluzeau AL, Schoepp-Cothenet B, van Lis R, Baymann F, Russell MJ, Nitschke W. The evolution of respiratory O2/NO reductases: an out-of-the-phylogenetic-box perspective. J R Soc Interface. 2014;11(98):20140196. doi: 10.1098/rsif.2014.0196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gutteridge JMC, Halliwell B. Mini-Review: Oxidative stress, redox stress or redox success? Biochem Biophys Res Commun. 2018;502(2):183–186. doi: 10.1016/j.bbrc.2018.05.045. [DOI] [PubMed] [Google Scholar]
- 25.Wang K, Mao W, Song X, Chen M, Feng W, Peng B, Chen Y. Reactive X (where X = O, N, S, C, Cl, Br, and I) species nanomedicine. Chem Soc Rev. 2023;52(20):6957–7035. doi: 10.1039/d2cs00435f. [DOI] [PubMed] [Google Scholar]
- 26.Cortese-Krott MM, Koning A, Kuhnle GGC, Nagy P, Bianco CL, Pasch A, Wink DA, Fukuto JM, Jackson AA, van Goor H, Olson KR, Feelisch M. The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine. Antioxid Redox Signal. 2017;27(10):684–712. doi: 10.1089/ars.2017.7083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang H, Pei Y, Wang K, Zuo Y, Wei M, Xiong J, Zhang P, Chen Z, Shang N, Zhong D, Pei P. First-Row Transition Metals for Catalyzing Oxygen Redox. Small. 2023;19(46):e2304863. doi: 10.1002/smll.202304863. [DOI] [PubMed] [Google Scholar]
- 28.Braymer JJ, Freibert SA, Rakwalska-Bange M, Lill R. Mechanistic concepts of iron-sulfur protein biogenesis in Biology. Biochim Biophys Acta Mol Cell Res. 2021;1868(1):118863. doi: 10.1016/j.bbamcr.2020.118863. [DOI] [PubMed] [Google Scholar]
- 29.Jones DP, Sies H. The Redox Code. Antioxid Redox Signal. 2015;23(9):734–746. doi: 10.1089/ars.2015.6247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hansen JM, Jones DP, Harris C. The Redox Theory of Development. Antioxid Redox Signal. 2020;32(10):715–740. doi: 10.1089/ars.2019.7976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jones DP. Redox theory of aging. Redox Biol. 2015;5:71–79. doi: 10.1016/j.redox.2015.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mittler R, Jones DP. The redox code of plants. Plant Cell Environ. 2023;47(8):2821–2829. doi: 10.1111/pce.14787. [DOI] [PubMed] [Google Scholar]
- 33.Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017;11:613–619. doi: 10.1016/j.redox.2016.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91(3C):31S–38S. doi: 10.1016/0002-9343(91)90281-2. [DOI] [PubMed] [Google Scholar]
- 35.Kurland CG, Andersson SG. Origin and evolution of the mitochondrial proteome. Microbiol Mol Biol Rev. 2000;64(4):786–820. doi: 10.1128/MMBR.64.4.786-820.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mattson MP, Rydel RE. Alzheimer's disease. Amyloid ox-tox transducers. Nature. 1996;382(6593):674–675. doi: 10.1038/382674a0. [DOI] [PubMed] [Google Scholar]
- 37.Olson KR. Hydrogen sulfide, reactive sulfur species and coping with reactive oxygen species. Free Radic Biol Med. 2019;140:74–83. doi: 10.1016/j.freeradbiomed.2019.01.020. [DOI] [PubMed] [Google Scholar]
- 38.Ao P. Laws in Darwinian evolutionary theory. Phys Life Rev. 2005;2(2):117–156. doi: 10.1016/j.plrev.2005.03.002. [DOI] [Google Scholar]
- 39.Santolini J, Wootton SA, Jackson AA, Feelisch M. The Redox architecture of physiological function. Current opinion in physiology. 2019;9:34–47. doi: 10.1016/j.cophys.2019.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Planavsky NJ, Asael D, Hofmann A, Reinhard CT, Lalonde SV, Knudsen A, Wang X, Ossa Ossa F, Pecoits E, Smith AJB, Beukes NJ, Bekker A, Johnson TM, Konhauser KO, Lyons TW, Rouxel OJ. Evidence for oxygenic photosynthesis half a billion years before the Great Oxidation Event. Nat Geosci. 2014;7(4):283–286. doi: 10.1038/ngeo2122. [DOI] [Google Scholar]
- 41.Grace SC. Phylogenetic distribution of superoxide dismutase supports an endosymbiotic origin for chloroplasts and mitochondria. Life Sci. 1990;47(21):1875–1886. doi: 10.1016/0024-3205(90)90399-c. [DOI] [PubMed] [Google Scholar]
- 42.Hanschmann EM, Godoy JR, Berndt C, Hudemann C, Lillig CH. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal. 2013;19(13):1539–1605. doi: 10.1089/ars.2012.4599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Miller AF. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett. 2012;586(5):585–595. doi: 10.1016/j.febslet.2011.10.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dibrova DV, Cherepanov DA, Galperin MY, Skulachev VP, Mulkidjanian AY. Evolution of cytochrome bc complexes: from membrane-anchored dehy-drogenases of ancient bacteria to triggers of apoptosis in vertebrates. Biochim Biophys Acta. 2013;1827(11-12):1407–1427. doi: 10.1016/j.bbabio.2013.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Slesak I, Kula M, Slesak H, Miszalski Z, Strzalka K. How to define obligatory anaerobiosis? An evolutionary view on the antioxidant response system and the early stages of the evolution of life on Earth. Free Radic Biol Med. 2019;140:61–73. doi: 10.1016/j.freeradbiomed.2019.03.004. [DOI] [PubMed] [Google Scholar]
- 46.Zamocky M, Gasselhuber B, Furtmuller PG, Obinger C. Molecular evolution of hydrogen peroxide degrading enzymes. Arch Biochem Biophys. 2012;525(2):131–144. doi: 10.1016/j.abb.2012.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Olson KR. H(2)S and polysulfide metabolism: Conventional and unconventional pathways. Biochem Pharmacol. 2018;149:77–90. doi: 10.1016/j.bcp.2017.12.010. [DOI] [PubMed] [Google Scholar]
- 48.Olson KR. Reactive oxygen species or reactive sulfur species: why we should consider the latter. J Exp Biol. 2020;223(Pt 4) doi: 10.1242/jeb.196352. [DOI] [PubMed] [Google Scholar]
- 49.Olson KR. A Case for Hydrogen Sulfide Metabolism as an Oxygen Sensing Mechanism. Antioxidants. 2021;10(11):1650. doi: 10.3390/antiox10111650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Feelisch M, Cortese-Krott MM, Santolini J, Wootton SA, Jackson AA. Systems redox biology in health and disease. EXCLI J. 2022;21:623–646. doi: 10.17179/excli2022-4793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Murphy MP, Bayir H, Belousov V, Chang CJ, Davies KJA, Davies MJ, Dick TP, Finkel T, Forman HJ, Janssen-Heininger Y, Gems D, Kagan VE, Kalyanaraman B, Larsson NG, Milne GL, Nystrom T, Poulsen HE, Radi R, Van Remmen H, Schumacker PT, Thornalley PJ, Toyokuni S, Winterbourn CC, Yin H, Halliwell B. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metab. 2022;4(6):651–662. doi: 10.1038/s42255-022-00591-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Olson KR, Gao Y. Effects of inhibiting antioxidant pathways on cellular hydrogen sulfide and polysulfide metabolism. Free Radic Biol Med. 2019;135:1–14. doi: 10.1016/j.freeradbiomed.2019.02.011. [DOI] [PubMed] [Google Scholar]
- 53.Olson KR. Are Reactive Sulfur Species the New Reactive Oxygen Species? Antioxid Redox Signal. 2020;33(16):1125–1142. doi: 10.1089/ars.2020.8132. [DOI] [PubMed] [Google Scholar]
- 54.Russell MJ, Nitschke W, Branscomb E. The inevitable journey to being. Philos Trans R Soc Lond B Biol Sci. 2013;368(1622):20120254. doi: 10.1098/rstb.2012.0254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Crowe SA, Dossing LN, Beukes NJ, Bau M, Kruger SJ, Frei R, Canfield DE. Atmospheric oxygenation three billion years ago. Nature. 2013;501(7468):535–538. doi: 10.1038/nature12426. [DOI] [PubMed] [Google Scholar]
- 56.Wong ML, Charnay BD, Gao P, Yung YL, Russell MJ. Nitrogen Oxides in Early Earth's Atmosphere as Electron Acceptors for Life's Emergence. Astrobi-ology. 2017;17(10):975–983. doi: 10.1089/ast.2016.1473. [DOI] [PubMed] [Google Scholar]
- 57.Tang SP. The Origin(s) of Cell(s): Pre-Darwinian Evolution from FUCAs to LUCA To Carl Woese (1928-2012), for his Conceptual Breakthrough of Cellu-lar Evolution. J Mol Evol. 2021;89(7):427–447. doi: 10.1007/s00239-021-10014-4. [DOI] [PubMed] [Google Scholar]
- 58.Wong ML, Cleland CE, Arend Jr D, Bartlett S, Cleaves 2nd HJ, Demarest H, Prabhu A, Lunine JI, Hazen RM. On the roles of function and selection in evolving systems. Proc Natl Acad Sci U S A. 2023;120(43):e2310223120. doi: 10.1073/pnas.2310223120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Otasevic V, Stancic A, Korac A, Jankovic A, Korac B. Reactive oxygen, nitrogen, and sulfur species in human male fertility. A crossroad of cellular signal-ing and pathology. Biofactors. 2020;46(2):206–219. doi: 10.1002/biof.1535. [DOI] [PubMed] [Google Scholar]
- 60.Barbieri M. A new theory of development: the generation of complexity in ontogenesis. Philos Trans A Math Phys Eng Sci. 2016;374(2063) doi: 10.1098/rsta.2015.0148. [DOI] [PubMed] [Google Scholar]
- 61.Barbieri M. What is code biology? Biosystems. 2018;164(1-10) doi: 10.1016/j.biosystems.2017.10.005.. [DOI] [PubMed] [Google Scholar]
- 62.Barbieri M. A general model on the origin of biological codes. Biosystems. 2019;181:11–19. doi: 10.1016/j.biosystems.2019.04.010. [DOI] [PubMed] [Google Scholar]
- 63.Colditz IG. A consideration of physiological regulation from the perspective of Bayesian enactivism. Physiol Behav. 2020;214:112758. doi: 10.1016/j.physbeh.2019.112758. [DOI] [PubMed] [Google Scholar]
- 64.Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363–383. doi: 10.1038/s41580-020-0230-3. [DOI] [PubMed] [Google Scholar]
- 65.Lennicke C, Cocheme HM. Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell. 2021;81(18):3691–3707. doi: 10.1016/j.molcel.2021.08.018. [DOI] [PubMed] [Google Scholar]
- 66.Imlay JA. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol. 2013;11(7):443–454. doi: 10.1038/nrmicro3032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Sawa T, Takata T, Matsunaga T, Ihara H, Motohashi H, Akaike T. Chemical Biology of Reactive Sulfur Species: Hydrolysis-Driven Equilibrium of Poly-sulfides as a Determinant of Physiological Functions. Antioxid Redox Signal. 2022;36(4-6):327–336. doi: 10.1089/ars.2021.0170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Feng L, Dong T, Jiang P, Yang Z, Dong A, Xie SQ, Griffin CH, Wu R. An eco-evo-devo genetic network model of stress response. Hortic Res. 2022;9:uhac135. doi: 10.1093/hr/uhac135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Abouheif E, Fave MJ, Ibarraran-Viniegra AS, Lesoway MP, Rafiqi AM, Rajakumar R. Eco-evo-devo: the time has come. Adv Exp Med Biol. 2014;781:107–125. doi: 10.1007/978-94-007-7347-9_6. [DOI] [PubMed] [Google Scholar]
- 70.Skulason S, Parsons KJ, Svanback R, Rasanen K, Ferguson MM, Adams CE, Amundsen PA, Bartels P, Bean CW, Boughman JW, Englund G, Guethbrandsson J, Hooker OE, Hudson AG, Kahilainen KK, Knudsen R, Kristjansson BK, Leblanc CA, Jonsson Z, Ohlund G, Smith C, Snorrason SS. A way forward with eco evo devo: an extended theory of resource polymorphism with postglacial fishes as model systems. Biol Rev Camb Philos Soc. 2019;94(5):1786–1808. doi: 10.1111/brv.12534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Ottaviano FG, Handy DE, Loscalzo J. Redox regulation in the extracellular environment. Circ J. 2008;72(1):1–16. doi: 10.1253/circj.72.1. [DOI] [PubMed] [Google Scholar]
- 72.Wojtovich AP, Berry BJ, Galkin A. Redox Signaling Through Compartmentalization of Reactive Oxygen Species: Implications for Health and Disease. Antioxid Redox Signal. 2019;31(9):591–593. doi: 10.1089/ars.2019.7804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Kaludercic N, Deshwal S, Di Lisa F. Reactive oxygen species and redox compartmentalization. Front Physiol. 2014;5:285. doi: 10.3389/fphys.2014.00285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Clark AD, Cumpstey AF, Santolini J, Jackson AA, Feelisch M. Uncoupled redox stress: how a temporal misalignment of redox-regulated processes and circadian rhythmicity exacerbates the stressed state. Open Biol. 2023;13(9):230151. doi: 10.1098/rsob.230151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Feng J, Song B, Zhang Y. Semantic parsing of the life process by quantum biology. Prog Biophys Mol Biol. 2022;175:79–89. doi: 10.1016/j.pbiomolbio.2022.09.005. [DOI] [PubMed] [Google Scholar]
- 76.Usselman RJ, Chavarriaga C, Castello PR, Procopio M, Ritz T, Dratz EA, Singel DJ, Martino CF. The Quantum Biology of Reactive Oxygen Species Partitioning Impacts Cellular Bioenergetics. Sci Rep. 2016;6:38543. doi: 10.1038/srep38543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Kong XY, Xiang M, Fang JC, Han D, Song B, Jiang L. The connection between meridians and physiological functions: A quantum principle. Nano Res. 2023;16:12817–12820. doi: 10.1007/s12274-023-6203-z. [DOI] [Google Scholar]
- 78.Barbieri M. The organic codes. The basic mechanism of macroevolution. Riv Biol. 1998;91(3):481–513. [PubMed] [Google Scholar]
- 79.Prinz R. Nothing in evolution makes sense except in the light of code biology. Biosystems. 2023;229:104907. doi: 10.1016/j.biosystems.2023.104907. [DOI] [PubMed] [Google Scholar]
- 80.Lawlor B, Sleator RD. The roles of code in biology. Sci Prog. 2021;104(2):368504211010570. doi: 10.1177/00368504211010570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Claire MW, Catling DC, Zahnle KJ. Biogeochemical modelling of the rise in atmospheric oxygen. Geobiology. 2006;4(4):239–269. doi: 10.1111/j.1472-4669.2006.00084.x. [DOI] [Google Scholar]
- 82.Li C, Love GD, Lyons TW, Fike DA, Sessions AL, Chu X. A stratified redox model for the Ediacaran ocean. Science. 2010;328(5974):80–83. doi: 10.1126/science.1182369. [DOI] [PubMed] [Google Scholar]
- 83.Schiller MR. The minimotif synthesis hypothesis for the origin of life. J Transl Sci. 2016;2(5):289–296. doi: 10.15761/JTS.1000154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Orgel LE. The origin of life--how long did it take? Orig Life Evol Biosph. 1998;28(1):91–96. doi: 10.1023/a:1006561308498. [DOI] [PubMed] [Google Scholar]
- 85.Orgel LE. The origin of life--a review of facts and speculations. Trends Biochem Sci. 1998;23(12):491–495. doi: 10.1016/s0968-0004(98)01300-0. [DOI] [PubMed] [Google Scholar]
- 86.Olson KR. The biological legacy of sulfur: A roadmap to the future. Comp Biochem Physiol A Mol Integr Physiol. 2021;252:110824. doi: 10.1016/j.cbpa.2020.110824. [DOI] [PubMed] [Google Scholar]
- 87.Zhang Y, Xiang Y. Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity. Biochem J. 2016;473(8):961–1000. doi: 10.1042/BJ20151182. [DOI] [PubMed] [Google Scholar]
- 88.Kultz D. Evolution of cellular stress response mechanisms. J Exp Zool A Ecol Integr Physiol. 2020;333(6):359–378. doi: 10.1002/jez.2347. [DOI] [PubMed] [Google Scholar]
- 89.Zhu YP, Zheng Z, Hu S, Ru X, Fan Z, Qiu L, Zhang Y. Unification of Opposites between Two Antioxidant Transcription Factors Nrf1 and Nrf2 in Mediating Distinct Cellular Responses to the Endoplasmic Reticulum Stressor Tunicamycin. Antioxidants. 2019;9(1):4. doi: 10.3390/antiox9010004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Harold FM. Molecules into cells: specifying spatial architecture. Microbiol Mol Biol Rev. 2005;69(4):544–564. doi: 10.1128/MMBR.69.4.544-564.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Lombard J, Moreira D. Origins and early evolution of the mevalonate pathway of isoprenoid biosynthesis in the three domains of life. Mol Biol Evol. 2011;28(1):87–99. doi: 10.1093/molbev/msq177. [DOI] [PubMed] [Google Scholar]
- 92.Griffiths G. Cell evolution and the problem of membrane topology. Nat Rev Mol Cell Biol. 2007;8(12):1018–1024. doi: 10.1038/nrm2287. [DOI] [PubMed] [Google Scholar]
- 93.Cavalier-Smith T. Obcells as proto-organisms: membrane heredity, lithophosphorylation, and the origins of the genetic code, the first cells, and photosyn-thesis. J Mol Evol. 2001;53(4-5):555–595. doi: 10.1007/s002390010245. [DOI] [PubMed] [Google Scholar]
- 94.Blobel G. Intracellular protein topogenesis. Proc Natl Acad Sci U S A. 1980;77(3):1496–1500. doi: 10.1073/pnas.77.3.1496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Engler AJ, Humbert PO, Wehrle-Haller B, Weaver VM. Multiscale modeling of form and function. Science. 2009;324(5924):208–212. doi: 10.1126/science.1170107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Edelman GM. Topobiology. Sci Am. 1989;260(5):76–82. doi: 10.1038/scientificamerican0589-76. [DOI] [PubMed] [Google Scholar]
- 97.Gerhart J. Topobiology. An Introduction to Molecular Embryology. Gerald M. Edelman. Basic Books, New York, 1988. xvi, 240 pp., illus. $21.95. . Science. 1989;243(4896):1373–1374. doi: 10.1126/science.243.4896.1373. [DOI] [PubMed] [Google Scholar]
- 98.Edelman GM. Topobiology: an introduction to molecular embryology. BasicBooks, A Subsidiary of Perseus Books, L.L.C., New. 1988;York. doi: 10.1126/science.243.4896.1373. [DOI] [Google Scholar]
- 99.Radulescu O, Lagarrigue S, Siegel A, Veber P, Le Borgne M. Topology and static response of interaction networks in molecular biology. J R Soc Inter-face. 2006;3(6):185–196. doi: 10.1098/rsif.2005.0092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Levene SD. Topology in biology: From DNA mechanics to enzymology. Biol Med Phys. 2007;Biomed:3–21. doi: 10.1007/978-3-540-49858-2_2. [DOI] [Google Scholar]
- 101.Nada SI, Zohny H. An application of relative topology in biology. Chaos Soliton Fract. 2009;42(1):202–204. doi: 10.1016/j.chaos.2008.11.003. [DOI] [Google Scholar]
- 102.Tang EM, Agudo-Canalejo J, Golestanian R. Topology Protects Robust Global Cycles in Stochastic Systems. Biophysical Journal. 2021;120(3):209a–209a. doi: 10.1016/j.bpj.2020.11.1419. [DOI] [Google Scholar]
- 103.Klein A, Bock M, Alt W. Simple mechanisms of early life - simulation model on the origin of semi-cells. Biosystems. 2017;151:34–42. doi: 10.1016/j.biosystems.2016.11.001. [DOI] [PubMed] [Google Scholar]
- 104.Davis BK. Molecular evolution before the origin of species. Prog Biophys Mol Biol. 2002;79(1-3):77–133. doi: 10.1016/s0079-6107(02)00012-3. [DOI] [PubMed] [Google Scholar]
- 105.Zimorski V, Mentel M, Tielens AGM, Martin WF. Energy metabolism in anaerobic eukaryotes and Earth's late oxygenation. Free Radic Biol Med. 2019;140:279–294. doi: 10.1016/j.freeradbiomed.2019.03.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Muller M, Mentel M, van Hellemond JJ, Henze K, Woehle C, Gould SB, Yu RY, van der Giezen M, Tielens AG, Martin WF. Biochemistry and evolution of anaerobic energy metabolism in eukaryotes. Microbiol Mol Biol Rev. 2012;76(2):444–495. doi: 10.1128/MMBR.05024-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Myllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol. 2003;22(1):15–24. doi: 10.1016/s0945-053x(03)00006-4. [DOI] [PubMed] [Google Scholar]
- 108.Aro E, Khatri R, Gerard-O'Riley R, Mangiavini L, Myllyharju J, Schipani E. Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induc-tion of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes. J Biol Chem. 2012;287(44):37134–37144. doi: 10.1074/jbc.M112.352872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Myllyharju J. Prolyl 4-hydroxylases, master regulators of the hypoxia response. Acta Physiol. 2013;208(2):148–165. doi: 10.1111/apha.12096. [DOI] [PubMed] [Google Scholar]
- 110.Myllyharju J, Koivunen P. Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles. Biol Chem. 2013;394(4):435–448. doi: 10.1515/hsz-2012-0328. [DOI] [PubMed] [Google Scholar]
- 111.Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative Stress in Cancer. Cancer Cell. 2020;38(2):167–197. doi: 10.1016/j.ccell.2020.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Zhang Y. Molecular and cellular control of the Nrf1 transcription factor: An integral membrane glycoprotein. Vdm Verlag Dr Müller Publishing House, Germany; 2009;pp1-264. [Google Scholar]
- 113.Sykiotis GP, Bohmann D. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal. 2010;3(112):re3. doi: 10.1126/scisignal.3112re3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Zhu YP, Wang M, Xiang Y, Qiu L, Hu S, Zhang Z, Mattjus P, Zhu X, Zhang Y. Nach Is a Novel Subgroup at an Early Evolutionary Stage of the CNC-bZIP Subfamily Transcription Factors from the Marine Bacteria to Humans. Int J Mol Sci. 2018;19(10):1–26. doi: 10.3390/ijms19102927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Hu S, Feng J, Wang M, Wufuer R, Liu K, Zhang Z, Zhang Y. Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks. Redox Biol. 2022;57:102470. doi: 10.1016/j.redox.2022.102470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, Attucks OC, Franklin S, Levonen AL, Kensler TW, Dinkova-Kostova AT. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019;18(4):295–317. doi: 10.1038/s41573-018-0008-x. [DOI] [PubMed] [Google Scholar]
- 117.Liu P, Kerins MJ, Tian W, Neupane D, Zhang DD, Ooi A. Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells. J Biol Chem. 2019;294(48):18131–18149. doi: 10.1074/jbc.RA119.009591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Chan K, Lu R, Chang JC, Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A. 1996;93(24):13943–13948. doi: 10.1073/pnas.93.24.13943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Lehrbach NJ, Ruvkun G. Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity. Elife. 2019;8:e44425. doi: 10.7554/eLife.44425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Karim MR, Taniguchi H, Kobayashi A. Constitutive activation of Drosophila CncC transcription factor reduces lipid formation in the fat body. Biochem Biophys Res Commun. 2015;463(4):693–698. doi: 10.1016/j.bbrc.2015.05.126. [DOI] [PubMed] [Google Scholar]
- 121.Zhang Y, Ren Y, Li S, Hayes JD. Transcription factor Nrf1 is topologically repartitioned across membranes to enable target gene transactivation through its acidic glucose-responsive domains. PLoS One. 2014;9(4):e93458. doi: 10.1371/journal.pone.0093458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Xiang Y, Halin J, Fan Z, Hu S, Wang M, Qiu L, Zhang Z, Mattjus P, Zhang Y. Topovectorial mechanisms control the juxtamembrane proteolytic pro-cessing of Nrf1 to remove its N-terminal polypeptides during maturation of the CNC-bZIP factor. Toxicol Appl Pharmacol. 2018;360:160–184. doi: 10.1016/j.taap.2018.09.039. [DOI] [PubMed] [Google Scholar]
- 123.Wang M, Ren Y, Hu S, Liu K, Qiu L, Zhang Y. TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1alpha by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2. Front Oncol. 2021;11:707032. doi: 10.3389/fonc.2021.707032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Kultz D. Defining biological stress and stress responses based on principles of physics. J Exp Zool A Ecol Integr Physiol. 2020;333(6):350–358. doi: 10.1002/jez.2340. [DOI] [PubMed] [Google Scholar]
- 125.Mojica EA, Kultz D. Physiological mechanisms of stress-induced evolution. J Exp Biol. 2022;225(Suppl_1):jeb243264. doi: 10.1242/jeb.243264. [DOI] [PubMed] [Google Scholar]
- 126.Agorastos A, Chrousos GP. The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Mol Psychiatry. 2022;27(1):502–513. doi: 10.1038/s41380-021-01224-9. [DOI] [PubMed] [Google Scholar]
- 127.Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. . JAMA. 1992;267(9):1244–1252. doi: 10.1001/jama.1992.03480090092034. [DOI] [PubMed] [Google Scholar]
- 128.Hinkle Jr LE. The concept of "stress" in the biological and social sciences. Int J Psychiatry Med. 1974;5(4):335–357. doi: 10.2190/91DK-NKAD-1XP0-Y4RG. [DOI] [PubMed] [Google Scholar]
- 129.Love A. The Mathematical Theory of Elasticity. 2nd Edition. Dover Publications, New. 1944;York. [Google Scholar]
- 130.Su H, Wang G, Yuan R, Wang J, Tang Y, Ao P, Zhu X. Decoding early myelopoiesis from dynamics of core endogenous network. Sci China Life Sci. 2017;60(6):627–646. doi: 10.1007/s11427-017-9059-y. [DOI] [PubMed] [Google Scholar]
- 131.Wang J, Yuan R, Zhu X, Ao P. Adaptive Landscape Shaped by Core Endogenous Network Coordinates Complex Early Progenitor Fate Commitments in Embryonic Pancreas. Sci Rep. 2020;10(1):1112. doi: 10.1038/s41598-020-57903-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Torday JS. The cell as the mechanistic basis for evolution. Wiley Interdiscip Rev Syst Biol Med. 2015;7(5):275–284. doi: 10.1002/wsbm.1305. [DOI] [PubMed] [Google Scholar]
- 133.Gao J, Weiner JH. Nature of stress on the atomic level in dense polymer systems. Science. 1994;266(5186):748–752. doi: 10.1126/science.266.5186.748. [DOI] [PubMed] [Google Scholar]
- 134.Selye H. Evolution of Stress Concept - Stress and Cardiovascular Disease. Am J Cardiol. 1970;26(3):289–289. doi: 10.1016/0002-9149(70)90796-4. [DOI] [PubMed] [Google Scholar]
- 135.Koolhaas JM, Bartolomucci A, Buwalda B, de Boer SF, Flugge G, Korte SM, Meerlo P, Murison R, Olivier B, Palanza P, Richter-Levin G, Sgoifo A, Steimer T, Stiedl O, van Dijk G, Wohr M, Fuchs E. Stress revisited: a critical evaluation of the stress concept. Neurosci Biobehav Rev. 2011;35(5):1291–1301. doi: 10.1016/j.neubiorev.2011.02.003. [DOI] [PubMed] [Google Scholar]
- 136.Lu S, Wei F, Li G. The evolution of the concept of stress and the framework of the stress system. Cell Stress. 2021;5(6):76–85. doi: 10.15698/cst2021.06.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Valencia-Florez KB, Sanchez-Castillo H, Vazquez P, Zarate P, Paz DB. Stress, a Brief Update. Int J Psychol Res. 2023;16(2):105–121. doi: 10.21500/20112084.5815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Martin RD. A critical review of the concept of stress in psychosomatic medicine. Perspect Biol Med. 1984;27(3):443–464. doi: 10.1353/pbm.1984.0041. [DOI] [PubMed] [Google Scholar]
- 139.Robin ED. Claude Bernard's (extended) milieu interieur revisited: autoregulation of cell and subcell integrity. Clin Sci Mol Med. 1977;52(5):443–448. doi: 10.1042/cs0520443. [DOI] [PubMed] [Google Scholar]
- 140.Noble D. Claude Bernard, the first systems biologist, and the future of physiology. Exp Physiol. 2008;93(1):16–26. doi: 10.1113/expphysiol.2007.038695. [DOI] [PubMed] [Google Scholar]
- 141.Cooper SJ. From Claude Bernard to Walter Cannon. Emergence of the concept of homeostasis. Appetite. 2008;51(3):419–427. doi: 10.1016/j.appet.2008.06.005. [DOI] [PubMed] [Google Scholar]
- 142.Cannon WB. Stresses and strains of homeostasis. Am J Med Sci. 1935;189:1–14. doi: 10.1097/00000441-193501000-00001. [DOI] [Google Scholar]
- 143.Selye H. Stress and disease. Science. 1955;122(3171):625–631. doi: 10.1126/science.122.3171.625. [DOI] [PubMed] [Google Scholar]
- 144.Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:32–32. doi: 10.1038/138032a0. [DOI] [PubMed] [Google Scholar]
- 145.O'Neill D. Stress and disease: a review of principles. Br Med J. 1958;2(5091):285–287. doi: 10.1136/bmj.2.5091.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Goldstein DS. Stress and the "extended" autonomic system. Auton Neurosci. 2021;236:102889. doi: 10.1016/j.autneu.2021.102889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Shapiro HM. Redox balance in the body: an approach to quantitation. J Surg Res. 1972;13(3):138–152. doi: 10.1016/0022-4804(72)90057-1. [DOI] [PubMed] [Google Scholar]
- 148.Loscalzo J. Adaptions to Hypoxia and Redox Stress: Essential Concepts Confounded by Misleading Terminology. Circ Res. 2016;119(4):511–513. doi: 10.1161/CIRCRESAHA.116.309394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Sies H, Chance B. The steady state level of catalase compound I in isolated hemoglobin-free perfused rat liver. FEBS Lett. 1970;11(3):172–176. doi: 10.1016/0014-5793(70)80521-x. [DOI] [PubMed] [Google Scholar]
- 150.Sies H. Oxidative stress: introductory remark. Academic Press, 1985;London. doi: 10.1016/b978-0-12-642760-8.50005-3. [DOI] [Google Scholar]
- 151.Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci. 1985;311(1152):617–631. doi: 10.1098/rstb.1985.0168. [DOI] [PubMed] [Google Scholar]
- 152.Lushchak VI, Storey KB. Oxidative stress concept updated: Definitions, classifications, and regulatory pathways implicated. EXCLI J. 2021;20:956–967. doi: 10.17179/excli2021-3596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Lichtenberg D, Pinchuk I, Yonassi E, Weber D, Grune T. Oxidative Stress Is a Concept, Not an Indication for Selective Antioxidant Treatment. Antioxi-dants. 2023;12(6):1188. doi: 10.3390/antiox12061188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Monaghan P, Metcalfe NB, Torres R. Oxidative stress as a mediator of life history trade-offs: mechanisms, measurements and interpretation. Ecol Lett. 2009;12(1):75–92. doi: 10.1111/j.1461-0248.2008.01258.x. [DOI] [PubMed] [Google Scholar]
- 155.Costantini D. Understanding diversity in oxidative status and oxidative stress: the opportunities and challenges ahead. J Exp Biol. 2019;222(Pt 13):jeb194688. doi: 10.1242/jeb.194688. [DOI] [PubMed] [Google Scholar]
- 156.Laitinen RAE, Nikoloski Z. Strategies to identify and dissect trade-offs in plants. Mol Ecol. 2022;33(10):e16780. doi: 10.1111/mec.16780.. [DOI] [PubMed] [Google Scholar]
- 157.Erofeeva EA. Environmental hormesis in living systems: The role of hormetic trade-offs. Sc Total Environ. 2023;901:166022. doi: 10.1016/j.scitotenv.2023.166022. [DOI] [PubMed] [Google Scholar]
- 158.Korte SM, Koolhaas JM, Wingfield JC, McEwen BS. The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci Biobehav Rev. 2005;29(1):3–38. doi: 10.1016/j.neubiorev.2004.08.009. [DOI] [PubMed] [Google Scholar]
- 159.Monaghan P, Spencer KA. Stress and life history. Curr Biol. 2014;24(10):R408–R412. doi: 10.1016/j.cub.2014.04.017. [DOI] [PubMed] [Google Scholar]
- 160.Selye H. A code for coping with stress. AORN J. 1977;25(1):35–42. doi: 10.1016/s0001-2092(07)68496-8. [DOI] [PubMed] [Google Scholar]
- 161.Koolhaas JM, Korte SM, De Boer SF, Van Der Vegt BJ, Van Reenen CG, Hopster H, De Jong IC, Ruis MA, Blokhuis HJ. Coping styles in animals: cur-rent status in behavior and stress-physiology. Neurosci Biobehav Rev. 1999;23(7):925–935. doi: 10.1016/s0149-7634(99)00026-3. [DOI] [PubMed] [Google Scholar]
- 162.Overli O, Sorensen C, Pulman KG, Pottinger TG, Korzan W, Summers CH, Nilsson GE. Evolutionary background for stress-coping styles: relationships between physiological, behavioral, and cognitive traits in non-mammalian vertebrates. Neurosci Biobehav Rev. 2007;31(3):396–412. doi: 10.1016/j.neubiorev.2006.10.006. [DOI] [PubMed] [Google Scholar]
- 163.Duckworth RA, Chenard KC, Meza L, Beiriz MC. Coping styles vary with species' sociality and life history: A systematic review and meta-regression analysis. Neurosci Biobehav Rev. 2023;151:105241. doi: 10.1016/j.neubiorev.2023.105241. [DOI] [PubMed] [Google Scholar]
- 164.Kultz D. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol. 2005;67:225–257. doi: 10.1146/annurev.physiol.67.040403.103635. [DOI] [PubMed] [Google Scholar]
- 165.Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374–381. doi: 10.1038/nrendo.2009.106. [DOI] [PubMed] [Google Scholar]
- 166.Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627. doi: 10.1126/science.1114397. [DOI] [PubMed] [Google Scholar]
- 167.Yuan J, Zhang S, Zhang Y. Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases. Toxicol Appl Pharmacol. 2018;360:273–283. doi: 10.1016/j.taap.2018.09.037. [DOI] [PubMed] [Google Scholar]
- 168.Lushchak VI. Classification of oxidative stress based on its intensity. EXCLI J. 2014;13:922–937. [PMC free article] [PubMed] [Google Scholar]
- 169.Sies H. Findings in redox biology: From H(2)O(2) to oxidative stress. J Biol Chem. 2020;295(39):13458–13473. doi: 10.1074/jbc.X120.015651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Ursini F, Maiorino M, Forman HJ. Redox homeostasis: The Golden Mean of healthy living. Redox Biol. 2016;8:205–215. doi: 10.1016/j.redox.2016.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Goldstein DS, McEwen B. Allostasis, homeostats, and the nature of stress. Stress. 2002;5(1):55–58. doi: 10.1080/102538902900012345. [DOI] [PubMed] [Google Scholar]
- 172.Chen L, Kwong M, Lu R, Ginzinger D, Lee C, Leung L, Chan JY. Nrf1 is critical for redox balance and survival of liver cells during development. Mol Cell Biol. 2003;23(13):4673–4686. doi: 10.1128/mcb.23.13.4673-4686.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Liu X, Xu C, Xiao W, Yan N. Unravelling the role of NFE2L1 in stress responses and related diseases. Redox Biol. 2023;65:102819. doi: 10.1016/j.redox.2023.102819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Luczynska K, Zhang Z, Pietras T, Zhang Y, Taniguchi H. NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. Redox Biol. 2024;69:103003. doi: 10.1016/j.redox.2023.103003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Xiao H, Lü F, Stewart D, Zhang Y. Mechanisms underlying chemopreventive effects of flavonoids via multiple signaling nodes within Nrf2-ARE and AhR-XRE gene regulatory networks. Curr Chem Biol . 2013;7(2):151–176. doi: 10.2174/2212796811307020008. [DOI] [Google Scholar]
- 176.Baird L, Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Mol Cell Biol. 2020;40(13):e00099–e00020. doi: 10.1128/MCB.00099-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Sies H. Oxidative eustress: On constant alert for redox homeostasis. Redox Biol. 2021;41:101867. doi: 10.1016/j.redox.2021.101867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Wang M, Qiu L, Ru X, Song Y, Zhang Y. Distinct isoforms of Nrf1 diversely regulate different subsets of its cognate target genes. Sci Rep. 2019;9(1):2960. doi: 10.1038/s41598-019-39536-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Ao P, Galas D, Hood L, Zhu X. Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. Med Hypotheses. 2008;70(3):678–684. doi: 10.1016/j.mehy.2007.03.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 180.Yuan R, Zhu X, Wang G, Li S, Ao P. Cancer as robust intrinsic state shaped by evolution: a key issues review. Rep Prog Phys. 2017;80(4):042701. doi: 10.1088/1361-6633/aa538e. [DOI] [PubMed] [Google Scholar]
- 181.Wang G, Yuan R, Zhu X, Ao P. Endogenous Molecular-Cellular Network Cancer Theory: A Systems Biology Approach. Methods Mol Biol. 2018;1702:215–245. doi: 10.1007/978-1-4939-7456-6_11. [DOI] [PubMed] [Google Scholar]
- 182.Lloyd D, Aon MA, Cortassa S. Why homeodynamics, not homeostasis? ScientificWorldJournal. 2001;1:133–145. doi: 10.1100/tsw.2001.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Sies H, Ursini F. Homeostatic control of redox status and health. IUBMB Life. 2022;74(1):24–28. doi: 10.1002/iub.2519. [DOI] [PubMed] [Google Scholar]
- 184.Hussain L. Molecular modeling study of new platinum(VI) complexes as anticancer chemotherapy. PhD Thesis, University of. 2018;Kufa doi: 10.21172/ijiet.84.001. [DOI] [Google Scholar]
- 185.Sthijns MM, Weseler AR, Bast A, Haenen GR. Time in Redox Adaptation Processes: From Evolution to Hormesis. Int J Mol Sci. 2016;17(10):1649. doi: 10.3390/ijms17101649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 186.Selye H. Homeostasis and heterostasis. Perspect Biol Med. 1973;16(3):441–445. doi: 10.1353/pbm.1973.0056. [DOI] [PubMed] [Google Scholar]
- 187.van Setten GB. Ocular Surface Allostasis-When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience. Biomolecules. 2023;13(8):1246. doi: 10.3390/biom13081246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Gunther B, Morgado E, Jimenez RF. Homeostasis and heterostasis: from invariant to dimensionless numbers. Biol Res. 2003;36(2):211–221. doi: 10.4067/s0716-97602003000200011. [DOI] [PubMed] [Google Scholar]
- 189.Mohler J, Vani K, Leung S, Epstein A. Segmentally restricted, cephalic expression of a leucine zipper gene during Drosophila embryogenesis. Mech Dev. 1991;34(1):3–9. doi: 10.1016/0925-4773(91)90086-L. [DOI] [PubMed] [Google Scholar]
- 190.Bowerman B, Eaton BA, Priess JR. skn-1, a maternally expressed gene required to specify the fate of ventral blastomeres in the early C. elegans embryo. Cell. 1992;68(6):1061–1075. doi: 10.1016/0092-8674(92)90078-q. [DOI] [PubMed] [Google Scholar]
- 191.Taverne YJ, Merkus D, Bogers AJ, Halliwell B, Duncker DJ, Lyons TW. Reactive Oxygen Species: Radical Factors in the Evolution of Animal Life: A molecular timescale from Earth's earliest history to the rise of complex life. Bioessays. 2018;40(3) doi: 10.1002/bies.201700158. [DOI] [PubMed] [Google Scholar]
- 192.Sies H. Oxidative eustress: the physiological role of oxidants. Sci China Life Sci. 2023;66(8):1947–1948. doi: 10.1007/s11427-023-2336-1. [DOI] [PubMed] [Google Scholar]
- 193.Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, Murphy MP, Yamamoto M, Winterbourn C. Defining roles of specific reactive oxy-gen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol. 2022;23(7):499–515. doi: 10.1038/s41580-022-00456-z. [DOI] [PubMed] [Google Scholar]
- 194.Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947. doi: 10.1038/nrd4002. [DOI] [PubMed] [Google Scholar]
- 195.Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators? J Mol Biol. 2008;376(4):913–925. doi: 10.1016/j.jmb.2007.11.074. [DOI] [PubMed] [Google Scholar]
- 196.Jeyapaul J, Jaiswal AK. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol. 2000;59(11):1433–1439. doi: 10.1016/s0006-2952(00)00256-2. [DOI] [PubMed] [Google Scholar]
- 197.Giudice A, Montella M. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. Bioessays. 2006;28(2):169–181. doi: 10.1002/bies.20359. [DOI] [PubMed] [Google Scholar]
- 198.Mohler J, Mahaffey JW, Deutsch E, Vani K. Control of Drosophila head segment identity by the bZIP homeotic gene cnc. Development. 1995;121(1):237–247. doi: 10.1242/dev.121.1.237. [DOI] [PubMed] [Google Scholar]
- 199.Rupert PB, Daughdrill GW, Bowerman B, Matthews BW. A new DNA-binding motif in the Skn-1 binding domain-DNA complex. Nat Struct Biol. 1998;5(6):484–491. doi: 10.1038/nsb0698-484. [DOI] [PubMed] [Google Scholar]
- 200.Yuping Zhu MW, Yuancai Xiang, Lu Qiu, Shaofan Hu, Zhengwen Zhang, Peter Mattjus, Yiguo Zhang. Nach is a novel subfamily of the CNC-bZIP tran-scription factors selected during evolution. 2018;BioRxiv. doi: 10.1101/287755. [DOI] [Google Scholar]
- 201.Kusunoki H, Motohashi H, Katsuoka F, Morohashi A, Yamamoto M, Tanaka T. Solution structure of the DNA-binding domain of MafG. Nat Struct Biol. 2002;9(4):252–256. doi: 10.1038/nsb0698-484. [DOI] [PubMed] [Google Scholar]
- 202.Mehari YT, Arivett BA, Farone AL, Gunderson JH, Farone MB. Draft Genome Sequences of Two Novel Amoeba-Resistant Intranuclear Bacteria, "Candi-datus Berkiella cookevillensis" and "Candidatus Berkiella aquae". Genome Announc. 2016;4(1):e01732–e01715. doi: 10.1128/genomeA.01732-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203.Zhang Y, Lucocq JM, Yamamoto M, Hayes JD. The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation. Biochem J. 2007;408(2):161–172. doi: 10.1042/BJ20070761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.Suzuki T, Takahashi J, Yamamoto M. Molecular Basis of the KEAP1-NRF2 Signaling Pathway. Mol Cells. 2023;46(3):133–141. doi: 10.14348/molcells.2023.0028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 205.Lo SC, Li X, Henzl MT, Beamer LJ, Hannink M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 2006;25(15):3605–3617. doi: 10.1038/sj.emboj.7601243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 206.Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M. Structural basis for defects of keap1 activity provoked by its point mutations in lung cancer. Mol Cell. 2006;21(5):689–700. doi: 10.1016/j.molcel.2006.01.013. [DOI] [PubMed] [Google Scholar]
- 207.Fuse Y, Kobayashi M. Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time. Molecules. 2017;22(3):436. doi: 10.3390/molecules22030436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 208.Catling DC, Zahnle KJ. The Archean atmosphere. Sci Adv. 2020;6(9):eaax1420. doi: 10.1126/sciadv.aax1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 209.Marty B, Zimmermann L, Pujol M, Burgess R, Philippot P. Nitrogen isotopic composition and density of the Archean atmosphere. Science. 2013;342(6154):101–104. doi: 10.1126/science.1240971. [DOI] [PubMed] [Google Scholar]
- 210.Avice G, Marty B, Burgess R, Hofmann A, Philippot P, Zahnle K, Zakharov D. Evolution of atmospheric xenon and other noble gases inferred from Arche-an to Paleoproterozoic rocks. Geochim Cosmochim Acta. 2018;232:82–100. doi: 10.1016/j.gca.2018.04.018. [DOI] [Google Scholar]
- 211.Kump LR. The rise of atmospheric oxygen. Nature. 2008;451(7176):277–278. doi: 10.1038/nature06587. [DOI] [PubMed] [Google Scholar]
- 212.Zhang SC, Wang XM, Wang HJ, Bjerrum CJ, Hammarlund EU, Dahl TW, Canfield DE. REPLY TO PLANAVSKY ET AL. Strong evidence for high atmos-pheric oxygen levels 1,400 million years ago. P Natl Acad Sci USA. 2016;113(19):E2552–E2553. doi: 10.1073/pnas.1603982113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 213.Sperling EA, Knoll AH, Girguis PR. The Ecological Physiology of Earth's Second Oxygen Revolution. Annu Rev Ecol Evol S. 2015;46:215–235. doi: 10.1146/annurev-ecolsys-110512-135808. [DOI] [Google Scholar]
- 214.Krissansen-Totton J, Arney GN, Catling DC. Constraining the climate and ocean pH of the early Earth with a geological carbon cycle model. Proc Natl Acad Sci U S A. 2018;115(16):4105–4110. doi: 10.1073/pnas.1721296115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 215.Foster GL, Royer DL, Lunt DJ. Future climate forcing potentially without precedent in the last 420 million years. Nat Commun. 2017;8:14845. doi: 10.1038/ncomms14845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 216.Kanzaki Y, Murakami T. Estimates of atmospheric CO2 in the Neoarchean-Paleoproterozoic from paleosols. Geochim Cosmochim Acta. 2015;159:190–219. doi: 10.1016/j.gca.2015.03.011. [DOI] [Google Scholar]
- 217.Driese SG, Jirsa MA, Ren M, Brantley SL, Sheldon ND, Parker D, Schmitz M. Neoarchean paleoweathering of tonalite and metabasalt: Implications for reconstructions of 2. 9Ga early terrestrial ecosystems and paleoatmospheric chemistry. Precambrian Res. 2011;189(1-2):1–17. doi: 10.1016/j.precamres.2011.04.003. [DOI] [Google Scholar]
- 218.Kah LC, Riding R. Mesoproterozoic carbon dioxide levels inferred from calcified cyanobacteria. Geology. 2007;35(9):799–802. doi: 10.1130/g23680a.1. [DOI] [Google Scholar]
- 219.Sheldon ND. Precambrian paleosols and atmospheric CO2 levels. Precambrian Res. 2006;147(1-2):148–155. doi: 10.1016/j.precamres.2006.02.004. [DOI] [Google Scholar]
- 220.Hessler AM, Lowe DR, Jones RL, Bird DK. A lower limit for atmospheric carbon dioxide levels 3. billion years ago. Nature. 2004;428(6984):736–738. doi: 10.1038/nature02471. [DOI] [PubMed] [Google Scholar]
- 221.Towe KM. The problematic rise of Archean oxygen - Response. Science. 2002;295(5559):1419. doi: 10.1126/science.295.5559.1419a. [DOI] [PubMed] [Google Scholar]
- 222.Catling DC, Zahnle KJ, McKay CP. Biogenic methane, hydrogen escape, and the irreversible oxidation of early Earth. Science. 2001;293(5531):839–843. doi: 10.1126/science.1061976. [DOI] [PubMed] [Google Scholar]
- 223.Pavlov AA, Hurtgen MT, Kasting JF, Arthur MA. Methane-rich Proterozoic atmosphere? Geology. 2003;31(1):87–90. doi: 10.1130/0091-7613(2003)031<0087:Mrpa>2.0.Co;2. [DOI] [Google Scholar]
- 224.Olson SL, Reinhard CT, Lyons TW. Limited role for methane in the mid-Proterozoic greenhouse. Proc Natl Acad Sci U S A. 2016;113(41):11447–11452. doi: 10.1073/pnas.1608549113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 225.Daines SJ, Lenton TM. The effect of widespread early aerobic marine ecosystems on methane cycling and the Great Oxidation. Earth and Planetary Science Letters. 2016;434:42–51. doi: 10.1016/j.epsl.2015.11.021. [DOI] [Google Scholar]
- 226.Zhao M, Reinhard CT, Planavsky N. Terrestrial methane fluxes and Proterozoic climate. Geology. 2017;46(2):139–142. doi: 10.1130/g39502.1. [DOI] [Google Scholar]
- 227.Berner RA, Beerling D, Mackenzie FT, Harfoot MB, Pyle JA. Atmospheric Methane over the past 400 million years. Geochim Cosmochim Acta. 2009;73(13):A115–A115. [Google Scholar]
- 228.Kah LC, Lyons TW, Frank TD. Low marine sulphate and protracted oxygenation of the Proterozoic biosphere. Nature. 2004;431(7010):834–838. doi: 10.1038/nature02974. [DOI] [PubMed] [Google Scholar]
- 229.Habicht KS, Gade M, Thamdrup B, Berg P, Canfield DE. Calibration of sulfate levels in the archean ocean. Science. 2002;298(5602):2372–2374. doi: 10.1126/science.1078265. [DOI] [PubMed] [Google Scholar]
- 230.Planavsky NJ, Bekker A, Hofmann A, Owens JD, Lyons TW. Sulfur record of rising and falling marine oxygen and sulfate levels during the Lomagundi event. Proc Natl Acad Sci U S A. 2012;109(45):18300–18305. doi: 10.1073/pnas.1120387109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 231.Li C, Planavsky NJ, Love GD, Reinhard CT, Hardisty D, Feng L, Bates SM, Huang J, Zhang Q, Chu X, Lyons TW. Marine redox conditions in the middle Proterozoic ocean and isotopic constraints on authigenic carbonate formation: Insights from the Chuanlinggou Formation, Yanshan Basin, North China. Geochim Cosmochim Acta. 2015;150:90–105. doi: 10.1016/j.gca.2014.12.005. [DOI] [Google Scholar]
- 232.Bjerrum CJ, Canfield DE. Ocean productivity before about 1. Gyr ago limited by phosphorus adsorption onto iron oxides. Nature. 2002;417(6885):159–162. doi: 10.1038/417159a. [DOI] [PubMed] [Google Scholar]
- 233.Planavsky NJ, Rouxel OJ, Bekker A, Lalonde SV, Konhauser KO, Reinhard CT, Lyons TW. The evolution of the marine phosphate reservoir. Nature. 2010;467(7319):1088–1090. doi: 10.1038/nature09485. [DOI] [PubMed] [Google Scholar]
- 234.Jones C, Nomosatryo S, Crowe SA, Bjerrum CJ, Canfield DE. Iron oxides, divalent cations, silica, and the early earth phosphorus crisis. Geology. 2015;43(2):135–138. doi: 10.1130/g36044.1. [DOI] [Google Scholar]
- 235.Reinhard CT, Planavsky NJ, Gill BC, Ozaki K, Robbins LJ, Lyons TW, Fischer WW, Wang C, Cole DB, Konhauser KO. Evolution of the global phosphorus cycle. Nature. 2017;541(7637):386–389. doi: 10.1038/nature20772. [DOI] [PubMed] [Google Scholar]
- 236.Song H, Jiang G, Poulton SW, Wignall PB, Tong J, Song H, An Z, Chu D, Tian L, She Z, Wang C. The onset of widespread marine red beds and the evolu-tion of ferruginous oceans. Nat Commun. 2017;8(1):399. doi: 10.1038/s41467-017-00502-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 237.Lowenstein TK, Kendall B, Anbar AD. The Geologic History of Seawater. 2014;In:569–622. [Google Scholar]
- 238.Lowenstein TK, Timofeeff MN, Brennan ST, Hardie LA, Demicco RV. Oscillations in Phanerozoic seawater chemistry: evidence from fluid inclusions. Science. 2001;294(5544):1086–1088. doi: 10.1126/science.1064280. [DOI] [PubMed] [Google Scholar]
- 239.Planavsky NJ, McGoldrick P, Scott CT, Li C, Reinhard CT, Kelly AE, Chu X, Bekker A, Love GD, Lyons TW. Widespread iron-rich conditions in the mid-Proterozoic ocean. Nature. 2011;477(7365):448–451. doi: 10.1038/nature10327. [DOI] [PubMed] [Google Scholar]
- 240.Canfield DE, Poulton SW, Narbonne GM. Late-Neoproterozoic deep-ocean oxygenation and the rise of animal life. Science. 2007;315(5808):92–95. doi: 10.1126/science.1135013. [DOI] [PubMed] [Google Scholar]
- 241.Canfield DE, Poulton SW, Knoll AH, Narbonne GM, Ross G, Goldberg T, Strauss H. Ferruginous conditions dominated later neoproterozoic deep-water chemistry. Science. 2008;321(5891):949–952. doi: 10.1126/science.1154499. [DOI] [PubMed] [Google Scholar]
- 242.Nutman AP, Bennett VC, Friend CR, Van Kranendonk MJ, Chivas AR. Rapid emergence of life shown by discovery of 3,700-million-year-old microbial structures. Nature. 2016;537(7621):535–538. doi: 10.1038/nature19355. [DOI] [PubMed] [Google Scholar]
- 243.Bell EA, Boehnke P, Harrison TM, Mao WL. Potentially biogenic carbon preserved in a 4. billion-year-old zircon. Proc Natl Acad Sci U S A. 2015;112(47):14518–14521. doi: 10.1073/pnas.1517557112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 244.Fischer WW, Hemp J, Johnson JE. Evolution of Oxygenic Photosynthesis. Annu Rev Earth Pl Sc. 2016;44:647–683. doi: 10.1146/annurev-earth-060313-054810. [DOI] [Google Scholar]
- 245.Butterfield NJ, Smith A. Early evolution of the Eukaryota. Palaeontology. 2014;58(1):5–17. doi: 10.1111/pala.12139. [DOI] [Google Scholar]
- 246.Javaux EJ, Marshall CP, Bekker A. Organic-walled microfossils in 3. -billion-year-old shallow-marine siliciclastic deposits. Nature. 2010;463(7283):934–938. doi: 10.1038/nature08793. [DOI] [PubMed] [Google Scholar]
- 247.Butterfield NJ. Bangiomorpha pubescensn. gen., n. sp.:: implications for the evolution of sex, multicellularity, and the Mesoproterozoic/Neoproterozoic radiation of eukaryotes. . Paleobiology. 2000;26(3):386–404. doi: 10.1666/0094-8373(2000)026<0386:Bpngns>2.0.Co;2. [DOI] [Google Scholar]
- 248.Zhu S, Zhu M, Knoll AH, Yin Z, Zhao F, Sun S, Qu Y, Shi M, Liu H. Decimetre-scale multicellular eukaryotes from the 1. 6-billion-year-old Gaoyuzhuang Formation in North China. Nat Commun. 2016;7:11500. doi: 10.1038/ncomms11500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 249.Love GD, Grosjean E, Stalvies C, Fike DA, Grotzinger JP, Bradley AS, Kelly AE, Bhatia M, Meredith W, Snape CE, Bowring SA, Condon DJ, Summons RE. Fossil steroids record the appearance of Demospongiae during the Cryogenian period. Nature. 2009;457(7230):718–721. doi: 10.1038/nature07673. [DOI] [PubMed] [Google Scholar]
- 250.Hofmann HJ, Narbonne GM, Aitken JD. Ediacaran Remains from Intertillite Beds in Northwestern Canada. Geology. 1990;18(12):1199–1202. doi: 10.1130/0091-7613(1990)018<1199:Erfibi>2.3.Co;2. [DOI] [Google Scholar]
- 251.Narbonne GM. THE EDIACARA BIOTA: Neoproterozoic Origin of Animals and Their Ecosystems. Annu Rev Earth Planet Sci. 2005;33(1):421–442. doi: 10.1146/annurev.earth.33.092203.122519. [DOI] [Google Scholar]
- 252.Peters SE. Geologic constraints on the macroevolutionary history of marine animals. Proc Natl Acad Sci U S A. 2005;102(35):12326–12331. doi: 10.1073/pnas.0502616102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 253.Marshall CR. Explaining the Cambrian "Explosion" of Animals. Ann Rev Earth Planet Sci. 2006;34(1):355–384. doi: 10.1146/annurev.earth.33.031504.103001. [DOI] [Google Scholar]
- 254.Martin MW, Grazhdankin DV, Bowring SA, Evans DA, Fedonkin MA, Kirschvink JL. Age of Neoproterozoic bilatarian body and trace fossils, White Sea, Russia: implications for metazoan evolution. Science. 2000;288(5467):841–845. doi: 10.1126/science.288.5467.841. [DOI] [PubMed] [Google Scholar]
- 255.Bengtson S, Zhao Y. Predatorial borings in late precambrian mineralized exoskeletons. Science. 1992;257(5068):367–369. doi: 10.1126/science.257.5068.367. [DOI] [PubMed] [Google Scholar]
- 256.Payne JL, Boyer AG, Brown JH, Finnegan S, Kowalewski M, Krause Jr RA, Lyons SK, McClain CR, McShea DW, Novack-Gottshall PM, Smith FA, Stempien JA, Wang SC. Two-phase increase in the maximum size of life over 3. billion years reflects biological innovation and environmental opportunity. Proc Natl Acad Sci U S A. 2009;106(1):24–27. doi: 10.1073/pnas.0806314106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 257.Schlundt A, Buchner S, Janowski R, Heydenreich T, Heermann R, Lassak J, Geerlof A, Stehle R, Niessing D, Jung K, Sattler M. Structure-function analysis of the DNA-binding domain of a transmembrane transcriptional activator. Sci Rep. 2017;7(1):1051. doi: 10.1038/s41598-017-01031-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 258.Eichinger A, Haneburger I, Koller C, Jung K, Skerra A. Crystal structure of the sensory domain of Escherichia coli CadC, a member of the ToxR-like protein family. Protein Sci. 2011;20(4):656–669. doi: 10.1002/pro.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 259.Martin WF, Garg S, Zimorski V. Endosymbiotic theories for eukaryote origin. Philos Trans R Soc Lond B Biol Sci. 2015;370(1678):20140330. doi: 10.1098/rstb.2014.0330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 260.Margulis L, Dolan MF, Guerrero R. The chimeric eukaryote: origin of the nucleus from the karyomastigont in amitochondriate protists. Proc Natl Acad Sci U S A. 2000;97(13):6954–6959. doi: 10.1073/pnas.97.13.6954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 261.Xu Z, Chen L, Leung L, Yen TS, Lee C, Chan JY. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci U S A. 2005;102(11):4120–4125. doi: 10.1073/pnas.0500660102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 262.Ohtsuji M, Katsuoka F, Kobayashi A, Aburatani H, Hayes JD, Yamamoto M. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem. 2008;283(48):33554–33562. doi: 10.1074/jbc.M804597200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 263.Deng R, Zheng Z, Hu S, Wang M, Feng J, Mattjus P, Zhang Z, Zhang Y. Loss of Nrf1 rather than Nrf2 leads to inflammatory accumulation of lipids and reac-tive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate. Biochim Biophys Acta Mol Cell Res. 2024;1871(2):119644. doi: 10.1016/j.bbamcr.2023.119644. [DOI] [PubMed] [Google Scholar]
- 264.Deng R, Zhu Y, Liu K, Zhang Q, Hu S, Wang M, Zhang Y. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway. Bioorg Chem. 2024;145:107212. doi: 10.1016/j.bioorg.2024.107212. [DOI] [PubMed] [Google Scholar]
- 265.Qiu L, Wang M, Hu S, Ru X, Ren Y, Zhang Z, Yu S, Zhang Y. Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1alpha that Acts as a Dominant Tumor Repressor. Cancers. 2018;10(12):520. doi: 10.3390/cancers10120520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 266.Ren Y, Qiu L, Lu F, Ru X, Li S, Xiang Y, Yu S, Zhang Y. TALENs-directed knockout of the full-length transcription factor Nrf1alpha that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. Sci Rep. 2016;6:23775. doi: 10.1038/srep23775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 267.Amend SR, Torga G, Lin KC, Kostecka LG, de Marzo A, Austin RH, Pienta KJ. Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance. Prostate. 2019;79(13):1489–1497. doi: 10.1002/pros.23877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 268.Pienta KJ, Hammarlund EU, Axelrod R, Amend SR, Brown JS. Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer. Mol Cancer Res. 2020;18(6):801–810. doi: 10.1158/1541-7786.MCR-19-1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 269.Pienta KJ, Hammarlund EU, Axelrod R, Brown JS, Amend SR. Poly-aneuploid cancer cells promote evolvability, generating lethal cancer. Evol Appl. 2020;13(7):1626–1634. doi: 10.1111/eva.12929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 270.Chen J, Niu N, Zhang J, Qi L, Shen W, Donkena KV, Feng Z, Liu J. Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer. Curr Cancer Drug Targets. 2019;19(5):360–367. doi: 10.2174/1568009618666180703154233. [DOI] [PubMed] [Google Scholar]
- 271.Tozzi A, Mazzeo M. The First Nucleic Acid Strands May Have Grown on Peptides via Primeval Reverse Translation. Acta Biotheor. 2023;71(4):23. doi: 10.1007/s10441-023-09474-6. [DOI] [PubMed] [Google Scholar]
- 272.Chang HY, Qi LS. Reversing the Central Dogma: RNA-guided control of DNA in epigenetics and genome editing. Mol Cell. 2023;83(3):442–451. doi: 10.1016/j.molcel.2023.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 273.Chien P, Weissman JS, DePace AH. Emerging principles of conformation-based prion inheritance. Annu Rev Biochem. 2004;73:617–656. doi: 10.1146/annurev.biochem.72.121801.161837. [DOI] [PubMed] [Google Scholar]
- 274.Zupicich J, Brenner SE, Skarnes WC. Computational prediction of membrane-tethered transcription factors. Genome Biol. 2001;2(12):RESEARCH0050. doi: 10.1186/gb-2001-2-12-research0050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 275.Zhang Y, Ren Y, Li S, Hayes J. Transcription factor Nrf1 is topologically repartitioned across membranes to enable target gene transactivation through its acidic glucose-responsive domains. PLoS One . 2014;9(4): e93456. doi: 10.1371/journal.pone.0093458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 276.Banares AB, Valdehuesa KNG, Ramos KRM, Nisola GM, Lee WK, Chung WJ. A pH-responsive genetic sensor for the dynamic regulation of D-xylonic acid accumulation in Escherichia coli. Appl Microbiol Biotechnol. 2020;104(5):2097–2108. doi: 10.1007/s00253-019-10297-0. [DOI] [PubMed] [Google Scholar]
- 277.Bina XR, Howard MF, Ante VM, Bina JE. Vibrio cholerae LeuO Links the ToxR Regulon to Expression of Lipid A Remodeling Genes. Infect Immun. 2016;84(11):3161–3171. doi: 10.1128/IAI.00445-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 278.Pennetzdorfer N, Lembke M, Pressler K, Matson JS, Reidl J, Schild S. Regulated Proteolysis in Vibrio cholerae Allowing Rapid Adaptation to Stress Conditions. Front Cell Infect Microbiol. 2019;9:214. doi: 10.3389/fcimb.2019.00214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 279.Therit B, Cheung JK, Rood JI, Melville SB. NanR, a Transcriptional Regulator That Binds to the Promoters of Genes Involved in Sialic Acid Metabolism in the Anaerobic Pathogen Clostridium perfringens. PLoS One. 2015;10(7):e0133217. doi: 10.1371/journal.pone.0133217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 280.Peters G, De Paepe B, De Wannemaeker L, Duchi D, Maertens J, Lammertyn J, De Mey M. Development of N-acetylneuraminic acid responsive bio-sensors based on the transcriptional regulator NanR. Biotechnol Bioeng. 2018;115(7):1855–1865. doi: 10.1002/bit.26586. [DOI] [PubMed] [Google Scholar]
- 281.Buzun E, Hsu CY, Sejane K, Oles RE, Vasquez Ayala A, Loomis LR, Zhao J, Rossitto LA, McGrosso DM, Gonzalez DJ, Bode L, Chu H. A bacterial sial-idase mediates early-life colonization by a pioneering gut commensal. Cell Host Microbe. 2024;32(2):181–190. doi: 10.1016/j.chom.2023.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 282.Dong X, Guthrie BGH, Alexander M, Noecker C, Ramirez L, Glasser NR, Turnbaugh PJ, Balskus EP. Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators. Nat Commun. 2022;13(1):7624. doi: 10.1038/s41467-022-33576-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 283.Piwko W, Jentsch S. Proteasome-mediated protein processing by bidirectional degradation initiated from an internal site. Nat Struct Mol Biol. 2006;13(8):691–697. doi: 10.1038/nsmb1122. [DOI] [PubMed] [Google Scholar]
- 284.Chellappa R, Kandasamy P, Oh CS, Jiang Y, Vemula M, Martin CE. The membrane proteins, Spt23p and Mga2p, play distinct roles in the activation of Saccharomyces cerevisiae OLE1 gene expression. Fatty acid-mediated regulation of Mga2p activity is independent of its proteolytic processing into a soluble tran-scription activator. J Biol Chem. 2001;276(47):43548–43556. doi: 10.1074/jbc.M107845200. [DOI] [PubMed] [Google Scholar]
- 285.Nakagawa Y, Sakumoto N, Kaneko Y, Harashima S. Mga2p is a putative sensor for low temperature and oxygen to induce OLE1 transcription in Sac-charomyces cerevisiae. Biochem Biophys Res Commun. 2002;291(3):707–713. doi: 10.1006/bbrc.2002.6507. [DOI] [PubMed] [Google Scholar]
- 286.Jiang Y, Vasconcelles MJ, Wretzel S, Light A, Gilooly L, McDaid K, Oh CS, Martin CE, Goldberg MA. Mga2p processing by hypoxia and unsaturated fatty acids in Saccharomyces cerevisiae: impact on LORE-dependent gene expression. Eukaryot Cell. 2002;1(3):481–490. doi: 10.1128/EC.1.3.481-490.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 287.Ballweg S, Ernst R. Control of membrane fluidity: the OLE pathway in focus. Biol Chem. 2017;398(2):215–228. doi: 10.1515/hsz-2016-0277. [DOI] [PubMed] [Google Scholar]
- 288.Halbleib K, Pesek K, Covino R, Hofbauer HF, Wunnicke D, Hanelt I, Hummer G, Ernst R. Activation of the Unfolded Protein Response by Lipid Bilayer Stress. Mol Cell. 2017;67(4):673–684. doi: 10.1016/j.molcel.2017.06.012. [DOI] [PubMed] [Google Scholar]
- 289.Le Goupil S, Laprade H, Aubry M, Chevet E. Exploring the IRE1 interactome: from canonical signaling functions to unexpected roles. J Biol Chem. 2024;300(4):107169. doi: 10.1016/j.jbc.2024.107169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 290.Thibault G, Shui G, Kim W, McAlister GC, Ismail N, Gygi SP, Wenk MR, Ng DT. The membrane stress response buffers lethal effects of lipid disequilibrium by reprogramming the protein homeostasis network. Mol Cell. 2012;48(1):16–27. doi: 10.1016/j.molcel.2012.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 291.Ho N, Yap WS, Xu J, Wu H, Koh JH, Goh WWB, George B, Chong SC, Taubert S, Thibault G. Stress sensor Ire1 deploys a divergent transcriptional program in response to lipid bilayer stress. J Cell Biol. 2020;219(7):e201909165. doi: 10.1083/jcb.201909165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 292.Tirosh B, Iwakoshi NN, Glimcher LH, Ploegh HL. Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response. J Biol Chem. 2006;281(9):5852–5860. doi: 10.1074/jbc.M509061200. [DOI] [PubMed] [Google Scholar]
- 293.Yanagitani K, Imagawa Y, Iwawaki T, Hosoda A, Saito M, Kimata Y, Kohno K. Cotranslational targeting of XBP1 protein to the membrane promotes cytoplasmic splicing of its own mRNA. Mol Cell. 2009;34(2):191–200. doi: 10.1016/j.molcel.2009.02.033. [DOI] [PubMed] [Google Scholar]
- 294.Yanagitani K, Kimata Y, Kadokura H, Kohno K. Translational pausing ensures membrane targeting and cytoplasmic splicing of XBP1u mRNA. Science. 2011;331(6017):586–589. doi: 10.1126/science.1197142. [DOI] [PubMed] [Google Scholar]
- 295.Ottolenghi C, Veitia R, Barbieri M, Fellous M, McElreavey K. The human doublesex-related gene, DMRT2, is homologous to a gene involved in somito-genesis and encodes a potential bicistronic transcript. Genomics. 2000;64(2):179–186. doi: 10.1006/geno.2000.6120. [DOI] [PubMed] [Google Scholar]
- 296.Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, Brown MS, Goldstein JL. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell. 2000;6(6):1355–1364. doi: 10.1016/s1097-2765(00)00133-7. [DOI] [PubMed] [Google Scholar]
- 297.Rawson RB. Regulated intramembrane proteolysis: from the endoplasmic reticulum to the nucleus. Essays Biochem. 2002;38:155–168. doi: 10.1042/bse0380155. [DOI] [PubMed] [Google Scholar]
- 298.Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 1994;77(1):53–62. doi: 10.1016/0092-8674(94)90234-8. [DOI] [PubMed] [Google Scholar]
- 299.Bujalka H, Koenning M, Jackson S, Perreau VM, Pope B, Hay CM, Mitew S, Hill AF, Lu QR, Wegner M, Srinivasan R, Svaren J, Willingham M, Barres BA, Emery B. MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol. 2013;11(8):e1001625. doi: 10.1371/journal.pbio.1001625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 300.Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH, Barres BA. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell. 2009;138(1):172–185. doi: 10.1016/j.cell.2009.04.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 301.Huang H, Zhou F, Zhou S, Qiu M. MYRF: A Mysterious Membrane-Bound Transcription Factor Involved in Myelin Development and Human Diseases. Neurosci Bull. 2021;37(6):881–884. doi: 10.1007/s12264-021-00678-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 302.Qi YB, Xu Z, Shen S, Wang Z, Wang Z. MYRF: A unique transmembrane transcription factor- from proteolytic self-processing to its multifaceted roles in animal development. Bioessays. 2024;46(4):e2300209. doi: 10.1002/bies.202300209. [DOI] [PubMed] [Google Scholar]
- 303.Zhang Y, Crouch DH, Yamamoto M, Hayes JD. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum. Biochem J. 2006;399(3):373–385. doi: 10.1042/BJ20060725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 304.Zhang Y, Hayes JD. Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endo-plasmic reticulum membrane. Biochem J. 2010;430(3):497–510. doi: 10.1042/BJ20100471. [DOI] [PubMed] [Google Scholar]
- 305.Zhang Y, Lucocq JM, Hayes JD. The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors. Biochem J. 2009;418(2):293–310. doi: 10.1042/BJ20081575. [DOI] [PubMed] [Google Scholar]
- 306.Tachida Y, Hirayama H, Suzuki T. Amino acid editing of NFE2L1 by PNGase causes abnormal mobility on SDS-PAGE. Biochim Biophys Acta Gen Subj. 2023;1867(12):130494. doi: 10.1016/j.bbagen.2023.130494. [DOI] [PubMed] [Google Scholar]
- 307.Zhang Y, Hayes JD. The membrane-topogenic vectorial behaviour of Nrf1 controls its post-translational modification and transactivation activity. Sci Rep. 2013;3:2006. doi: 10.1038/srep02006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 308.Lehrbach NJ, Breen PC, Ruvkun G. Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression. Cell. 2019;177(3):737–750. doi: 10.1016/j.cell.2019.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 309.Chen J, Liu X, Lu F, Liu X, Ru Y, Ren Y, Yao L, Zhang Y. Transcription factor Nrf1 is negatively regulated by its O-GlcNAcylation status. FEBS Lett. 2015;589(18):2347–2358. doi: 10.1016/j.febslet.2015.07.030. [DOI] [PubMed] [Google Scholar]
- 310.Sekine H, Okazaki K, Kato K, Alam MM, Shima H, Katsuoka F, Tsujita T, Suzuki N, Kobayashi A, Igarashi K, Yamamoto M, Motohashi H. O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1. Mol Cell Biol. 2018;38(17):e00252–e00218. doi: 10.1128/MCB.00252-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 311.Han JW, Valdez JL, Ho DV, Lee CS, Kim HM, Wang X, Huang L, Chan JY. Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase. Free Radic Biol Med. 2017;110:196–205. doi: 10.1016/j.freeradbiomed.2017.06.008. [DOI] [PubMed] [Google Scholar]
- 312.Zhang Y, Li S, Xiang Y, Qiu L, Zhao H, Hayes JD. The selective post-translational processing of transcription factor Nrf1 yields distinct isoforms that dic-tate its ability to differentially regulate gene expression. Sci Rep. 2015;5:12983. doi: 10.1038/srep12983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 313.Xiang Y, Wang M, Hu S, Qiu L, Yang F, Zhang Z, Yu S, Pi J, Zhang Y. Mechanisms controlling the multistage post-translational processing of endogenous Nrf1alpha/TCF11 proteins to yield distinct isoforms within the coupled positive and negative feedback circuits. Toxicol Appl Pharmacol. 2018;360:212–235. doi: 10.1016/j.taap.2018.09.036. [DOI] [PubMed] [Google Scholar]
- 314.Koizumi T, Irie T, Hirayama S, Sakurai Y, Yashiroda H, Naguro I, Ichijo H, Hamazaki J, Murata S. The aspartyl protease DDI2 activates Nrf1 to compen-sate for proteasome dysfunction. Elife . 2016;5: e18357. doi: 10.7554/eLife.18357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 315.Ruvkun G, Lehrbach N. Regulation and Functions of the ER-Associated Nrf1 Transcription Factor. Cold Spring Harb Perspect Biol. 2023;15(1):a041266. doi: 10.1101/cshperspect.a041266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 316.Chavarria C, Zaffalon L, Ribeiro ST, Op M, Quadroni M, Iatrou MS, Chapuis C, Martinon F. ER-trafficking triggers NRF1 ubiquitination to promote its proteolytic activation. iScience. 2023;26(10):107777. doi: 10.1016/j.isci.2023.107777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 317.Hu S, Xiang Y, Qiu L, Wang M, Zhang Y. Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitin-specific protease C-terminally anchored in the endoplasmic reticulum. Biochim Biophys Acta Mol Cell Res. 2022;1869(9):119299. doi: 10.1016/j.bbamcr.2022.119299. [DOI] [PubMed] [Google Scholar]
- 318.Collins GA, Sha Z, Kuo CL, Erbil B, Goldberg AL. Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation. J Biol Chem. 2022;298(5):101875. doi: 10.1016/j.jbc.2022.101875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 319.Liu K, Hu S, Qiu L, Wang M, Zhang Z, Sun G, Zhang Y. Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cells. PLoS One. 2023;18(11):e0294508. doi: 10.1371/journal.pone.0294508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 320.Ibtisam I, Kisselev AF. Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2. Elife. 2024;12:RP91678. doi: 10.7554/eLife.91678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 321.Zhang Y, Qiu L, Li S, Xiang Y, Chen J, Ren Y. The C-terminal domain of Nrf1 negatively regulates the full-length CNC-bZIP factor and its shorter isoform LCR-F1/Nrf1ß; both are also inhibited by the small dominant-negative Nrf1γ/δ isoforms that down-regulate ARE-battery gene expression. PLoS One. 2014;9(10):e109159. doi: 10.1371/journal.pone.0109159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 322.Yuan J, Wang H, Xiang Y, Hu S, Li S, Wang M, Qiu L, Zhang Y. Nrf1D Is the First Candidate Secretory Transcription Factor in the Blood Plasma, Its Precur-sor Existing as a Unique Redox-Sensitive Transmembrane CNC-bZIP Protein in Hemopoietic and Somatic Tissues. Int J Mol Sci. 2018;19(10):2940. doi: 10.3390/ijms19102940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 323.Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313–322. doi: 10.1006/bbrc.1997.6943. [DOI] [PubMed] [Google Scholar]
- 324.Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2 small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Bioph Res Co. 1997;236(2):313–322. doi: 10.1006/bbrc.1997.6943. [DOI] [PubMed] [Google Scholar]
- 325.Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN. Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 2006;66(16):8293–8296. doi: 10.1158/0008-5472.CAN-06-0300. [DOI] [PubMed] [Google Scholar]
- 326.Kwong M, Kan YW, Chan JY. The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts. J Biol Chem. 1999;274(52):37491–37498. doi: 10.1074/jbc.274.52.37491. [DOI] [PubMed] [Google Scholar]
- 327.Farmer SC, Sun CW, Winnier GE, Hogan BL, Townes TM. The bZIP transcription factor LCR-F1 is essential for mesoderm formation in mouse devel-opment. Genes Dev. 1997;11(6):786–798. doi: 10.1101/gad.11.6.786. [DOI] [PubMed] [Google Scholar]
- 328.Chan JY, Kwong M, Lu R, Chang J, Wang B, Yen TS, Kan YW. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 1998;17(6):1779–1787. doi: 10.1093/emboj/17.6.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 329.Hirotsu Y, Higashi C, Fukutomi T, Katsuoka F, Tsujita T, Yagishita Y, Matsuyama Y, Motohashi H, Uruno A, Yamamoto M. Transcription factor NF-E2-related factor 1 impairs glucose metabolism in mice. Genes Cells. 2014;19(8):650–665. doi: 10.1111/gtc.12165. [DOI] [PubMed] [Google Scholar]
- 330.Murphy P, Kolsto A. Expression of the bZIP transcription factor TCF11 and its potential dimerization partners during development. Mech Dev. 2000;97(1-2):141–148. doi: 10.1016/s0925-4773(00)00413-5. [DOI] [PubMed] [Google Scholar]
- 331.Sekine H, Motohashi H. Unique and overlapping roles of NRF2 and NRF1 in transcriptional regulation. J Clin Biochem Nutr. 2024;74(2):91–96. doi: 10.3164/jcbn.23-106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 332.Leung L, Kwong M, Hou S, Lee C, Chan JY. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem. 2003;278(48):48021–48029. doi: 10.1074/jbc.M308439200. [DOI] [PubMed] [Google Scholar]
- 333.Brouzes E, Supatto W, Farge E. Is mechano-sensitive expression of twist involved In mesoderm formation? Biol Cell. 2004;96(7):471–477. doi: 10.1016/j.biolcel.2004.04.009. [DOI] [PubMed] [Google Scholar]
- 334.Viebahn C. Epithelio-mesenchymal transformation during formation of the mesoderm in the mammalian embryo. Acta Anat. 1995;154(1):79–97. doi: 10.1159/000147753. [DOI] [PubMed] [Google Scholar]
- 335.Smith JC, Cunliffe V, Green JB, New HV. Intercellular signalling in mesoderm formation during amphibian development. Philos Trans R Soc Lond B Biol Sci . 1993;340(1293):287–296. doi: 10.1098/rstb.1993.0070. [DOI] [PubMed] [Google Scholar]
- 336.Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature. 1993;362(6422):722–728. doi: 10.1038/362722a0. [DOI] [PubMed] [Google Scholar]
- 337.Chan JY, Han XL, Kan YW. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci U S A. 1993;90(23):11371–11375. doi: 10.1073/pnas.90.23.11371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 338.Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A. 1994;91(21):9926–9930. doi: 10.1073/pnas.91.21.9926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 339.Luna L, Johnsen O, Skartlien AH, Pedeutour F, Turc-Carel C, Prydz H, Kolsto AB. Molecular cloning of a putative novel human bZIP transcription factor on chromosome 17q22. Genomics. 1994;22(3):553–562. doi: 10.1006/geno.1994.1428. [DOI] [PubMed] [Google Scholar]
- 340.Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, Deshaies RJ. Transcription factor Nrf1 mediates the proteasome recovery pathway after pro-teasome inhibition in mammalian cells. Mol Cell. 2010;38(1):17–28. doi: 10.1016/j.molcel.2010.02.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 341.Wang W, Chan JY. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J Biol Chem. 2006;281(28):19676–19687. doi: 10.1074/jbc.M602802200. [DOI] [PubMed] [Google Scholar]
- 342.Wang W, Kwok AM, Chan JY. The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol Chem. 2007;282(34):24670–24678. doi: 10.1074/jbc.M700159200. [DOI] [PubMed] [Google Scholar]
- 343.Oh DH, Rigas D, Cho A, Chan JY. Deficiency in the nuclear-related factor erythroid 2 transcription factor (Nrf1) leads to genetic instability. Febs J. 2012;279(22):4121–4130. doi: 10.1111/febs.12005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 344.Hirotsu Y, Hataya N, Katsuoka F, Yamamoto M. NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1beta genes. Mol Cell Biol. 2012;32(14):2760–2770. doi: 10.1128/MCB.06706-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 345.Lee CS, Ho DV, Chan JY. Nuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in mice. FEBS J. 2013;280(15):3609–3620. doi: 10.1111/febs.12350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 346.Tsujita T, Peirce V, Baird L, Matsuyama Y, Takaku M, Walsh SV, Griffin JL, Uruno A, Yamamoto M, Hayes JD. Transcription factor Nrf1 negatively regu-lates the cystine/glutamate transporter and lipid-metabolizing enzymes. Mol Cell Biol. 2014;34(20):3800–3816. doi: 10.1128/MCB.00110-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 347.Widenmaier SB, Snyder NA, Nguyen TB, Arduini A, Lee GY, Arruda AP, Saksi J, Bartelt A, Hotamisligil GS. NRF1 Is an ER Membrane Sensor that Is Central to Cholesterol Homeostasis. Cell. 2017;171(5):1094–1109. doi: 10.1016/j.cell.2017.10.003. [DOI] [PubMed] [Google Scholar]
- 348.Akl MG, Li L, Baccetto R, Phanse S, Zhang Q, Trites MJ, McDonald S, Aoki H, Babu M, Widenmaier SB. Complementary gene regulation by NRF1 and NRF2 protects against hepatic cholesterol overload. Cell Rep. 2023;42(4):112399. doi: 10.1016/j.celrep.2023.112399. [DOI] [PubMed] [Google Scholar]
- 349.Ioannou GN, Subramanian S, Chait A, Haigh WG, Yeh MM, Farrell GC, Lee SP, Savard C. Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH. J Lipid Res. 2017;58(6):1067–1079. doi: 10.1194/jlr.M072454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 350.Ioannou GN, Landis CS, Jin GY, Haigh WG, Farrell GC, Kuver R, Lee SP, Savard C. Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Asso-ciated With Human Nonalcoholic Steatohepatitis. Hepatol Commun. 2019;3(6):776–791. doi: 10.1002/hep4.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 351.Zhu C, Tabas I, Schwabe RF, Pajvani UB. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. Nat Rev Gas-troenterol Hepatol. 2021;18(2):131–142. doi: 10.1038/s41575-020-00365-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 352.Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B, Masia R, Chung RT, Lefkowitch JH, Schwabe RF, Tabas I. Hepatocyte TAZ/WWTR1 Pro-motes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2016;24(6):848–862. doi: 10.1016/j.cmet.2016.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 353.Trites MJ, Stebbings BM, Aoki H, Phanse S, Akl MG, Li L, Babu M, Widenmaier SB. HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2. Front Physiol. 2023;14:1212785. doi: 10.3389/fphys.2023.1212785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 354.Zhu YP, Zheng Z, Xiang Y, Zhang Y. Glucose Starvation-Induced Rapid Death of Nrf1alpha-Deficient, but Not Nrf2-Deficient, Hepatoma Cells Results from Its Fatal Defects in the Redox Metabolism Reprogramming. Oxid Med Cell Longev. 2020;2020:4959821. doi: 10.1155/2020/4959821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 355.Qiu L, Yang Q, Zhao W, Xing Y, Li P, Zhou X, Ning H, Shi R, Gou S, Chen Y, Zhai W, Wu Y, Li G, Chen Z, Ren Y, Gao Y, Zhang Y, Qi Y. Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming. Cell Death Dis. 2022;13(5):501. doi: 10.1038/s41419-022-04917-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 356.Akl MG, Baccetto R, Stebbings BM, Li L, Widenmaier SB. Euglycemia is affected by stress defense factor hepatocyte NRF1, but not NRF2. Biochem Bio-phys Res Commun. 2023;668:96–103. doi: 10.1016/j.bbrc.2023.05.082. [DOI] [PubMed] [Google Scholar]
- 357.Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Lango Allen H, Lindgren CM, Luan J, Magi R, Randall JC, Vedantam S, Winkler TW, Qi L, Workalemahu T, Heid IM, Steinthorsdottir V, Stringham HM, Weedon MN, Wheeler E, Wood AR, Ferreira T, Weyant RJ, Segre AV, Estrada K, Liang L, Nemesh J, Park JH, Gustafsson S, Kilpelainen TO. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937–948. doi: 10.1038/ng.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 358.Tanikawa J, Yasukawa T, Enari M, Ogata K, Nishimura Y, Ishii S, Sarai A. Recognition of specific DNA sequences by the c-myb protooncogene product: role of three repeat units in the DNA-binding domain. Proc Natl Acad Sci U S A. 1993;90(20):9320–9324. doi: 10.1073/pnas.90.20.9320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 359.Uruno A, Furusawa Y, Yagishita Y, Fukutomi T, Muramatsu H, Negishi T, Sugawara A, Kensler TW, Yamamoto M. The keap1-nrf2 system prevents onset of diabetes mellitus. Mol Cell Biol. 2013;33(15):2996–3010. doi: 10.1128/MCB.00225-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 360.Yagishita Y, Fukutomi T, Sugawara A, Kawamura H, Takahashi T, Pi J, Uruno A, Yamamoto M. Nrf2 protects pancreatic beta-cells from oxidative and nitrosative stress in diabetic model mice. Diabetes. 2014;63(2):605–618. doi: 10.2337/db13-0909. [DOI] [PubMed] [Google Scholar]
- 361.Zheng H, Fu J, Xue P, Zhao R, Dong J, Liu D, Yamamoto M, Tong Q, Teng W, Qu W, Zhang Q, Andersen ME, Pi J. CNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretion. Antioxid Redox Signal. 2015;22(10):819–831. doi: 10.1089/ars.2014.6017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 362.Buettner C. Is hyperinsulinemia required to develop overeating-induced obesity? Cell Metab. 2012;16(6):691–692. doi: 10.1016/j.cmet.2012.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 363.Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes. 2012;61(1):4–13. doi: 10.2337/db11-1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 364.Zhu YP, Xiang Y, L'Honore A, Montarras D, Buckingham M, Zhang Y. Commentary on Distinct, but Previously Confused, Nrf1 Transcription Factors and Their Functions in Redox Regulation. Dev Cell. 2020;53(4):377–378. doi: 10.1016/j.devcel.2020.04.022. [DOI] [PubMed] [Google Scholar]
- 365.Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi: 10.1126/science.1160809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 366.Wang Y, Patti GJ. The Warburg effect: a signature of mitochondrial overload. Trends Cell Biol. 2023;33(12):1014–1020. doi: 10.1016/j.tcb.2023.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 367.Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 2010;330(6009):1340–1344. doi: 10.1126/science.1193494. [DOI] [PubMed] [Google Scholar]
- 368.Vosselman MJ, van Marken Lichtenbelt WD, Schrauwen P. Energy dissipation in brown adipose tissue: from mice to men. Mol Cell Endocrinol. 2013;379(1-2):43–50. doi: 10.1016/j.mce.2013.04.017. [DOI] [PubMed] [Google Scholar]
- 369.Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab. 2010;11(4):253–256. doi: 10.1016/j.cmet.2010.03.004. [DOI] [PubMed] [Google Scholar]
- 370.Gunawardana SC, Piston DW. Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes. 2012;61(3):674–682. doi: 10.2337/db11-0510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 371.Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Weller H, Waurisch C, Eychmuller A, Gordts PL, Rinninger F, Brue-gelmann K, Freund B, Nielsen P, Merkel M, Heeren J. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17(2):200–205. doi: 10.1038/nm.2297. [DOI] [PubMed] [Google Scholar]
- 372.Morigny P, Boucher J, Arner P, Langin D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Rev Endo-crinol. 2021;17(5):276–295. doi: 10.1038/s41574-021-00471-8. [DOI] [PubMed] [Google Scholar]
- 373.Bartelt A, Widenmaier SB, Schlein C, Johann K, Goncalves RLS, Eguchi K, Fischer AW, Parlakgul G, Snyder NA, Nguyen TB, Bruns OT, Franke D, Bawendi MG, Lynes MD, Leiria LO, Tseng YH, Inouye KE, Arruda AP, Hotamisligil GS. Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity. Nat Med. 2018;24(3):292–303. doi: 10.1038/nm.4481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 374.Hou Y, Liu Z, Zuo Z, Gao T, Fu J, Wang H, Xu Y, Liu D, Yamamoto M, Zhu B, Zhang Y, Andersen ME, Zhang Q, Pi J. Adipocyte-specific deficiency of Nfe2l1 disrupts plasticity of white adipose tissues and metabolic homeostasis in mice. Biochem Biophys Res Commun. 2018;503(1):264–270. doi: 10.1016/j.bbrc.2018.06.013. [DOI] [PubMed] [Google Scholar]
- 375.Ren S, Bian Y, Hou Y, Wang Z, Zuo Z, Liu Z, Teng Y, Fu J, Wang H, Xu Y, Zhang Q, Chen Y, Pi J. The roles of NFE2L1 in adipocytes: Structural and mecha-nistic insight from cell and mouse models. Redox Biol. 2021;44:102015. doi: 10.1016/j.redox.2021.102015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 376.Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol. 2011;214(Pt 2):242–253. doi: 10.1242/jeb.050989. [DOI] [PubMed] [Google Scholar]
- 377.Shen W, Ren S, Hou Y, Zuo Z, Liu S, Liu Z, Fu J, Wang H, Yang B, Zhao R, Chen Y, Yamamoto M, Xu Y, Zhang Q, Pi J. Single-nucleus RNA-sequencing reveals NRF1/NFE2L1 as a key factor determining the thermogenesis and cellular heterogeneity and dynamics of brown adipose tissues in mice. Redox Biol. 2023;67:102879. doi: 10.1016/j.redox.2023.102879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 378.Xue P, Hou Y, Zuo Z, Wang Z, Ren S, Dong J, Fu J, Wang H, Andersen ME, Zhang Q, Xu Y, Pi J. Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARgamma expression. Redox Biol. 2020;30:101414. doi: 10.1016/j.redox.2019.101414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 379.Wang Z, Hou Y, Ren S, Liu Z, Zuo Z, Huang S, Wang W, Wang H, Chen Y, Xu Y, Yamamoto M, Zhang Q, Fu J, Pi J. CL316243 treatment mitigates the in-flammation in white adipose tissues of juvenile adipocyte-specific Nfe2l1 knockout mice. Free Radic Biol Med. 2021;165:289–298. doi: 10.1016/j.freeradbiomed.2021.01.043. [DOI] [PubMed] [Google Scholar]
- 380.Ren S, Hou Y, Zuo Z, Liu Z, Wang H, Xu Y, Yamamoto M, Zhang Q, Fu J, Pi J. Protracted rosiglitazone treatment exacerbates inflammation in white adipose tissues of adipocyte-specific Nfe2l1 knockout mice. Food Chem Toxicol. 2020;146:111836. doi: 10.1016/j.fct.2020.111836. [DOI] [PubMed] [Google Scholar]
- 381.Lemmer IL, Haas DT, Willemsen N, Kotschi S, Toksöz I, Gjika E, Khani S, Rohm M, Diercksen N, Nguyen PBH, Menden MP, Egu DT, Waschke J, Larsen S, Ma T, Gerhart-Hines Z, Herzig S, Dyar K, Krahmer N, Bartelt A. Nfe2l1-mediated proteasome function controls muscle energy metabolism in obesity. 2023;bioRxiv. doi: 10.1101/2023.04.20.537611. [DOI] [Google Scholar]
- 382.Cui M, Atmanli A, Morales MG, Tan W, Chen K, Xiao X, Xu L, Liu N, Bassel-Duby R, Olson EN. Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance. Nat Commun. 2021;12(1):5270. doi: 10.1038/s41467-021-25653-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 383.Tao G, Kahr PC, Morikawa Y, Zhang M, Rahmani M, Heallen TR, Li L, Sun Z, Olson EN, Amendt BA, Martin JF. Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury. Nature. 2016;534(7605):119–123. doi: 10.1038/nature17959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 384.Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res. 1994;9(6):843–854. doi: 10.1002/jbmr.5650090610. [DOI] [PubMed] [Google Scholar]
- 385.Hadzir SN, Ibrahim SN, Abdul Wahab RM, Zainol Abidin IZ, Senafi S, Ariffin ZZ, Abdul Razak M, Zainal Ariffin SH. Ascorbic acid induces osteoblast differen-tiation of human suspension mononuclear cells. Cytotherapy. 2014;16(5):674–682. doi: 10.1016/j.jcyt.2013.07.013. [DOI] [PubMed] [Google Scholar]
- 386.Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ, Mohan S. Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expres-sion via interaction with antioxidant-responsive element in bone cells. J Biol Chem. 2007;282(30):22052–22061. doi: 10.1074/jbc.M702614200. [DOI] [PubMed] [Google Scholar]
- 387.Mohan S, Kapoor A, Singgih A, Zhang Z, Taylor T, Yu H, Chadwick RB, Chung YS, Donahue LR, Rosen C, Crawford GC, Wergedal J, Baylink DJ. Spon-taneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency. J Bone Miner Res. 2005;20(9):1597–1610. doi: 10.1359/JBMR.050406. [DOI] [PubMed] [Google Scholar]
- 388.Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, Yoneda Y. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcrip-tional activation. J Biol Chem. 2006;281(26):18015–18024. doi: 10.1074/jbc.M600603200. [DOI] [PubMed] [Google Scholar]
- 389.Hinoi E, Takarada T, Fujimori S, Wang L, Iemata M, Uno K, Yoneda Y. Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis. Bone. 2007;40(2):337–344. doi: 10.1016/j.bone.2006.08.016. [DOI] [PubMed] [Google Scholar]
- 390.Lee CS, Lee C, Hu T, Nguyen JM, Zhang J, Martin MV, Vawter MP, Huang EJ, Chan JY. Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc Natl Acad Sci U S A. 2011;108(20):8408–8413. doi: 10.1073/pnas.1019209108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 391.Kim J, Xing W, Wergedal J, Chan JY, Mohan S. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice. Physiol Genomics. 2010;40(2):100–110. doi: 10.1152/physiolgenomics.00105.2009. [DOI] [PubMed] [Google Scholar]
- 392.Chevillard G, Nouhi Z, Anna D, Paquet M, Blank V. Nrf3-deficient mice are not protected against acute lung and adipose tissue damages induced by bu-tylated hydroxytoluene. FEBS Lett. 2010;584(5):923–928. doi: 10.1016/j.febslet.2010.01.028. [DOI] [PubMed] [Google Scholar]
- 393.Nouhi Z, Chevillard G, Derjuga A, Blank V. Endoplasmic reticulum association and N-linked glycosylation of the human Nrf3 transcription factor. FEBS Lett. 2007;581(28):5401–5406. doi: 10.1016/j.febslet.2007.10.041. [DOI] [PubMed] [Google Scholar]
- 394.Zhang Y, Kobayashi A, Yamamoto M, Hayes JD. The Nrf3 transcription factor is a membrane-bound glycoprotein targeted to the endoplasmic reticulum through its N-terminal homology box 1 sequence. J Biol Chem. 2009;284(5):3195–3210. doi: 10.1074/jbc.M805337200. [DOI] [PubMed] [Google Scholar]
- 395.Liu Z, Wang H, Hou Y, Yang Y, Jia J, Wu J, Zuo Z, Gao T, Ren S, Bian Y, Liu S, Fu J, Sun Y, Li J, Yamamoto M, Zhang Q, Xu Y, Pi J. CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners. Redox Biol. 2021;48:102180. doi: 10.1016/j.redox.2021.102180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 396.Narayanan K, Ramachandran A, Peterson MC, Hao J, Kolsto AB, Friedman AD, George A. The CCAAT enhancer-binding protein (C/EBP)beta and Nrf1 interact to regulate dentin sialophosphoprotein (DSPP) gene expression during odontoblast differentiation. J Biol Chem. 2004;279(44):45423–45432. doi: 10.1074/jbc.M405031200. [DOI] [PubMed] [Google Scholar]
- 397.Kobayashi A, Tsukide T, Miyasaka T, Morita T, Mizoroki T, Saito Y, Ihara Y, Takashima A, Noguchi N, Fukamizu A, Hirotsu Y, Ohtsuji M, Katsuoka F, Yamamoto M. Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells. 2011;16(6):692–703. doi: 10.1111/j.1365-2443.2011.01522.x. [DOI] [PubMed] [Google Scholar]
- 398.Taniguchi H, Okamuro S, Koji M, Waku T, Kubo K, Hatanaka A, Sun Y, Chowdhury A, Fukamizu A, Kobayashi A. Possible roles of the transcription factor Nrf1 (NFE2L1) in neural homeostasis by regulating the gene expression of deubiquitinating enzymes. Biochem Biophys Res Commun. 2017;484(1):176–183. doi: 10.1016/j.bbrc.2017.01.038. [DOI] [PubMed] [Google Scholar]
- 399.Onodera K, Shavit JA, Motohashi H, Yamamoto M, Engel JD. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. Embo J. 2000;19(6):1335–1345. doi: 10.1093/emboj/19.6.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 400.Katsuoka F, Motohashi H, Tamagawa Y, Kure S, Igarashi K, Engel JD, Yamamoto M. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol Cell Biol. 2003;23(4):1163–1174. doi: 10.1128/MCB.23.4.1163-1174.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 401.Bernal A, Arranz L. Nestin-expressing progenitor cells: function, identity and therapeutic implications. Cell Mol Life Sci. 2018;75(12):2177–2195. doi: 10.1007/s00018-018-2794-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 402.Wilson SM, Bhattacharyya B, Rachel RA, Coppola V, Tessarollo L, Householder DB, Fletcher CF, Miller RJ, Copeland NG, Jenkins NA. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat Genet. 2002;32(3):420–425. doi: 10.1038/ng1006. [DOI] [PubMed] [Google Scholar]
- 403.Han KJ, Foster DG, Zhang NY, Kanisha K, Dzieciatkowska M, Sclafani RA, Hansen KC, Peng J, Liu CW. Ubiquitin-specific protease 9x deubiquitinates and stabilizes the spinal muscular atrophy protein-survival motor neuron. J Biol Chem. 2012;287(52):43741–43752. doi: 10.1074/jbc.M112.372318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 404.Xu J, Taya S, Kaibuchi K, Arnold AP. Spatially and temporally specific expression in mouse hippocampus of Usp9x, a ubiquitin-specific protease involved in synaptic development. J Neurosci Res. 2005;80(1):47–55. doi: 10.1002/jnr.20429. [DOI] [PubMed] [Google Scholar]
- 405.Rott R, Szargel R, Haskin J, Bandopadhyay R, Lees AJ, Shani V, Engelender S. alpha-Synuclein fate is determined by USP9X-regulated monoubiquitina-tion. Proc Natl Acad Sci U S A. 2011;108(46):18666–18671. doi: 10.1073/pnas.1105725108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 406.Shivdasani RA, Orkin SH. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci U S A. 1995;92(19):8690–8694. doi: 10.1073/pnas.92.19.8690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 407.Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, Igarashi K. Hem-oprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. Embo J. 2002;21(19):5216–5224. doi: 10.1093/emboj/cdf516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 408.Kobayashi A, Ohta T, Yamamoto M. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol. 2004;378:273–286. doi: 10.1016/S0076-6879(04)78021-0. [DOI] [PubMed] [Google Scholar]
- 409.Muto A, Tashiro S, Nakajima O, Hoshino H, Takahashi S, Sakoda E, Ikebe D, Yamamoto M, Igarashi K. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature. 2004;429(6991):566–571. doi: 10.1038/nature02596. [DOI] [PubMed] [Google Scholar]
- 410.Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol Rev. 2018;98(3):1169–1203. doi: 10.1152/physrev.00023.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 411.Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Anti-oxid Redox Signal. 2010;13(11):1713–1748. doi: 10.1089/ars.2010.3221. [DOI] [PubMed] [Google Scholar]
- 412.Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell. 2018;34(1):21–43. doi: 10.1016/j.ccell.2018.03.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 413.Chen J, Wang M, Xiang Y, Ru X, Ren Y, Liu X, Qiu L, Zhang Y. Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/beta-Catenin-Dependent and Wnt/beta-Catenin-Independent Signaling Networks in the Human Liver Cancer. Oxid Med Cell Longev. 2020;2020:5138539. doi: 10.1155/2020/5138539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 414.Bu Q, Deng Y, Wang Q, Deng R, Hu S, Pei Z, Zhang Y. STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1alpha-deficient cells, but downregulated in Nrf2-deficient cells. Int J Biol Macromol. 2023;253(Pt 8):127575. doi: 10.1016/j.ijbiomac.2023.127575. [DOI] [PubMed] [Google Scholar]
- 415.Bathish B, Robertson H, Dillon JF, Dinkova-Kostova AT, Hayes JD. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activa-tion of the CNC-bZIP transcription factor Nrf2. Free Radic Biol Med. 2022;188:221–261. doi: 10.1016/j.freeradbiomed.2022.06.226. [DOI] [PubMed] [Google Scholar]
- 416.Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 2018;1865(5):721–733. doi: 10.1016/j.bbamcr.2018.02.010. [DOI] [PubMed] [Google Scholar]
- 417.Tian W, de la Vega MR, Schmidlin CJ, Ooi A, Zhang DD. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2). J Biol Chem. 2018;293(6):2029–2040. doi: 10.1074/jbc.RA117.000428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 418.Zhang S, Deng Y, Xiang Y, Hu S, Qiu L, Zhang Y. Synergism and Antagonism of Two Distinct, but Confused, Nrf1 Factors in Integral Regulation of the Nuclear-to-Mitochondrial Respiratory and Antioxidant Transcription Networks. Oxid Med Cell Longev. 2020;2020:5097109. doi: 10.1155/2020/5097109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 419.Chen F, Wang Q, Xiao M, Lou D, Wufur R, Hu S, Zhang Z, Wang Y, Zhang Y. A novel crosstalk between Nrf2 and Smad2/3 bridged by two nuanced Keap1 isoforms with their divergent effects on these distinct family transcription factors. Free Radic Biol Med. 2024;213:190–207. doi: 10.1016/j.freeradbiomed.2024.01.025. [DOI] [PubMed] [Google Scholar]
- 420.Lyu D, Wang M, Qiu L, Hu S, Zhang Y. Deletion of Nrf1 exacerbates oxidative stress-induced cellular senescence by disrupting cell homeostasis. Bio-chim Biophys Acta Mol Cell Res. 2025;1872(6):119970. doi: 10.1016/j.bbamcr.2025.119970. [DOI] [PubMed] [Google Scholar]
- 421.Jiang T, Harder B, Rojo de la Vega M, Wong PK, Chapman E, Zhang DD. p62 links autophagy and Nrf2 signaling. Free Radic Biol Med. 2015;88(Pt B):199–204. doi: 10.1016/j.freeradbiomed.2015.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 422.Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 2015;282(24):4672–4678. doi: 10.1111/febs.13540. [DOI] [PubMed] [Google Scholar]
- 423.Kageyama S, Saito T, Obata M, Koide RH, Ichimura Y, Komatsu M. Negative regulation of the Keap1-Nrf2 pathway by a p62/Sqstm1 splicing variant. Mol Cell Biol. 2018;38(7):e00642–e00617. doi: 10.1128/MCB.00642-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 424.Jain A, Rusten TE, Katheder N, Elvenes J, Bruun JA, Sjottem E, Lamark T, Johansen T. p62/Sequestosome-1, Autophagy-related Gene 8, and Autopha-gy in Drosophila Are Regulated by Nuclear Factor Erythroid 2-related Factor 2 (NRF2), Independent of Transcription Factor TFEB. J Biol Chem. 2015;290(24):14945–14962. doi: 10.1074/jbc.M115.656116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 425.Sha Z, Schnell HM, Ruoff K, Goldberg A. Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation. J Cell Biol. 2018;217(5):1757–1776. doi: 10.1083/jcb.201708168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 426.Steffen J, Seeger M, Koch A, Kruger E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell. 2010;40(1):147–158. doi: 10.1016/j.molcel.2010.09.012. [DOI] [PubMed] [Google Scholar]
- 427.Hatanaka A, Nakada S, Matsumoto G, Satoh K, Aketa I, Watanabe A, Hirakawa T, Tsujita T, Waku T, Kobayashi A. The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis. Sci Rep. 2023;13(1):14405. doi: 10.1038/s41598-023-41492-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 428.Ward MA, Vangala JR, Kamber Kaya HE, Byers HA, Hosseini N, Diaz A, Cuervo AM, Kaushik S, Radhakrishnan SK. Transcription factor Nrf1 regulates proteotoxic stress-induced autophagy. J Cell Biol. 2024;223(6):e202306150. doi: 10.1083/jcb.202306150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 429.Xie Y, Varshavsky A. RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit. Proc Natl Acad Sci U S A. 2001;98(6):3056–3061. doi: 10.1073/pnas.071022298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 430.Ju D, Wang L, Mao X, Xie Y. Homeostatic regulation of the proteasome via an Rpn4-dependent feedback circuit. Biochem Biophys Res Commun. 2004;321(1):51–57. doi: 10.1016/j.bbrc.2004.06.105. [DOI] [PubMed] [Google Scholar]
- 431.Dohmen RJ, Willers I, Marques AJ. Biting the hand that feeds: Rpn4-dependent feedback regulation of proteasome function. Biochim Biophys Acta. 2007;1773(11):1599–1604. doi: 10.1016/j.bbamcr.2007.05.015. [DOI] [PubMed] [Google Scholar]
- 432.Kahn NW, Rea SL, Moyle S, Kell A, Johnson TE. Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans. Biochem J. 2008;409(1):205–213. doi: 10.1042/BJ20070521. [DOI] [PubMed] [Google Scholar]
- 433.Pickering AM, Staab TA, Tower J, Sieburth D, Davies KJ. A conserved role for the 20S proteasome and Nrf2 transcription factor in oxidative stress adap-tation in mammals, Caenorhabditis elegans and Drosophila melanogaster. J Exp Biol. 2013;216(Pt 4):543–553. doi: 10.1242/jeb.074757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 434.Meiners S, Heyken D, Weller A, Ludwig A, Stangl K, Kloetzel PM, Kruger E. Inhibition of proteasome activity induces concerted expression of pro-teasome genes and de novo formation of Mammalian proteasomes. J Biol Chem. 2003;278(24):21517–21525. doi: 10.1074/jbc.M301032200. [DOI] [PubMed] [Google Scholar]
- 435.Radhakrishnan SK, den Besten W, Deshaies RJ. p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition. Elife. 2014;3:e01856. doi: 10.7554/eLife.01856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 436.Sha Z, Goldberg AL. Proteasome-Mediated Processing of Nrf1 Is Essential for Coordinate Induction of All Proteasome Subunits and p97. Curr Biol. 2014;24(14):1573–1583. doi: 10.1016/j.cub.2014.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 437.Keith SA, Maddux SK, Zhong Y, Chinchankar MN, Ferguson AA, Ghazi A, Fisher AL. Graded Proteasome Dysfunction in Caenorhabditis elegans Acti-vates an Adaptive Response Involving the Conserved SKN-1 and ELT-2 Transcription Factors and the Autophagy-Lysosome Pathway. PLoS Genet. 2016;12(2):e1005823. doi: 10.1371/journal.pgen.1005823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 438.Grover M, Gang SS, Troemel ER, Barkoulas M. Proteasome inhibition triggers tissue-specific immune responses against different pathogens in C. ele-gans. PLoS Biol. 2024;22(3):e3002543. doi: 10.1371/journal.pbio.3002543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 439.Wufuer R, Fan Z, Liu K, Zhang Y. Differential Yet Integral Contributions of Nrf1 and Nrf2 in the Human HepG2 Cells on Antioxidant Cytoprotective Re-sponse against Tert-Butylhydroquinone as a Pro-Oxidative Stressor. Antioxidants. 2021;10(10):1610. doi: 10.3390/antiox10101610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 440.Wufuer R, Fan Z, Yuan J, Zheng Z, Hu S, Sun G, Zhang Y. Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT). Antioxidants. 2022;11(8):1535. doi: 10.3390/antiox11081535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 441.Wufuer R, Liu K, Feng J, Wang M, Hu S, Chen F, Lin S, Zhang Y. Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells. Free Radic Biol Med. 2024;213:488–511. doi: 10.1016/j.freeradbiomed.2024.01.031. [DOI] [PubMed] [Google Scholar]
- 442.Katsuoka F, Otsuki A, Hatanaka N, Okuyama H, Yamamoto M. Target Gene Diversity of the Nrf1-MafG Transcription Factor Revealed by a Tethered Heterodimer. Mol Cell Biol. 2022;42(3):e0052021. doi: 10.1128/mcb.00520-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 443.Zucker SN, Fink EE, Bagati A, Mannava S, Bianchi-Smiraglia A, Bogner PN, Wawrzyniak JA, Foley C, Leonova KI, Grimm MJ, Moparthy K, Ionov Y, Wang J, Liu S, Sexton S, Kandel ES, Bakin AV, Zhang Y, Kaminski N, Segal BH, Nikiforov MA. Nrf2 amplifies oxidative stress via induction of Klf9. Mol Cell. 2014;53(6):916–928. doi: 10.1016/j.molcel.2014.01.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 444.Martinez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669–680. doi: 10.1038/s41568-021-00378-6. [DOI] [PubMed] [Google Scholar]
- 445.Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473. doi: 10.1126/science.aaw5473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 446.Semenza GL. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol. 2011;76:347–353. doi: 10.1101/sqb.2011.76.010678. [DOI] [PubMed] [Google Scholar]
- 447.Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010;20(1):51–56. doi: 10.1016/j.gde.2009.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 448.Kim Y, Mavodza G, Senkal CE, Burd CG. Cholesterol-dependent homeostatic regulation of very long chain sphingolipid synthesis. J Cell Biol. 2023;222(12):e202308055. doi: 10.1083/jcb.202308055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 449.Liu F, Ma M, Gao A, Ma F, Ma G, Liu P, Jia C, Wang Y, Donahue K, Zhang S, Ong IM, Keles S, Li L, Xu W. PKM2-TMEM33 axis regulates lipid homeosta-sis in cancer cells by controlling SCAP stability. EMBO J. 2021;40(22):e108065. doi: 10.15252/embj.2021108065.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 450.Zhang Y, Nicholatos J, Dreier JR, Ricoult SJ, Widenmaier SB, Hotamisligil GS, Kwiatkowski DJ, Manning BD. Coordinated regulation of protein synthe-sis and degradation by mTORC1. Nature. 2014;513(7518):440–443. doi: 10.1038/nature13492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 451.Wang G, Zhu X, Gu J, Ao P. Quantitative implementation of the endogenous molecular-cellular network hypothesis in hepatocellular carcinoma. Inter-face Focus. 2014;4(3):20130064. doi: 10.1098/rsfs.2013.0064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 452.Ibrahim L, Mesgarzadeh J, Xu I, Powers ET, Wiseman RL, Bollong MJ. Defining the Functional Targets of Cap'n'collar Transcription Factors NRF1, NRF2, and NRF3. Antioxidants. 2020;9(10):1025. doi: 10.3390/antiox9101025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 453.Chevillard G, Blank V. NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors. Cell Mol Life Sci. 2011;68(20):3337–3348. doi: 10.1007/s00018-011-0747-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 454.Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT. The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem. 2003;278(41):40296–40304. doi: 10.1074/jbc.M302560200. [DOI] [PubMed] [Google Scholar]
- 455.Law AY, Lai KP, Ip CK, Wong AS, Wagner GF, Wong CK. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp Cell Res. 2008;314(8):1823–1830. doi: 10.1016/j.yexcr.2008.03.001. [DOI] [PubMed] [Google Scholar]
- 456.Xiang Y, Wang M, Hu S, Qiu L, Yang F, Zhang Z, Yu S, Pi J, Zhang Y. Molecular mechanisms controlling the multistage post-translational processing of endogenous Nrf1α/TCF11 proteins to yield distinct proteoforms within the coupled positive and negative feedback circuits. Toxicol Appl Pharmacol. 2018;360:212–235. doi: 10.1016/j.taap.2018.09.036. [DOI] [PubMed] [Google Scholar]
- 457.Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 2003;23(20):7198–7209. doi: 10.1128/MCB.23.20.7198-7209.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 458.Cullinan SB, Diehl JA. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem. 2004;279(19):20108–20117. doi: 10.1074/jbc.M314219200. [DOI] [PubMed] [Google Scholar]
- 459.Ye J. Nrf1 to the rescue. Elife. 2014;3:e02062. doi: 10.7554/eLife.02062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 460.Tomlin FM, Gerling-Driessen UIM, Liu YC, Flynn RA, Vangala JR, Lentz CS, Clauder-Muenster S, Jakob P, Mueller WF, Ordonez-Rueda D, Paulsen M, Matsui N, Foley D, Rafalko A, Suzuki T, Bogyo M, Steinmetz LM, Radhakrishnan SK, Bertozzi CR. Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity. ACS Cent Sci. 2017;3(11):1143–1155. doi: 10.1021/acscentsci.7b00224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 461.Owings KG, Lowry JB, Bi Y, Might M, Chow CY. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches. Hum Mol Genet. 2018;27(6):1055–1066. doi: 10.1093/hmg/ddy026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 462.van Keulen BJ, Rotteveel J, Finken MJJ. Unexplained death in patients with NGLY1 mutations may be explained by adrenal insufficiency. Physiol Rep. 2019;7(3):e13979. doi: 10.14814/phy2.13979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 463.Fujihira H, Masahara-Negishi Y, Akimoto Y, Hirayama H, Lee HC, Story BA, Mueller WF, Jakob P, Clauder-Munster S, Steinmetz LM, Radhakrishnan SK, Kawa-kami H, Kamada Y, Miyoshi E, Yokomizo T, Suzuki T. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165588. doi: 10.1016/j.bbadis.2019.165588. [DOI] [PubMed] [Google Scholar]
- 464.Miao X, Wu J, Chen H, Lu G. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disor-der of Deglycosylation. Nutrients. 2022;14(9):1690. doi: 10.3390/nu14091690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 465.Yoshida Y, Asahina M, Murakami A, Kawawaki J, Yoshida M, Fujinawa R, Iwai K, Tozawa R, Matsuda N, Tanaka K, Suzuki T. Loss of peptide:N-glycanase causes proteasome dysfunction mediated by a sugar-recognizing ubiquitin ligase. Proc Natl Acad Sci U S A. 2021;118(27):e2102902118. doi: 10.1073/pnas.2102902118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 466.Rios-Flores IM, Bonal-Perez MA, Castellanos-Gonzalez A, Velez-Gomez E, Bertoli-Avella AM, Bobadilla-Morales L, Pena-Padilla C, Appendini-Andrade V, Corona-Rivera A, Romero-Valenzuela I, Corona-Rivera JR. Acute liver failure in a male patient with NGLY1-congenital disorder of deglycosylation. Eur J Med Genet. 2020;63(8):103952. doi: 10.1016/j.ejmg.2020.103952. [DOI] [PubMed] [Google Scholar]
- 467.Tong S, Ventola P, Frater CH, Klotz J, Phillips JM, Muppidi S, Dwight SS, Mueller WF, Beahm BJ, Wilsey M, Lee KJ. NGLY1 deficiency: a prospective natural history study. Hum Mol Genet. 2023;32(18):2787–2796. doi: 10.1093/hmg/ddad106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 468.Asahina M, Fujinawa R, Nakamura S, Yokoyama K, Tozawa R, Suzuki T. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological ab-normalities in their peripheral and central nervous systems. Hum Mol Genet. 2020;29(10):1635–1647. doi: 10.1093/hmg/ddaa059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 469.Rauscher B, Mueller WF, Clauder-Munster S, Jakob P, Islam MS, Sun H, Ghidelli-Disse S, Boesche M, Bantscheff M, Pflaumer H, Collier P, Haase B, Chen S, Hoffman R, Wang G, Benes V, Drewes G, Snyder M, Steinmetz LM. Patient-derived gene and protein expression signatures of NGLY1 deficiency. J Biochem. 2022;171(2):187–199. doi: 10.1093/jb/mvab131. [DOI] [PubMed] [Google Scholar]
- 470.Dirac-Svejstrup AB, Walker J, Faull P, Encheva V, Akimov V, Puglia M, Perkins D, Kumper S, Hunjan SS, Blagoev B, Snijders AP, Powell DJ, Svejstrup JQ. DDI2 Is a Ubiquitin-Directed Endoprotease Responsible for Cleavage of Transcription Factor NRF1. Mol Cell. 2020;79(2):332–341. doi: 10.1016/j.molcel.2020.05.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 471.Siva M, Svoboda M, Veverka V, Trempe JF, Hofmann K, Kozisek M, Hexnerova R, Sedlak F, Belza J, Brynda J, Sacha P, Hubalek M, Starkova J, Flaisigova I, Konvalinka J, Saskova KG. Human DNA-Damage-Inducible 2 Protein Is Structurally and Functionally Distinct from Its Yeast Ortholog. Sci Rep. 2016;6:30443. doi: 10.1038/srep30443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 472.Kottemann MC, Conti BA, Lach FP, Smogorzewska A. Removal of RTF2 from Stalled Replisomes Promotes Maintenance of Genome Integrity. Mol Cell. 2018;69(1):24–35. doi: 10.1016/j.molcel.2017.11.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 473.Siva M, Haberecht-Müller S, Prochazkova M, Prochazka J, Sedlak F, Chawengsaksophak K, Kasparek P, Sedlacek R, Konvalinka J, Krüger E, Grantz Saskova K. DDI2 protease activity controls embryonic development and inflammation via TCF11/NRF1. iScience. 2020;27(10):110893. doi: 10.1016/j.isci.2024.110893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 474.Ofoghi A, Kotschi S, Lemmer IL, Haas DT, Willemsen N, Bayer B, Möller S, Haberecht-Müller S, Krüger E, Krahmer N, Bartelt A. Activating the NFE2L1-ubiquitin-proteasome system by DDI2 protects from ferroptosis. Cell Death Differ. 2023;32(3):480–487. doi: 10.1038/s41418-024-01398-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 475.Kotschi S, Jung A, Willemsen N, Ofoghi A, Proneth B, Conrad M, Bartelt A. NFE2L1-mediated proteasome function protects from ferroptosis. Mol Metab. 2022;57:101436. doi: 10.1016/j.molmet.2022.101436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 476.Han JJW, Ho DV, Kim HM, Lee JY, Jeon YS, Chan JY. The deubiquitinating enzyme USP7 regulates the transcription factor Nrf1 by modulating its stabil-ity in response to toxic metal exposure. J Biol Chem. 2021;296:100732. doi: 10.1016/j.jbc.2021.100732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 477.Fukagai K, Waku T, Chowdhury AM, Kubo K, Matsumoto M, Kato H, Natsume T, Tsuruta F, Chiba T, Taniguchi H, Kobayashi A. USP15 stabilizes the transcription factor Nrf1 in the nucleus, promoting the proteasome gene expression. Biochem Biophys Res Commun. 2016;478(1):363–370. doi: 10.1016/j.bbrc.2016.07.045. [DOI] [PubMed] [Google Scholar]
- 478.Villeneuve NF, Tian W, Wu T, Sun Z, Lau A, Chapman E, Fang D, Zhang DD. USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1. Mol Cell. 2013;51(1):68–79. doi: 10.1016/j.molcel.2013.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 479.Tsuchiya Y, Morita T, Kim M, Iemura S, Natsume T, Yamamoto M, Kobayashi A. Dual Regulation of the Transcriptional Activity of Nrf1 by beta-TrCP- and Hrd1-Dependent Degradation Mechanisms. Mol Cell Biol. 2011;31(22):4500–4512. doi: 10.1128/MCB.05663-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 480.Carvalho P, Stanley AM, Rapoport TA. Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p. Cell. 2010;143(4):579–591. doi: 10.1016/j.cell.2010.10.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 481.Schoebel S, Mi W, Stein A, Ovchinnikov S, Pavlovicz R, DiMaio F, Baker D, Chambers MG, Su H, Li D, Rapoport TA, Liao M. Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3. Nature. 2017;548(7667):352–355. doi: 10.1038/nature23314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 482.Baldridge RD, Rapoport TA. Autoubiquitination of the Hrd1 Ligase Triggers Protein Retrotranslocation in ERAD. Cell. 2016;166(2):394–407. doi: 10.1016/j.cell.2016.05.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 483.L'Honore A, Commere PH, Ouimette JF, Montarras D, Drouin J, Buckingham M. Redox regulation by Pitx2 and Pitx3 is critical for fetal myogenesis. Dev Cell. 2014;29(4):392–405. doi: 10.1016/j.devcel.2014.04.006. [DOI] [PubMed] [Google Scholar]
- 484.Kainoh K, Takano R, Sekiya M, Saito K, Sugasawa T, Ma Y, Murayama Y, Sugano Y, Osaki Y, Iwasaki H, Takeuchi Y, Yahagi N, Suzuki H, Miyamoto T, Nak-agawa Y, Matsuzaka T, Shimano H. CtBP2 confers protection against oxidative stress through interactions with NRF1 and NRF2. Biochem Biophys Res Commun. 2021;562:146–153. doi: 10.1016/j.bbrc.2021.05.069. [DOI] [PubMed] [Google Scholar]
- 485.Byers HA, Brooks AN, Vangala JR, Grible JM, Feygin A, Clevenger CV, Harrell JC, Radhakrishnan SK. Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer. Sci Rep. 2023;13(1):15843. doi: 10.1038/s41598-023-43121-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 486.Shi C, Chen L, Pi H, Cui H, Fan C, Tan F, Qu X, Sun R, Zhao F, Song Y, Wu Y, Chen M, Ni W, Qu L, Mao R, Fan Y. Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion. Oncogenesis. 2023;12(1):56. doi: 10.1038/s41389-023-00500-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 487.Zhang M, Wang Z, Yang G, Han L, Wang X. NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma. J Bioenerg Biomembr. 2023;55(6):467–478. doi: 10.1007/s10863-023-09987-2. [DOI] [PubMed] [Google Scholar]
- 488.Qiu L, Ning H, Zhu Y, Yang Q, Liu L, Luo L, Gao Y, Xing Y. Feedback regulation of antioxidant transcription factor NFE2L1 and immunostimulatory factor 41BBL mediates the crosstalk between oxidative stress and tumor immunity. Mol Immunol. 2022;141:265–272. doi: 10.1016/j.molimm.2021.12.001. [DOI] [PubMed] [Google Scholar]
- 489.Yang K, Huang R, Fujihira H, Suzuki T, Yan N. N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1. J Exp Med. 2018;215(10):2600–2616. doi: 10.1084/jem.20180783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 490.Shanley K, Hu C, Bizzozero O. Decreased levels of constitutive proteasomes in experimental autoimmune encephalomyelitis may be caused by a combination of subunit displacement and reduced Nfe2l1 expression. J Neurochem. 2019;152(5):585–601. doi: 10.1111/jnc.14912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 491.Ao P. Metabolic network modelling: Including stochastic effects. Comput Chem Eng. 2005;29(11-12):2297–2303. doi: 10.1016/j.compchemeng.2005.05.007. [DOI] [Google Scholar]
- 492.Zheng W, Zhu XM, Chen YC, Lin PH, Ao P. Towards kinetic modeling of metabolic networks with incomplete parameters. Ieee Int C Syst Biol. 2013;97-102. doi: 10.1109/ISB.2013.6623801. [DOI] [Google Scholar]
- 493.Chen YC, Yuan RS, Ao P, Xu MJ, Zhu XM. Towards stable kinetics of large metabolic networks: Nonequilibrium potential function approach. Phys Rev E. 2016;93(6):062409. doi: 10.1103/PhysRevE.93.062409. [DOI] [PubMed] [Google Scholar]
- 494.Schluesener JK, Zhu X, Schluesener HJ, Wang GW, Ao P. Key network approach reveals new insight into Alzheimer's disease. IET Syst Biol. 2014;8(4):169–175. doi: 10.1049/iet-syb.2013.0047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 495.Ao P, Lee L-W, Lidstrom M-E, Yin L, Zhu X-M. Towards Kinetic Modeling of Global Metabolic Networks: Methylobacterium extorquens AM1 Growth as Validation. Chinese Journal of Biotechnology. 2008;24(6):980–994. doi: 10.1016/s1872-2075(08)60046-1. [DOI] [PubMed] [Google Scholar]
- 496.Schluesener JK, Zhu XM, Schluesener HJ, Wang GW, Ao P. Key network approach reveals new insight into Alzheimer's disease. Iet Syst Biol. 2014;8(4):169–175. doi: 10.1049/iet-syb.2013.0047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 497.Manoj KM. Murburn concept: a paradigm shift in cellular metabolism and physiology. Biomol Concepts. 2020;11(1):7–22. doi: 10.1515/bmc-2020-0002. [DOI] [PubMed] [Google Scholar]
- 498.Manoj KM. Murburn posttranslational modifications of proteins: Cellular redox processes and murzyme-mediated metabolo-proteomics. J Cell Physiol. 2024;239(3):e30954. doi: 10.1002/jcp.30954. [DOI] [PubMed] [Google Scholar]
- 499.Manoj KM, Jaeken L. Synthesis of theories on cellular powering, coherence, homeostasis and electro-mechanics: Murburn concept and evolutionary perspectives. J Cell Physiol. 2023;238(5):931–953. doi: 10.1002/jcp.31000. [DOI] [PubMed] [Google Scholar]
- 500.Hammond AL. Neutral currents: new hope for a unified field theory. Science. 1973;182(4110):372–374. doi: 10.1126/science.182.4110.372. [DOI] [PubMed] [Google Scholar]
- 501.Sauer T, Schutz T. Einstein's Washington Manuscript on Unified Field Theory*. Ber Wiss. 2021;44(1):94–105. doi: 10.1002/bewi.202000007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 502.Sekaran S, Bindech O, Fromager E. A unified density matrix functional construction of quantum baths in density matrix embedding theory beyond the mean-field approximation. J Chem Phys. 2023;159(3):034107. doi: 10.1063/5.0157746. [DOI] [PubMed] [Google Scholar]
- 503.Negro G, Semeraro M, Cook PR, Marenduzzo D. A unified-field theory of genome organization and gene regulation. iScience. 2024;27(12):111218. doi: 10.1016/j.isci.2024.111218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 504.Jaeken L, Manoj KM. Murburn redox bioenergetics and ROS-radiations connectivity: Insights into the origin, evolution, sustenance and termination of life! OSF. 2024;Preprints. doi: 10.31219/osf.io/ms83n. [DOI] [Google Scholar]
- 505.Crick FH. On protein synthesis. Symp Soc Exp Biol. 1958;12:138–163. [PubMed] [Google Scholar]
- 506.Quake SR. The cellular dogma. Cell. 2024;187(23):6421–6423. doi: 10.1016/j.cell.2024.10.029. [DOI] [PubMed] [Google Scholar]
- 507.Herschy B, Whicher A, Camprubi E, Watson C, Dartnell L, Ward J, Evans JR, Lane N. An origin-of-life reactor to simulate alkaline hydrothermal vents. J Mol Evol. 2014;79(5-6):213–227. doi: 10.1007/s00239-014-9658-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 508.Kitadai N. Energetics of Amino Acid Synthesis in Alkaline Hydrothermal Environments. Orig Life Evol Biosph. 2015;45(4):377–409. doi: 10.1007/s11084-015-9428-3. [DOI] [PubMed] [Google Scholar]
- 509.Mills DB, Boyle RA, Daines SJ, Sperling EA, Pisani D, Donoghue PCJ, Lenton TM. Eukaryogenesis and oxygen in Earth history. Nat Ecol Evol. 2022;6(5):520–532. doi: 10.1038/s41559-022-01733-y. [DOI] [PubMed] [Google Scholar]
- 510.Shimizu C, Ikeda K, Nakao H, Nakano M. Amphipathic peptide-phospholipid nanofibers: Kinetics of fiber formation and molecular transfer between as-semblies. Biophys Chem. 2023;296:106985. doi: 10.1016/j.bpc.2023.106985. [DOI] [PubMed] [Google Scholar]
- 511.Kornmueller K, Lehofer B, Leitinger G, Amenitsch H, Prassl R. Peptide self-assembly into lamellar phases and the formation of lipid-peptide nanostructures. Nano Res. 2018;11(2):913–928. doi: 10.1007/s12274-017-1702-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 512.Kahana A, Lancet D. Self-reproducing catalytic micelles as nanoscopic protocell precursors. Nat Rev Chem. 2021;5(12):870–878. doi: 10.1038/s41570-021-00329-7. [DOI] [PubMed] [Google Scholar]
- 513.Moreno A. The Origin of a Trans-Generational Organization in the Phenomenon of Biogenesis. Front Physiol. 2019;10:1222. doi: 10.3389/fphys.2019.01222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 514.Rhee SG, Kil IS. Mitochondrial H(2)O(2) signaling is controlled by the concerted action of peroxiredoxin III and sulfiredoxin: Linking mitochondrial func-tion to circadian rhythm. Free Radic Biol Med. 2016;100(73-80) doi: 10.1016/j.freeradbiomed.2016.10.011. [DOI] [PubMed] [Google Scholar]
- 515.Kil IS, Ryu KW, Lee SK, Kim JY, Chu SY, Kim JH, Park S, Rhee SG. Circadian Oscillation of Sulfiredoxin in the Mitochondria. Mol Cell. 2015;59(4):651–663. doi: 10.1016/j.molcel.2015.06.031. [DOI] [PubMed] [Google Scholar]
- 516.Manoj KM, Gideon DA. Structural foundations for explaining the physiological roles of murzymes embedded in diverse phospholipid membranes. Bio-chim Biophys Acta Biomembranes. 2022;1864(10):183981. doi: 10.1016/j.bbamem.2022.183981. [DOI] [PubMed] [Google Scholar]
- 517.Manoj KM, Jaeken L, Bazhin NM, Tamagawa H, Kavdia M, Manekkathodi A. Murburn concept in cellular function and bioenergetics, Part I: Understand-ing murzymes at the molecular level. AIP Advances. 2023;13(120702):1–22. doi: 10.31219/osf.io/uv6f7. [DOI] [Google Scholar]
- 518.Manoj KM, Jaeken L, Bazhin NM, Tamagawa H, Gideon DA, Kavdia M. Murburn concept in cellular function and bioenergetics, Part II: Understanding integrations-translations from molecular to macroscopic levels. AIP Advances. 2023;13(120701):1–22. doi: 10.31219/osf.io/uv6f7. [DOI] [Google Scholar]
- 519.Semin BK, Seibert M. Flash-induced blocking of the high-affinity manganese-binding site in photosystem II by iron cations: dependence on the dark inter-val between flashes and binary oscillations of fluorescence yield. J Phys Chem B. 2006;110(50):25532–25542. doi: 10.1021/jp0652796. [DOI] [PubMed] [Google Scholar]
- 520.Weise K, Triola G, Janosch S, Waldmann H, Winter R. Visualizing association of lipidated signaling proteins in heterogeneous membranes--partitioning into subdomains, lipid sorting, interfacial adsorption, and protein association. Biochim Biophys Acta. 2010;1798(7):1409–1417. doi: 10.1016/j.bbamem.2009.12.006. [DOI] [PubMed] [Google Scholar]
- 521.Liu Y, Lipowsky R, Dimova R. Giant Vesicles Encapsulating Aqueous Two-Phase Systems: From Phase Diagrams to Membrane Shape Transformations. Front Chem. 2019;7:213. doi: 10.3389/fchem.2019.00213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 522.Landino LM, Hasan R, McGaw A, Cooley S, Smith AW, Masselam K, Kim G. Peroxynitrite oxidation of tubulin sulfhydryls inhibits microtubule polymeriza-tion. Arch Biochem Biophys. 2002;398(2):213–220. doi: 10.1006/abbi.2001.2729. [DOI] [PubMed] [Google Scholar]
- 523.Landino LM, Robinson SH, Skreslet TE, Cabral DM. Redox modulation of tau and microtubule-associated protein-2 by the glutathione/glutaredoxin reductase system. Biochem Biophys Res Commun. 2004;323(1):112–117. doi: 10.1016/j.bbrc.2004.08.065. [DOI] [PubMed] [Google Scholar]
- 524.Clark HM, Hagedorn TD, Landino LM. Hypothiocyanous acid oxidation of tubulin cysteines inhibits microtubule polymerization. Arch Biochem Bio-phys. 2014;541:67–73. doi: 10.1016/j.abb.2013.10.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 525.Gao L, Zhu X, Chen G, Ma X, Zhang Y, Khand AA, Shi H, Gu F, Lin H, Chen Y, Zhang H, He L, Tao Q. A novel role for Ascl1 in the regulation of mesendo-derm formation via HDAC-dependent antagonism of VegT. Development. 2016;143(3):492–503. doi: 10.1242/dev.126292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 526.Meinhardt H. Organizer and axes formation as a self-organizing process. Int J Dev Biol. 2001;45(1):177–188. doi: 10.1387/ijdb.11291845. [DOI] [PubMed] [Google Scholar]
- 527.Xanthos JB, Kofron M, Tao Q, Schaible K, Wylie C, Heasman J. The roles of three signaling pathways in the formation and function of the Spemann Organizer. Development. 2002;129(17):4027–4043. doi: 10.1242/dev.129.17.4027. [DOI] [PubMed] [Google Scholar]
- 528.Wang M, Zhang H, Zhao X, Zhou J, Qin G, Liu Y, Kou X, Zhao Z, Wu T, Zhu JK, Feng X, Li L. SYNTAXIN OF PLANTS81 regulates root meristem activity and stem cell niche maintenance via ROS signaling. Plant Physiol. 2023;191(2):1365–1382. doi: 10.1093/plphys/kiac530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 529.Wang Z, Mao JL, Zhao YJ, Li CY, Xiang CB. L-Cysteine inhibits root elongation through auxin/PLETHORA and SCR/SHR pathway in Arabidopsis thali-ana. J Integr Plant Biol. 2015;57(2):186–197. doi: 10.1111/jipb.12213. [DOI] [PubMed] [Google Scholar]
- 530.Namani T, Ruf RJ, Arsano I, Hu R, Wesdemiotis C, Sahai N. Novel Chimeric Amino Acid-Fatty Alcohol Ester Amphiphiles Self-Assemble into Stable Primi-tive Membranes in Diverse Geological Settings. Astrobiology. 2023;23(3):327–343. doi: 10.1089/ast.2022.0056. [DOI] [PubMed] [Google Scholar]
- 531.Jia J, Arif A, Willard B, Smith JD, Stuehr DJ, Hazen SL, Fox PL. Protection of extraribosomal RPL13a by GAPDH and dysregulation by S-nitrosylation. Mol Cell. 2012;47(4):656–663. doi: 10.1016/j.molcel.2012.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 532.Van Walraven HS, Scholts MJ, Zakharov SD, Kraayenhof R, Dilley RA. pH-dependent Ca2+ binding to the F0 c-subunit affects proton translocation of the ATP synthase from Synechocystis 6803. J Bioenerg Biomembr. 2002;34(6):455–464. doi: 10.1023/a:1022518109371. [DOI] [PubMed] [Google Scholar]
- 533.Mattes A, Seitz O. Sequence fidelity of a template-directed PNA-ligation reaction. Chem Commun. 2001;20:2050–2051. doi: 10.1039/b106109g. [DOI] [PubMed] [Google Scholar]
- 534.Barluenga S, Winssinger N. PNA as a Biosupramolecular Tag for Programmable Assemblies and Reactions. Acc Chem Res. 2015;48(5):1319–1331. doi: 10.1021/acs.accounts.5b00109. [DOI] [PubMed] [Google Scholar]
- 535.Kim NH, Choi JK, Jeong BH, Kim JI, Kwon MS, Carp RI, Kim YS. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J. 2005;19(7):783–785. doi: 10.1096/fj.04-2117fje. [DOI] [PubMed] [Google Scholar]
- 536.Beierle JM, Ura Y, Ghadiri MR, Leman LJ. Templated Self-Assembly of Dynamic Peptide Nucleic Acids. Biochemistry. 2018;57(1):160–172. doi: 10.1021/acs.biochem.7b00656. [DOI] [PubMed] [Google Scholar]
- 537.Lee HH, Kim YS, Kim KH, Heo I, Kim SK, Kim O, Kim HK, Yoon JY, Kim HS, Kim DJ, Lee SJ, Yoon HJ, Kim SJ, Lee BG, Song HK, Kim VN, Park CM, Suh SW. Structural and functional insights into Dom34, a key component of no-go mRNA decay. Mol Cell. 2007;27(6):938–950. doi: 10.1016/j.molcel.2007.07.019. [DOI] [PubMed] [Google Scholar]
- 538.Torrez M, Schultehenrich M, Livesay DR. Conferring thermostability to mesophilic proteins through optimized electrostatic surfaces. Biophys J. 2003;85(5):2845–2853. doi: 10.1016/S0006-3495(03)74707-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 539.Kakuta Y, Ishimatsu I, Numata T, Kimura K, Yao M, Tanaka I, Kimura M. Crystal structure of a ribonuclease P protein Ph1601p from Pyrococcus horikoshii OT3: an archaeal homologue of human nuclear ribonuclease P protein Rpp21. Biochemistry. 2005;44(36):12086–12093. doi: 10.1021/bi050738z. [DOI] [PubMed] [Google Scholar]
- 540.Figiel M, Nowotny M. Structural Studies of RNases H2 as an Example of Crystal Structure Determination of Protein-Nucleic Acid Complexes. Methods Enzymol. 2017;592:123–143. doi: 10.1016/bs.mie.2017.03.009. [DOI] [PubMed] [Google Scholar]
- 541.Schneider C, Tollervey D. Threading the barrel of the RNA exosome. Trends Biochem Sci. 2013;38(10):485–493. doi: 10.1016/j.tibs.2013.06.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 542.Evans D, Marquez SM, Pace NR. RNase P: interface of the RNA and protein worlds. Trends Biochem Sci. 2006;31(6):333–341. doi: 10.1016/j.tibs.2006.04.007. [DOI] [PubMed] [Google Scholar]
- 543.Clark KA, Covington BC, Seyedsayamdost MR. Biosynthesis-guided discovery reveals enteropeptins as alternative sactipeptides containing N-methylornithine. Nat Chem. 2022;14(12):1390–1398. doi: 10.1038/s41557-022-01063-3. [DOI] [PubMed] [Google Scholar]
- 544.Buzas DM, Nakamura M, Kinoshita T. Epigenetic role for the conserved Fe-S cluster biogenesis protein AtDRE2 in Arabidopsis thaliana. Proc Natl Acad Sci U S A. 2014;111(37):13565–13570. doi: 10.1073/pnas.1404058111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 545.Ellaby N, Doumith M, Hopkins KL, Woodford N, Ellington MJ. Emergence of diversity in carbapenemase-producing Escherichia coli ST131, England, January 2014 to June 2016. Euro Surveill. 2019;24(37):1800627. doi: 10.2807/1560-7917.ES.2019.24.37.1800627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 546.Matsuda F, Miyagawa H, Ueno T. Involvement of reactive oxygen species in the induction of (S)-N-p-coumaroyloctopamine accumulation by beta-1,3-glucooligosaccharide elicitors in potato tuber tissues. Z Naturforsch C J Biosci. 2001;56(3-4):228–234. doi: 10.1515/znc-2001-3-410. [DOI] [PubMed] [Google Scholar]
- 547.Membrillo-Hernandez J, Coopamah MD, Anjum MF, Stevanin TM, Kelly A, Hughes MN, Poole RK. The flavohemoglobin of Escherichia coli confers resistance to a nitrosating agent, a "Nitric oxide Releaser," and paraquat and is essential for transcriptional responses to oxidative stress. J Biol Chem. 1999;274(2):748–754. doi: 10.1074/jbc.274.2.748. [DOI] [PubMed] [Google Scholar]
- 548.Nakata K, Koh MM, Tsuchido T, Matsumura Y. All genomic mutations in the antimicrobial surfactant-resistant mutant, Escherichia coli OW66, are involved in cell resistance to surfactant. Appl Microbiol Biotechnol. 2010;87(5):1895–1905. doi: 10.1007/s00253-010-2638-8. [DOI] [PubMed] [Google Scholar]
- 549.Bowler RP, Nicks M, Olsen DA, Thogersen IB, Valnickova Z, Hojrup P, Franzusoff A, Enghild JJ, Crapo JD. Furin proteolytically processes the heparin-binding region of extracellular superoxide dismutase. J Biol Chem. 2002;277(19):16505–16511. doi: 10.1074/jbc.M105409200. [DOI] [PubMed] [Google Scholar]
- 550.de Sa Junior PL, Camara DAD, Porcacchia AS, Fonseca PMM, Jorge SD, Araldi RP, Ferreira AK. The Roles of ROS in Cancer Heterogeneity and Thera-py. Oxid Med Cell Longev. 2017;2017:2467940. doi: 10.1155/2017/2467940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 551.Wang J, Sun X, Mao W, Sun W, Tang J, Sui M, Shen Y, Gu Z. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv Mater. 2013;25(27):3670–3676. doi: 10.1002/adma.201300929. [DOI] [PubMed] [Google Scholar]
- 552.Saoudi Gonzalez N, Salva F, Ros J, Baraibar I, Rodriguez-Castells M, Garcia A, Alcaraz A, Vega S, Bueno S, Tabernero J, Elez E. Unravelling the Com-plexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. Cancers. 2023;15(16):4020. doi: 10.3390/cancers15164020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 553.Sakamoto H, Attiyeh MA, Gerold JM, Makohon-Moore AP, Hayashi A, Hong J, Kappagantula R, Zhang L, Melchor JP, Reiter JG, Heyde A, Bielski CM, Penson AV, Gonen M, Chakravarty D, O'Reilly EM, Wood LD, Hruban RH, Nowak MA, Socci ND, Taylor BS, Iacobuzio-Donahue CA. The Evolutionary Origins of Recurrent Pancreatic Cancer. Cancer Discov. 2020;10(6):792–805. doi: 10.1158/2159-8290.CD-19-1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 554.Jenkinson G, Abante J, Feinberg AP, Goutsias J. An information-theoretic approach to the modeling and analysis of whole-genome bisulfite sequencing data. BMC Bioinformatics. 2018;19(1):87. doi: 10.1186/s12859-018-2086-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 555.Sun X, Wang D, Zhu J, Sun S. A novel nonparametric computational strategy for identifying differential methylation regions. BMC Bioinformatics. 2022;23(Suppl 1):29. doi: 10.1186/s12859-022-04563-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 556.Wang T, Huang Y, Yang J. Statistical Models for High-Risk Intestinal Metaplasia with DNA Methylation Profiling. Epigenomes. 2024;8(2):19. doi: 10.3390/epigenomes8020019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 557.Zhao Z, Peng T, Oh JI, Glaeser J, Weber L, Li Q, Klug G. A response regulator of the OmpR family is part of the regulatory network controlling the oxidative stress response of Rhodobacter sphaeroides. Environ Microbiol Rep. 2019;11(2):118–128. doi: 10.1111/1758-2229.12718. [DOI] [PubMed] [Google Scholar]
- 558.Kumar JK, Tabor S, Richardson CC. Proteomic analysis of thioredoxin-targeted proteins in Escherichia coli. Proc Natl Acad Sci U S A. 2004;101(11):3759–3764. doi: 10.1073/pnas.0308701101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 559.Kadowaki T, Nishiyama Y, Hisabori T, Hihara Y. Identification of OmpR-family response regulators interacting with thioredoxin in the Cyanobacterium Synechocystis sp. PCC 6803. PLoS One. 2015;10(3):e0119107. doi: 10.1371/journal.pone.0119107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 560.Yang VC, Jackson JJ, Kempes CP. Inter-city firm connections and the scaling of urban economic indicators. PNAS Nexus. 2024;3(11):pgae503. doi: 10.1093/pnasnexus/pgae503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 561.Oishi S, Cha Y, Komiya A, Ono H. Money and happiness: the income-happiness correlation is higher when income inequality is higher. PNAS Nexus. 2022;1(5):pgac224. doi: 10.1093/pnasnexus/pgac224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 562.Brown JH, Burger JR, Burnside WR, Chang M, Davidson AD, Fristoe TS, Hamilton MJ, Hammond ST, Kodric-Brown A, Mercado-Silva N, Nekola JC, Okie JG. Macroecology Meets Macroeconomics: Resource Scarcity and Global Sustainability. Ecol Eng. 2014;6:(24–(32. doi: 10.1016/j.ecoleng.2013.07.071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 563.Feiferyte-Skiriene A, Stasiskiene Z. Measuring economic crises impact transitioning to a circular economy. Environ Dev Sustain. 2023;23:1–25. doi: 10.1007/s10668-023-03367-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 564.Ahmed W, Vidal-Alaball J, Lopez Segui F, Moreno-Sanchez PA. A Social Network Analysis of Tweets Related to Masks during the COVID-19 Pandemic. Int J Environ Res Public Health. 2020;17(21):8235. doi: 10.3390/ijerph17218235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 565.Schone JP, Garcia D, Parkinson B, Goldenberg A. Negative expressions are shared more on Twitter for public figures than for ordinary users. PNAS Nexus. 2023;2(7):pgad219. doi: 10.1093/pnasnexus/pgad219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 566.Bak-Coleman JB, Kennedy I, Wack M, Beers A, Schafer JS, Spiro ES, Starbird K, West JD. Combining interventions to reduce the spread of viral misin-formation. Nat Hum Behav. 2022;6(10):1372–1380. doi: 10.1038/s41562-022-01388-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 567.Chen X, Liu X, Zhao Y, Zhou DX. Histone H3K4me3 and H3K27me3 regulatory genes control stable transmission of an epimutation in rice. Sci Rep. 2015;5:13251. doi: 10.1038/srep13251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 568.Alhabash S, McAlister AR, Hagerstrom A, Quilliam ET, Rifon NJ, Richards JI. Between likes and shares: effects of emotional appeal and virality on the persuasiveness of anticyberbullying messages on Facebook. Cyberpsychol Behav Soc Netw. 2013;16(3):175–182. doi: 10.1089/cyber.2012.0265. [DOI] [PubMed] [Google Scholar]
- 569.Nave G, Minxha J, Greenberg DM, Kosinski M, Stillwell D, Rentfrow J. Musical Preferences Predict Personality: Evidence From Active Listening and Fa-cebook Likes. Psychol Sci. 2018;29(7):1145–1158. doi: 10.1177/0956797618761659. [DOI] [PubMed] [Google Scholar]
- 570.Manoj KM, Bazhin N, Tamagawa H. The murburn precepts for cellular ionic homeostasis and electrophysiology. J Cell Physiol. 2022;237(1):804–814. doi: 10.1002/jcp.30547. [DOI] [PubMed] [Google Scholar]
- 571.Gideon DA, Nirusimhan V, Manoj KM. Are plastocyanin and ferredoxin specific electron carriers or generic redox capacitors? Classical and murburn perspectives on two photosynthetic proteins. J Biomol Struct Dyn. 2022;40(5):1995–2009. doi: 10.1080/07391102.2020.1835715. [DOI] [PubMed] [Google Scholar]
- 572.Zhang T, Ghosh A, Behringer-Pliess L, Chouhan L, Cunha AV, Havenith RWA, Butkevich E, Zhang L, Vazquez O, Debroye E, Enderlein J, Das S. Proton Tunneling Allows a Proton-Coupled Electron Transfer Process in the Cancer Cell. JACS Au. 2024;4(12):4856–4865. doi: 10.1021/jacsau.4c00815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 573.Nunn AV, Guy GW, Bell JD. The quantum mitochondrion and optimal health. Biochem Soc Trans. 2016;44(4):1101–1110. doi: 10.1042/BST20160096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 574.Zhu JW, Yuan JF, Yang HM, Wang ST, Zhang CG, Sun LL, Yang H, Zhang H. Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity. Biochimie. 2012;94(3):617–627. doi: 10.1016/j.biochi.2011.09.013. [DOI] [PubMed] [Google Scholar]
- 575.Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med. 2000;28(9):1405–1420. doi: 10.1016/s0891-5849(00)00215-x. [DOI] [PubMed] [Google Scholar]
- 576.Wani R, Nagata A, Murray BW. Protein redox chemistry: post-translational cysteine modifications that regulate signal transduction and drug pharmacolo-gy. Front Pharmacol. 2014;5:224. doi: 10.3389/fphar.2014.00224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 577.Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol. 2007;292(2):C670–C686. doi: 10.1152/ajpcell.00213.2006. [DOI] [PubMed] [Google Scholar]
- 578.Pamplona R. Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity. Biochim Biophys Acta. 2008;1777(10):1249–1262. doi: 10.1016/j.bbabio.2008.07.003. [DOI] [PubMed] [Google Scholar]
- 579.Manoj KM, Gideon DA, Bazhin NM, Tamagawa H, Nirusimhan V, Kavdia M, Jaeken L. Na,K-ATPase: A murzyme facilitating thermodynamic equilibriums at the membrane-interface. J Cell Physiol. 2023;238(1):109–136. doi: 10.1002/jcp.30925. [DOI] [PubMed] [Google Scholar]
- 580.Manoj KM, Bazhin NM, Tamagawa H, Jaeken L, Parashar A. The physiological role of complex V in ATP synthesis: Murzyme functioning is viable whereas rotary conformation change model is untenable. J Biomol Struct Dyn. 2023;41(9):3993–4012. doi: 10.1080/07391102.2022.2060307. [DOI] [PubMed] [Google Scholar]
- 581.Lutz A, Raina JB, Motti CA, Miller DJ, van Oppen MJ. Host Coenzyme Q Redox State Is an Early Biomarker of Thermal Stress in the Coral Acropora millepora. PLoS One. 2015;10(10):e0139290. doi: 10.1371/journal.pone.0139290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 582.Jiang S, Lu H, Xie Y, Zhou T, Dai Z, Sun R, He L, Li C. Toxicity of microplastics and nano-plastics to coral-symbiotic alga (Dinophyceae Symbiodinium): Evidence from alga physiology, ultrastructure, OJIP kinetics and multi-omics. Water Res. 2025;273:123002. doi: 10.1016/j.watres.2024.123002. [DOI] [PubMed] [Google Scholar]
- 583.Bancone N, Pantaleone S, Ugliengo P, Rimola A, Corno M. Exploring Forsterite Surface Catalysis in HCN Polymerization: Computational Insights for Astrobiology and Prebiotic Chemistry. ACS Earth Space Chem. 2025;9(2):303–313. doi: 10.1021/acsearthspacechem.4c00282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 584.Tosca NJ, Agee CB, Cockell CS, Glavin DP, Hutzler A, Marty B, McCubbin FM, Regberg AB, Velbel MA, Kminek G, Meyer MA, Beaty DW, Carrier BL, Haltigin T, Hays LE, Busemann H, Cavalazzi B, Debaille V, Grady MM, Hauber E, Pratt LM, Smith AL, Smith CL, Summons RE, Swindle TD, Tait KT, Udry A, Usui T, Wadhwa M, Westall F. Time-Sensitive Aspects of Mars Sample Return (MSR) Science. Astrobiology. 2022;22(S1):S81–S111. doi: 10.1089/AST.2021.0115. [DOI] [PubMed] [Google Scholar]
- 585.Smirnov AY, Mourokh LG, Nori F. Electrostatic models of electron-driven proton transfer across a lipid membrane. J Phys Condens Matter. 2011;23(23):234101. doi: 10.1088/0953-8984/23/23/234101. [DOI] [PubMed] [Google Scholar]
- 586.Kaila VR, Johansson MP, Sundholm D, Wikstrom M. Interheme electron tunneling in cytochrome c oxidase. Proc Natl Acad Sci U S A. 2010;107(50):21470–21475. doi: 10.1073/pnas.1005889107.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 587.Jiang N, Kuznetsov A, Nocek JM, Hoffman BM, Crane BR, Hu X, Beratan DN. Distance-independent charge recombination kinetics in cytochrome c-cytochrome c peroxidase complexes: compensating changes in the electronic coupling and reorganization energies. J Phys Chem B. 2013;117(31):9129–9141. doi: 10.1021/jp401551t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 588.Manoj KM, Gideon DA, Jaeken L. Interaction of membrane-embedded cytochrome b-complexes with quinols: Classical Q-cycle and murburn model. Cell Biochem Funct. 2022;40(2):118–126. doi: 10.1002/cbf.3682. [DOI] [PubMed] [Google Scholar]
- 589.Babot M, Galkin A. Molecular mechanism and physiological role of active-deactive transition of mitochondrial complex I. Biochem Soc Trans. 2013;41(5):1325–1330. doi: 10.1042/BST20130088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 590.Malagnac F, Lalucque H, Lepere G, Silar P. Two NADPH oxidase isoforms are required for sexual reproduction and ascospore germination in the fila-mentous fungus Podospora anserina. Fungal Genet Biol. 2004;41(11):982–997. doi: 10.1016/j.fgb.2004.07.008. [DOI] [PubMed] [Google Scholar]
- 591.Kassim R, Ramseyer C, Enescu M. Oxidation of zinc-thiolate complexes of biological interest by hydrogen peroxide: a theoretical study. Inorg Chem. 2011;50(12):5407–5416. doi: 10.1021/ic200267x. [DOI] [PubMed] [Google Scholar]
- 592.Manoj KM, Bazhin NM. The murburn precepts for aerobic respiration and redox homeostasis. Prog Biophys Mol Biol. 2021;167:104–120. doi: 10.1016/j.pbiomolbio.2021.05.010. [DOI] [PubMed] [Google Scholar]
- 593.Wang B, Wang W, Xu Y, Liu R, Li R, Yang P, Zhao C, Dai Z, Wang Y. Manipulating Redox Homeostasis of Cancer Stem Cells Overcome Chemotherapeu-tic Resistance through Photoactivatable Biomimetic Nanodiscs. Small. 2024;20(28):e2308539. doi: 10.1002/smll.202308539. [DOI] [PubMed] [Google Scholar]
- 594.Bataller M, Sanchez-Garcia A, Garcia-Mayea Y, Mir C, Rodriguez I, ME LL. The Role of Sphingolipids Metabolism in Cancer Drug Resistance. Front Oncol. 2021;11:807636. doi: 10.3389/fonc.2021.807636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 595.Beretti F, Gatti M, Zavatti M, Bassoli S, Pellacani G, Maraldi T. Reactive Oxygen Species Regulation of Chemoresistance and Metastatic Capacity of Mela-noma: Role of the Cancer Stem Cell Marker CD271. Biomedicines. 2023;11(4):1229. doi: 10.3390/biomedicines11041229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 596.Romashko DN, Marban E, O'Rourke B. Subcellular metabolic transients and mitochondrial redox waves in heart cells. Proc Natl Acad Sci U S A. 1998;95(4):1618–1623. doi: 10.1073/pnas.95.4.1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 597.Davidson SM, Yellon DM, Murphy MP, Duchen MR. Slow calcium waves and redox changes precede mitochondrial permeability transition pore open-ing in the intact heart during hypoxia and reoxygenation. Cardiovasc Res. 2012;93(3):445–453. doi: 10.1093/cvr/cvr349.. [DOI] [PubMed] [Google Scholar]
- 598.King SM. Axonemal Dynein Arms. Cold Spring Harb Perspect Biol. 2016;8(11):a028100. doi: 10.1101/cshperspect.a028100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 599.Michalkiewicz S. Anodic oxidation of oxidized forms of coenzymes Q(10) and Q(0) on carbon electrodes in acetic acid solutions. Bioelectrochem. 2011;82(2):103–111. doi: 10.1016/j.bioelechem.2011.06.003. [DOI] [PubMed] [Google Scholar]
- 600.Manoj KM, Gideon DA, Parashar A. What is the Role of Lipid Membrane-embedded Quinones in Mitochondria and Chloroplasts? Chemiosmotic Q-cycle versus Murburn Reaction Perspective. Cell Biochem Biophys. 2021;79(1):3–10. doi: 10.1007/s12013-020-00945-y. [DOI] [PubMed] [Google Scholar]
- 601.Yamada K, St Croix C, Stolz DB, Tyurina YY, Tyurin VA, Bradley LR, Kapralov AA, Deng Y, Zhou X, Wei Q, Liao B, Fukuda N, Sullivan M, Trudeau J, Ray A, Kagan VE, Zhao J, Wenzel SE. Compartmentalized mitochondrial ferroptosis converges with optineurin-mediated mitophagy to impact airway epithelial cell phenotypes and asthma outcomes. Nat Commun. 2024;15(1):5818. doi: 10.1038/s41467-024-50222-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 602.Megarioti AH, Esch BM, Athanasopoulos A, Koulouris D, Makridakis M, Lygirou V, Samiotaki M, Zoidakis J, Sophianopoulou V, Andre B, Frohlich F, Gournas C. Ferroptosis-protective membrane domains in quiescence. Cell Rep. 2023;42(12):113561. doi: 10.1016/j.celrep.2023.113561. [DOI] [PubMed] [Google Scholar]
- 603.Laurent M, Deschatrette J, Wolfrom CM. Unmasking chaotic attributes in time series of living cell populations. PLoS One. 2010;5(2):e9346. doi: 10.1371/journal.pone.0009346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 604.Costa AC, Ahamed T, Stephens GJ. Adaptive, locally linear models of complex dynamics. Proc Natl Acad Sci U S A. 2019;116(5):1501–1510. doi: 10.1073/pnas.1813476116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 605.Amemiya T, Shibata K, Itoh Y, Itoh K, Watanabe M, Yamaguchi T. Primordial oscillations in life: Direct observation of glycolytic oscillations in individual HeLa cervical cancer cells. Chaos. 2017;27(10):104602. doi: 10.1063/1.4986865. [DOI] [PubMed] [Google Scholar]
- 606.Manoj KM, Nirusimhan V, Parashar A, Edward J, Gideon DA. Murburn precepts for lactic-acidosis, Cori cycle, and Warburg effect: Interactive dynamics of dehydrogenases, protons, and oxygen. J Cell Physiol. 2022;237(3):1902–1922. doi: 10.1002/jcp.30661. [DOI] [PubMed] [Google Scholar]
- 607.Duan JG, Li HY, Ru Y, Liang HG, Wang JS, Li MQ, Yang FJ. [O2-* burst of tobacco leaves triggered by Erwinia carotovora subsp. carotovora inocula-tion]. Zhi wu sheng li yu fen zi sheng wu xue xue bao. 2005;31(3):322–326. [PubMed] [Google Scholar]
- 608.Liu J, Zhang W, Wang X, Ding Q, Wu C, Zhang W, Wu L, James TD, Li P, Tang B. Unveiling the Crucial Roles of O(2)(*-) and ATP in Hepatic Ischemia-Reperfusion Injury Using Dual-Color/Reversible Fluorescence Imaging. J Am Chem Soc. 2023;145(36):19662–19675. doi: 10.1021/jacs.3c04303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 609.Yu FX, Dai RP, Goh SR, Zheng L, Luo Y. Logic of a mammalian metabolic cycle: an oscillated NAD+/NADH redox signaling regulates coordinated his-tone expression and S-phase progression. Cell Cycle. 2009;8(5):773–779. doi: 10.4161/cc.8.5.7880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 610.Isobe Y, Hida H, Nishino H. Circadian rhythm of metabolic oscillation in suprachiasmatic nucleus depends on the mitochondrial oxidation state, reflected by cytochrome C oxidase and lactate dehydrogenase. J Neurosci Res. 2011;89(6):929–935. doi: 10.1002/jnr.22609. [DOI] [PubMed] [Google Scholar]
- 611.Isobe Y, Hida H, Nishino H. Circadian rhythm of enolase in suprachiasmatic nucleus depends on mitochondrial function. J Neurosci Res. 2011;89(6):936–944. doi: 10.1002/jnr.22610. [DOI] [PubMed] [Google Scholar]
- 612.Tong X, Zhang D, Arthurs B, Li P, Durudogan L, Gupta N, Yin L. Palmitate Inhibits SIRT1-Dependent BMAL1/CLOCK Interaction and Disrupts Circadian Gene Oscillations in Hepatocytes. PLoS One. 2015;10(6):e0130047. doi: 10.1371/journal.pone.0130047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 613.Zhang Y, Zheng L, Yun L, Ji L, Li G, Ji M, Shi Y, Zheng X. Catalase (CAT) Gene Family in Wheat (Triticum aestivum L. : Evolution, Expression Pattern and Function Analysis. Int J Mol Sci. 2022;23(1):542. doi: 10.3390/ijms23010542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 614.Gao S, Gold SE, Glenn AE. Characterization of two catalase-peroxidase-encoding genes in Fusarium verticillioides reveals differential responses to in vitro versus in planta oxidative challenges. Mol Plant Pathol. 2018;19(5):1127–1139. doi: 10.1111/mpp.12591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 615.Aleem M, Aleem S, Sharif I, Aleem M, Shahzad R, Khan MI, Batool A, Sarwar G, Farooq J, Iqbal A, Jan BL, Kaushik P, Feng X, Bhat JA, Ahmad P. Whole-Genome Identification of APX and CAT Gene Families in Cultivated and Wild Soybeans and Their Regulatory Function in Plant Development and Stress Response. Antioxidants. 2022;11(8):1626. doi: 10.3390/antiox11081626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 616.Berthelier TH, Cabanac SC, Callot C, Bellec A, Mathe C, Jamet E, Dunand C. Evolutionary Analysis of Six Gene Families Part of the Reactive Oxygen Species (ROS) Gene Network in Three Brassicaceae Species. Int J Mol Sci. 2024;25(3):1938. doi: 10.3390/ijms25031938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 617.Manoj KM, Gideon DA, Jaeken L. Why do cells need oxygen? Insights from mitochondrial composition and function. Cell Biol Int. 2022;46(3):344–358. doi: 10.1002/cbin.11746. [DOI] [PubMed] [Google Scholar]
- 618.Martin W, Baross J, Kelley D, Russell MJ. Hydrothermal vents and the origin of life. Nat Rev Microbiol. 2008;6(11):805–814. doi: 10.1038/nrmicro1991. [DOI] [PubMed] [Google Scholar]
- 619.Laska S, Kletzin A. Improved purification of the membrane-bound hydrogenase-sulfur-reductase complex from thermophilic archaea using epsilon-aminocaproic acid-containing chromatography buffers. J Chromatogr B Biomed Sci Appl. 2000;737(1-2):151–160. doi: 10.1016/s0378-4347(99)00362-x. [DOI] [PubMed] [Google Scholar]
- 620.Kletzin A, Urich T, Muller F, Bandeiras TM, Gomes CM. Dissimilatory oxidation and reduction of elemental sulfur in thermophilic archaea. J Bioenerg Biomembr. 2004;36(1):77–91. doi: 10.1023/b:jobb.0000019600.36757.8c. [DOI] [PubMed] [Google Scholar]
- 621.Ding S, Grossi V, Hopmans EC, Bale NJ, Cravo-Laureau C, Sinninghe Damste JS. Nitrogen and sulfur for phosphorus: Lipidome adaptation of anaero-bic sulfate-reducing bacteria in phosphorus-deprived conditions. Proc Natl Acad Sci U S A. 2024;121(24):e2400711121. doi: 10.1073/pnas.2400711121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 622.Wideman JG, Moore BP. The Evolutionary History of MAPL (Mitochondria-Associated Protein Ligase) and Other Eukaryotic BAM/GIDE Domain Proteins. PLoS One. 2015;10(6):e0128795. doi: 10.1371/journal.pone.0128795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 623.Avena P, Anselmo W, Whitaker-Menezes D, Wang C, Pestell RG, Lamb RS, Hulit J, Casaburi I, Ando S, Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Compartment-specific activation of PPARgamma governs breast cancer tumor growth, via metabolic reprogramming and symbiosis. Cell Cycle. 2013;12(9):1360–1370. doi: 10.4161/cc.24289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 624.Gibb AJ, Colquhoun D. Glutamate activation of a single NMDA receptor-channel produces a cluster of channel openings. Proc Biol Sci. 1991;243(1306):39–45. doi: 10.1098/rspb.1991.0007. [DOI] [PubMed] [Google Scholar]
- 625.Bloodgood BL, Sabatini BL. Nonlinear regulation of unitary synaptic signals by CaV(2. ) voltage-sensitive calcium channels located in dendritic spines. Neuron. 2007;53(2):249–260. doi: 10.1016/j.neuron.2006.12.017. [DOI] [PubMed] [Google Scholar]
- 626.Macedo DS, de Vasconcelos SM, dos Santos RS, Aguiar LM, Lima VT, Viana GS, de Sousa FC. Cocaine alters catalase activity in prefrontal cortex and striatum of mice. Neurosci Lett. 2005;387(1):53–56. doi: 10.1016/j.neulet.2005.07.024. [DOI] [PubMed] [Google Scholar]
- 627.Yada Y, Mita T, Sanada A, Yano R, Kanzaki R, Bakkum DJ, Hierlemann A, Takahashi H. Development of neural population activity toward self-organized criticality. Neuroscience. 2017;343:55–65. doi: 10.1016/j.neuroscience.2016.11.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 628.Mastrovito D, Liu YH, Kusmierz L, Shea-Brown E, Koch C, Mihalas S. Transition to chaos separates learning regimes and relates to measure of con-sciousness in recurrent neural networks. 2024;bioRxiv. doi: 10.1101/2024.05.15.594236. [DOI] [Google Scholar]
- 629.Parashar A, Jacob VD, Gideon DA, Manoj KM. Hemoglobin catalyzes ATP-synthesis in human erythrocytes: a murburn model. J Biomol Struct Dyn. 2022;40(19):8783–8795. doi: 10.1080/07391102.2021.1925592. [DOI] [PubMed] [Google Scholar]
- 630.Balsera M, Buchanan BB. Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress. Free Radic Biol Med. 2019;140:28–35. doi: 10.1016/j.freeradbiomed.2019.03.003. [DOI] [PubMed] [Google Scholar]
- 631.Copley SD, Novak WR, Babbitt PC. Divergence of function in the thioredoxin fold suprafamily: evidence for evolution of peroxiredoxins from a thiore-doxin-like ancestor. Biochem. 2004;43(44):13981–13995. doi: 10.1021/bi048947r. [DOI] [PubMed] [Google Scholar]
- 632.Cadenas E, Sies H. The lag phase. Free Radic Res. 1998;28(6):601–609. doi: 10.3109/10715769809065816.. [DOI] [PubMed] [Google Scholar]
- 633.Dinu MV, Spulber M, Renggli K, Wu D, Monnier CA, Petri-Fink A, Bruns N. Filling polymersomes with polymers by peroxidase-catalyzed atom transfer radical polymerization. Macromol Rapid Commun. 2015;36(6):507–514. doi: 10.1002/marc.201400642. [DOI] [PubMed] [Google Scholar]
- 634.Aicardo A, Mastrogiovanni M, Cassina A, Radi R. Propagation of free-radical reactions in concentrated protein solutions. Free Radic Res. 2018;52(2):159–170. doi: 10.1080/10715762.2017.1420905. [DOI] [PubMed] [Google Scholar]
- 635.Palatnik JF, Valle EM, Carrillo N. Oxidative stress causes ferredoxin-NADP+ reductase solubilization from the thylakoid membranes in methyl viologen-treated plants. Plant Physiol. 1997;115(4):1721–1727. doi: 10.1104/pp.115.4.1721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 636.Leibl W, Breton J, Deprez J, Trissl HW. Photoelectric study on the kinetics of trapping and charge stabilization in oriented PS II membranes. Photosynth Res. 1989;22(3):257–275. doi: 10.1007/BF00048304. [DOI] [PubMed] [Google Scholar]
- 637.Manoj KM, Bazhin NM, Jacob VD, Parashar A, Gideon DA, Manekkathodi A. Structure-function correlations and system dynamics in oxygenic photo-synthesis: classical perspectives and murburn precepts. J Biomol Struct Dyn. 2022;40(21):10997–11023. doi: 10.1080/07391102.2021.1953606. [DOI] [PubMed] [Google Scholar]
- 638.Chiang YT, Yen YW, Lo CL. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Biomaterials. 2015;61:150–161. doi: 10.1016/j.biomaterials.2015.05.007. [DOI] [PubMed] [Google Scholar]
- 639.Chen J, Qu X, Qi G, Xu W, Jin Y, Xu S. Electrostimulus-triggered reactive oxygen species level in organelles revealed by organelle-targeting SERS na-noprobes. Anal Bioanal Chem. 2022;414(23):6965–6975. doi: 10.1007/s00216-022-04265-3. [DOI] [PubMed] [Google Scholar]
- 640.Gao Q, Liu R, Wu Y, Wang F, Wu X. Versatile self-assembled near-infrared SERS nanoprobes for multidrug-resistant bacterial infection-specific surveil-lance and therapy. Acta Biomater. 2024;189:559–573. doi: 10.1016/j.actbio.2024.09.054. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



















